data_2n2j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n2j _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.849 ' HE2' ' HB3' ' A' ' 55' ' ' PHE . 12.2 ptm . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.106 0.479 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.914 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 16.7 Cg_endo -56.94 132.35 51.12 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.546 2.831 . . . . 0.0 112.616 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m -116.11 137.33 52.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.588 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.56 145.97 46.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -129.15 124.05 33.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.125 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.92 158.52 43.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.689 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 128.1 48.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' B' ' 22' ' ' VAL . 51.8 mt -122.0 140.98 51.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.616 -173.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.722 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 35.5 m80 -71.7 129.23 38.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.48 115.14 7.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.006 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.58 10.74 56.49 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.976 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.944 ' HA ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -109.4 150.94 27.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 110.732 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 m -91.56 137.86 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.104 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.34 153.0 48.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.573 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.1 m170 -96.27 117.55 31.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.265 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD11 HD12 ' A' ' 32' ' ' LEU . 8.3 tp -109.08 119.63 40.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.103 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 mt -128.07 125.85 65.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.833 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' B' ' 12' ' ' LEU . 13.0 p -112.27 134.89 53.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -146.85 170.71 16.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 p -117.03 142.29 47.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.462 0.648 . . . . 0.0 112.164 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.12 164.68 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.461 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -56.49 -30.68 63.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.398 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.04 -18.01 62.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.48 1.75 53.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.956 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 78.5 m-20 -84.79 132.19 47.02 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.246 0.546 . . . . 0.0 110.082 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 56' ' ' VAL . 11.8 Cg_exo -66.39 150.02 84.58 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 122.983 2.455 . . . . 0.0 112.482 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -132.74 139.87 47.8 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.95 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 54' ' ' ILE . 13.8 tp -124.63 134.66 52.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.935 0.397 . . . . 0.0 111.162 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.8 m -134.89 123.29 23.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.392 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 68.8 t -125.98 122.4 61.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.94 131.04 24.59 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.872 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.76 42.12 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.417 2.078 . . . . 0.0 112.099 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.8 m -67.83 -23.67 65.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.241 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB3' ' OE1' ' A' ' 41' ' ' GLN . 77.1 m-20 -131.68 103.15 14.77 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.502 172.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.77 -23.8 22.15 Favored 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.096 2.53 . . . . 0.0 113.232 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -80.07 -22.71 41.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.692 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.606 ' OE1' ' HB3' ' A' ' 38' ' ' ASN . 12.1 mp0 -73.48 -20.93 60.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.254 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.722 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 46.6 mm-40 -67.38 -32.23 73.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.641 172.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.5 -43.15 16.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.89 77.58 3.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.742 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -91.3 78.69 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.335 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.01 -5.92 58.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 p -101.82 135.89 19.64 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.851 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.43 149.56 50.54 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.341 2.028 . . . . 0.0 111.853 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.62 123.73 35.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.3 mt -96.72 124.91 48.74 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.5 136.48 13.95 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.126 1.884 . . . . 0.0 111.135 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.23 133.17 46.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -110.14 115.95 30.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.68 HG12 HG12 ' B' ' 54' ' ' ILE . 31.3 mt -106.38 121.0 58.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.0 110.509 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.849 ' HB3' ' HE2' ' A' ' 5' ' ' MET . 41.6 m-85 -106.37 137.23 44.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.622 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.914 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -85.45 135.3 25.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.185 0.517 . . . . 0.0 110.799 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.03 178.284 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.861 ' HE2' ' HB3' ' B' ' 55' ' ' PHE . 12.1 ptm . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.094 0.473 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.919 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 16.5 Cg_endo -56.9 132.34 51.05 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.59 2.86 . . . . 0.0 112.635 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -116.07 137.43 52.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.538 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -120.77 145.81 47.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.486 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -128.84 123.9 33.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.18 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.65 158.53 43.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.95 128.02 48.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.916 0.389 . . . . 0.0 110.02 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 22' ' ' VAL . 52.9 mt -121.89 140.9 51.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.734 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 35.6 m80 -71.67 129.51 38.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 115.52 8.02 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.018 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 10.57 56.7 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.963 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.917 HE21 ' HA ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -109.36 150.99 27.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 8.4 m -91.83 137.75 32.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.027 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.36 152.95 48.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.577 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.1 m170 -96.25 117.41 30.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.374 173.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.469 HD11 HD12 ' B' ' 32' ' ' LEU . 8.3 tp -108.89 119.27 39.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.53 125.85 66.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.014 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 12' ' ' LEU . 13.2 p -112.07 134.67 53.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -146.67 170.75 16.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -116.83 142.61 46.7 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.475 0.655 . . . . 0.0 112.238 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.34 164.27 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.491 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -56.11 -30.95 62.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.53 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.87 -17.97 62.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.09 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.56 1.37 53.16 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.008 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 30' ' ' PRO . 79.4 m-20 -84.53 132.06 48.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.519 . . . . 0.0 109.913 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.566 ' HG2' HG11 ' B' ' 56' ' ' VAL . 11.7 Cg_exo -66.24 149.91 85.07 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.202 2.601 . . . . 0.0 112.402 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -132.54 139.93 48.08 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.787 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.485 HD23 HD12 ' B' ' 54' ' ' ILE . 13.8 tp -124.75 134.77 52.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.106 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -135.01 123.57 23.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.4 t -126.17 122.49 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.006 0.432 . . . . 0.0 110.517 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.02 130.97 24.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.862 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.412 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.32 40.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.433 2.089 . . . . 0.0 112.194 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 69.9 m -67.31 -23.87 65.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.126 0.489 . . . . 0.0 110.209 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . 0.626 ' HB3' ' OE1' ' B' ' 41' ' ' GLN . 77.8 m-20 -131.67 103.27 14.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.418 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.05 -23.83 21.19 Favored 'Trans proline' 0 CA--C 1.526 0.078 0 C-N-CA 123.115 2.544 . . . . 0.0 113.171 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.8 -22.88 42.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.856 0.36 . . . . 0.0 110.706 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' B' ' 38' ' ' ASN . 12.5 mp0 -73.48 -20.8 60.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.734 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 49.1 mm-40 -67.55 -32.12 72.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.678 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.57 -43.21 15.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.855 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.96 77.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 11.3 p -91.35 78.63 5.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.245 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.97 -5.56 58.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 166.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.1 p -102.32 135.8 19.53 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.9 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.45 149.55 50.4 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.246 1.964 . . . . 0.0 111.913 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.49 123.54 34.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.434 ' O ' HD12 ' B' ' 52' ' ' LEU . 64.8 mt -96.6 124.86 49.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.36 136.27 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.117 1.878 . . . . 0.0 111.129 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.3 mp -129.95 133.16 46.63 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.055 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -109.78 116.03 30.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.341 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.68 HG12 HG12 ' A' ' 54' ' ' ILE . 30.8 mt -106.52 120.86 58.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.226 0.536 . . . . 0.0 110.508 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.861 ' HB3' ' HE2' ' B' ' 5' ' ' MET . 43.2 m-85 -106.25 137.13 44.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.598 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.919 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -85.53 135.17 25.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 0.0 110.607 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.757 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.034 178.152 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.1 ptp . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 86.1 Cg_exo -49.16 131.36 26.22 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 123.593 2.862 . . . . 0.0 113.14 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -117.74 138.38 52.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.69 142.34 51.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.647 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.13 125.02 40.47 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.162 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.94 158.07 44.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.02 127.59 51.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.897 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' B' ' 22' ' ' VAL . 57.7 mt -122.61 140.73 52.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.299 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.41 126.93 30.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.32 99.65 0.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.453 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -0.58 17.93 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.817 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -96.5 155.53 16.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.769 0.318 . . . . 0.0 110.645 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 6.9 m -98.19 136.9 37.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.389 0.614 . . . . 0.0 110.565 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.468 ' HB3' HG13 ' A' ' 34' ' ' VAL . 96.5 m-85 -129.3 153.22 48.04 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.411 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m80 -95.29 117.16 29.79 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.605 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.01 119.53 39.62 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.463 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.62 125.72 64.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.91 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 12' ' ' LEU . 14.8 p -112.19 132.52 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 24.2 t0 -135.91 169.87 16.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.74 0.305 . . . . 0.0 110.831 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -179.46 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -58.48 -30.87 67.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 59.3 mt -82.23 -22.23 35.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.413 . . . . 0.0 111.204 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 19.22 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.282 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.591 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 29.5 m-80 -88.33 136.99 31.06 Favored Pre-proline 0 CA--C 1.511 -0.53 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HG3' HG13 ' A' ' 56' ' ' VAL . 1.1 Cg_endo -80.47 144.27 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.858 2.372 . . . . 0.0 111.681 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.7 t -127.88 140.18 52.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 54' ' ' ILE . 14.4 tp -115.77 132.14 56.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.43 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -130.6 120.4 23.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.133 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.4 t -127.0 122.2 59.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.96 131.04 23.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.89 139.76 69.75 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.347 2.031 . . . . 0.0 111.811 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.592 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 12.7 p -67.38 -29.86 69.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.345 0.593 . . . . 0.0 110.5 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.08 102.72 4.81 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.457 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.41 -15.03 44.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.162 2.575 . . . . 0.0 112.707 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -66.19 -35.65 81.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.112 0.482 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -74.83 -22.2 58.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.043 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -70.13 -43.71 70.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.673 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.547 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.8 pt20 -78.38 -33.89 48.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.746 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 22.7 mt -102.11 56.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 p -74.79 96.76 3.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.157 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.84 -18.49 40.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.07 137.89 19.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.532 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.33 157.68 52.96 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.972 2.448 . . . . 0.0 112.843 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.8 mt -85.26 124.46 31.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.693 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.462 ' O ' HD11 ' A' ' 52' ' ' LEU . 70.6 mt -96.21 126.88 42.48 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.58 135.54 18.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.146 1.898 . . . . 0.0 111.599 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.473 ' HB2' HD11 ' A' ' 10' ' ' LEU . 4.9 mp -134.87 131.1 36.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.379 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 m -110.9 119.05 37.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.802 HG12 HG12 ' B' ' 54' ' ' ILE . 30.0 mt -107.04 125.73 63.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.939 0.4 . . . . 0.0 110.711 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -108.56 137.47 46.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.234 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 5' ' ' MET . 40.3 t -93.58 119.44 41.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.629 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.56 0 C-N-CA 118.853 -1.641 . . . . 0.0 114.275 169.79 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.552 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 13.5 ptp . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -49.39 131.13 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -117.72 138.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.284 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.38 142.32 51.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.684 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.26 125.22 40.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.912 0.387 . . . . 0.0 110.143 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.88 158.08 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.12 127.65 51.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 22' ' ' VAL . 57.5 mt -122.75 140.72 52.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.451 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.45 126.9 30.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.36 99.54 0.29 Allowed Glycine 0 C--O 1.228 -0.237 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.502 -176.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.19 0.58 18.99 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.797 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -97.2 155.66 16.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.34 . . . . 0.0 110.585 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.579 ' HB ' ' OG ' ' B' ' 37' ' ' SER . 7.1 m -98.21 136.76 37.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.461 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.474 ' HB3' HG13 ' B' ' 34' ' ' VAL . 96.4 m-85 -129.33 153.33 47.95 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.674 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.3 m80 -95.26 117.65 30.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.312 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.43 119.76 40.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.292 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.77 125.64 63.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.945 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 12' ' ' LEU . 14.8 p -112.22 132.32 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 23.4 t0 -135.87 170.23 16.32 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.87 133.51 45.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.93 -179.73 7.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.254 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -58.33 -31.02 67.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.594 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 58.2 mt -81.92 -22.5 36.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.94 0.4 . . . . 0.0 111.116 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.22 18.89 9.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.263 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 29.0 m-80 -87.8 137.29 31.85 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.494 ' HG3' HG13 ' B' ' 56' ' ' VAL . 1.1 Cg_endo -80.48 144.66 16.13 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.757 2.304 . . . . 0.0 111.614 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -128.41 140.27 51.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.494 HD22 HD13 ' B' ' 54' ' ' ILE . 14.6 tp -116.28 131.42 56.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 110.438 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 21.3 m -130.15 120.21 24.21 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.944 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.8 t -126.64 122.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.518 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 131.03 23.66 Favored Pre-proline 0 C--O 1.223 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.79 139.46 68.82 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.376 2.051 . . . . 0.0 111.769 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.579 ' OG ' ' HB ' ' B' ' 17' ' ' THR . 12.4 p -67.15 -30.08 69.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.472 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -143.87 103.05 4.87 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.84 -15.09 43.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.109 2.539 . . . . 0.0 112.632 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -66.15 -35.47 80.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.177 0.513 . . . . 0.0 109.76 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.65 -22.44 58.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.198 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -69.85 -44.05 70.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.55 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.8 pt20 -78.14 -33.59 50.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.55 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 23.3 mt -102.37 56.22 0.79 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.319 0.58 . . . . 0.0 109.582 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -74.69 96.21 2.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.392 -173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.13 -18.47 42.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.23 138.14 19.64 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.457 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.47 157.65 52.56 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.914 2.409 . . . . 0.0 112.963 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.04 124.56 31.87 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.742 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.463 ' O ' HD11 ' B' ' 52' ' ' LEU . 70.9 mt -96.27 127.0 41.92 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.49 135.62 18.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.06 1.84 . . . . 0.0 111.559 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.463 HD11 ' O ' ' B' ' 50' ' ' ILE . 4.9 mp -134.85 131.19 37.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -111.2 118.9 37.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.659 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.802 HG12 HG12 ' A' ' 54' ' ' ILE . 29.7 mt -106.93 125.73 62.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.962 0.411 . . . . 0.0 110.696 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -108.72 137.27 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.297 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.552 ' O ' ' HB2' ' B' ' 5' ' ' MET . 39.5 t -93.35 119.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.401 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.619 0 C-N-CA 118.77 -1.681 . . . . 0.0 114.37 169.56 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.2 ptp . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.034 0.445 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.84 131.66 43.27 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.977 2.451 . . . . 0.0 111.639 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -112.13 136.82 51.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -115.1 139.81 49.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.11 123.37 36.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.98 158.63 43.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.525 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 129.38 50.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.816 0.341 . . . . 0.0 110.494 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD22 ' B' ' 20' ' ' LEU . 57.7 mt -119.98 146.29 45.98 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.32 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' A' ' 45' ' ' SER . 20.0 m-70 -70.77 127.35 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.001 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.55 112.03 3.97 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.171 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.24 3.98 56.5 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.422 -0.418 . . . . 0.0 113.125 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.4 156.66 17.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.965 0.412 . . . . 0.0 110.948 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -96.39 138.53 33.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.086 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.31 154.46 46.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.716 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.5 m80 -95.84 117.67 31.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.639 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.456 HD22 HD11 ' B' ' 12' ' ' LEU . 8.4 tp -108.85 120.83 43.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.37 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 10.5 mt -129.22 126.52 64.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.914 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.29 133.76 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.28 169.77 16.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 132.79 55.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 112.369 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.5 160.08 32.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.7 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.0 t -61.03 -24.56 66.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.96 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.563 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.1 mt -83.53 -12.38 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.441 . . . . 0.0 110.41 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.29 13.63 26.18 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.861 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.563 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 55.7 m-80 -85.65 129.34 55.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.56 148.74 42.82 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.962 . . . . 0.0 111.896 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -130.4 143.25 50.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.18 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.496 HD22 HD11 ' A' ' 54' ' ' ILE . 17.9 tp -124.29 133.33 53.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.635 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 15.7 m -131.96 120.82 23.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.5 t -127.77 122.11 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.268 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -121.78 133.15 24.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.62 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.82 137.14 66.16 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.307 2.005 . . . . 0.0 111.702 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.7 t -65.9 -23.65 66.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.51 . . . . 0.0 109.87 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -143.38 107.14 5.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.346 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.64 -18.59 64.89 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.073 2.515 . . . . 0.0 113.166 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.55 -22.72 43.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.632 0.253 . . . . 0.0 110.77 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -68.37 -25.08 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.136 0.493 . . . . 0.0 110.124 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.57 -32.98 72.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.345 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -79.57 -43.02 23.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.01 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -92.64 63.87 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.548 ' HB3' ' HE1' ' A' ' 13' ' ' HIS . 5.4 p -82.77 73.02 9.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.38 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.82 2.32 53.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.15 131.0 23.12 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.042 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.23 144.61 69.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.31 2.006 . . . . 0.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -87.25 129.79 34.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 52' ' ' LEU . 68.5 mt -104.91 122.25 43.9 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 168.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.24 137.34 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.397 2.065 . . . . 0.0 111.557 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -129.21 136.6 50.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.082 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 m -111.29 116.82 31.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.844 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.778 HG12 HG12 ' B' ' 54' ' ' ILE . 38.6 mt -107.66 127.07 63.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.949 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.35 141.41 46.11 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.738 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.0 141.41 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.935 0.398 . . . . 0.0 110.021 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.012 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.033 177.864 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 17.4 ptp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.978 0.418 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.61 132.21 46.88 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.844 2.363 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -112.86 136.85 52.03 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.991 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.21 140.09 49.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.54 122.87 34.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.59 158.46 43.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.538 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.0 129.19 50.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.956 0.408 . . . . 0.0 110.585 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.456 HD11 HD22 ' A' ' 20' ' ' LEU . 57.6 mt -119.85 146.25 45.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.465 -173.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' B' ' 45' ' ' SER . 19.7 m-70 -70.92 127.54 32.93 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.89 112.11 4.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.032 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 4.32 56.46 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.01 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.75 156.35 17.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.949 0.404 . . . . 0.0 110.849 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 15.3 m -95.97 138.65 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.128 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -129.43 154.19 47.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.737 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.621 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.5 m80 -95.59 117.73 30.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.454 HD22 HD11 ' A' ' 12' ' ' LEU . 8.2 tp -108.99 120.86 43.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.344 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 10.4 mt -129.23 126.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.986 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.23 133.59 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.51 169.5 17.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.6 55.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.76 0.791 . . . . 0.0 112.526 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.97 160.23 32.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.751 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 t -61.44 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.082 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.581 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 52.1 mt -84.04 -12.43 55.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.33 13.75 25.8 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.985 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 52.9 m-80 -85.95 129.37 54.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 110.334 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.59 148.72 42.66 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.253 1.969 . . . . 0.0 111.917 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -130.59 142.96 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.244 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.493 HD22 HD11 ' B' ' 54' ' ' ILE . 18.0 tp -123.96 133.56 53.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.901 0.381 . . . . 0.0 110.497 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.5 m -132.26 120.5 22.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.942 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.9 t -127.32 122.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.63 133.21 24.18 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.766 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.11 137.6 67.57 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.149 1.9 . . . . 0.0 111.667 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -66.16 -23.46 66.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.232 0.539 . . . . 0.0 109.876 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -143.62 106.88 5.06 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.404 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.63 -18.64 65.15 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.174 2.583 . . . . 0.0 113.087 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.48 -22.6 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.704 0.287 . . . . 0.0 110.852 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.39 -25.44 65.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.23 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.45 -32.71 71.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.398 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -79.69 -43.11 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 110.042 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.8 mt -92.38 63.62 4.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.063 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' SER . . . . . 0.548 ' HB3' ' HE1' ' B' ' 13' ' ' HIS . 4.9 p -82.69 72.54 9.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.28 2.11 53.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.95 131.73 22.41 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.992 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.48 144.41 67.04 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.478 2.119 . . . . 0.0 112.142 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -87.41 129.79 34.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.419 ' O ' HD12 ' B' ' 52' ' ' LEU . 68.9 mt -104.89 122.3 43.76 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 137.32 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.461 2.107 . . . . 0.0 111.599 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.419 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -129.4 136.32 49.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -110.94 116.64 31.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.834 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.778 HG12 HG12 ' A' ' 54' ' ' ILE . 39.5 mt -107.53 127.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.209 0.528 . . . . 0.0 111.096 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -112.35 141.34 46.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.699 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.07 141.74 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.845 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.061 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.03 177.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.704 ' HE2' ' HB3' ' A' ' 55' ' ' PHE . 16.0 ptm . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.439 0.637 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.853 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 20.1 Cg_endo -59.9 140.4 92.82 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 112.353 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 m -115.75 136.46 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.168 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.69 147.0 45.09 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.97 124.03 30.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.97 158.1 44.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 49' ' ' LEU . . . -122.16 129.01 51.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.932 0.396 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.44 HD11 HD23 ' B' ' 20' ' ' LEU . 60.7 mt -118.36 141.44 48.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.585 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.528 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 29.1 m80 -71.17 127.64 33.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.196 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.63 110.43 2.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.699 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.44 -1.12 46.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.787 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -87.88 152.27 22.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.025 0.44 . . . . 0.0 110.846 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.7 m -100.25 133.08 45.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.413 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.463 ' HB3' HG13 ' A' ' 34' ' ' VAL . 88.0 m-85 -124.19 152.88 42.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.638 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m170 -95.51 117.21 29.98 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.444 HD23 HD11 ' B' ' 12' ' ' LEU . 11.8 tp -108.02 121.08 44.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.395 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -131.34 126.2 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.345 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.94 132.41 61.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.79 152.34 39.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.984 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 p -107.17 141.68 38.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -175.04 4.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.3 p -55.38 -31.65 61.98 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.3 mt -87.06 -20.71 26.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.981 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 16.87 14.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.289 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 42.0 m-80 -82.33 128.82 65.84 Favored Pre-proline 0 CA--C 1.511 -0.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.532 ' CG ' HG22 ' A' ' 56' ' ' VAL . 56.6 Cg_endo -73.02 143.13 35.74 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.44 2.093 . . . . 0.0 112.182 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -127.72 147.39 50.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 HD13 ' A' ' 54' ' ' ILE . 14.5 tp -119.35 129.82 55.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.899 0.381 . . . . 0.0 110.844 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -127.06 119.59 26.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.755 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.0 t -125.62 122.47 62.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.057 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.18 131.19 24.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 148.51 81.01 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.78 2.32 . . . . 0.0 112.205 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 p -68.88 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.353 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -132.99 104.41 12.7 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.526 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.08 74.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.842 2.361 . . . . 0.0 112.238 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -82.6 -24.46 33.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.729 ' HA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.34 -24.72 61.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.118 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.528 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 49.3 mm-40 -65.76 -31.73 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.129 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.97 -43.1 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.4 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 58.94 5.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.81 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -77.48 76.43 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.395 0.617 . . . . 0.0 112.02 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.11 -15.58 61.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.079 0.942 . . . . 0.0 108.498 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -101.89 145.12 29.92 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.951 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.52 159.73 32.13 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 111.765 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 60.4 mt -94.55 131.59 40.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.137 0.494 . . . . 0.0 111.013 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 52' ' ' LEU . 69.8 mt -99.54 124.05 45.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 57.8 Cg_endo -74.7 137.47 22.5 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.194 1.929 . . . . 0.0 111.391 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.449 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -133.48 131.9 40.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 m -109.64 117.5 34.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.493 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.607 HG12 HG12 ' B' ' 54' ' ' ILE . 24.5 mt -107.03 123.33 62.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.341 0.591 . . . . 0.0 110.686 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.704 ' HB3' ' HE2' ' A' ' 5' ' ' MET . 58.0 m-85 -106.67 137.88 43.87 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.663 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.853 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.7 t -83.66 133.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.452 . . . . 0.0 109.881 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.572 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.901 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.644 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.688 ' HE2' ' HB3' ' B' ' 55' ' ' PHE . 15.7 ptm . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.862 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 19.9 Cg_endo -59.72 140.67 94.57 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.378 2.719 . . . . 0.0 112.247 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.08 136.03 53.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.234 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.32 147.13 44.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.06 124.09 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.78 158.27 44.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.555 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . . . -122.41 128.82 51.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.444 HD11 HD23 ' A' ' 20' ' ' LEU . 60.8 mt -118.43 141.46 48.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.674 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 29.4 m80 -71.07 127.39 32.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.78 110.94 3.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.544 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.96 -2.59 44.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.715 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -86.96 152.37 22.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.93 0.395 . . . . 0.0 110.925 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -100.59 132.98 45.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.463 175.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.479 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.5 m-85 -123.84 152.85 41.84 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.152 0.501 . . . . 0.0 110.644 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.4 m170 -95.66 117.12 29.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.44 HD23 HD11 ' A' ' 12' ' ' LEU . 11.6 tp -108.13 121.1 44.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.14 126.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.316 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 p -112.62 132.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.51 152.27 39.49 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -107.18 141.85 37.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -175.21 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.34 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 48.4 p -55.31 -31.74 61.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.527 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 54.8 mt -86.71 -21.27 26.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 16.8 14.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.273 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.6 m-80 -82.41 128.98 65.01 Favored Pre-proline 0 CA--C 1.51 -0.569 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.535 ' CG ' HG22 ' B' ' 56' ' ' VAL . 56.9 Cg_endo -73.21 143.37 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.292 1.995 . . . . 0.0 112.221 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -127.69 147.29 50.38 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.43 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.514 HD22 HD13 ' B' ' 54' ' ' ILE . 14.4 tp -119.2 130.03 55.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.855 0.36 . . . . 0.0 110.753 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -127.37 119.63 26.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.843 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.1 t -125.78 122.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.034 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.26 131.01 24.34 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.682 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.15 148.76 81.48 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.76 2.307 . . . . 0.0 112.335 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.5 p -69.4 -27.16 65.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.321 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -133.64 104.32 12.03 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.491 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.57 74.13 Favored 'Trans proline' 0 C--N 1.34 0.101 0 C-N-CA 122.748 2.299 . . . . 0.0 112.122 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.92 -24.61 35.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.716 ' HA ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -72.08 -24.72 61.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.146 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.514 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 50.0 mm-40 -65.85 -32.06 73.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.903 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.44 -43.06 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.538 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.8 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.3 p -77.56 76.32 4.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.326 0.584 . . . . 0.0 111.989 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.78 -15.92 61.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -101.62 145.06 29.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.855 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.42 159.66 32.52 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.611 2.207 . . . . 0.0 111.653 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' B' ' 11' ' ' ALA . 61.3 mt -94.15 131.53 39.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.004 0.43 . . . . 0.0 111.134 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.427 ' O ' HD13 ' B' ' 52' ' ' LEU . 69.2 mt -99.49 124.11 45.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 168.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.572 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 57.4 Cg_endo -74.79 137.46 22.25 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.237 1.958 . . . . 0.0 111.406 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.458 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.4 mp -133.38 132.22 40.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.907 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -109.91 117.42 33.76 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 54' ' ' ILE . 24.3 mt -106.9 123.37 61.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.18 0.514 . . . . 0.0 110.702 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.688 ' HB3' ' HE2' ' B' ' 5' ' ' MET . 56.6 m-85 -106.69 137.95 43.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.553 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.862 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.7 t -83.55 133.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.562 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.93 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.606 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.83 ' HE2' ' HB3' ' A' ' 55' ' ' PHE . 16.9 ptm . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.296 0.569 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.705 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 32.7 Cg_endo -64.69 134.76 42.17 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.356 2.704 . . . . 0.0 112.251 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m -116.63 134.72 54.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.232 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -115.3 140.42 49.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.905 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -125.61 123.71 39.61 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.496 HD21 HG21 ' A' ' 34' ' ' VAL . 1.7 pp -141.11 158.15 44.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.688 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -121.74 128.6 51.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 110.44 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.428 HD13 HD23 ' B' ' 20' ' ' LEU . 58.0 mt -120.62 141.23 50.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.536 -174.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 36.5 m80 -70.91 132.96 46.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.378 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.71 110.93 3.31 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.737 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.9 58.24 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.552 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -89.56 144.17 26.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 37' ' ' SER . 12.2 m -93.74 137.32 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.017 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.448 ' HB3' HG12 ' A' ' 34' ' ' VAL . 85.9 m-85 -129.75 154.64 46.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 0.0 110.802 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.674 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 3.1 m170 -95.26 117.41 30.23 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.071 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 32' ' ' LEU . 11.8 tp -108.74 121.4 44.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.173 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 11.2 mt -131.3 126.59 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -116.07 133.56 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -142.99 170.02 16.48 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -124.18 141.53 51.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.7 0.286 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -176.13 6.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.721 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -65.88 -30.43 71.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.057 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.459 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 61.1 mt -76.28 -23.97 54.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 0.0 111.305 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.41 20.42 9.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.436 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 40.2 m-80 -94.73 135.95 23.43 Favored Pre-proline 0 CA--C 1.509 -0.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' CB ' HG21 ' A' ' 56' ' ' VAL . 72.2 Cg_endo -76.27 147.67 29.63 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.542 2.161 . . . . 0.0 112.09 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -126.52 140.04 52.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 20' ' ' LEU . 10.9 tp -122.44 122.32 38.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.037 0.446 . . . . 0.0 110.507 -175.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 16.7 m -116.86 119.18 34.59 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.913 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 77.8 t -123.86 122.17 63.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.9 131.27 23.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.482 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.1 Cg_endo -61.22 133.51 47.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.168 1.912 . . . . 0.0 111.922 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.457 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 8.7 t -70.62 -37.07 73.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -107.81 101.18 39.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.65 -29.4 29.82 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.522 2.148 . . . . 0.0 111.926 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.6 -23.42 56.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.781 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.27 -28.63 66.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 15.2 mm-40 -69.67 -21.75 63.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -87.55 -42.25 12.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.987 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.0 43.49 1.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.697 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -74.4 87.42 2.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.37 0.605 . . . . 0.0 112.16 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -92.61 -1.62 56.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.81 142.39 24.5 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.48 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.12 152.3 50.67 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.464 2.109 . . . . 0.0 112.158 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.455 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 29.9 mt -92.49 120.63 33.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.713 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 52' ' ' LEU . 78.2 mt -93.06 123.62 60.52 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.01 136.37 16.38 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.269 1.979 . . . . 0.0 111.521 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 50' ' ' ILE . 5.3 mp -129.32 133.55 47.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.989 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -109.42 115.67 30.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.74 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' B' ' 54' ' ' ILE . 28.5 mt -107.6 125.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.187 0.518 . . . . 0.0 110.715 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.83 ' HB3' ' HE2' ' A' ' 5' ' ' MET . 72.8 m-85 -108.64 132.84 53.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -84.85 136.91 21.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.071 0.462 . . . . 0.0 110.661 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.81 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.889 176.761 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.806 ' HE2' ' HB3' ' B' ' 55' ' ' PHE . 17.0 ptm . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.7 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 34.4 Cg_endo -64.54 134.43 41.25 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.241 2.628 . . . . 0.0 112.256 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.44 134.92 54.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -115.39 140.56 49.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.926 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.406 ' HH ' ' HB2' ' B' ' 51' ' ' PRO . 8.7 t80 -125.98 123.68 39.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.49 HD21 HG21 ' B' ' 34' ' ' VAL . 1.7 pp -141.21 158.35 44.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.729 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.1 128.33 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.861 0.362 . . . . 0.0 110.534 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.434 HD13 HD23 ' A' ' 20' ' ' LEU . 58.1 mt -120.38 141.22 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.585 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 36.4 m80 -70.68 132.64 45.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.422 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.16 110.71 3.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.686 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.07 -0.43 58.89 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.522 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -89.68 144.22 26.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' B' ' 37' ' ' SER . 14.3 m -93.8 137.12 33.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.996 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.434 ' HB3' HG12 ' B' ' 34' ' ' VAL . 85.5 m-85 -129.67 154.46 47.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.235 0.541 . . . . 0.0 110.572 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.667 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 3.1 m170 -95.09 117.27 29.91 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.118 172.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.532 HD13 HD13 ' B' ' 32' ' ' LEU . 11.6 tp -108.54 121.36 44.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.251 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 11.3 mt -131.39 126.29 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.86 133.56 61.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -143.0 170.19 16.16 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.855 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.6 p -124.16 141.63 51.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.661 0.267 . . . . 0.0 110.948 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -175.57 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t -66.54 -30.56 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.943 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 64.6 mt -76.11 -23.66 54.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.607 0.242 . . . . 0.0 111.162 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 20.27 9.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.278 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.2 m-80 -94.68 135.75 23.65 Favored Pre-proline 0 CA--C 1.511 -0.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.515 ' CB ' HG21 ' B' ' 56' ' ' VAL . 71.7 Cg_endo -75.98 147.87 30.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.472 2.114 . . . . 0.0 112.178 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -126.81 139.91 52.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.532 HD13 HD13 ' B' ' 20' ' ' LEU . 11.1 tp -122.44 122.12 38.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.208 0.527 . . . . 0.0 110.609 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.9 m -116.42 119.26 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.904 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 78.1 t -124.14 121.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 110.234 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.83 131.1 23.74 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.377 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.473 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.4 Cg_endo -61.38 133.27 45.22 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.229 1.953 . . . . 0.0 112.007 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.445 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 8.7 t -70.13 -37.01 75.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -107.98 101.34 40.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.84 -29.1 29.08 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.447 2.098 . . . . 0.0 112.121 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.73 -23.43 56.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.841 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.398 0.618 . . . . 0.0 110.182 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 15.9 mm-40 -69.76 -21.71 63.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.148 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -87.63 -42.41 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.003 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 16.1 mt -87.56 43.1 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.823 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -74.13 87.84 1.92 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.461 0.648 . . . . 0.0 112.072 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.26 -1.46 56.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.74 142.36 24.44 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.663 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 152.24 51.11 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.509 2.139 . . . . 0.0 112.135 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.457 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 30.7 mt -92.47 120.82 33.33 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.761 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.448 ' O ' HD11 ' B' ' 52' ' ' LEU . 78.0 mt -93.15 123.86 59.66 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.406 ' HB2' ' HH ' ' B' ' 9' ' ' TYR . 75.7 Cg_endo -77.21 136.13 15.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.289 1.993 . . . . 0.0 111.651 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.448 HD11 ' O ' ' B' ' 50' ' ' ILE . 5.3 mp -129.14 133.28 47.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.959 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -109.25 115.76 30.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.678 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' A' ' 54' ' ' ILE . 27.4 mt -107.74 125.05 64.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.767 -176.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.806 ' HB3' ' HE2' ' B' ' 5' ' ' MET . 72.3 m-85 -108.45 132.8 53.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.7 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -84.82 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.846 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.927 176.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 21.3 ptp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.692 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 21.7 Cg_endo -60.27 132.01 41.71 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.052 2.501 . . . . 0.0 111.809 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -114.24 141.28 47.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.673 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -121.69 148.81 44.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.697 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.43 125.03 26.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 52' ' ' LEU . 1.4 pp -141.17 158.07 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.166 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.29 127.36 53.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.02 140.14 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.567 -175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 16' ' ' GLN . 34.7 m80 -71.71 133.06 45.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.302 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.74 110.93 3.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.848 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.83 47.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.931 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 13' ' ' HIS . 16.4 mm100 -95.46 143.4 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.911 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -87.97 136.25 33.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.07 153.91 47.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.9 m80 -95.74 117.64 30.9 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.602 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 32' ' ' LEU . 9.1 tp -108.39 120.84 43.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.317 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.13 125.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.79 133.65 63.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.08 170.1 16.37 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p -123.56 136.63 54.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.37 168.7 19.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.765 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 p -54.77 -30.65 57.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.3 mt -73.89 -13.6 60.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.233 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.6 1.07 62.25 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.577 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -75.78 133.58 73.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' ' 56' ' ' VAL . 91.7 Cg_endo -80.15 152.77 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 112.322 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -133.97 140.2 46.58 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 54' ' ' ILE . 13.4 tp -124.78 125.84 44.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -173.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.13 120.62 32.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.03 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.9 t -125.49 122.51 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.17 129.07 24.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.68 136.27 57.19 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.539 2.159 . . . . 0.0 112.332 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 73.1 m -70.48 -25.56 63.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -134.69 103.6 11.05 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.72 -21.16 29.41 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -75.93 -35.73 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.469 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 110.331 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' CD ' ' HD1' ' A' ' 13' ' ' HIS . 27.3 mm-40 -69.97 -41.55 74.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.57 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -73.55 -42.94 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.272 0.558 . . . . 0.0 109.943 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 mt -99.9 71.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 13' ' ' HIS . 1.1 m -67.94 -66.24 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.222 -167.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 44.72 25.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.783 0.801 . . . . 0.0 111.729 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -136.73 138.48 26.41 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.909 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.64 143.6 62.88 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.181 1.92 . . . . 0.0 111.822 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.11 119.46 30.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.071 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.1 mt -87.28 125.71 64.93 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 43.5 Cg_endo -73.84 136.68 23.37 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.826 1.684 . . . . 0.0 110.558 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.511 ' HB2' HD13 ' A' ' 10' ' ' LEU . 4.8 mp -134.39 131.78 38.63 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -111.32 117.65 33.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.797 HG12 HG12 ' B' ' 54' ' ' ILE . 24.9 mt -107.24 123.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.185 0.517 . . . . 0.0 110.764 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 70.4 m-85 -107.68 138.42 43.94 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.015 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.692 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.6 t -84.09 130.42 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.167 0.508 . . . . 0.0 109.951 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.606 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.433 -1.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.806 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.542 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 21.2 ptp . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.691 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 22.3 Cg_endo -60.01 131.93 41.97 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.414 . . . . 0.0 111.761 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -114.36 141.88 47.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.555 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.98 148.9 44.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.74 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.48 125.07 26.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.11 158.06 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.22 127.4 53.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.0 140.14 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.436 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.46 ' HB2' ' HG3' ' B' ' 16' ' ' GLN . 34.5 m80 -71.79 133.07 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.297 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.49 110.88 3.41 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.858 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.58 -0.49 49.43 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.329 -0.463 . . . . 0.0 113.077 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.46 ' HG3' ' HB2' ' B' ' 13' ' ' HIS . 16.6 mm100 -95.58 143.42 26.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 111.006 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 4.1 m -87.82 136.33 33.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.516 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -128.92 153.93 47.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.592 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.9 m80 -95.76 117.78 31.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.47 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.452 HD12 HD12 ' B' ' 32' ' ' LEU . 9.0 tp -108.5 120.8 43.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.417 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.09 125.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.18 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.75 133.67 63.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -140.96 169.91 16.74 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.451 HG23 HD13 ' A' ' 50' ' ' ILE . 1.3 p -122.93 137.03 55.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.21 0.528 . . . . 0.0 111.46 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.67 168.85 18.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.804 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -54.81 -30.89 58.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -73.51 -14.3 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.113 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.88 1.32 61.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.547 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.405 HD21 ' N ' ' B' ' 29' ' ' ASN . 0.9 OUTLIER -76.15 133.15 72.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.435 ' HG3' HG21 ' B' ' 56' ' ' VAL . 93.0 Cg_endo -79.91 152.79 22.16 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.793 2.329 . . . . 0.0 112.284 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -134.06 140.32 46.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.498 HD21 HD13 ' B' ' 54' ' ' ILE . 13.5 tp -125.09 125.89 44.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 -173.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -124.17 120.46 32.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.3 t -125.38 122.36 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.08 128.69 24.1 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.404 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.69 135.67 53.81 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.55 2.166 . . . . 0.0 112.398 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 72.5 m -70.31 -25.23 63.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -134.78 103.72 10.94 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.09 -20.62 28.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.726 2.284 . . . . 0.0 112.843 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -76.25 -35.88 58.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.4 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.42 -23.01 60.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.094 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.402 ' CD ' ' HD1' ' B' ' 13' ' ' HIS . 27.6 mm-40 -70.05 -41.16 74.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.607 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.06 -42.88 59.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.142 0.496 . . . . 0.0 109.967 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.77 70.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' SER . . . . . 0.407 ' HB3' ' NE2' ' B' ' 13' ' ' HIS . 1.1 m -67.71 -66.49 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.155 -167.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.97 25.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.824 0.821 . . . . 0.0 111.48 -171.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -136.71 138.51 26.52 Favored Pre-proline 0 N--CA 1.442 -0.855 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.97 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.77 143.66 62.35 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 23.0 mt -89.95 119.79 30.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.971 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.471 ' O ' HD12 ' B' ' 52' ' ' LEU . 67.0 mt -87.55 125.67 64.53 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.606 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.0 Cg_endo -73.75 136.43 23.18 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.874 1.716 . . . . 0.0 110.716 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' B' ' 10' ' ' LEU . 4.8 mp -134.25 131.71 38.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.971 0.415 . . . . 0.0 110.496 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 5.1 m -111.4 117.32 32.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.631 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.797 HG12 HG12 ' A' ' 54' ' ' ILE . 25.6 mt -107.24 123.74 62.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 71.0 m-85 -107.48 138.4 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.913 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.691 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.5 t -84.01 130.79 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.018 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.603 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.434 -1.492 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.002 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.2 131.19 39.78 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.505 2.137 . . . . 0.0 111.595 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 m -116.88 136.84 52.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.923 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -115.49 145.14 42.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.822 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.96 123.89 29.82 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.8 158.45 43.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.93 128.21 49.1 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' B' ' 22' ' ' VAL . 51.8 mt -121.06 141.34 50.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.677 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 30.2 m80 -71.49 131.32 43.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.52 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.58 111.55 3.99 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.024 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.63 0.87 52.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.723 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -95.09 150.71 19.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.17 0.509 . . . . 0.0 111.204 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -95.03 135.3 36.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.604 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.55 152.89 47.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.48 0.657 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.7 m80 -95.98 117.88 31.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.839 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.403 HD21 HD12 ' B' ' 12' ' ' LEU . 7.7 tp -108.78 121.36 44.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.159 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mt -129.57 126.49 63.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.076 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' B' ' 12' ' ' LEU . 13.5 p -117.92 135.05 59.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -147.54 170.88 16.5 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.32 136.24 54.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.309 0.576 . . . . 0.0 111.88 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.25 165.64 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.005 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.1 m -54.88 -31.16 59.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 71.4 mt -73.11 -17.57 61.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.421 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.88 2.9 39.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.546 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 7.7 p30 -85.99 142.23 36.17 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CG ' HG23 ' A' ' 56' ' ' VAL . 44.2 Cg_endo -85.25 153.02 10.79 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.565 2.176 . . . . 0.0 112.434 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -126.24 149.9 48.77 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 54' ' ' ILE . 11.3 tp -128.67 123.86 34.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.703 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.5 m -122.0 119.47 31.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.999 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.8 t -124.17 122.42 64.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.072 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.76 131.34 24.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.783 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.34 136.36 50.76 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 122.331 2.02 . . . . 0.0 111.68 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.4 m -70.68 -25.18 62.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.078 0.466 . . . . 0.0 110.362 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -132.82 102.92 13.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.65 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.67 -21.31 39.25 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.797 2.331 . . . . 0.0 112.253 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -74.89 -32.71 61.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -73.65 -21.34 60.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.245 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 19.0 mm-40 -69.27 -35.19 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.923 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.88 -43.26 36.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.046 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 67.46 4.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 p -78.39 81.34 4.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.466 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.78 -7.85 59.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 p -102.44 137.66 19.46 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.603 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.16 156.36 46.83 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.435 2.09 . . . . 0.0 111.281 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.4 mt -87.66 138.8 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 52' ' ' LEU . 87.0 mt -108.73 124.06 35.4 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.547 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 73.5 Cg_endo -77.58 136.57 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.294 1.996 . . . . 0.0 111.675 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 50' ' ' ILE . 4.9 mp -133.93 130.09 37.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 m -109.21 118.63 37.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.564 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.744 HG12 HG12 ' B' ' 54' ' ' ILE . 37.0 mt -107.5 126.38 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.107 0.48 . . . . 0.0 110.777 -176.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -109.57 138.71 45.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.571 HG23 ' CG ' ' A' ' 30' ' ' PRO . 1.1 t -89.4 140.86 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.228 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.514 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.937 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.18 131.39 40.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 111.593 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.2 m -116.94 137.03 52.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.51 144.92 43.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.143 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.68 123.9 30.38 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.64 158.57 43.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.666 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.96 128.37 49.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.476 ' HB2' HG12 ' A' ' 22' ' ' VAL . 50.9 mt -121.14 141.47 50.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 -173.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 30.0 m80 -71.45 130.98 42.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.558 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.39 111.88 4.25 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.085 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 1.16 53.34 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.842 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -95.64 150.62 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.18 0.514 . . . . 0.0 111.129 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -94.88 135.36 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.445 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -128.62 153.12 47.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.351 0.596 . . . . 0.0 110.68 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.8 m80 -96.23 117.83 31.57 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.842 172.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 tp -108.56 121.51 45.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.222 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.65 126.3 62.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.095 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 12' ' ' LEU . 13.6 p -117.23 134.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -147.44 170.97 16.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.12 136.83 53.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.225 0.536 . . . . 0.0 111.737 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.09 165.97 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.115 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -55.03 -30.93 60.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.544 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 71.9 mt -73.35 -17.94 61.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.828 0.347 . . . . 0.0 111.293 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.06 39.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.544 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 7.7 p30 -85.96 142.61 36.56 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.403 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.566 ' CG ' HG23 ' B' ' 56' ' ' VAL . 44.2 Cg_endo -85.46 153.37 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.658 2.239 . . . . 0.0 112.377 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -126.51 150.12 48.95 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.465 HD21 HD12 ' B' ' 54' ' ' ILE . 11.3 tp -128.85 123.7 33.42 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.746 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -121.96 119.24 30.92 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.144 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.0 t -123.99 122.67 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 110.081 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.91 131.47 24.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.859 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.62 136.21 48.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.293 1.995 . . . . 0.0 111.708 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 52.0 m -70.43 -25.34 63.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -132.87 102.91 13.26 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.725 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.01 -21.04 37.54 Favored 'Trans proline' 0 CA--C 1.526 0.116 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -74.99 -32.72 61.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.593 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -73.71 -21.53 60.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.25 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.45 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 20.0 mm-40 -68.82 -35.68 77.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.868 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.57 -43.36 39.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.036 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.9 mt -92.75 67.42 4.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -78.32 81.17 4.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.482 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -80.83 -7.08 59.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.958 0.885 . . . . 0.0 108.712 167.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 5.0 p -103.11 137.72 19.34 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.437 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.24 156.1 46.53 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.454 2.103 . . . . 0.0 111.58 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 48.9 mt -87.79 138.55 31.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.0 110.708 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.44 ' O ' HD12 ' B' ' 52' ' ' LEU . 85.3 mt -108.53 123.82 36.22 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 167.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.514 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 74.0 Cg_endo -77.37 136.55 15.94 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.065 . . . . 0.0 111.475 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.44 ' HB2' HD13 ' B' ' 10' ' ' LEU . 4.9 mp -133.89 130.11 37.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 m -108.83 118.72 37.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.733 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.744 HG12 HG12 ' A' ' 54' ' ' ILE . 37.0 mt -107.57 126.49 63.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.115 0.483 . . . . 0.0 110.793 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -109.66 138.61 45.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.512 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.566 HG23 ' CG ' ' B' ' 30' ' ' PRO . 1.1 t -89.45 140.72 15.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.155 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.547 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.66 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.533 ' HE1' ' HB3' ' A' ' 55' ' ' PHE . 80.5 mtp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 55' ' ' PHE . 86.4 Cg_exo -51.85 139.25 50.35 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.502 2.801 . . . . 0.0 112.096 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.2 132.28 56.68 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.597 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -122.01 140.94 51.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.703 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 124.32 41.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.261 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD23 HG23 ' A' ' 34' ' ' VAL . 1.5 pp -141.42 157.9 44.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.249 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . . . -119.27 127.42 53.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.368 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.401 HD12 HD21 ' B' ' 20' ' ' LEU . 65.6 mt -119.49 141.99 48.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.189 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -70.56 127.16 31.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.99 104.34 0.79 Allowed Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.144 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.29 11.86 26.58 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.623 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.425 ' OE1' ' HG2' ' A' ' 41' ' ' GLN . 25.4 mm-40 -109.57 154.83 22.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 111.599 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -96.66 137.16 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.654 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.438 ' HB3' HG11 ' A' ' 34' ' ' VAL . 74.4 m-85 -129.61 154.89 46.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.852 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.685 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.6 m170 -95.03 117.62 30.47 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.321 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD11 HD13 ' A' ' 32' ' ' LEU . 11.9 tp -110.64 123.15 49.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.51 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 13.8 mt -131.25 126.53 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.56 127.9 74.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.54 151.09 47.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.181 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -108.09 135.53 49.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -174.87 5.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -64.05 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.727 0.298 . . . . 0.0 111.563 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.546 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -80.39 -24.48 39.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.59 17.96 9.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.436 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 31.1 m-80 -92.88 135.53 25.93 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.445 ' CG ' HG22 ' A' ' 56' ' ' VAL . 71.4 Cg_endo -75.07 144.08 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.522 2.148 . . . . 0.0 111.85 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.2 t -127.48 140.24 52.28 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD23 HD12 ' A' ' 54' ' ' ILE . 12.6 tp -120.05 129.19 54.11 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.744 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 36.1 m -126.13 119.98 28.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.995 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 74.1 t -123.41 121.77 63.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.5 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.12 129.66 24.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.445 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.46 137.04 75.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.545 2.163 . . . . 0.0 112.16 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.0 t -68.94 -21.05 64.22 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.431 0.634 . . . . 0.0 109.998 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -140.29 103.24 6.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -11.71 33.0 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.541 2.161 . . . . 0.0 112.728 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -86.95 -27.67 23.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.033 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HG2' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mp0 -69.41 -23.78 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.85 -33.26 75.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.442 0.639 . . . . 0.0 109.672 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -85.21 -42.23 14.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.668 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.16 55.27 2.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.9 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -78.88 94.84 5.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.402 0.62 . . . . 0.0 112.075 -174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.13 -10.99 51.37 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 p -101.94 132.55 21.48 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.229 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.86 160.07 48.83 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 48.1 mt -92.91 120.15 32.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.111 0.481 . . . . 0.0 111.082 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.503 ' O ' HD13 ' A' ' 52' ' ' LEU . 80.8 mt -91.13 127.94 49.46 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.001 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.28 134.86 19.71 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.109 1.873 . . . . 0.0 111.739 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -136.02 135.18 39.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.371 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.4 m -115.38 120.95 41.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.849 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.81 HG12 HG12 ' B' ' 54' ' ' ILE . 31.8 mt -108.56 129.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' HB3' ' HE1' ' A' ' 5' ' ' MET . 85.6 m-85 -111.56 138.75 47.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG22 ' CG ' ' A' ' 30' ' ' PRO . 42.4 t -95.27 118.45 41.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.68 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.569 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.606 169.485 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.547 ' HE1' ' HB3' ' B' ' 55' ' ' PHE . 80.6 mtp . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' B' ' 55' ' ' PHE . 88.9 Cg_exo -51.86 139.15 50.66 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 C-N-CA 123.439 2.76 . . . . 0.0 112.248 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.36 132.18 56.64 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.709 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.9 140.8 51.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.631 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.57 123.98 41.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.294 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.507 HD23 HG23 ' B' ' 34' ' ' VAL . 1.6 pp -141.12 158.09 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.18 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . . . -119.91 127.09 52.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.134 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.404 HD12 HD21 ' A' ' 20' ' ' LEU . 65.8 mt -119.43 141.74 48.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.189 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -70.31 127.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.62 104.13 0.73 Allowed Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.159 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 11.74 26.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.676 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.419 ' OE1' ' HG2' ' B' ' 41' ' ' GLN . 26.3 mm-40 -109.53 155.14 21.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -97.18 137.07 36.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.416 ' HB3' HG11 ' B' ' 34' ' ' VAL . 73.3 m-85 -129.61 154.85 46.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.789 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.686 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 5.6 m170 -95.19 117.56 30.44 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.256 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.486 HD11 HD13 ' B' ' 32' ' ' LEU . 11.7 tp -110.35 123.11 49.25 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.489 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mt -131.26 126.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.47 127.84 73.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -138.81 151.24 46.87 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -108.1 136.07 48.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.968 0.413 . . . . 0.0 111.041 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -175.03 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.48 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.2 m -63.79 -30.57 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.714 0.292 . . . . 0.0 111.52 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.537 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 41.7 mt -80.63 -24.3 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.265 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.19 18.22 9.42 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.474 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 30.0 m-80 -92.76 135.43 26.23 Favored Pre-proline 0 CA--C 1.511 -0.548 0 CA-C-O 121.028 0.442 . . . . 0.0 109.841 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.436 ' CG ' HG22 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -75.04 143.98 29.58 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.499 2.132 . . . . 0.0 111.858 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -127.61 140.28 52.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.526 HD23 HD12 ' B' ' 54' ' ' ILE . 12.6 tp -119.62 129.75 54.76 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.768 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m -126.47 120.04 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.751 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 74.9 t -123.71 121.48 62.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 0.0 110.419 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.89 129.75 24.47 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 136.62 71.99 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.196 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 16.4 t -68.25 -21.68 64.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.155 0.503 . . . . 0.0 109.789 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -139.81 103.46 6.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.938 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.6 -12.22 34.94 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.694 2.262 . . . . 0.0 112.601 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -86.43 -27.7 23.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.103 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.419 ' HG2' ' OE1' ' B' ' 16' ' ' GLN . 1.2 mp0 -69.38 -24.0 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 175.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.62 -33.51 75.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.773 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -85.03 -42.06 15.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.787 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.31 55.37 2.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.037 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p -78.92 95.02 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.126 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.89 -10.08 51.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.0 p -102.22 132.46 21.46 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.157 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.85 160.07 48.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.841 2.361 . . . . 0.0 111.802 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' B' ' 11' ' ' ALA . 47.4 mt -93.17 120.06 33.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.933 0.397 . . . . 0.0 111.202 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.5 ' O ' HD13 ' B' ' 52' ' ' LEU . 81.3 mt -91.08 128.02 49.25 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.25 134.98 19.93 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.125 1.883 . . . . 0.0 111.784 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.5 HD13 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -136.19 134.77 38.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.518 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -115.01 120.97 41.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.81 HG12 HG12 ' A' ' 54' ' ' ILE . 30.4 mt -108.56 129.44 63.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.812 0.339 . . . . 0.0 110.769 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.547 ' HB3' ' HE1' ' B' ' 5' ' ' MET . 86.8 m-85 -111.27 138.52 47.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.779 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.436 HG22 ' CG ' ' B' ' 30' ' ' PRO . 41.7 t -95.26 118.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.474 0 C-N-CA 119.119 -1.515 . . . . 0.0 113.583 169.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 18.8 ptp . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.335 0.588 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.595 ' HD2' ' CG1' ' A' ' 56' ' ' VAL . 2.8 Cg_exo -68.88 135.52 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.917 2.411 . . . . 0.0 111.569 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 m -113.85 148.73 36.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.158 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -123.47 140.09 53.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.878 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -127.12 123.78 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 34' ' ' VAL . 2.1 pp -140.62 158.62 43.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.85 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.23 128.46 51.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.686 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.433 HD12 HD23 ' B' ' 20' ' ' LEU . 50.0 mt -123.01 140.5 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 98.2 m-70 -72.05 132.11 43.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.99 108.03 1.57 Allowed Glycine 0 CA--C 1.516 0.142 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.792 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.84 -8.32 42.71 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.595 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -84.16 147.03 27.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.825 0.345 . . . . 0.0 110.255 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 4.4 m -96.22 136.3 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 34' ' ' VAL . 92.1 m-85 -129.7 153.09 48.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.313 0.578 . . . . 0.0 111.158 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.66 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.4 m80 -95.82 117.64 30.94 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.736 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.545 HD13 HD13 ' A' ' 32' ' ' LEU . 9.7 tp -107.98 123.32 48.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.508 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.65 126.43 54.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.327 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.64 133.69 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -147.17 159.82 43.17 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -116.13 140.69 49.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.87 0.366 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 23.3 p30 -81.3 -174.98 5.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.98 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -62.15 -28.89 69.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 0.0 111.401 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 44.9 mt -82.82 -23.67 33.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 110.64 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.53 19.71 10.21 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.916 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 34.4 m-80 -87.57 131.0 45.12 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 56' ' ' VAL . 58.0 Cg_endo -74.42 144.25 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.277 1.985 . . . . 0.0 112.093 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.6 t -130.06 140.18 50.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.545 HD13 HD13 ' A' ' 20' ' ' LEU . 13.0 tp -122.97 130.09 52.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.905 0.383 . . . . 0.0 110.734 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -127.29 120.69 29.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.977 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.8 t -123.67 121.77 63.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.087 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.87 132.3 24.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.97 133.57 42.06 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.127 1.885 . . . . 0.0 111.713 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.494 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 50.5 m -73.41 -27.8 61.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.458 . . . . 0.0 110.248 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -121.32 103.57 41.62 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.35 -25.49 42.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.728 2.286 . . . . 0.0 112.86 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -81.75 -16.13 52.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.268 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -73.21 -26.15 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.031 0.443 . . . . 0.0 110.318 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.36 -43.21 13.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.435 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.42 58.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.926 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 16.0 m -83.89 91.1 7.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -172.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -85.64 -7.41 58.84 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.42 131.91 22.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.843 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.01 155.26 71.62 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.977 2.451 . . . . 0.0 112.173 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -91.04 120.05 31.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.09 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 70.6 mt -91.5 129.25 43.57 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.563 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 44.0 Cg_endo -86.99 136.92 4.34 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.393 2.062 . . . . 0.0 110.953 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' A' ' 10' ' ' LEU . 5.2 mp -130.8 128.72 41.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.769 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -106.22 115.87 30.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.586 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.659 HG12 HG12 ' B' ' 54' ' ' ILE . 27.9 mt -108.38 126.05 65.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -110.27 139.7 45.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.243 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' ' HD2' ' A' ' 6' ' ' PRO . 12.2 p -87.37 142.78 12.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.197 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.301 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 19.0 ptp . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.591 ' HD2' ' CG1' ' B' ' 56' ' ' VAL . 2.8 Cg_exo -69.43 135.44 31.26 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.744 2.296 . . . . 0.0 111.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 m -113.86 148.51 36.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.253 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -123.26 140.3 53.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.893 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.31 123.62 36.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.469 HD22 HG23 ' B' ' 34' ' ' VAL . 2.0 pp -140.56 158.78 43.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.57 128.53 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.801 0.334 . . . . 0.0 110.591 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 20' ' ' LEU . 49.9 mt -123.1 140.54 52.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 98.2 m-70 -71.99 131.97 43.65 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.71 107.71 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.883 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.89 -8.22 42.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.714 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -84.05 147.23 27.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 4.1 m -96.4 136.22 37.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.453 ' HB3' HG12 ' B' ' 34' ' ' VAL . 92.6 m-85 -129.69 153.21 48.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.113 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.664 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.4 m80 -95.78 117.74 31.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.659 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.528 HD13 HD13 ' B' ' 32' ' ' LEU . 9.7 tp -108.11 123.27 48.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.431 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.57 126.51 55.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.172 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 133.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.54 160.96 41.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 140.21 49.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.917 0.389 . . . . 0.0 110.482 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' B' ' 29' ' ' ASN . 21.1 p30 -81.2 -175.41 5.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.832 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 22.2 t -61.24 -29.59 69.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.775 0.321 . . . . 0.0 111.505 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.557 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 45.5 mt -82.63 -23.9 34.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 0.0 110.463 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.0 10.49 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.048 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 34.2 m-80 -86.95 130.92 46.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.454 ' HG3' HG13 ' B' ' 56' ' ' VAL . 57.9 Cg_endo -74.09 144.36 33.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.313 2.009 . . . . 0.0 112.174 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 41.6 t -130.3 140.02 50.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.528 HD13 HD13 ' B' ' 20' ' ' LEU . 13.0 tp -122.77 130.33 52.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.907 0.384 . . . . 0.0 110.543 -174.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m -127.58 120.73 28.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.056 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.6 t -123.78 121.52 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.331 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.73 132.38 24.28 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.07 133.45 41.17 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.082 1.855 . . . . 0.0 111.688 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 50.5 m -73.35 -27.9 61.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.157 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -121.29 103.65 41.6 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.56 -25.3 41.06 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.803 2.336 . . . . 0.0 112.879 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -81.78 -16.03 52.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.331 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -73.2 -26.04 61.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.077 0.465 . . . . 0.0 110.517 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -70.12 -27.68 64.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.33 -43.25 13.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.319 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -99.48 58.33 1.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.919 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 15.2 m -84.07 91.78 7.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.287 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.4 -7.24 58.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.672 0.749 . . . . 0.0 109.035 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.36 132.3 22.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.775 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.15 155.4 70.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.818 2.345 . . . . 0.0 112.124 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 29.7 mt -90.96 119.98 31.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 71.6 mt -91.51 129.21 43.7 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.573 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.4 Cg_endo -87.25 136.96 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.373 2.049 . . . . 0.0 110.912 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.457 ' HB2' HD11 ' B' ' 10' ' ' LEU . 5.2 mp -130.52 128.81 41.91 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.74 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.5 m -106.29 115.97 31.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 54' ' ' ILE . 27.5 mt -108.5 126.4 65.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -110.57 139.62 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.116 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' HD2' ' B' ' 6' ' ' PRO . 11.8 p -87.35 142.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.132 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.66 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.288 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 18.3 ptp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.552 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 30.6 Cg_exo -42.75 130.98 5.55 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.786 2.99 . . . . 0.0 113.414 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -118.07 132.45 56.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.246 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.87 140.07 53.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.421 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -124.82 123.77 40.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.08 157.92 44.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.748 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . . . -120.37 128.35 53.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 0.0 110.095 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.455 HD13 HD21 ' B' ' 20' ' ' LEU . 60.0 mt -117.2 141.21 48.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.535 ' CE1' ' HB3' ' A' ' 45' ' ' SER . 97.2 m-70 -70.7 127.58 33.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.7 7.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.533 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -0.74 65.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.631 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -85.73 151.62 23.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 110.608 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 3.0 m -102.03 135.65 43.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.579 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.493 ' HB3' HG12 ' A' ' 34' ' ' VAL . 77.9 m-85 -128.59 154.04 46.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.266 0.555 . . . . 0.0 111.03 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.6 m170 -95.42 116.98 29.54 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 32' ' ' LEU . 15.7 tp -106.36 122.48 46.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.378 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.58 126.36 54.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.315 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.58 139.82 38.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.48 171.21 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -123.02 135.2 54.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.048 0.451 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -178.24 4.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.401 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 m -60.46 -31.09 70.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.8 0.333 . . . . 0.0 111.621 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -81.81 -23.94 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 111.292 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.84 13.12 12.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.384 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 36.0 m-80 -91.63 141.9 26.23 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.565 ' CB ' HG23 ' A' ' 56' ' ' VAL . 74.2 Cg_endo -72.06 147.25 48.39 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.803 2.335 . . . . 0.0 112.329 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.2 t -128.23 141.17 51.54 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 54' ' ' ILE . 15.5 tp -120.73 129.98 53.86 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.619 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -126.17 125.94 43.28 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 55.4 t -127.24 121.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.824 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.54 129.2 24.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.463 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.4 Cg_endo -60.91 133.74 49.33 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.442 2.095 . . . . 0.0 111.951 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 42.1 m -75.81 -22.35 56.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.2 0.524 . . . . 0.0 109.713 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -130.09 102.47 17.4 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.451 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.49 -13.93 30.47 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.801 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -76.88 -31.85 57.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.597 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.92 -19.74 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.949 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 74.9 mm-40 -69.61 -34.59 74.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.044 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.551 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.9 pt20 -87.02 -42.21 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 174.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 19.4 mt -97.13 60.87 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.535 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 5.1 m -83.42 85.88 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.143 -172.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.93 -3.59 58.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.732 0.777 . . . . 0.0 108.992 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.9 128.74 28.94 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.69 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.56 157.19 62.86 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.84 2.36 . . . . 0.0 112.67 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 62.1 mt -98.85 126.07 44.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.432 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.451 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.7 mt -99.87 127.75 32.91 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.42 136.43 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.857 1.705 . . . . 0.0 111.754 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.4 mp -131.13 133.39 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.967 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -110.0 118.49 36.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.697 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.693 HG12 HG12 ' B' ' 54' ' ' ILE . 28.4 mt -106.91 125.79 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.918 0.39 . . . . 0.0 110.729 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 86.7 m-85 -111.17 134.97 52.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.083 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.565 HG23 ' CB ' ' A' ' 30' ' ' PRO . 1.5 t -84.54 131.69 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.637 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.906 -178.705 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 18.5 ptp . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.533 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 33.6 Cg_exo -43.12 130.75 6.15 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.645 2.897 . . . . 0.0 113.513 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -117.73 132.52 56.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 112.239 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.93 140.41 53.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.382 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -125.36 123.6 39.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.16 158.14 44.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . . . -120.78 128.31 52.77 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 20' ' ' LEU . 61.3 mt -117.3 141.31 48.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.502 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.525 ' CE1' ' HB3' ' B' ' 45' ' ' SER . 97.2 m-70 -70.58 127.63 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 115.47 7.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.432 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.99 -0.72 64.57 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.759 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -85.84 151.88 23.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.0 110.639 178.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 3.0 m -102.14 135.55 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.629 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' TYR . . . . . 0.486 ' HB3' HG12 ' B' ' 34' ' ' VAL . 78.2 m-85 -128.65 154.05 46.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.7 m170 -95.38 116.79 29.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.459 HD12 HD11 ' B' ' 32' ' ' LEU . 15.9 tp -106.24 122.47 46.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.342 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mt -132.56 126.13 54.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.438 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.4 140.06 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -149.38 171.57 16.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 3.5 p -124.03 134.33 53.46 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.43 -177.76 4.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.472 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 m -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.765 0.316 . . . . 0.0 111.554 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 43.0 mt -81.68 -24.29 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.275 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.15 13.06 12.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.54 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 36.3 m-80 -91.41 141.92 26.5 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.556 ' CB ' HG23 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -72.0 147.2 48.66 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.642 2.228 . . . . 0.0 112.321 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -127.95 141.18 51.61 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.526 HD21 HD11 ' B' ' 54' ' ' ILE . 15.4 tp -120.91 129.37 53.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.033 0.444 . . . . 0.0 110.819 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -125.91 125.64 43.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.508 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 54.6 t -127.22 121.23 57.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.859 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -124.61 129.22 24.71 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.477 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.448 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.2 Cg_endo -60.82 134.08 51.61 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.447 2.098 . . . . 0.0 111.821 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 37.2 m -75.93 -22.5 55.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.379 0.609 . . . . 0.0 109.689 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.98 102.45 17.58 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.577 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.6 -13.9 30.16 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.727 2.284 . . . . 0.0 112.672 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -76.8 -32.12 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.521 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -73.55 -19.98 60.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.953 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 76.2 mm-40 -69.58 -34.32 73.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.967 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.557 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.9 pt20 -87.29 -41.9 13.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.575 174.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.557 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 19.7 mt -97.42 60.36 1.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.788 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' SER . . . . . 0.525 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 5.2 m -83.04 85.85 7.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.281 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.56 -3.86 58.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.904 0.859 . . . . 0.0 108.919 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.72 128.6 29.52 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.711 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.75 157.37 62.14 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.873 2.382 . . . . 0.0 112.551 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 11' ' ' ALA . 61.9 mt -99.43 125.18 45.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.514 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.461 ' O ' HD12 ' B' ' 52' ' ' LEU . 79.0 mt -99.13 127.42 34.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.12 136.45 18.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.782 1.655 . . . . 0.0 111.702 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.461 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.4 mp -131.15 133.36 45.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.131 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -109.87 118.44 36.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 54' ' ' ILE . 28.3 mt -106.93 125.95 62.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.083 0.468 . . . . 0.0 110.696 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.6 m-85 -111.29 134.89 52.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.072 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' VAL . . . . . 0.556 HG23 ' CB ' ' B' ' 30' ' ' PRO . 1.5 t -84.59 131.47 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.815 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.927 -178.626 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.59 18.48 3.1 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.666 -0.314 . . . . 0.0 111.713 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.417 ' HG3' ' HG3' ' A' ' 4' ' ' GLU . 26.3 ptm -131.94 -31.67 1.49 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.15 0.5 . . . . 0.0 110.861 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -96.49 12.2 32.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.505 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.849 ' HE2' ' HB3' ' A' ' 55' ' ' PHE . 12.2 ptm -66.92 126.96 93.27 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.425 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.914 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 16.7 Cg_endo -56.94 132.35 51.12 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.546 2.831 . . . . 0.0 112.616 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m -116.11 137.33 52.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.588 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.56 145.97 46.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -129.15 124.05 33.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.125 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.92 158.52 43.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.689 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 128.1 48.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' B' ' 22' ' ' VAL . 51.8 mt -122.0 140.98 51.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.616 -173.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.722 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 35.5 m80 -71.7 129.23 38.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.48 115.14 7.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.006 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.58 10.74 56.49 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.976 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.944 ' HA ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -109.4 150.94 27.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 110.732 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 m -91.56 137.86 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.104 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.34 153.0 48.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.573 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.1 m170 -96.27 117.55 31.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.265 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD11 HD12 ' A' ' 32' ' ' LEU . 8.3 tp -109.08 119.63 40.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.103 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 mt -128.07 125.85 65.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.833 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' B' ' 12' ' ' LEU . 13.0 p -112.27 134.89 53.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -146.85 170.71 16.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 p -117.03 142.29 47.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.462 0.648 . . . . 0.0 112.164 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.12 164.68 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.461 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -56.49 -30.68 63.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.398 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.04 -18.01 62.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.48 1.75 53.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.956 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 78.5 m-20 -84.79 132.19 47.02 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.246 0.546 . . . . 0.0 110.082 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 56' ' ' VAL . 11.8 Cg_exo -66.39 150.02 84.58 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 122.983 2.455 . . . . 0.0 112.482 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -132.74 139.87 47.8 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.95 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 54' ' ' ILE . 13.8 tp -124.63 134.66 52.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.935 0.397 . . . . 0.0 111.162 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.8 m -134.89 123.29 23.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.392 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 68.8 t -125.98 122.4 61.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.94 131.04 24.59 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.872 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.76 42.12 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.417 2.078 . . . . 0.0 112.099 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.8 m -67.83 -23.67 65.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.241 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HB3' ' OE1' ' A' ' 41' ' ' GLN . 77.1 m-20 -131.68 103.15 14.77 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.502 172.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.77 -23.8 22.15 Favored 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.096 2.53 . . . . 0.0 113.232 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -80.07 -22.71 41.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.692 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.606 ' OE1' ' HB3' ' A' ' 38' ' ' ASN . 12.1 mp0 -73.48 -20.93 60.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.254 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.722 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 46.6 mm-40 -67.38 -32.23 73.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.641 172.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.5 -43.15 16.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.89 77.58 3.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.742 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -91.3 78.69 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.335 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.01 -5.92 58.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 p -101.82 135.89 19.64 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.851 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.43 149.56 50.54 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.341 2.028 . . . . 0.0 111.853 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.62 123.73 35.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.3 mt -96.72 124.91 48.74 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.5 136.48 13.95 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.126 1.884 . . . . 0.0 111.135 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.23 133.17 46.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -110.14 115.95 30.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.68 HG12 HG12 ' B' ' 54' ' ' ILE . 31.3 mt -106.38 121.0 58.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.0 110.509 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.849 ' HB3' ' HE2' ' A' ' 5' ' ' MET . 41.6 m-85 -106.37 137.23 44.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.622 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.914 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -85.45 135.3 25.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.185 0.517 . . . . 0.0 110.799 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.61 156.86 18.29 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.03 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.81 115.96 26.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.402 ' HB2' ' HD3' ' B' ' 51' ' ' PRO . 17.0 t-20 -84.15 66.82 9.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.701 0.763 . . . . 0.0 109.013 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.6 m -75.97 -34.3 59.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.295 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.53 155.83 19.07 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.56 179.555 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.66 19.0 3.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.737 0.303 . . . . 0.0 111.595 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' MET . . . . . 0.431 ' HG3' ' HG3' ' B' ' 4' ' ' GLU . 26.3 ptm -132.42 -31.31 1.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.97 0.414 . . . . 0.0 110.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.431 ' HG3' ' HG3' ' B' ' 3' ' ' MET . 0.0 OUTLIER -96.96 12.56 31.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.459 0.647 . . . . 0.0 110.562 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.861 ' HE2' ' HB3' ' B' ' 55' ' ' PHE . 12.1 ptm -67.24 126.75 92.99 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.302 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.919 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 16.5 Cg_endo -56.9 132.34 51.05 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.59 2.86 . . . . 0.0 112.635 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -116.07 137.43 52.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.538 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -120.77 145.81 47.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.486 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -128.84 123.9 33.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.18 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.455 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.65 158.53 43.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.95 128.02 48.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.916 0.389 . . . . 0.0 110.02 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 22' ' ' VAL . 52.9 mt -121.89 140.9 51.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.734 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 35.6 m80 -71.67 129.51 38.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 115.52 8.02 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.018 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 10.57 56.7 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.963 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.917 HE21 ' HA ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -109.36 150.99 27.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 8.4 m -91.83 137.75 32.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.027 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.36 152.95 48.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.577 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.1 m170 -96.25 117.41 30.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.374 173.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.469 HD11 HD12 ' B' ' 32' ' ' LEU . 8.3 tp -108.89 119.27 39.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.53 125.85 66.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.014 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 12' ' ' LEU . 13.2 p -112.07 134.67 53.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -146.67 170.75 16.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -116.83 142.61 46.7 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.475 0.655 . . . . 0.0 112.238 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.34 164.27 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.491 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -56.11 -30.95 62.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.53 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.87 -17.97 62.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.09 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.56 1.37 53.16 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.008 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 30' ' ' PRO . 79.4 m-20 -84.53 132.06 48.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.519 . . . . 0.0 109.913 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.566 ' HG2' HG11 ' B' ' 56' ' ' VAL . 11.7 Cg_exo -66.24 149.91 85.07 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.202 2.601 . . . . 0.0 112.402 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -132.54 139.93 48.08 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.787 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.485 HD23 HD12 ' B' ' 54' ' ' ILE . 13.8 tp -124.75 134.77 52.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.106 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -135.01 123.57 23.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.4 t -126.17 122.49 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.006 0.432 . . . . 0.0 110.517 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.02 130.97 24.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.862 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.412 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.32 40.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.433 2.089 . . . . 0.0 112.194 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 69.9 m -67.31 -23.87 65.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.126 0.489 . . . . 0.0 110.209 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . 0.626 ' HB3' ' OE1' ' B' ' 41' ' ' GLN . 77.8 m-20 -131.67 103.27 14.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.418 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.05 -23.83 21.19 Favored 'Trans proline' 0 CA--C 1.526 0.078 0 C-N-CA 123.115 2.544 . . . . 0.0 113.171 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.8 -22.88 42.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.856 0.36 . . . . 0.0 110.706 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' B' ' 38' ' ' ASN . 12.5 mp0 -73.48 -20.8 60.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.734 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 49.1 mm-40 -67.55 -32.12 72.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.678 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.57 -43.21 15.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.855 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.96 77.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 11.3 p -91.35 78.63 5.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.245 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.97 -5.56 58.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 166.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.1 p -102.32 135.8 19.53 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.9 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.45 149.55 50.4 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.246 1.964 . . . . 0.0 111.913 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.49 123.54 34.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.434 ' O ' HD12 ' B' ' 52' ' ' LEU . 64.8 mt -96.6 124.86 49.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 59' ' ' ASN . 76.4 Cg_endo -78.36 136.27 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.117 1.878 . . . . 0.0 111.129 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.3 mp -129.95 133.16 46.63 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.055 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -109.78 116.03 30.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.341 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.68 HG12 HG12 ' A' ' 54' ' ' ILE . 30.8 mt -106.52 120.86 58.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.226 0.536 . . . . 0.0 110.508 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.861 ' HB3' ' HE2' ' B' ' 5' ' ' MET . 43.2 m-85 -106.25 137.13 44.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.598 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.919 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -85.53 135.17 25.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 0.0 110.607 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.41 157.39 18.3 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.034 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.04 116.22 27.16 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -84.86 66.94 9.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -76.19 -34.58 59.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.23 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.75 156.35 18.73 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.598 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.712 179.253 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.74 86.57 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 111.732 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ttt 65.45 41.69 4.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.077 169.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.61 20.28 16.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.033 0.92 . . . . 0.0 109.642 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.56 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.1 ptp -98.13 141.34 22.8 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.006 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 86.1 Cg_exo -49.16 131.36 26.22 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 123.593 2.862 . . . . 0.0 113.14 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -117.74 138.38 52.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.69 142.34 51.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.647 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.13 125.02 40.47 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.162 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.94 158.07 44.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.02 127.59 51.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.897 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' B' ' 22' ' ' VAL . 57.7 mt -122.61 140.73 52.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.299 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.41 126.93 30.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.32 99.65 0.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.453 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -0.58 17.93 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.817 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -96.5 155.53 16.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.769 0.318 . . . . 0.0 110.645 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 6.9 m -98.19 136.9 37.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.389 0.614 . . . . 0.0 110.565 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.468 ' HB3' HG13 ' A' ' 34' ' ' VAL . 96.5 m-85 -129.3 153.22 48.04 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.411 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m80 -95.29 117.16 29.79 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.605 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.01 119.53 39.62 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.463 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.62 125.72 64.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.91 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' B' ' 12' ' ' LEU . 14.8 p -112.19 132.52 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 24.2 t0 -135.91 169.87 16.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.74 0.305 . . . . 0.0 110.831 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -179.46 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -58.48 -30.87 67.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 59.3 mt -82.23 -22.23 35.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.413 . . . . 0.0 111.204 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 19.22 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.282 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.591 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 29.5 m-80 -88.33 136.99 31.06 Favored Pre-proline 0 CA--C 1.511 -0.53 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HG3' HG13 ' A' ' 56' ' ' VAL . 1.1 Cg_endo -80.47 144.27 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.858 2.372 . . . . 0.0 111.681 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.7 t -127.88 140.18 52.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD22 HD13 ' A' ' 54' ' ' ILE . 14.4 tp -115.77 132.14 56.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.43 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -130.6 120.4 23.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.133 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.4 t -127.0 122.2 59.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.96 131.04 23.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.89 139.76 69.75 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.347 2.031 . . . . 0.0 111.811 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.592 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 12.7 p -67.38 -29.86 69.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.345 0.593 . . . . 0.0 110.5 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.08 102.72 4.81 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.457 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.41 -15.03 44.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.162 2.575 . . . . 0.0 112.707 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -66.19 -35.65 81.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.112 0.482 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -74.83 -22.2 58.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.043 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -70.13 -43.71 70.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.673 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.547 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.8 pt20 -78.38 -33.89 48.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.746 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 22.7 mt -102.11 56.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 p -74.79 96.76 3.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.157 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.84 -18.49 40.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.07 137.89 19.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.532 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.33 157.68 52.96 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.972 2.448 . . . . 0.0 112.843 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.8 mt -85.26 124.46 31.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.693 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.462 ' O ' HD11 ' A' ' 52' ' ' LEU . 70.6 mt -96.21 126.88 42.48 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.58 135.54 18.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.146 1.898 . . . . 0.0 111.599 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.473 ' HB2' HD11 ' A' ' 10' ' ' LEU . 4.9 mp -134.87 131.1 36.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.379 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 m -110.9 119.05 37.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.802 HG12 HG12 ' B' ' 54' ' ' ILE . 30.0 mt -107.04 125.73 63.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.939 0.4 . . . . 0.0 110.711 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -108.56 137.47 46.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.234 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 5' ' ' MET . 40.3 t -93.58 119.44 41.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.629 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.52 170.67 15.88 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 118.853 -1.641 . . . . 0.0 114.275 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 60' ' ' THR . 33.0 mt-10 -70.18 -39.72 75.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.302 -169.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 71.13 -26.53 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 58' ' ' GLU . 21.0 m 83.87 -16.9 0.51 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.925 0.89 . . . . 0.0 111.065 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.36 64.51 4.25 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.557 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.704 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.1 86.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.546 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ttt 65.43 41.39 4.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.233 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.37 19.76 17.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.995 0.902 . . . . 0.0 109.647 172.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.552 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 13.5 ptp -97.78 141.74 23.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.984 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -49.39 131.13 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -117.72 138.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.284 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.38 142.32 51.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.684 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.26 125.22 40.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.912 0.387 . . . . 0.0 110.143 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.88 158.08 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.12 127.65 51.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.411 ' HB2' HG13 ' A' ' 22' ' ' VAL . 57.5 mt -122.75 140.72 52.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.451 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.45 126.9 30.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.36 99.54 0.29 Allowed Glycine 0 C--O 1.228 -0.237 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.502 -176.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.19 0.58 18.99 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.797 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -97.2 155.66 16.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.34 . . . . 0.0 110.585 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.579 ' HB ' ' OG ' ' B' ' 37' ' ' SER . 7.1 m -98.21 136.76 37.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.461 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.474 ' HB3' HG13 ' B' ' 34' ' ' VAL . 96.4 m-85 -129.33 153.33 47.95 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.674 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.3 m80 -95.26 117.65 30.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.312 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.43 119.76 40.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.292 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.77 125.64 63.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.945 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 12' ' ' LEU . 14.8 p -112.22 132.32 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 23.4 t0 -135.87 170.23 16.32 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.87 133.51 45.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.93 -179.73 7.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.254 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -58.33 -31.02 67.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.594 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 58.2 mt -81.92 -22.5 36.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.94 0.4 . . . . 0.0 111.116 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.22 18.89 9.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.263 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 29.0 m-80 -87.8 137.29 31.85 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.494 ' HG3' HG13 ' B' ' 56' ' ' VAL . 1.1 Cg_endo -80.48 144.66 16.13 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.757 2.304 . . . . 0.0 111.614 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -128.41 140.27 51.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.494 HD22 HD13 ' B' ' 54' ' ' ILE . 14.6 tp -116.28 131.42 56.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 110.438 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 21.3 m -130.15 120.21 24.21 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.944 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.8 t -126.64 122.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.518 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 131.03 23.66 Favored Pre-proline 0 C--O 1.223 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.79 139.46 68.82 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.376 2.051 . . . . 0.0 111.769 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.579 ' OG ' ' HB ' ' B' ' 17' ' ' THR . 12.4 p -67.15 -30.08 69.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.472 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -143.87 103.05 4.87 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.84 -15.09 43.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.109 2.539 . . . . 0.0 112.632 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -66.15 -35.47 80.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.177 0.513 . . . . 0.0 109.76 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.65 -22.44 58.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.198 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -69.85 -44.05 70.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.55 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.8 pt20 -78.14 -33.59 50.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.55 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 23.3 mt -102.37 56.22 0.79 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.319 0.58 . . . . 0.0 109.582 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -74.69 96.21 2.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.392 -173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.13 -18.47 42.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.23 138.14 19.64 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.457 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.47 157.65 52.56 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.914 2.409 . . . . 0.0 112.963 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.04 124.56 31.87 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.742 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.463 ' O ' HD11 ' B' ' 52' ' ' LEU . 70.9 mt -96.27 127.0 41.92 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.49 135.62 18.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.06 1.84 . . . . 0.0 111.559 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.463 HD11 ' O ' ' B' ' 50' ' ' ILE . 4.9 mp -134.85 131.19 37.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -111.2 118.9 37.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.659 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.802 HG12 HG12 ' A' ' 54' ' ' ILE . 29.7 mt -106.93 125.73 62.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.962 0.411 . . . . 0.0 110.696 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -108.72 137.27 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.297 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.552 ' O ' ' HB2' ' B' ' 5' ' ' MET . 39.5 t -93.35 119.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.401 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.3 171.11 16.1 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 118.77 -1.681 . . . . 0.0 114.37 169.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' B' ' 60' ' ' THR . 33.7 mt-10 -70.63 -40.01 73.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.719 -0.741 . . . . 0.0 112.184 -169.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.38 -26.6 0.17 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' THR . . . . . 0.494 ' H ' ' C ' ' B' ' 58' ' ' GLU . 23.7 m 83.65 -16.61 0.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.972 0.909 . . . . 0.0 111.13 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 64.51 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.347 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.462 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.72 -89.95 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.055 0.542 . . . . 0.0 111.676 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -96.88 -25.59 15.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.111 0.482 . . . . 0.0 110.397 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.12 103.18 12.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.2 ptp -120.53 133.29 24.02 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.167 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.84 131.66 43.27 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.977 2.451 . . . . 0.0 111.639 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -112.13 136.82 51.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -115.1 139.81 49.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.11 123.37 36.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.98 158.63 43.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.525 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 129.38 50.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.816 0.341 . . . . 0.0 110.494 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD22 ' B' ' 20' ' ' LEU . 57.7 mt -119.98 146.29 45.98 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.32 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' A' ' 45' ' ' SER . 20.0 m-70 -70.77 127.35 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.001 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.55 112.03 3.97 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.171 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.24 3.98 56.5 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.422 -0.418 . . . . 0.0 113.125 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.4 156.66 17.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.965 0.412 . . . . 0.0 110.948 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -96.39 138.53 33.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.086 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.31 154.46 46.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.716 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.651 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.5 m80 -95.84 117.67 31.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.639 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD22 HD11 ' B' ' 12' ' ' LEU . 8.4 tp -108.85 120.83 43.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.37 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 10.5 mt -129.22 126.52 64.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.914 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.29 133.76 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.28 169.77 16.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 132.79 55.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 112.369 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.5 160.08 32.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.7 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.0 t -61.03 -24.56 66.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.96 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.563 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.1 mt -83.53 -12.38 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.441 . . . . 0.0 110.41 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.29 13.63 26.18 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.861 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.563 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 55.7 m-80 -85.65 129.34 55.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.56 148.74 42.82 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.962 . . . . 0.0 111.896 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -130.4 143.25 50.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.18 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.496 HD22 HD11 ' A' ' 54' ' ' ILE . 17.9 tp -124.29 133.33 53.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.635 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 15.7 m -131.96 120.82 23.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.5 t -127.77 122.11 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.268 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -121.78 133.15 24.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.62 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.82 137.14 66.16 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.307 2.005 . . . . 0.0 111.702 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.7 t -65.9 -23.65 66.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.51 . . . . 0.0 109.87 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -143.38 107.14 5.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.346 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.64 -18.59 64.89 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.073 2.515 . . . . 0.0 113.166 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.55 -22.72 43.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.632 0.253 . . . . 0.0 110.77 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -68.37 -25.08 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.136 0.493 . . . . 0.0 110.124 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.57 -32.98 72.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.345 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -79.57 -43.02 23.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.01 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -92.64 63.87 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.548 ' HB3' ' HE1' ' A' ' 13' ' ' HIS . 5.4 p -82.77 73.02 9.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.38 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.82 2.32 53.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.15 131.0 23.12 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.042 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.23 144.61 69.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.31 2.006 . . . . 0.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -87.25 129.79 34.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 52' ' ' LEU . 68.5 mt -104.91 122.25 43.9 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 168.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HG3' ' H ' ' B' ' 59' ' ' ASN . 73.0 Cg_endo -77.24 137.34 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.397 2.065 . . . . 0.0 111.557 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.42 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -129.21 136.6 50.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.082 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 m -111.29 116.82 31.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.844 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.778 HG12 HG12 ' B' ' 54' ' ' ILE . 38.6 mt -107.66 127.07 63.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.949 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.35 141.41 46.11 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.738 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.0 141.41 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.935 0.398 . . . . 0.0 110.021 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.92 159.54 13.68 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.033 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.63 54.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 109.979 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.478 ' H ' ' HG3' ' B' ' 51' ' ' PRO . 9.0 t30 60.74 81.72 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.96 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.8 p -115.14 6.28 15.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.7 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.68 -32.65 57.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.767 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.474 HG21 HD22 ' A' ' 59' ' ' ASN . 8.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.981 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.1 -90.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.698 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -96.79 -24.97 15.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 110.494 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -107.7 102.96 12.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.576 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 17.4 ptp -120.56 133.02 23.98 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.245 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.61 132.21 46.88 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.844 2.363 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -112.86 136.85 52.03 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.991 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.21 140.09 49.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.54 122.87 34.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.59 158.46 43.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.538 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.0 129.19 50.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.956 0.408 . . . . 0.0 110.585 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.456 HD11 HD22 ' A' ' 20' ' ' LEU . 57.6 mt -119.85 146.25 45.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.465 -173.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' B' ' 45' ' ' SER . 19.7 m-70 -70.92 127.54 32.93 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.89 112.11 4.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.032 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 4.32 56.46 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.01 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.75 156.35 17.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.949 0.404 . . . . 0.0 110.849 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 15.3 m -95.97 138.65 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.128 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -129.43 154.19 47.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.737 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.621 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.5 m80 -95.59 117.73 30.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.454 HD22 HD11 ' A' ' 12' ' ' LEU . 8.2 tp -108.99 120.86 43.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.344 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 10.4 mt -129.23 126.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.986 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.23 133.59 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.51 169.5 17.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.6 55.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.76 0.791 . . . . 0.0 112.526 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.97 160.23 32.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.751 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 t -61.44 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.082 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.581 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 52.1 mt -84.04 -12.43 55.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.33 13.75 25.8 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.985 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 52.9 m-80 -85.95 129.37 54.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 110.334 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.59 148.72 42.66 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.253 1.969 . . . . 0.0 111.917 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -130.59 142.96 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.244 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.493 HD22 HD11 ' B' ' 54' ' ' ILE . 18.0 tp -123.96 133.56 53.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.901 0.381 . . . . 0.0 110.497 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.5 m -132.26 120.5 22.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.942 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.9 t -127.32 122.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.63 133.21 24.18 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.766 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.11 137.6 67.57 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.149 1.9 . . . . 0.0 111.667 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -66.16 -23.46 66.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.232 0.539 . . . . 0.0 109.876 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -143.62 106.88 5.06 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.404 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.63 -18.64 65.15 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.174 2.583 . . . . 0.0 113.087 -175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.48 -22.6 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.704 0.287 . . . . 0.0 110.852 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.39 -25.44 65.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.23 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.45 -32.71 71.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.398 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -79.69 -43.11 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 110.042 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.8 mt -92.38 63.62 4.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.063 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' SER . . . . . 0.548 ' HB3' ' HE1' ' B' ' 13' ' ' HIS . 4.9 p -82.69 72.54 9.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.28 2.11 53.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.95 131.73 22.41 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.992 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.48 144.41 67.04 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.478 2.119 . . . . 0.0 112.142 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -87.41 129.79 34.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.419 ' O ' HD12 ' B' ' 52' ' ' LEU . 68.9 mt -104.89 122.3 43.76 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.478 ' HG3' ' H ' ' A' ' 59' ' ' ASN . 72.4 Cg_endo -77.11 137.32 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.461 2.107 . . . . 0.0 111.599 175.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.419 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -129.4 136.32 49.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -110.94 116.64 31.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.834 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.778 HG12 HG12 ' A' ' 54' ' ' ILE . 39.5 mt -107.53 127.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.209 0.528 . . . . 0.0 111.096 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -112.35 141.34 46.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.699 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.07 141.74 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.845 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.93 159.19 13.87 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.03 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.68 55.32 0.82 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.412 0.625 . . . . 0.0 110.001 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.494 ' H ' ' HG3' ' A' ' 51' ' ' PRO . 8.8 t30 60.02 81.54 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.057 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 17.3 p -115.17 6.5 15.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.25 -32.89 55.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.718 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.467 HG21 HD22 ' B' ' 59' ' ' ASN . 6.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.218 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.95 64.03 1.55 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -66.9 0.87 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.98 -172.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.23 58.2 1.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.604 . . . . 0.0 110.277 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.704 ' HE2' ' HB3' ' A' ' 55' ' ' PHE . 16.0 ptm -88.97 114.63 60.88 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.372 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.853 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 20.1 Cg_endo -59.9 140.4 92.82 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 112.353 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 m -115.75 136.46 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.168 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.69 147.0 45.09 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.97 124.03 30.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.97 158.1 44.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 49' ' ' LEU . . . -122.16 129.01 51.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.932 0.396 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD11 HD23 ' B' ' 20' ' ' LEU . 60.7 mt -118.36 141.44 48.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.585 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.528 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 29.1 m80 -71.17 127.64 33.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.196 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.63 110.43 2.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.699 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.44 -1.12 46.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.787 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -87.88 152.27 22.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.025 0.44 . . . . 0.0 110.846 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.7 m -100.25 133.08 45.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.413 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.463 ' HB3' HG13 ' A' ' 34' ' ' VAL . 88.0 m-85 -124.19 152.88 42.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.638 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m170 -95.51 117.21 29.98 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.444 HD23 HD11 ' B' ' 12' ' ' LEU . 11.8 tp -108.02 121.08 44.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.395 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -131.34 126.2 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.345 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.94 132.41 61.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.79 152.34 39.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.984 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 p -107.17 141.68 38.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -175.04 4.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.3 p -55.38 -31.65 61.98 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.3 mt -87.06 -20.71 26.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.981 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 16.87 14.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.289 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 42.0 m-80 -82.33 128.82 65.84 Favored Pre-proline 0 CA--C 1.511 -0.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' CG ' HG22 ' A' ' 56' ' ' VAL . 56.6 Cg_endo -73.02 143.13 35.74 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.44 2.093 . . . . 0.0 112.182 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -127.72 147.39 50.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 HD13 ' A' ' 54' ' ' ILE . 14.5 tp -119.35 129.82 55.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.899 0.381 . . . . 0.0 110.844 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -127.06 119.59 26.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.755 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.0 t -125.62 122.47 62.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.057 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.18 131.19 24.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 148.51 81.01 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.78 2.32 . . . . 0.0 112.205 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 p -68.88 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.353 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -132.99 104.41 12.7 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.526 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.08 74.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.842 2.361 . . . . 0.0 112.238 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -82.6 -24.46 33.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.729 ' HA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.34 -24.72 61.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.118 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.528 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 49.3 mm-40 -65.76 -31.73 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.129 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.97 -43.1 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.4 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 58.94 5.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.81 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -77.48 76.43 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.395 0.617 . . . . 0.0 112.02 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.11 -15.58 61.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.079 0.942 . . . . 0.0 108.498 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -101.89 145.12 29.92 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.951 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.52 159.73 32.13 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 111.765 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 60.4 mt -94.55 131.59 40.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.137 0.494 . . . . 0.0 111.013 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 52' ' ' LEU . 69.8 mt -99.54 124.05 45.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 57.8 Cg_endo -74.7 137.47 22.5 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.194 1.929 . . . . 0.0 111.391 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.449 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -133.48 131.9 40.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 m -109.64 117.5 34.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.493 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.607 HG12 HG12 ' B' ' 54' ' ' ILE . 24.5 mt -107.03 123.33 62.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.341 0.591 . . . . 0.0 110.686 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.704 ' HB3' ' HE2' ' A' ' 5' ' ' MET . 58.0 m-85 -106.67 137.88 43.87 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.663 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.853 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.7 t -83.66 133.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.452 . . . . 0.0 109.881 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.572 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -81.31 122.47 5.71 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.644 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.06 95.62 3.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.061 0.934 . . . . 0.0 110.413 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -54.49 110.0 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.948 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 t -137.74 165.89 25.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.71 77.44 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.284 -178.68 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.31 63.9 1.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.6 mmm -97.09 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.02 -172.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.9 57.69 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.303 0.573 . . . . 0.0 110.12 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.688 ' HE2' ' HB3' ' B' ' 55' ' ' PHE . 15.7 ptm -88.39 114.44 59.63 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.442 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.862 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 19.9 Cg_endo -59.72 140.67 94.57 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.378 2.719 . . . . 0.0 112.247 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.08 136.03 53.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.234 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.32 147.13 44.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.06 124.09 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.78 158.27 44.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.555 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . . . -122.41 128.82 51.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.444 HD11 HD23 ' A' ' 20' ' ' LEU . 60.8 mt -118.43 141.46 48.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.674 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 29.4 m80 -71.07 127.39 32.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.78 110.94 3.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.544 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.96 -2.59 44.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.715 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -86.96 152.37 22.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.93 0.395 . . . . 0.0 110.925 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -100.59 132.98 45.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.463 175.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.479 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.5 m-85 -123.84 152.85 41.84 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.152 0.501 . . . . 0.0 110.644 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.4 m170 -95.66 117.12 29.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.44 HD23 HD11 ' A' ' 12' ' ' LEU . 11.6 tp -108.13 121.1 44.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.14 126.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.316 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 p -112.62 132.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.51 152.27 39.49 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -107.18 141.85 37.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.57 -175.21 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.34 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 48.4 p -55.31 -31.74 61.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.527 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 54.8 mt -86.71 -21.27 26.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 16.8 14.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.273 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.6 m-80 -82.41 128.98 65.01 Favored Pre-proline 0 CA--C 1.51 -0.569 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.535 ' CG ' HG22 ' B' ' 56' ' ' VAL . 56.9 Cg_endo -73.21 143.37 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.292 1.995 . . . . 0.0 112.221 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -127.69 147.29 50.38 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.43 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.514 HD22 HD13 ' B' ' 54' ' ' ILE . 14.4 tp -119.2 130.03 55.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.855 0.36 . . . . 0.0 110.753 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -127.37 119.63 26.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.843 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.1 t -125.78 122.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.034 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.26 131.01 24.34 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.682 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.15 148.76 81.48 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.76 2.307 . . . . 0.0 112.335 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.5 p -69.4 -27.16 65.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.321 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -133.64 104.32 12.03 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.491 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.57 74.13 Favored 'Trans proline' 0 C--N 1.34 0.101 0 C-N-CA 122.748 2.299 . . . . 0.0 112.122 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.92 -24.61 35.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.716 ' HA ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -72.08 -24.72 61.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.146 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.514 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 50.0 mm-40 -65.85 -32.06 73.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.903 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.44 -43.06 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.538 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.8 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.3 p -77.56 76.32 4.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.326 0.584 . . . . 0.0 111.989 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.78 -15.92 61.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -101.62 145.06 29.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.855 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.42 159.66 32.52 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.611 2.207 . . . . 0.0 111.653 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' B' ' 11' ' ' ALA . 61.3 mt -94.15 131.53 39.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.004 0.43 . . . . 0.0 111.134 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.427 ' O ' HD13 ' B' ' 52' ' ' LEU . 69.2 mt -99.49 124.11 45.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 168.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.572 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 57.4 Cg_endo -74.79 137.46 22.25 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.237 1.958 . . . . 0.0 111.406 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.458 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.4 mp -133.38 132.22 40.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.907 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -109.91 117.42 33.76 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 54' ' ' ILE . 24.3 mt -106.9 123.37 61.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.18 0.514 . . . . 0.0 110.702 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.688 ' HB3' ' HE2' ' B' ' 5' ' ' MET . 56.6 m-85 -106.69 137.95 43.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.553 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.862 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.7 t -83.55 133.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.562 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -81.41 121.98 5.57 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.606 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -74.71 94.94 2.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -54.09 109.92 0.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.841 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -137.51 166.28 24.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.52 77.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.274 -177.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 111.846 -0.501 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.59 48.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.017 0.437 . . . . 0.0 111.114 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.7 -58.97 2.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.479 . . . . 0.0 109.722 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.87 82.02 2.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.83 ' HE2' ' HB3' ' A' ' 55' ' ' PHE . 16.9 ptm -78.39 128.51 77.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.27 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.705 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 32.7 Cg_endo -64.69 134.76 42.17 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.356 2.704 . . . . 0.0 112.251 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m -116.63 134.72 54.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.232 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -115.3 140.42 49.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.905 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -125.61 123.71 39.61 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.496 HD21 HG21 ' A' ' 34' ' ' VAL . 1.7 pp -141.11 158.15 44.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.688 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -121.74 128.6 51.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 110.44 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD13 HD23 ' B' ' 20' ' ' LEU . 58.0 mt -120.62 141.23 50.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.536 -174.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 36.5 m80 -70.91 132.96 46.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.378 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.71 110.93 3.31 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.737 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.9 58.24 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.552 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -89.56 144.17 26.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 37' ' ' SER . 12.2 m -93.74 137.32 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.017 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.448 ' HB3' HG12 ' A' ' 34' ' ' VAL . 85.9 m-85 -129.75 154.64 46.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 0.0 110.802 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.674 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 3.1 m170 -95.26 117.41 30.23 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.071 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 32' ' ' LEU . 11.8 tp -108.74 121.4 44.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.173 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 11.2 mt -131.3 126.59 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -116.07 133.56 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -142.99 170.02 16.48 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -124.18 141.53 51.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.7 0.286 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -176.13 6.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.721 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -65.88 -30.43 71.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.057 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.459 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 61.1 mt -76.28 -23.97 54.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 0.0 111.305 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.41 20.42 9.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.436 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 40.2 m-80 -94.73 135.95 23.43 Favored Pre-proline 0 CA--C 1.509 -0.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' CB ' HG21 ' A' ' 56' ' ' VAL . 72.2 Cg_endo -76.27 147.67 29.63 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.542 2.161 . . . . 0.0 112.09 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -126.52 140.04 52.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD13 HD13 ' A' ' 20' ' ' LEU . 10.9 tp -122.44 122.32 38.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.037 0.446 . . . . 0.0 110.507 -175.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 16.7 m -116.86 119.18 34.59 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.913 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 77.8 t -123.86 122.17 63.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.9 131.27 23.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.482 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.1 Cg_endo -61.22 133.51 47.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.168 1.912 . . . . 0.0 111.922 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.457 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 8.7 t -70.62 -37.07 73.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -107.81 101.18 39.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.65 -29.4 29.82 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.522 2.148 . . . . 0.0 111.926 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.6 -23.42 56.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.781 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.27 -28.63 66.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 15.2 mm-40 -69.67 -21.75 63.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -87.55 -42.25 12.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.987 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.0 43.49 1.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.697 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -74.4 87.42 2.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.37 0.605 . . . . 0.0 112.16 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -92.61 -1.62 56.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.81 142.39 24.5 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.48 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.12 152.3 50.67 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.464 2.109 . . . . 0.0 112.158 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.455 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 29.9 mt -92.49 120.63 33.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.713 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HD11 ' A' ' 52' ' ' LEU . 78.2 mt -93.06 123.62 60.52 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.01 136.37 16.38 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.269 1.979 . . . . 0.0 111.521 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 50' ' ' ILE . 5.3 mp -129.32 133.55 47.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.989 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -109.42 115.67 30.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.74 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' B' ' 54' ' ' ILE . 28.5 mt -107.6 125.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.187 0.518 . . . . 0.0 110.715 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.83 ' HB3' ' HE2' ' A' ' 5' ' ' MET . 72.8 m-85 -108.64 132.84 53.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -84.85 136.91 21.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.071 0.462 . . . . 0.0 110.661 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.61 15.65 Favored Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.889 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -137.05 41.0 2.49 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.06 0.933 . . . . 0.0 109.032 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -127.64 123.15 34.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.468 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -147.55 84.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.365 0.602 . . . . 0.0 109.575 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.47 -55.26 0.51 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.77 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.595 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.179 -0.368 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.35 48.57 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.093 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.0 mtp -87.12 -59.93 2.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.09 82.46 2.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.806 ' HE2' ' HB3' ' B' ' 55' ' ' PHE . 17.0 ptm -78.98 128.34 76.75 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.235 -174.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.7 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 34.4 Cg_endo -64.54 134.43 41.25 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.241 2.628 . . . . 0.0 112.256 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.44 134.92 54.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -115.39 140.56 49.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.926 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.406 ' HH ' ' HB2' ' B' ' 51' ' ' PRO . 8.7 t80 -125.98 123.68 39.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.49 HD21 HG21 ' B' ' 34' ' ' VAL . 1.7 pp -141.21 158.35 44.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.729 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.1 128.33 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.861 0.362 . . . . 0.0 110.534 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.434 HD13 HD23 ' A' ' 20' ' ' LEU . 58.1 mt -120.38 141.22 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.585 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 36.4 m80 -70.68 132.64 45.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.422 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.16 110.71 3.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.686 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.07 -0.43 58.89 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.522 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -89.68 144.22 26.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' B' ' 37' ' ' SER . 14.3 m -93.8 137.12 33.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.996 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.434 ' HB3' HG12 ' B' ' 34' ' ' VAL . 85.5 m-85 -129.67 154.46 47.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.235 0.541 . . . . 0.0 110.572 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.667 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 3.1 m170 -95.09 117.27 29.91 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.118 172.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.532 HD13 HD13 ' B' ' 32' ' ' LEU . 11.6 tp -108.54 121.36 44.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.251 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 11.3 mt -131.39 126.29 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.86 133.56 61.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -143.0 170.19 16.16 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.855 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.6 p -124.16 141.63 51.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.661 0.267 . . . . 0.0 110.948 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -175.57 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t -66.54 -30.56 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.943 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 64.6 mt -76.11 -23.66 54.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.607 0.242 . . . . 0.0 111.162 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 20.27 9.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.278 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.2 m-80 -94.68 135.75 23.65 Favored Pre-proline 0 CA--C 1.511 -0.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.515 ' CB ' HG21 ' B' ' 56' ' ' VAL . 71.7 Cg_endo -75.98 147.87 30.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.472 2.114 . . . . 0.0 112.178 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -126.81 139.91 52.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.532 HD13 HD13 ' B' ' 20' ' ' LEU . 11.1 tp -122.44 122.12 38.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.208 0.527 . . . . 0.0 110.609 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.9 m -116.42 119.26 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.904 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 78.1 t -124.14 121.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 110.234 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.83 131.1 23.74 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.377 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.473 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.4 Cg_endo -61.38 133.27 45.22 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.229 1.953 . . . . 0.0 112.007 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.445 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 8.7 t -70.13 -37.01 75.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -107.98 101.34 40.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.84 -29.1 29.08 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.447 2.098 . . . . 0.0 112.121 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.73 -23.43 56.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.841 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.398 0.618 . . . . 0.0 110.182 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 15.9 mm-40 -69.76 -21.71 63.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.148 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -87.63 -42.41 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.003 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 16.1 mt -87.56 43.1 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.823 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -74.13 87.84 1.92 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.461 0.648 . . . . 0.0 112.072 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.26 -1.46 56.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.74 142.36 24.44 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.663 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 152.24 51.11 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.509 2.139 . . . . 0.0 112.135 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.457 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 30.7 mt -92.47 120.82 33.33 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.761 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.448 ' O ' HD11 ' B' ' 52' ' ' LEU . 78.0 mt -93.15 123.86 59.66 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.406 ' HB2' ' HH ' ' B' ' 9' ' ' TYR . 75.7 Cg_endo -77.21 136.13 15.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.289 1.993 . . . . 0.0 111.651 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.448 HD11 ' O ' ' B' ' 50' ' ' ILE . 5.3 mp -129.14 133.28 47.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.959 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -109.25 115.76 30.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.678 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' A' ' 54' ' ' ILE . 27.4 mt -107.74 125.05 64.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.767 -176.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.806 ' HB3' ' HE2' ' B' ' 5' ' ' MET . 72.3 m-85 -108.45 132.8 53.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.848 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.7 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -84.82 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.52 168.86 15.67 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.927 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.48 41.45 2.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.919 0.866 . . . . 0.0 109.046 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -127.69 123.55 35.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.37 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -147.98 83.64 1.51 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.556 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.92 -54.21 0.55 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.678 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.744 -179.619 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.64 69.4 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptp -168.96 155.59 6.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.94 97.17 7.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.255 0.55 . . . . 0.0 109.947 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 21.3 ptp -74.23 142.68 79.02 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.761 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.692 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 21.7 Cg_endo -60.27 132.01 41.71 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.052 2.501 . . . . 0.0 111.809 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -114.24 141.28 47.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.673 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -121.69 148.81 44.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.697 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.43 125.03 26.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 52' ' ' LEU . 1.4 pp -141.17 158.07 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.166 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.29 127.36 53.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.02 140.14 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.567 -175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 16' ' ' GLN . 34.7 m80 -71.71 133.06 45.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.302 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.74 110.93 3.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.848 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.83 47.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.931 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 13' ' ' HIS . 16.4 mm100 -95.46 143.4 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.911 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -87.97 136.25 33.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.07 153.91 47.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.677 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.9 m80 -95.74 117.64 30.9 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.602 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 32' ' ' LEU . 9.1 tp -108.39 120.84 43.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.317 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.13 125.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.79 133.65 63.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.08 170.1 16.37 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p -123.56 136.63 54.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.37 168.7 19.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.765 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 p -54.77 -30.65 57.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.3 mt -73.89 -13.6 60.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.233 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.6 1.07 62.25 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.577 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -75.78 133.58 73.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' ' 56' ' ' VAL . 91.7 Cg_endo -80.15 152.77 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 112.322 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -133.97 140.2 46.58 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 54' ' ' ILE . 13.4 tp -124.78 125.84 44.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -173.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.13 120.62 32.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.03 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.9 t -125.49 122.51 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.17 129.07 24.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.68 136.27 57.19 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.539 2.159 . . . . 0.0 112.332 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 73.1 m -70.48 -25.56 63.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -134.69 103.6 11.05 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.72 -21.16 29.41 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -75.93 -35.73 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.469 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 110.331 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' CD ' ' HD1' ' A' ' 13' ' ' HIS . 27.3 mm-40 -69.97 -41.55 74.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.57 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -73.55 -42.94 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.272 0.558 . . . . 0.0 109.943 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 mt -99.9 71.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 13' ' ' HIS . 1.1 m -67.94 -66.24 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.222 -167.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 44.72 25.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.783 0.801 . . . . 0.0 111.729 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -136.73 138.48 26.41 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.909 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.64 143.6 62.88 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.181 1.92 . . . . 0.0 111.822 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.11 119.46 30.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.071 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.1 mt -87.28 125.71 64.93 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 43.5 Cg_endo -73.84 136.68 23.37 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.826 1.684 . . . . 0.0 110.558 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.511 ' HB2' HD13 ' A' ' 10' ' ' LEU . 4.8 mp -134.39 131.78 38.63 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -111.32 117.65 33.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.797 HG12 HG12 ' B' ' 54' ' ' ILE . 24.9 mt -107.24 123.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.185 0.517 . . . . 0.0 110.764 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 70.4 m-85 -107.68 138.42 43.94 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.015 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.692 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.6 t -84.09 130.42 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.167 0.508 . . . . 0.0 109.951 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.606 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -71.37 122.82 9.84 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.806 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.84 -41.6 87.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 110.958 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -170.41 117.97 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 49.3 m -149.65 81.66 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.62 138.51 18.34 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.464 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.99 179.335 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.49 70.28 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.717 0.294 . . . . 0.0 111.742 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptp -169.74 154.94 5.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.166 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.67 97.84 8.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.093 0.473 . . . . 0.0 109.929 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.542 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 21.2 ptp -74.81 142.57 76.98 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.833 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.691 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 22.3 Cg_endo -60.01 131.93 41.97 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.414 . . . . 0.0 111.761 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -114.36 141.88 47.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.555 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.98 148.9 44.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.74 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.48 125.07 26.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.11 158.06 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.22 127.4 53.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.0 140.14 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.436 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.46 ' HB2' ' HG3' ' B' ' 16' ' ' GLN . 34.5 m80 -71.79 133.07 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.297 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.49 110.88 3.41 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.858 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.58 -0.49 49.43 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.329 -0.463 . . . . 0.0 113.077 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.46 ' HG3' ' HB2' ' B' ' 13' ' ' HIS . 16.6 mm100 -95.58 143.42 26.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 111.006 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 4.1 m -87.82 136.33 33.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.516 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -128.92 153.93 47.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.592 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.9 m80 -95.76 117.78 31.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.47 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.452 HD12 HD12 ' B' ' 32' ' ' LEU . 9.0 tp -108.5 120.8 43.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.417 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.09 125.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.18 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.75 133.67 63.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -140.96 169.91 16.74 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.451 HG23 HD13 ' A' ' 50' ' ' ILE . 1.3 p -122.93 137.03 55.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.21 0.528 . . . . 0.0 111.46 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.67 168.85 18.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.804 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -54.81 -30.89 58.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -73.51 -14.3 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.113 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.88 1.32 61.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.547 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.405 HD21 ' N ' ' B' ' 29' ' ' ASN . 0.9 OUTLIER -76.15 133.15 72.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.435 ' HG3' HG21 ' B' ' 56' ' ' VAL . 93.0 Cg_endo -79.91 152.79 22.16 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.793 2.329 . . . . 0.0 112.284 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -134.06 140.32 46.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.498 HD21 HD13 ' B' ' 54' ' ' ILE . 13.5 tp -125.09 125.89 44.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 -173.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -124.17 120.46 32.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.3 t -125.38 122.36 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.08 128.69 24.1 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.404 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.69 135.67 53.81 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.55 2.166 . . . . 0.0 112.398 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 72.5 m -70.31 -25.23 63.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -134.78 103.72 10.94 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.09 -20.62 28.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.726 2.284 . . . . 0.0 112.843 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -76.25 -35.88 58.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.4 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.42 -23.01 60.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.094 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.402 ' CD ' ' HD1' ' B' ' 13' ' ' HIS . 27.6 mm-40 -70.05 -41.16 74.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.607 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.06 -42.88 59.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.142 0.496 . . . . 0.0 109.967 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.77 70.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' SER . . . . . 0.407 ' HB3' ' NE2' ' B' ' 13' ' ' HIS . 1.1 m -67.71 -66.49 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.155 -167.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.97 25.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.824 0.821 . . . . 0.0 111.48 -171.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -136.71 138.51 26.52 Favored Pre-proline 0 N--CA 1.442 -0.855 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.97 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.77 143.66 62.35 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 23.0 mt -89.95 119.79 30.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.971 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.471 ' O ' HD12 ' B' ' 52' ' ' LEU . 67.0 mt -87.55 125.67 64.53 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.606 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.0 Cg_endo -73.75 136.43 23.18 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.874 1.716 . . . . 0.0 110.716 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' B' ' 10' ' ' LEU . 4.8 mp -134.25 131.71 38.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.971 0.415 . . . . 0.0 110.496 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 5.1 m -111.4 117.32 32.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.631 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.797 HG12 HG12 ' A' ' 54' ' ' ILE . 25.6 mt -107.24 123.74 62.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 71.0 m-85 -107.48 138.4 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.913 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.691 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.5 t -84.01 130.79 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.018 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.603 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -71.4 122.69 9.72 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.002 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.62 -41.78 87.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.443 -0.378 . . . . 0.0 110.994 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -170.29 116.91 0.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.497 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 53.8 m -148.71 81.99 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.52 138.92 19.03 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.155 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.078 178.732 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 127.72 37.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 110.734 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.84 -18.1 17.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 110.061 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -119.29 106.19 12.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -118.6 153.27 52.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.031 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.2 131.19 39.78 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.505 2.137 . . . . 0.0 111.595 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 m -116.88 136.84 52.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.923 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -115.49 145.14 42.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.822 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.96 123.89 29.82 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.8 158.45 43.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.93 128.21 49.1 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' B' ' 22' ' ' VAL . 51.8 mt -121.06 141.34 50.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.677 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 30.2 m80 -71.49 131.32 43.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.52 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.58 111.55 3.99 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.024 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.63 0.87 52.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.723 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -95.09 150.71 19.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.17 0.509 . . . . 0.0 111.204 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -95.03 135.3 36.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.604 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.55 152.89 47.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.48 0.657 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.7 m80 -95.98 117.88 31.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.839 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD21 HD12 ' B' ' 12' ' ' LEU . 7.7 tp -108.78 121.36 44.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.159 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mt -129.57 126.49 63.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.076 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' B' ' 12' ' ' LEU . 13.5 p -117.92 135.05 59.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -147.54 170.88 16.5 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.32 136.24 54.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.309 0.576 . . . . 0.0 111.88 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.25 165.64 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.005 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.1 m -54.88 -31.16 59.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 71.4 mt -73.11 -17.57 61.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.421 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.88 2.9 39.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.546 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 7.7 p30 -85.99 142.23 36.17 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CG ' HG23 ' A' ' 56' ' ' VAL . 44.2 Cg_endo -85.25 153.02 10.79 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.565 2.176 . . . . 0.0 112.434 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -126.24 149.9 48.77 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 54' ' ' ILE . 11.3 tp -128.67 123.86 34.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.703 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.5 m -122.0 119.47 31.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.999 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.8 t -124.17 122.42 64.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.072 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.76 131.34 24.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.783 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.34 136.36 50.76 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 122.331 2.02 . . . . 0.0 111.68 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.4 m -70.68 -25.18 62.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.078 0.466 . . . . 0.0 110.362 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -132.82 102.92 13.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.65 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.67 -21.31 39.25 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.797 2.331 . . . . 0.0 112.253 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -74.89 -32.71 61.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -73.65 -21.34 60.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.245 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 19.0 mm-40 -69.27 -35.19 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.923 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.88 -43.26 36.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.046 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 67.46 4.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 p -78.39 81.34 4.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.466 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.78 -7.85 59.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 p -102.44 137.66 19.46 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.603 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.16 156.36 46.83 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.435 2.09 . . . . 0.0 111.281 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.4 mt -87.66 138.8 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.445 ' O ' HD12 ' A' ' 52' ' ' LEU . 87.0 mt -108.73 124.06 35.4 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.547 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 73.5 Cg_endo -77.58 136.57 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.294 1.996 . . . . 0.0 111.675 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 50' ' ' ILE . 4.9 mp -133.93 130.09 37.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 m -109.21 118.63 37.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.564 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.744 HG12 HG12 ' B' ' 54' ' ' ILE . 37.0 mt -107.5 126.38 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.107 0.48 . . . . 0.0 110.777 -176.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -109.57 138.71 45.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.571 HG23 ' CG ' ' A' ' 30' ' ' PRO . 1.1 t -89.4 140.86 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.228 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.514 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -110.71 -171.18 19.6 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.937 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -112.39 101.19 9.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.923 0.361 . . . . 0.0 111.504 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 72.0 -52.58 0.7 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.735 0.814 . . . . 0.0 113.196 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -144.57 162.88 35.51 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.994 -0.441 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.76 35.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.93 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.447 178.76 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.71 128.04 37.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.772 0.32 . . . . 0.0 110.725 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 73.2 mtm -100.17 -19.09 16.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -118.49 106.46 12.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.17 153.47 53.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.865 -174.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.18 131.39 40.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 111.593 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.2 m -116.94 137.03 52.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.51 144.92 43.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.143 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.68 123.9 30.38 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.64 158.57 43.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.666 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.96 128.37 49.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.476 ' HB2' HG12 ' A' ' 22' ' ' VAL . 50.9 mt -121.14 141.47 50.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 -173.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 30.0 m80 -71.45 130.98 42.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.558 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.39 111.88 4.25 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.085 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 1.16 53.34 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.842 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -95.64 150.62 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.18 0.514 . . . . 0.0 111.129 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -94.88 135.36 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.445 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -128.62 153.12 47.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.351 0.596 . . . . 0.0 110.68 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.8 m80 -96.23 117.83 31.57 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.842 172.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 tp -108.56 121.51 45.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.222 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.65 126.3 62.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.095 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.427 HG12 ' HB2' ' A' ' 12' ' ' LEU . 13.6 p -117.23 134.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -147.44 170.97 16.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.12 136.83 53.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.225 0.536 . . . . 0.0 111.737 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.09 165.97 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.115 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -55.03 -30.93 60.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.544 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 71.9 mt -73.35 -17.94 61.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.828 0.347 . . . . 0.0 111.293 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.06 39.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.544 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 7.7 p30 -85.96 142.61 36.56 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.403 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.566 ' CG ' HG23 ' B' ' 56' ' ' VAL . 44.2 Cg_endo -85.46 153.37 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.658 2.239 . . . . 0.0 112.377 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -126.51 150.12 48.95 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.465 HD21 HD12 ' B' ' 54' ' ' ILE . 11.3 tp -128.85 123.7 33.42 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.746 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -121.96 119.24 30.92 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.144 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.0 t -123.99 122.67 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 110.081 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.91 131.47 24.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.859 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.62 136.21 48.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.293 1.995 . . . . 0.0 111.708 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 52.0 m -70.43 -25.34 63.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -132.87 102.91 13.26 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.725 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.01 -21.04 37.54 Favored 'Trans proline' 0 CA--C 1.526 0.116 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -74.99 -32.72 61.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.593 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -73.71 -21.53 60.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.25 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.45 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 20.0 mm-40 -68.82 -35.68 77.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.868 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.57 -43.36 39.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.036 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.9 mt -92.75 67.42 4.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -78.32 81.17 4.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.482 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -80.83 -7.08 59.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.958 0.885 . . . . 0.0 108.712 167.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 5.0 p -103.11 137.72 19.34 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.437 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.24 156.1 46.53 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.454 2.103 . . . . 0.0 111.58 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 48.9 mt -87.79 138.55 31.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.0 110.708 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.44 ' O ' HD12 ' B' ' 52' ' ' LEU . 85.3 mt -108.53 123.82 36.22 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 167.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.514 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 74.0 Cg_endo -77.37 136.55 15.94 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.065 . . . . 0.0 111.475 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.44 ' HB2' HD13 ' B' ' 10' ' ' LEU . 4.9 mp -133.89 130.11 37.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 m -108.83 118.72 37.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.733 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.744 HG12 HG12 ' A' ' 54' ' ' ILE . 37.0 mt -107.57 126.49 63.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.115 0.483 . . . . 0.0 110.793 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -109.66 138.61 45.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.512 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.566 HG23 ' CG ' ' B' ' 30' ' ' PRO . 1.1 t -89.45 140.72 15.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.155 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.547 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -110.6 -171.5 19.74 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.136 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -112.17 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.614 -0.345 . . . . 0.0 111.642 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.11 -52.41 0.7 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 170.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -144.92 163.02 35.41 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.81 35.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.991 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.243 0.758 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.368 179.185 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.12 54.79 3.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.501 . . . . 0.0 110.371 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.1 ttp -160.32 110.15 1.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.52 144.19 28.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.919 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.533 ' HE1' ' HB3' ' A' ' 55' ' ' PHE . 80.5 mtp -108.78 113.47 59.61 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 110.618 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 55' ' ' PHE . 86.4 Cg_exo -51.85 139.25 50.35 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.502 2.801 . . . . 0.0 112.096 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.2 132.28 56.68 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.597 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -122.01 140.94 51.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.703 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 124.32 41.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.261 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD23 HG23 ' A' ' 34' ' ' VAL . 1.5 pp -141.42 157.9 44.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.249 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . . . -119.27 127.42 53.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.368 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.401 HD12 HD21 ' B' ' 20' ' ' LEU . 65.6 mt -119.49 141.99 48.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.189 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -70.56 127.16 31.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.99 104.34 0.79 Allowed Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.144 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.29 11.86 26.58 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.623 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.425 ' OE1' ' HG2' ' A' ' 41' ' ' GLN . 25.4 mm-40 -109.57 154.83 22.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 111.599 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -96.66 137.16 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.654 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' HB3' HG11 ' A' ' 34' ' ' VAL . 74.4 m-85 -129.61 154.89 46.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.852 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.685 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.6 m170 -95.03 117.62 30.47 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.321 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD11 HD13 ' A' ' 32' ' ' LEU . 11.9 tp -110.64 123.15 49.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.51 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 13.8 mt -131.25 126.53 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.56 127.9 74.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.54 151.09 47.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.181 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -108.09 135.53 49.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -174.87 5.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -64.05 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.727 0.298 . . . . 0.0 111.563 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.546 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -80.39 -24.48 39.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.59 17.96 9.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.436 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 31.1 m-80 -92.88 135.53 25.93 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.445 ' CG ' HG22 ' A' ' 56' ' ' VAL . 71.4 Cg_endo -75.07 144.08 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.522 2.148 . . . . 0.0 111.85 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.2 t -127.48 140.24 52.28 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD23 HD12 ' A' ' 54' ' ' ILE . 12.6 tp -120.05 129.19 54.11 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.744 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 36.1 m -126.13 119.98 28.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.995 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 74.1 t -123.41 121.77 63.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.5 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.12 129.66 24.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.445 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.46 137.04 75.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.545 2.163 . . . . 0.0 112.16 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.0 t -68.94 -21.05 64.22 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.431 0.634 . . . . 0.0 109.998 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -140.29 103.24 6.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -11.71 33.0 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.541 2.161 . . . . 0.0 112.728 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -86.95 -27.67 23.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.033 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HG2' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mp0 -69.41 -23.78 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.85 -33.26 75.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.442 0.639 . . . . 0.0 109.672 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -85.21 -42.23 14.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.668 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.16 55.27 2.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.9 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -78.88 94.84 5.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.402 0.62 . . . . 0.0 112.075 -174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.13 -10.99 51.37 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 p -101.94 132.55 21.48 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.229 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.86 160.07 48.83 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 48.1 mt -92.91 120.15 32.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.111 0.481 . . . . 0.0 111.082 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.503 ' O ' HD13 ' A' ' 52' ' ' LEU . 80.8 mt -91.13 127.94 49.46 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.001 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.28 134.86 19.71 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.109 1.873 . . . . 0.0 111.739 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -136.02 135.18 39.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.371 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.4 m -115.38 120.95 41.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.849 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.81 HG12 HG12 ' B' ' 54' ' ' ILE . 31.8 mt -108.56 129.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' HB3' ' HE1' ' A' ' 5' ' ' MET . 85.6 m-85 -111.56 138.75 47.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG22 ' CG ' ' A' ' 30' ' ' PRO . 42.4 t -95.27 118.45 41.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.68 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.97 175.07 17.81 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.606 169.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.41 105.08 17.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.859 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.52 -8.3 47.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.7 p -67.56 -57.25 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.041 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 65.21 2.68 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.635 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.835 -178.187 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.41 55.06 3.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.179 0.514 . . . . 0.0 110.323 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 53.5 ttp -160.5 109.66 1.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.124 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.15 144.08 29.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.075 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.547 ' HE1' ' HB3' ' B' ' 55' ' ' PHE . 80.6 mtp -108.56 113.22 60.22 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.564 -176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' B' ' 55' ' ' PHE . 88.9 Cg_exo -51.86 139.15 50.66 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 C-N-CA 123.439 2.76 . . . . 0.0 112.248 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.36 132.18 56.64 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.709 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.9 140.8 51.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.631 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.57 123.98 41.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.294 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.507 HD23 HG23 ' B' ' 34' ' ' VAL . 1.6 pp -141.12 158.09 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.18 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . . . -119.91 127.09 52.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.134 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.404 HD12 HD21 ' A' ' 20' ' ' LEU . 65.8 mt -119.43 141.74 48.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.189 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -70.31 127.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.62 104.13 0.73 Allowed Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.159 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 11.74 26.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.676 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.419 ' OE1' ' HG2' ' B' ' 41' ' ' GLN . 26.3 mm-40 -109.53 155.14 21.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -97.18 137.07 36.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.416 ' HB3' HG11 ' B' ' 34' ' ' VAL . 73.3 m-85 -129.61 154.85 46.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.789 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.686 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 5.6 m170 -95.19 117.56 30.44 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.256 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.486 HD11 HD13 ' B' ' 32' ' ' LEU . 11.7 tp -110.35 123.11 49.25 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.489 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mt -131.26 126.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.47 127.84 73.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -138.81 151.24 46.87 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -108.1 136.07 48.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.968 0.413 . . . . 0.0 111.041 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -175.03 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.48 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.2 m -63.79 -30.57 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.714 0.292 . . . . 0.0 111.52 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.537 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 41.7 mt -80.63 -24.3 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.265 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.19 18.22 9.42 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.474 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.537 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 30.0 m-80 -92.76 135.43 26.23 Favored Pre-proline 0 CA--C 1.511 -0.548 0 CA-C-O 121.028 0.442 . . . . 0.0 109.841 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.436 ' CG ' HG22 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -75.04 143.98 29.58 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.499 2.132 . . . . 0.0 111.858 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -127.61 140.28 52.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.526 HD23 HD12 ' B' ' 54' ' ' ILE . 12.6 tp -119.62 129.75 54.76 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.768 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m -126.47 120.04 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.751 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 74.9 t -123.71 121.48 62.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 0.0 110.419 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.89 129.75 24.47 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 136.62 71.99 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.196 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 16.4 t -68.25 -21.68 64.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.155 0.503 . . . . 0.0 109.789 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -139.81 103.46 6.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.938 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.6 -12.22 34.94 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.694 2.262 . . . . 0.0 112.601 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -86.43 -27.7 23.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.103 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.419 ' HG2' ' OE1' ' B' ' 16' ' ' GLN . 1.2 mp0 -69.38 -24.0 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 175.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.62 -33.51 75.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.773 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -85.03 -42.06 15.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.787 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.31 55.37 2.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.037 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p -78.92 95.02 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.126 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.89 -10.08 51.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.0 p -102.22 132.46 21.46 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.157 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.85 160.07 48.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.841 2.361 . . . . 0.0 111.802 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' B' ' 11' ' ' ALA . 47.4 mt -93.17 120.06 33.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.933 0.397 . . . . 0.0 111.202 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.5 ' O ' HD13 ' B' ' 52' ' ' LEU . 81.3 mt -91.08 128.02 49.25 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.25 134.98 19.93 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.125 1.883 . . . . 0.0 111.784 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.5 HD13 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -136.19 134.77 38.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.518 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -115.01 120.97 41.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.81 HG12 HG12 ' A' ' 54' ' ' ILE . 30.4 mt -108.56 129.44 63.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.812 0.339 . . . . 0.0 110.769 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.547 ' HB3' ' HE1' ' B' ' 5' ' ' MET . 86.8 m-85 -111.27 138.52 47.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.779 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.436 HG22 ' CG ' ' B' ' 30' ' ' PRO . 41.7 t -95.26 118.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 175.35 18.02 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.119 -1.515 . . . . 0.0 113.583 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -89.04 104.89 17.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -91.22 -7.93 49.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -67.8 -57.03 6.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.07 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.29 2.34 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.582 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.008 -177.875 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.14 -57.43 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.871 0.367 . . . . 0.0 110.701 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp -133.01 150.62 52.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.09 137.84 41.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.435 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 18.8 ptp -125.69 141.42 39.12 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.335 0.588 . . . . 0.0 111.066 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.595 ' HD2' ' CG1' ' A' ' 56' ' ' VAL . 2.8 Cg_exo -68.88 135.52 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.917 2.411 . . . . 0.0 111.569 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 m -113.85 148.73 36.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.158 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -123.47 140.09 53.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.878 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -127.12 123.78 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 34' ' ' VAL . 2.1 pp -140.62 158.62 43.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.85 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.23 128.46 51.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.686 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 HD12 HD23 ' B' ' 20' ' ' LEU . 50.0 mt -123.01 140.5 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 98.2 m-70 -72.05 132.11 43.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.99 108.03 1.57 Allowed Glycine 0 CA--C 1.516 0.142 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.792 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.84 -8.32 42.71 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.595 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -84.16 147.03 27.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.825 0.345 . . . . 0.0 110.255 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 4.4 m -96.22 136.3 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.451 ' HB3' HG12 ' A' ' 34' ' ' VAL . 92.1 m-85 -129.7 153.09 48.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.313 0.578 . . . . 0.0 111.158 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.66 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.4 m80 -95.82 117.64 30.94 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.736 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.545 HD13 HD13 ' A' ' 32' ' ' LEU . 9.7 tp -107.98 123.32 48.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.508 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.65 126.43 54.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.327 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.64 133.69 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -147.17 159.82 43.17 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -116.13 140.69 49.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.87 0.366 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 23.3 p30 -81.3 -174.98 5.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.98 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -62.15 -28.89 69.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 0.0 111.401 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 44.9 mt -82.82 -23.67 33.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 110.64 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.53 19.71 10.21 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.916 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 34.4 m-80 -87.57 131.0 45.12 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 56' ' ' VAL . 58.0 Cg_endo -74.42 144.25 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.277 1.985 . . . . 0.0 112.093 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.6 t -130.06 140.18 50.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 HD13 HD13 ' A' ' 20' ' ' LEU . 13.0 tp -122.97 130.09 52.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.905 0.383 . . . . 0.0 110.734 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -127.29 120.69 29.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.977 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.8 t -123.67 121.77 63.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.087 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.87 132.3 24.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.97 133.57 42.06 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.127 1.885 . . . . 0.0 111.713 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.494 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 50.5 m -73.41 -27.8 61.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.458 . . . . 0.0 110.248 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -121.32 103.57 41.62 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.35 -25.49 42.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.728 2.286 . . . . 0.0 112.86 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -81.75 -16.13 52.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.268 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -73.21 -26.15 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.031 0.443 . . . . 0.0 110.318 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.36 -43.21 13.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.435 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.42 58.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.926 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.405 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 16.0 m -83.89 91.1 7.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -172.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -85.64 -7.41 58.84 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.42 131.91 22.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.843 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.01 155.26 71.62 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.977 2.451 . . . . 0.0 112.173 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -91.04 120.05 31.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.09 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 70.6 mt -91.5 129.25 43.57 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.563 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 44.0 Cg_endo -86.99 136.92 4.34 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.393 2.062 . . . . 0.0 110.953 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' A' ' 10' ' ' LEU . 5.2 mp -130.8 128.72 41.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.769 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -106.22 115.87 30.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.586 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.659 HG12 HG12 ' B' ' 54' ' ' ILE . 27.9 mt -108.38 126.05 65.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -110.27 139.7 45.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.243 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' CG1' ' HD2' ' A' ' 6' ' ' PRO . 12.2 p -87.37 142.78 12.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.197 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -102.53 -167.21 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.301 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 59' ' ' ASN . 1.2 pp20? -108.97 -160.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.795 0.331 . . . . 0.0 111.474 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.467 ' H ' ' HB2' ' A' ' 58' ' ' GLU . 25.4 t-20 -44.72 -43.21 8.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.175 -175.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 p 43.26 52.49 5.65 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 112.172 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.27 109.19 3.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.621 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 119.215 -0.422 . . . . 0.0 109.904 176.466 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.48 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.08 -56.9 1.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.877 0.37 . . . . 0.0 110.755 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 84.4 mtp -133.35 150.73 51.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.277 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.31 137.36 41.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 19.0 ptp -125.23 141.77 39.6 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.409 0.623 . . . . 0.0 111.163 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.591 ' HD2' ' CG1' ' B' ' 56' ' ' VAL . 2.8 Cg_exo -69.43 135.44 31.26 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.744 2.296 . . . . 0.0 111.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 m -113.86 148.51 36.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.253 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -123.26 140.3 53.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.893 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.31 123.62 36.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.469 HD22 HG23 ' B' ' 34' ' ' VAL . 2.0 pp -140.56 158.78 43.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.57 128.53 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.801 0.334 . . . . 0.0 110.591 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 20' ' ' LEU . 49.9 mt -123.1 140.54 52.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 98.2 m-70 -71.99 131.97 43.65 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.71 107.71 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.883 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.89 -8.22 42.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.714 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -84.05 147.23 27.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 4.1 m -96.4 136.22 37.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.453 ' HB3' HG12 ' B' ' 34' ' ' VAL . 92.6 m-85 -129.69 153.21 48.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.113 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.664 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.4 m80 -95.78 117.74 31.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.659 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.528 HD13 HD13 ' B' ' 32' ' ' LEU . 9.7 tp -108.11 123.27 48.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.431 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.57 126.51 55.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.172 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 133.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.54 160.96 41.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 140.21 49.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.917 0.389 . . . . 0.0 110.482 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' B' ' 29' ' ' ASN . 21.1 p30 -81.2 -175.41 5.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.832 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 22.2 t -61.24 -29.59 69.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.775 0.321 . . . . 0.0 111.505 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.557 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 45.5 mt -82.63 -23.9 34.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 0.0 110.463 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.0 10.49 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.048 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 34.2 m-80 -86.95 130.92 46.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.454 ' HG3' HG13 ' B' ' 56' ' ' VAL . 57.9 Cg_endo -74.09 144.36 33.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.313 2.009 . . . . 0.0 112.174 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 41.6 t -130.3 140.02 50.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.528 HD13 HD13 ' B' ' 20' ' ' LEU . 13.0 tp -122.77 130.33 52.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.907 0.384 . . . . 0.0 110.543 -174.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m -127.58 120.73 28.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.056 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.6 t -123.78 121.52 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.331 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.73 132.38 24.28 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.07 133.45 41.17 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.082 1.855 . . . . 0.0 111.688 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 50.5 m -73.35 -27.9 61.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.157 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -121.29 103.65 41.6 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.56 -25.3 41.06 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.803 2.336 . . . . 0.0 112.879 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -81.78 -16.03 52.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.331 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -73.2 -26.04 61.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.077 0.465 . . . . 0.0 110.517 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -70.12 -27.68 64.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.33 -43.25 13.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.319 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -99.48 58.33 1.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.919 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 15.2 m -84.07 91.78 7.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.287 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.4 -7.24 58.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.672 0.749 . . . . 0.0 109.035 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.36 132.3 22.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.775 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.15 155.4 70.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.818 2.345 . . . . 0.0 112.124 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 29.7 mt -90.96 119.98 31.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 71.6 mt -91.51 129.21 43.7 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.573 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.4 Cg_endo -87.25 136.96 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.373 2.049 . . . . 0.0 110.912 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.457 ' HB2' HD11 ' B' ' 10' ' ' LEU . 5.2 mp -130.52 128.81 41.91 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.74 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.5 m -106.29 115.97 31.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 54' ' ' ILE . 27.5 mt -108.5 126.4 65.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -110.57 139.62 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.116 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.591 ' CG1' ' HD2' ' B' ' 6' ' ' PRO . 11.8 p -87.35 142.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.132 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -102.83 -167.22 26.17 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.288 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.473 ' HB2' ' H ' ' B' ' 59' ' ' ASN . 1.1 pp20? -108.83 -159.93 0.7 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.741 0.305 . . . . 0.0 111.505 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' B' ' 58' ' ' GLU . 25.6 t-20 -44.99 -42.92 8.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.226 -174.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 6.6 p 43.23 51.93 5.68 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.91 109.46 3.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.246 0.905 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.025 176.864 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.54 74.44 9.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.21 0.529 . . . . 0.0 110.995 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptm -140.25 147.95 40.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.019 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -96.9 146.36 25.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 18.3 ptp -115.66 141.11 26.92 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.782 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 30.6 Cg_exo -42.75 130.98 5.55 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.786 2.99 . . . . 0.0 113.414 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -118.07 132.45 56.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.246 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.87 140.07 53.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.421 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -124.82 123.77 40.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.08 157.92 44.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.748 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . . . -120.37 128.35 53.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 0.0 110.095 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.455 HD13 HD21 ' B' ' 20' ' ' LEU . 60.0 mt -117.2 141.21 48.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.535 ' CE1' ' HB3' ' A' ' 45' ' ' SER . 97.2 m-70 -70.7 127.58 33.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.7 7.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.533 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -0.74 65.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.631 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -85.73 151.62 23.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 110.608 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 3.0 m -102.03 135.65 43.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.579 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.493 ' HB3' HG12 ' A' ' 34' ' ' VAL . 77.9 m-85 -128.59 154.04 46.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.266 0.555 . . . . 0.0 111.03 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.6 m170 -95.42 116.98 29.54 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 32' ' ' LEU . 15.7 tp -106.36 122.48 46.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.378 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.58 126.36 54.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.315 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.58 139.82 38.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.48 171.21 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -123.02 135.2 54.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.048 0.451 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -178.24 4.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.401 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 m -60.46 -31.09 70.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.8 0.333 . . . . 0.0 111.621 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -81.81 -23.94 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 111.292 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.84 13.12 12.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.384 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 36.0 m-80 -91.63 141.9 26.23 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.565 ' CB ' HG23 ' A' ' 56' ' ' VAL . 74.2 Cg_endo -72.06 147.25 48.39 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.803 2.335 . . . . 0.0 112.329 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.2 t -128.23 141.17 51.54 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 54' ' ' ILE . 15.5 tp -120.73 129.98 53.86 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.619 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -126.17 125.94 43.28 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 55.4 t -127.24 121.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.824 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.54 129.2 24.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.463 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.4 Cg_endo -60.91 133.74 49.33 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.442 2.095 . . . . 0.0 111.951 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 42.1 m -75.81 -22.35 56.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.2 0.524 . . . . 0.0 109.713 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -130.09 102.47 17.4 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.451 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.49 -13.93 30.47 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.801 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -76.88 -31.85 57.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.597 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.92 -19.74 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.949 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 74.9 mm-40 -69.61 -34.59 74.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.044 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.551 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.9 pt20 -87.02 -42.21 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 174.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 19.4 mt -97.13 60.87 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.535 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 5.1 m -83.42 85.88 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.143 -172.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.93 -3.59 58.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.732 0.777 . . . . 0.0 108.992 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.9 128.74 28.94 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.69 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.56 157.19 62.86 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.84 2.36 . . . . 0.0 112.67 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 62.1 mt -98.85 126.07 44.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.432 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.451 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.7 mt -99.87 127.75 32.91 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.643 ' HG3' ' HB3' ' B' ' 59' ' ' ASN . 70.6 Cg_endo -76.42 136.43 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.857 1.705 . . . . 0.0 111.754 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.4 mp -131.13 133.39 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.967 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -110.0 118.49 36.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.697 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.693 HG12 HG12 ' B' ' 54' ' ' ILE . 28.4 mt -106.91 125.79 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.918 0.39 . . . . 0.0 110.729 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 86.7 m-85 -111.17 134.97 52.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.083 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.565 HG23 ' CB ' ' A' ' 30' ' ' PRO . 1.5 t -84.54 131.69 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.04 150.5 25.03 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.906 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.34 11.26 24.27 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.207 1.003 . . . . 0.0 108.889 175.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.615 ' HB3' ' HG3' ' B' ' 51' ' ' PRO . 61.3 t30 -80.81 73.32 7.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.041 -172.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 p -91.79 2.99 56.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.787 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.81 132.12 3.27 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.525 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.438 -0.792 . . . . 0.0 109.974 -179.594 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.03 74.23 9.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.017 0.437 . . . . 0.0 111.063 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptm -140.14 147.62 40.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.015 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.4 146.94 24.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.367 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' MET . . . . . 0.525 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 18.5 ptp -115.84 141.29 27.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.901 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.533 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 33.6 Cg_exo -43.12 130.75 6.15 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.645 2.897 . . . . 0.0 113.513 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -117.73 132.52 56.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 112.239 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.93 140.41 53.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.382 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -125.36 123.6 39.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.16 158.14 44.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . . . -120.78 128.31 52.77 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.465 HD13 HD21 ' A' ' 20' ' ' LEU . 61.3 mt -117.3 141.31 48.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.502 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.525 ' CE1' ' HB3' ' B' ' 45' ' ' SER . 97.2 m-70 -70.58 127.63 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 115.47 7.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.432 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.99 -0.72 64.57 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.759 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -85.84 151.88 23.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.0 110.639 178.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 3.0 m -102.14 135.55 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.629 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' TYR . . . . . 0.486 ' HB3' HG12 ' B' ' 34' ' ' VAL . 78.2 m-85 -128.65 154.05 46.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.7 m170 -95.38 116.79 29.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.459 HD12 HD11 ' B' ' 32' ' ' LEU . 15.9 tp -106.24 122.47 46.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.342 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mt -132.56 126.13 54.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.438 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.4 140.06 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -149.38 171.57 16.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 3.5 p -124.03 134.33 53.46 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.43 -177.76 4.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.472 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 m -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.765 0.316 . . . . 0.0 111.554 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 43.0 mt -81.68 -24.29 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.275 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.15 13.06 12.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.54 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 36.3 m-80 -91.41 141.92 26.5 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.556 ' CB ' HG23 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -72.0 147.2 48.66 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.642 2.228 . . . . 0.0 112.321 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -127.95 141.18 51.61 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.526 HD21 HD11 ' B' ' 54' ' ' ILE . 15.4 tp -120.91 129.37 53.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.033 0.444 . . . . 0.0 110.819 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -125.91 125.64 43.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.508 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 54.6 t -127.22 121.23 57.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.859 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -124.61 129.22 24.71 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.477 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.448 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.2 Cg_endo -60.82 134.08 51.61 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.447 2.098 . . . . 0.0 111.821 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 37.2 m -75.93 -22.5 55.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.379 0.609 . . . . 0.0 109.689 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.98 102.45 17.58 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.577 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.6 -13.9 30.16 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.727 2.284 . . . . 0.0 112.672 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -76.8 -32.12 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.521 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -73.55 -19.98 60.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.953 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 76.2 mm-40 -69.58 -34.32 73.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.967 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.557 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.9 pt20 -87.29 -41.9 13.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.575 174.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.557 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 19.7 mt -97.42 60.36 1.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.788 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' SER . . . . . 0.525 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 5.2 m -83.04 85.85 7.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.281 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.56 -3.86 58.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.904 0.859 . . . . 0.0 108.919 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.72 128.6 29.52 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.711 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.75 157.37 62.14 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.873 2.382 . . . . 0.0 112.551 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 11' ' ' ALA . 61.9 mt -99.43 125.18 45.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.514 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.461 ' O ' HD12 ' B' ' 52' ' ' LEU . 79.0 mt -99.13 127.42 34.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.615 ' HG3' ' HB3' ' A' ' 59' ' ' ASN . 67.9 Cg_endo -76.12 136.45 18.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.782 1.655 . . . . 0.0 111.702 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.461 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.4 mp -131.15 133.36 45.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.131 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -109.87 118.44 36.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 54' ' ' ILE . 28.3 mt -106.93 125.95 62.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.083 0.468 . . . . 0.0 110.696 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.6 m-85 -111.29 134.89 52.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.072 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.556 HG23 ' CB ' ' B' ' 30' ' ' PRO . 1.5 t -84.59 131.47 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.66 150.24 25.27 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.927 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.2 11.48 23.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.069 0.938 . . . . 0.0 109.014 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.643 ' HB3' ' HG3' ' A' ' 51' ' ' PRO . 61.1 t30 -80.96 73.8 7.98 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.084 -172.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 7.9 p -92.16 3.27 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.727 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.0 131.72 3.12 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.487 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.754 -179.407 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.2 ptm . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.106 0.479 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.954 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 16.7 Cg_endo -56.94 132.35 51.12 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.546 2.831 . . . . 0.0 112.616 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m -116.11 137.33 52.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.588 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.56 145.97 46.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -129.15 124.05 33.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.125 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.92 158.52 43.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.689 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 128.1 48.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -122.0 140.98 51.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.616 -173.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.73 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 35.5 m80 -71.7 129.23 38.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.48 115.14 7.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.006 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.58 10.74 56.49 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.976 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 11.0 mm-40 -109.4 150.94 27.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 110.732 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 m -91.56 137.86 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.104 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.34 153.0 48.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.573 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.1 m170 -96.27 117.55 31.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.265 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD11 HD11 ' A' ' 32' ' ' LEU . 8.3 tp -109.08 119.63 40.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.103 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 mt -128.07 125.85 65.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.833 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.0 p -112.27 134.89 53.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -146.85 170.71 16.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 p -117.03 142.29 47.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.462 0.648 . . . . 0.0 112.164 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.12 164.68 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.461 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -56.49 -30.68 63.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.398 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.04 -18.01 62.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.48 1.75 53.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.956 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 78.5 m-20 -84.79 132.19 47.02 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.246 0.546 . . . . 0.0 110.082 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 56' ' ' VAL . 11.8 Cg_exo -66.39 150.02 84.58 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 122.983 2.455 . . . . 0.0 112.482 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -132.74 139.87 47.8 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.95 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 54' ' ' ILE . 13.8 tp -124.63 134.66 52.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.935 0.397 . . . . 0.0 111.162 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.8 m -134.89 123.29 23.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.392 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 68.8 t -125.98 122.4 61.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.94 131.04 24.59 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.872 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.76 42.12 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.417 2.078 . . . . 0.0 112.099 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.8 m -67.83 -23.67 65.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.241 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' OE1' ' A' ' 41' ' ' GLN . 77.1 m-20 -131.68 103.15 14.77 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.502 172.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.77 -23.8 22.15 Favored 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.096 2.53 . . . . 0.0 113.232 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -80.07 -22.71 41.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.692 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.615 ' OE1' ' HB3' ' A' ' 38' ' ' ASN . 12.1 mp0 -73.48 -20.93 60.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.254 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.73 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 46.6 mm-40 -67.38 -32.23 73.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.641 172.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -83.5 -43.15 16.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.89 77.58 3.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.742 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -91.3 78.69 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.335 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.01 -5.92 58.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 p -101.82 135.89 19.64 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.851 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.43 149.56 50.54 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.341 2.028 . . . . 0.0 111.853 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.62 123.73 35.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.3 mt -96.72 124.91 48.74 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.5 136.48 13.95 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.126 1.884 . . . . 0.0 111.135 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.23 133.17 46.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -110.14 115.95 30.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' B' ' 54' ' ' ILE . 31.3 mt -106.38 121.0 58.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.0 110.509 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -106.37 137.23 44.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.622 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.954 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -85.45 135.3 25.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.185 0.517 . . . . 0.0 110.799 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.03 178.284 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.094 0.473 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.949 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 16.5 Cg_endo -56.9 132.34 51.05 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.59 2.86 . . . . 0.0 112.635 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -116.07 137.43 52.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.538 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -120.77 145.81 47.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.486 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -128.84 123.9 33.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.18 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.65 158.53 43.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.95 128.02 48.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.916 0.389 . . . . 0.0 110.02 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 22' ' ' VAL . 52.9 mt -121.89 140.9 51.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.741 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 35.6 m80 -71.67 129.51 38.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 115.52 8.02 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.018 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 10.57 56.7 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.963 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 11.0 mm-40 -109.36 150.99 27.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 8.4 m -91.83 137.75 32.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.027 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.405 ' HB3' HG13 ' B' ' 34' ' ' VAL . 86.7 m-85 -129.36 152.95 48.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.577 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.1 m170 -96.25 117.41 30.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.374 173.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 8.3 tp -108.89 119.27 39.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.53 125.85 66.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.014 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.2 p -112.07 134.67 53.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -146.67 170.75 16.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -116.83 142.61 46.7 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.475 0.655 . . . . 0.0 112.238 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.34 164.27 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.491 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -56.11 -30.95 62.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.53 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.87 -17.97 62.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.09 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.56 1.37 53.16 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.008 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 30' ' ' PRO . 79.4 m-20 -84.53 132.06 48.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.519 . . . . 0.0 109.913 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.708 ' HG2' HG11 ' B' ' 56' ' ' VAL . 11.7 Cg_exo -66.24 149.91 85.07 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.202 2.601 . . . . 0.0 112.402 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -132.54 139.93 48.08 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.787 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.518 HD21 HD12 ' B' ' 54' ' ' ILE . 13.8 tp -124.75 134.77 52.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.106 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -135.01 123.57 23.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.4 t -126.17 122.49 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.006 0.432 . . . . 0.0 110.517 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.02 130.97 24.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.862 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.439 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.32 40.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.433 2.089 . . . . 0.0 112.194 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 69.9 m -67.31 -23.87 65.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.126 0.489 . . . . 0.0 110.209 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ASN . . . . . 0.635 ' HB3' ' OE1' ' B' ' 41' ' ' GLN . 77.8 m-20 -131.67 103.27 14.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.418 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.05 -23.83 21.19 Favored 'Trans proline' 0 CA--C 1.526 0.078 0 C-N-CA 123.115 2.544 . . . . 0.0 113.171 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.8 -22.88 42.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.856 0.36 . . . . 0.0 110.706 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.635 ' OE1' ' HB3' ' B' ' 38' ' ' ASN . 12.5 mp0 -73.48 -20.8 60.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.741 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 49.1 mm-40 -67.55 -32.12 72.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.678 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -83.57 -43.21 15.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.855 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.96 77.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 11.3 p -91.35 78.63 5.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.245 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.97 -5.56 58.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 166.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.1 p -102.32 135.8 19.53 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.9 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.45 149.55 50.4 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.246 1.964 . . . . 0.0 111.913 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.49 123.54 34.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.45 ' O ' HD12 ' B' ' 52' ' ' LEU . 64.8 mt -96.6 124.86 49.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.36 136.27 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.117 1.878 . . . . 0.0 111.129 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.3 mp -129.95 133.16 46.63 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.055 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -109.78 116.03 30.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.341 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' A' ' 54' ' ' ILE . 30.8 mt -106.52 120.86 58.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.226 0.536 . . . . 0.0 110.508 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -106.25 137.13 44.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.598 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.949 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -85.53 135.17 25.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 0.0 110.607 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.757 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.034 178.152 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.1 ptp . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 86.1 Cg_exo -49.16 131.36 26.22 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 123.593 2.862 . . . . 0.0 113.14 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -117.74 138.38 52.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.69 142.34 51.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.647 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.13 125.02 40.47 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.162 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.94 158.07 44.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.02 127.59 51.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.897 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB2' HG11 ' B' ' 22' ' ' VAL . 57.7 mt -122.61 140.73 52.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.299 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.41 126.93 30.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.32 99.65 0.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.453 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -0.58 17.93 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.817 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -96.5 155.53 16.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.769 0.318 . . . . 0.0 110.645 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.599 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 6.9 m -98.19 136.9 37.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.389 0.614 . . . . 0.0 110.565 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 34' ' ' VAL . 96.5 m-85 -129.3 153.22 48.04 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.411 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m80 -95.29 117.16 29.79 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.605 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.01 119.53 39.62 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.463 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.62 125.72 64.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.91 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' B' ' 12' ' ' LEU . 14.8 p -112.19 132.52 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 24.2 t0 -135.91 169.87 16.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.74 0.305 . . . . 0.0 110.831 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -179.46 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -58.48 -30.87 67.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 59.3 mt -82.23 -22.23 35.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.413 . . . . 0.0 111.204 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 19.22 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.282 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.605 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 29.5 m-80 -88.33 136.99 31.06 Favored Pre-proline 0 CA--C 1.511 -0.53 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HG3' HG11 ' A' ' 56' ' ' VAL . 1.1 Cg_endo -80.47 144.27 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.858 2.372 . . . . 0.0 111.681 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.7 t -127.88 140.18 52.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.574 HD21 HD12 ' A' ' 54' ' ' ILE . 14.4 tp -115.77 132.14 56.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.43 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -130.6 120.4 23.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.133 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.4 t -127.0 122.2 59.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.96 131.04 23.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.89 139.76 69.75 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.347 2.031 . . . . 0.0 111.811 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 12.7 p -67.38 -29.86 69.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.345 0.593 . . . . 0.0 110.5 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.08 102.72 4.81 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.457 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.41 -15.03 44.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.162 2.575 . . . . 0.0 112.707 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -66.19 -35.65 81.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.112 0.482 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -74.83 -22.2 58.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.043 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -70.13 -43.71 70.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.673 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.566 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 12.9 pt20 -78.38 -33.89 48.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.746 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 22.7 mt -102.11 56.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 p -74.79 96.76 3.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.157 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.84 -18.49 40.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.07 137.89 19.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.532 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.33 157.68 52.96 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.972 2.448 . . . . 0.0 112.843 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.8 mt -85.26 124.46 31.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.693 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 52' ' ' LEU . 70.6 mt -96.21 126.88 42.48 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.58 135.54 18.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.146 1.898 . . . . 0.0 111.599 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.9 mp -134.87 131.1 36.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.379 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 m -110.9 119.05 37.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' B' ' 54' ' ' ILE . 30.0 mt -107.04 125.73 63.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.939 0.4 . . . . 0.0 110.711 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -108.56 137.47 46.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.234 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 5' ' ' MET . 40.3 t -93.58 119.44 41.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.629 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.56 0 C-N-CA 118.853 -1.641 . . . . 0.0 114.275 169.79 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.572 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 13.5 ptp . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.4 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 90.1 Cg_exo -49.39 131.13 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -117.72 138.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.284 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.38 142.32 51.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.684 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.26 125.22 40.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.912 0.387 . . . . 0.0 110.143 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.88 158.08 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.12 127.65 51.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 22' ' ' VAL . 57.5 mt -122.75 140.72 52.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.451 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.45 126.9 30.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.36 99.54 0.29 Allowed Glycine 0 C--O 1.228 -0.237 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.502 -176.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.19 0.58 18.99 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.797 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -97.2 155.66 16.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.34 . . . . 0.0 110.585 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.588 ' HB ' ' OG ' ' B' ' 37' ' ' SER . 7.1 m -98.21 136.76 37.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.461 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' B' ' 34' ' ' VAL . 96.4 m-85 -129.33 153.33 47.95 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.3 m80 -95.26 117.65 30.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.312 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.43 119.76 40.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.292 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.77 125.64 63.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.945 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 12' ' ' LEU . 14.8 p -112.22 132.32 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 23.4 t0 -135.87 170.23 16.32 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.87 133.51 45.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.93 -179.73 7.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.254 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -58.33 -31.02 67.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.609 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 58.2 mt -81.92 -22.5 36.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.94 0.4 . . . . 0.0 111.116 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.22 18.89 9.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.263 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 29.0 m-80 -87.8 137.29 31.85 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.53 ' HG3' HG11 ' B' ' 56' ' ' VAL . 1.1 Cg_endo -80.48 144.66 16.13 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.757 2.304 . . . . 0.0 111.614 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -128.41 140.27 51.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 54' ' ' ILE . 14.6 tp -116.28 131.42 56.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 110.438 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 21.3 m -130.15 120.21 24.21 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.944 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.8 t -126.64 122.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.518 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 131.03 23.66 Favored Pre-proline 0 C--O 1.223 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.79 139.46 68.82 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.376 2.051 . . . . 0.0 111.769 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' B' ' 17' ' ' THR . 12.4 p -67.15 -30.08 69.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.472 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -143.87 103.05 4.87 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.84 -15.09 43.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.109 2.539 . . . . 0.0 112.632 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -66.15 -35.47 80.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.177 0.513 . . . . 0.0 109.76 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.65 -22.44 58.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.198 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -69.85 -44.05 70.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.573 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 13.0 pt20 -78.14 -33.59 50.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.573 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 23.3 mt -102.37 56.22 0.79 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.319 0.58 . . . . 0.0 109.582 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -74.69 96.21 2.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.392 -173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.13 -18.47 42.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.23 138.14 19.64 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.457 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.47 157.65 52.56 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.914 2.409 . . . . 0.0 112.963 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.04 124.56 31.87 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.742 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.475 ' O ' HD12 ' B' ' 52' ' ' LEU . 70.9 mt -96.27 127.0 41.92 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.49 135.62 18.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.06 1.84 . . . . 0.0 111.559 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 50' ' ' ILE . 4.9 mp -134.85 131.19 37.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -111.2 118.9 37.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.659 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' A' ' 54' ' ' ILE . 29.7 mt -106.93 125.73 62.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.962 0.411 . . . . 0.0 110.696 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -108.72 137.27 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.297 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' B' ' 5' ' ' MET . 39.5 t -93.35 119.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.401 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.619 0 C-N-CA 118.77 -1.681 . . . . 0.0 114.37 169.56 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.408 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 17.2 ptp . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.034 0.445 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.84 131.66 43.27 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.977 2.451 . . . . 0.0 111.639 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -112.13 136.82 51.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -115.1 139.81 49.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.11 123.37 36.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.98 158.63 43.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 129.38 50.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.816 0.341 . . . . 0.0 110.494 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.44 HD11 HD21 ' B' ' 20' ' ' LEU . 57.7 mt -119.98 146.29 45.98 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.32 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.562 ' HE1' ' HB3' ' A' ' 45' ' ' SER . 20.0 m-70 -70.77 127.35 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.001 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.55 112.03 3.97 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.171 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.24 3.98 56.5 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.422 -0.418 . . . . 0.0 113.125 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.4 156.66 17.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.965 0.412 . . . . 0.0 110.948 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -96.39 138.53 33.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.086 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.31 154.46 46.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.716 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.5 m80 -95.84 117.67 31.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.639 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 HD11 ' B' ' 12' ' ' LEU . 8.4 tp -108.85 120.83 43.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.37 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 10.5 mt -129.22 126.52 64.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.914 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.29 133.76 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.28 169.77 16.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 132.79 55.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 112.369 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.5 160.08 32.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.7 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.0 t -61.03 -24.56 66.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.96 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.425 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 54.1 mt -83.53 -12.38 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.441 . . . . 0.0 110.41 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.29 13.63 26.18 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.861 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 27' ' ' LEU . 27.2 m120 -85.65 129.34 55.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.56 148.74 42.82 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.962 . . . . 0.0 111.896 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -130.4 143.25 50.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.18 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.578 HD21 HD12 ' A' ' 54' ' ' ILE . 17.9 tp -124.29 133.33 53.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.635 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 15.7 m -131.96 120.82 23.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.5 t -127.77 122.11 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.268 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -121.78 133.15 24.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.62 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.82 137.14 66.16 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.307 2.005 . . . . 0.0 111.702 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.7 t -65.9 -23.65 66.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.51 . . . . 0.0 109.87 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -143.38 107.14 5.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.346 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.64 -18.59 64.89 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.073 2.515 . . . . 0.0 113.166 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.55 -22.72 43.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.632 0.253 . . . . 0.0 110.77 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -68.37 -25.08 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.136 0.493 . . . . 0.0 110.124 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.57 -32.98 72.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.345 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -79.57 -43.02 23.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.01 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -92.64 63.87 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.562 ' HB3' ' HE1' ' A' ' 13' ' ' HIS . 5.4 p -82.77 73.02 9.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.38 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.82 2.32 53.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.15 131.0 23.12 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.042 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.23 144.61 69.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.31 2.006 . . . . 0.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -87.25 129.79 34.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 52' ' ' LEU . 68.5 mt -104.91 122.25 43.9 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 168.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HG2' ' C ' ' B' ' 57' ' ' GLY . 73.0 Cg_endo -77.24 137.34 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.397 2.065 . . . . 0.0 111.557 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -129.21 136.6 50.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.082 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 m -111.29 116.82 31.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.844 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' B' ' 54' ' ' ILE . 38.6 mt -107.66 127.07 63.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.949 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 66.2 m-85 -112.35 141.41 46.11 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.738 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.0 141.41 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.935 0.398 . . . . 0.0 110.021 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.012 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.033 177.864 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 17.4 ptp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.978 0.418 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.61 132.21 46.88 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.844 2.363 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -112.86 136.85 52.03 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.991 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.21 140.09 49.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.54 122.87 34.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.59 158.46 43.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.538 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.0 129.19 50.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.956 0.408 . . . . 0.0 110.585 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 20' ' ' LEU . 57.6 mt -119.85 146.25 45.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.465 -173.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.56 ' HE1' ' HB3' ' B' ' 45' ' ' SER . 19.7 m-70 -70.92 127.54 32.93 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.89 112.11 4.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.032 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 4.32 56.46 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.01 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.75 156.35 17.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.949 0.404 . . . . 0.0 110.849 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 15.3 m -95.97 138.65 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.128 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -129.43 154.19 47.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.737 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.5 m80 -95.59 117.73 30.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 12' ' ' LEU . 8.2 tp -108.99 120.86 43.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.344 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 10.4 mt -129.23 126.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.986 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.23 133.59 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.51 169.5 17.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.6 55.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.76 0.791 . . . . 0.0 112.526 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.97 160.23 32.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.751 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 t -61.44 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.082 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.444 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 52.1 mt -84.04 -12.43 55.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.33 13.75 25.8 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.985 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' B' ' 27' ' ' LEU . 26.5 m120 -85.95 129.37 54.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 110.334 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.59 148.72 42.66 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.253 1.969 . . . . 0.0 111.917 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -130.59 142.96 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.244 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 18.0 tp -123.96 133.56 53.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.901 0.381 . . . . 0.0 110.497 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.5 m -132.26 120.5 22.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.942 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.9 t -127.32 122.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.63 133.21 24.18 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.766 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.11 137.6 67.57 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.149 1.9 . . . . 0.0 111.667 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -66.16 -23.46 66.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.232 0.539 . . . . 0.0 109.876 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' B' ' 39' ' ' PRO . 27.8 t-20 -143.62 106.88 5.06 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.404 174.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' B' ' 38' ' ' ASN . 28.8 Cg_endo -63.63 -18.64 65.15 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.174 2.583 . . . . 0.0 113.087 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.48 -22.6 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.704 0.287 . . . . 0.0 110.852 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.39 -25.44 65.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.23 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.45 -32.71 71.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.398 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.69 -43.11 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 110.042 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.8 mt -92.38 63.62 4.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.063 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' SER . . . . . 0.56 ' HB3' ' HE1' ' B' ' 13' ' ' HIS . 4.9 p -82.69 72.54 9.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.28 2.11 53.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.95 131.73 22.41 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.992 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.48 144.41 67.04 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.478 2.119 . . . . 0.0 112.142 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -87.41 129.79 34.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.425 ' O ' HD12 ' B' ' 52' ' ' LEU . 68.9 mt -104.89 122.3 43.76 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 137.32 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.461 2.107 . . . . 0.0 111.599 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.425 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -129.4 136.32 49.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -110.94 116.64 31.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.834 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' A' ' 54' ' ' ILE . 39.5 mt -107.53 127.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.209 0.528 . . . . 0.0 111.096 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.404 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 65.0 m-85 -112.35 141.34 46.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.699 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.07 141.74 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.845 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.404 ' C ' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.44 -1.061 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.03 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.466 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 16.0 ptm . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.439 0.637 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.838 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 20.1 Cg_endo -59.9 140.4 92.82 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 112.353 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 m -115.75 136.46 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.168 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.69 147.0 45.09 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.97 124.03 30.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.97 158.1 44.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.16 129.01 51.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.932 0.396 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 HD21 ' B' ' 20' ' ' LEU . 60.7 mt -118.36 141.44 48.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.585 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.539 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 29.1 m80 -71.17 127.64 33.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.196 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.63 110.43 2.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.699 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.44 -1.12 46.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.787 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -87.88 152.27 22.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.025 0.44 . . . . 0.0 110.846 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.7 m -100.25 133.08 45.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.413 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.482 ' HB3' HG13 ' A' ' 34' ' ' VAL . 88.0 m-85 -124.19 152.88 42.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m170 -95.51 117.21 29.98 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 12' ' ' LEU . 11.8 tp -108.02 121.08 44.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.395 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -131.34 126.2 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.345 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.94 132.41 61.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.79 152.34 39.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.984 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 p -107.17 141.68 38.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -79.49 -175.04 4.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.3 p -55.38 -31.65 61.98 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.54 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.3 mt -87.06 -20.71 26.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.981 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 16.87 14.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.289 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 42.0 m-80 -82.33 128.82 65.84 Favored Pre-proline 0 CA--C 1.511 -0.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' CG ' HG21 ' A' ' 56' ' ' VAL . 56.6 Cg_endo -73.02 143.13 35.74 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.44 2.093 . . . . 0.0 112.182 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -127.72 147.39 50.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 54' ' ' ILE . 14.5 tp -119.35 129.82 55.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.899 0.381 . . . . 0.0 110.844 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -127.06 119.59 26.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.755 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.0 t -125.62 122.47 62.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.057 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.18 131.19 24.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 148.51 81.01 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.78 2.32 . . . . 0.0 112.205 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 p -68.88 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.353 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 50.2 t-20 -132.99 104.41 12.7 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.526 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 24.2 Cg_endo -62.95 -25.08 74.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.842 2.361 . . . . 0.0 112.238 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -82.6 -24.46 33.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -72.34 -24.72 61.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.118 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 49.3 mm-40 -65.76 -31.73 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.129 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.97 -43.1 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.4 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 58.94 5.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.81 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -77.48 76.43 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.395 0.617 . . . . 0.0 112.02 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.11 -15.58 61.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.079 0.942 . . . . 0.0 108.498 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -101.89 145.12 29.92 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.951 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.52 159.73 32.13 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 111.765 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 60.4 mt -94.55 131.59 40.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.137 0.494 . . . . 0.0 111.013 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 52' ' ' LEU . 69.8 mt -99.54 124.05 45.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 57.8 Cg_endo -74.7 137.47 22.5 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.194 1.929 . . . . 0.0 111.391 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -133.48 131.9 40.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 m -109.64 117.5 34.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.493 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' B' ' 54' ' ' ILE . 24.5 mt -107.03 123.33 62.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.341 0.591 . . . . 0.0 110.686 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.67 137.88 43.87 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.663 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.838 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.7 t -83.66 133.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.452 . . . . 0.0 109.881 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.901 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.644 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.463 ' HA ' ' HD2' ' B' ' 6' ' ' PRO . 15.7 ptm . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.863 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 19.9 Cg_endo -59.72 140.67 94.57 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.378 2.719 . . . . 0.0 112.247 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.08 136.03 53.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.234 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.32 147.13 44.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.06 124.09 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.78 158.27 44.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.555 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.41 128.82 51.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 20' ' ' LEU . 60.8 mt -118.43 141.46 48.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.674 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 29.4 m80 -71.07 127.39 32.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.78 110.94 3.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.544 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.96 -2.59 44.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.715 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -86.96 152.37 22.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.93 0.395 . . . . 0.0 110.925 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -100.59 132.98 45.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.463 175.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.503 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.5 m-85 -123.84 152.85 41.84 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.152 0.501 . . . . 0.0 110.644 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.4 m170 -95.66 117.12 29.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 12' ' ' LEU . 11.6 tp -108.13 121.1 44.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.14 126.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.316 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 p -112.62 132.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.51 152.27 39.49 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -107.18 141.85 37.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -79.57 -175.21 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.34 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 48.4 p -55.31 -31.74 61.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.542 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 54.8 mt -86.71 -21.27 26.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 16.8 14.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.273 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.542 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.6 m-80 -82.41 128.98 65.01 Favored Pre-proline 0 CA--C 1.51 -0.569 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' B' ' 56' ' ' VAL . 56.9 Cg_endo -73.21 143.37 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.292 1.995 . . . . 0.0 112.221 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -127.69 147.29 50.38 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.43 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.571 HD21 HD12 ' B' ' 54' ' ' ILE . 14.4 tp -119.2 130.03 55.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.855 0.36 . . . . 0.0 110.753 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -127.37 119.63 26.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.843 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.1 t -125.78 122.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.034 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.26 131.01 24.34 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.682 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.15 148.76 81.48 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.76 2.307 . . . . 0.0 112.335 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.5 p -69.4 -27.16 65.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.321 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -133.64 104.32 12.03 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.491 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.57 74.13 Favored 'Trans proline' 0 C--N 1.34 0.101 0 C-N-CA 122.748 2.299 . . . . 0.0 112.122 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.92 -24.61 35.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -72.08 -24.72 61.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.146 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.523 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 50.0 mm-40 -65.85 -32.06 73.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.903 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.44 -43.06 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.538 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.8 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.3 p -77.56 76.32 4.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.326 0.584 . . . . 0.0 111.989 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.78 -15.92 61.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -101.62 145.06 29.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.855 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.42 159.66 32.52 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.611 2.207 . . . . 0.0 111.653 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.3 mt -94.15 131.53 39.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.004 0.43 . . . . 0.0 111.134 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.434 ' O ' HD12 ' B' ' 52' ' ' LEU . 69.2 mt -99.49 124.11 45.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 168.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 57.4 Cg_endo -74.79 137.46 22.25 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.237 1.958 . . . . 0.0 111.406 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.4 mp -133.38 132.22 40.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.907 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -109.91 117.42 33.76 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 54' ' ' ILE . 24.3 mt -106.9 123.37 61.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.18 0.514 . . . . 0.0 110.702 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -106.69 137.95 43.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.553 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.863 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.7 t -83.55 133.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.93 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.606 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.296 0.569 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.731 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 32.7 Cg_endo -64.69 134.76 42.17 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.356 2.704 . . . . 0.0 112.251 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m -116.63 134.72 54.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.232 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -115.3 140.42 49.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.905 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -125.61 123.71 39.61 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 1.7 pp -141.11 158.15 44.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.688 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -121.74 128.6 51.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 110.44 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' B' ' 20' ' ' LEU . 58.0 mt -120.62 141.23 50.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.536 -174.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 36.5 m80 -70.91 132.96 46.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.378 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.71 110.93 3.31 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.737 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.9 58.24 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.552 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -89.56 144.17 26.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 37' ' ' SER . 12.2 m -93.74 137.32 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.017 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.468 ' HB3' HG13 ' A' ' 34' ' ' VAL . 85.9 m-85 -129.75 154.64 46.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 0.0 110.802 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 3.1 m170 -95.26 117.41 30.23 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.071 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 32' ' ' LEU . 11.8 tp -108.74 121.4 44.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.173 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 11.2 mt -131.3 126.59 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -116.07 133.56 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -142.99 170.02 16.48 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -124.18 141.53 51.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.7 0.286 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -176.13 6.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.721 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -65.88 -30.43 71.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.057 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.28 -23.97 54.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 0.0 111.305 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.41 20.42 9.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.436 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -94.73 135.95 23.43 Favored Pre-proline 0 CA--C 1.509 -0.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' CB ' HG21 ' A' ' 56' ' ' VAL . 72.2 Cg_endo -76.27 147.67 29.63 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.542 2.161 . . . . 0.0 112.09 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -126.52 140.04 52.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' ILE . 10.9 tp -122.44 122.32 38.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.037 0.446 . . . . 0.0 110.507 -175.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 16.7 m -116.86 119.18 34.59 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.913 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 77.8 t -123.86 122.17 63.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.9 131.27 23.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.1 Cg_endo -61.22 133.51 47.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.168 1.912 . . . . 0.0 111.922 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 8.7 t -70.62 -37.07 73.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -107.81 101.18 39.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.65 -29.4 29.82 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.522 2.148 . . . . 0.0 111.926 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.6 -23.42 56.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.781 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.27 -28.63 66.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 15.2 mm-40 -69.67 -21.75 63.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -87.55 -42.25 12.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.987 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.0 43.49 1.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.697 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -74.4 87.42 2.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.37 0.605 . . . . 0.0 112.16 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -92.61 -1.62 56.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.81 142.39 24.5 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.48 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.12 152.3 50.67 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.464 2.109 . . . . 0.0 112.158 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 29.9 mt -92.49 120.63 33.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.713 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.2 mt -93.06 123.62 60.52 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.01 136.37 16.38 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.269 1.979 . . . . 0.0 111.521 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.3 mp -129.32 133.55 47.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.989 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -109.42 115.67 30.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.74 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' B' ' 54' ' ' ILE . 28.5 mt -107.6 125.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.187 0.518 . . . . 0.0 110.715 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -108.64 132.84 53.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.731 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -84.85 136.91 21.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.071 0.462 . . . . 0.0 110.661 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.81 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.889 176.761 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 34.4 Cg_endo -64.54 134.43 41.25 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.241 2.628 . . . . 0.0 112.256 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.44 134.92 54.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -115.39 140.56 49.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.926 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.98 123.68 39.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.511 HD22 HG21 ' B' ' 34' ' ' VAL . 1.7 pp -141.21 158.35 44.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.729 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.1 128.33 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.861 0.362 . . . . 0.0 110.534 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 20' ' ' LEU . 58.1 mt -120.38 141.22 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.585 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 36.4 m80 -70.68 132.64 45.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.422 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.16 110.71 3.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.686 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.07 -0.43 58.89 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.522 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -89.68 144.22 26.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 37' ' ' SER . 14.3 m -93.8 137.12 33.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.996 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.459 ' HB3' HG13 ' B' ' 34' ' ' VAL . 85.5 m-85 -129.67 154.46 47.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.235 0.541 . . . . 0.0 110.572 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.67 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 3.1 m170 -95.09 117.27 29.91 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.118 172.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.532 HD11 HD11 ' B' ' 32' ' ' LEU . 11.6 tp -108.54 121.36 44.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.251 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 11.3 mt -131.39 126.29 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.86 133.56 61.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -143.0 170.19 16.16 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.855 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.6 p -124.16 141.63 51.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.661 0.267 . . . . 0.0 110.948 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -175.57 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t -66.54 -30.56 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.943 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -76.11 -23.66 54.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.607 0.242 . . . . 0.0 111.162 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 20.27 9.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.278 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -94.68 135.75 23.65 Favored Pre-proline 0 CA--C 1.511 -0.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.521 ' CB ' HG21 ' B' ' 56' ' ' VAL . 71.7 Cg_endo -75.98 147.87 30.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.472 2.114 . . . . 0.0 112.178 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -126.81 139.91 52.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' B' ' 54' ' ' ILE . 11.1 tp -122.44 122.12 38.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.208 0.527 . . . . 0.0 110.609 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.9 m -116.42 119.26 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.904 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 78.1 t -124.14 121.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 110.234 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.83 131.1 23.74 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.377 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.4 Cg_endo -61.38 133.27 45.22 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.229 1.953 . . . . 0.0 112.007 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.473 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 8.7 t -70.13 -37.01 75.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -107.98 101.34 40.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.84 -29.1 29.08 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.447 2.098 . . . . 0.0 112.121 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.73 -23.43 56.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.841 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.398 0.618 . . . . 0.0 110.182 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.495 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 15.9 mm-40 -69.76 -21.71 63.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.148 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -87.63 -42.41 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.003 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 16.1 mt -87.56 43.1 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.823 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -74.13 87.84 1.92 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.461 0.648 . . . . 0.0 112.072 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.26 -1.46 56.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.74 142.36 24.44 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.663 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 152.24 51.11 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.509 2.139 . . . . 0.0 112.135 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 30.7 mt -92.47 120.82 33.33 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.761 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' B' ' 52' ' ' LEU . 78.0 mt -93.15 123.86 59.66 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.21 136.13 15.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.289 1.993 . . . . 0.0 111.651 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.3 mp -129.14 133.28 47.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.959 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -109.25 115.76 30.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.678 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' A' ' 54' ' ' ILE . 27.4 mt -107.74 125.05 64.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.767 -176.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -108.45 132.8 53.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.848 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.729 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -84.82 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.846 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.927 176.829 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.547 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 21.3 ptp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 21.7 Cg_endo -60.27 132.01 41.71 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.052 2.501 . . . . 0.0 111.809 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -114.24 141.28 47.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.673 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -121.69 148.81 44.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.697 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.43 125.03 26.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.4 pp -141.17 158.07 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.166 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.29 127.36 53.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.02 140.14 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.567 -175.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 16' ' ' GLN . 34.7 m80 -71.71 133.06 45.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.302 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.74 110.93 3.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.848 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.83 47.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.931 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HG3' ' HB2' ' A' ' 13' ' ' HIS . 16.4 mm100 -95.46 143.4 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.911 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -87.97 136.25 33.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.07 153.91 47.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.9 m80 -95.74 117.64 30.9 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.602 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 32' ' ' LEU . 9.1 tp -108.39 120.84 43.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.317 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.13 125.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.79 133.65 63.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.08 170.1 16.37 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p -123.56 136.63 54.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.37 168.7 19.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.765 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 p -54.77 -30.65 57.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.3 mt -73.89 -13.6 60.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.233 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.6 1.07 62.25 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.577 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -75.78 133.58 73.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HG3' HG21 ' A' ' 56' ' ' VAL . 91.7 Cg_endo -80.15 152.77 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 112.322 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -133.97 140.2 46.58 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.528 HD21 HD12 ' A' ' 54' ' ' ILE . 13.4 tp -124.78 125.84 44.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.13 120.62 32.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.03 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.9 t -125.49 122.51 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.17 129.07 24.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.68 136.27 57.19 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.539 2.159 . . . . 0.0 112.332 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 73.1 m -70.48 -25.56 63.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -134.69 103.6 11.05 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.72 -21.16 29.41 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -75.93 -35.73 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.469 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 110.331 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' CD ' ' HD1' ' A' ' 13' ' ' HIS . 27.3 mm-40 -69.97 -41.55 74.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.57 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -73.55 -42.94 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.272 0.558 . . . . 0.0 109.943 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 mt -99.9 71.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' NE2' ' A' ' 13' ' ' HIS . 1.1 m -67.94 -66.24 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.222 -167.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 44.72 25.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.783 0.801 . . . . 0.0 111.729 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -136.73 138.48 26.41 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.909 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.64 143.6 62.88 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.181 1.92 . . . . 0.0 111.822 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.11 119.46 30.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.071 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.1 mt -87.28 125.71 64.93 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 43.5 Cg_endo -73.84 136.68 23.37 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.826 1.684 . . . . 0.0 110.558 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.8 mp -134.39 131.78 38.63 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -111.32 117.65 33.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' B' ' 54' ' ' ILE . 24.9 mt -107.24 123.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.185 0.517 . . . . 0.0 110.764 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.547 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 70.4 m-85 -107.68 138.42 43.94 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.015 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.696 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.6 t -84.09 130.42 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.167 0.508 . . . . 0.0 109.951 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.433 -1.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.806 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 21.2 ptp . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.714 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 22.3 Cg_endo -60.01 131.93 41.97 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.414 . . . . 0.0 111.761 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -114.36 141.88 47.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.555 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.98 148.9 44.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.74 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.48 125.07 26.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.11 158.06 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.22 127.4 53.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.0 140.14 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.436 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.497 ' HB2' ' HG3' ' B' ' 16' ' ' GLN . 34.5 m80 -71.79 133.07 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.297 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.49 110.88 3.41 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.858 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.58 -0.49 49.43 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.329 -0.463 . . . . 0.0 113.077 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' B' ' 13' ' ' HIS . 16.6 mm100 -95.58 143.42 26.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 111.006 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 4.1 m -87.82 136.33 33.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.516 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.402 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.1 m-85 -128.92 153.93 47.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.672 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.9 m80 -95.76 117.78 31.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.47 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.456 HD11 HD11 ' B' ' 32' ' ' LEU . 9.0 tp -108.5 120.8 43.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.417 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.09 125.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.18 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.75 133.67 63.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -140.96 169.91 16.74 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 50' ' ' ILE . 1.3 p -122.93 137.03 55.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.21 0.528 . . . . 0.0 111.46 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.67 168.85 18.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.804 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -54.81 -30.89 58.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -73.51 -14.3 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.113 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.88 1.32 61.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.547 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -76.15 133.15 72.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.442 ' HG3' HG21 ' B' ' 56' ' ' VAL . 93.0 Cg_endo -79.91 152.79 22.16 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.793 2.329 . . . . 0.0 112.284 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -134.06 140.32 46.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.537 HD21 HD12 ' B' ' 54' ' ' ILE . 13.5 tp -125.09 125.89 44.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 -173.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -124.17 120.46 32.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.3 t -125.38 122.36 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.08 128.69 24.1 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.404 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.69 135.67 53.81 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.55 2.166 . . . . 0.0 112.398 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 72.5 m -70.31 -25.23 63.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -134.78 103.72 10.94 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.09 -20.62 28.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.726 2.284 . . . . 0.0 112.843 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -76.25 -35.88 58.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.4 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.42 -23.01 60.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.094 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.418 ' CD ' ' HD1' ' B' ' 13' ' ' HIS . 27.6 mm-40 -70.05 -41.16 74.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.607 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -74.06 -42.88 59.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.142 0.496 . . . . 0.0 109.967 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.77 70.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' B' ' 13' ' ' HIS . 1.1 m -67.71 -66.49 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.155 -167.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.97 25.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.824 0.821 . . . . 0.0 111.48 -171.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -136.71 138.51 26.52 Favored Pre-proline 0 N--CA 1.442 -0.855 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.97 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.77 143.66 62.35 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 23.0 mt -89.95 119.79 30.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.971 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.483 ' O ' HD12 ' B' ' 52' ' ' LEU . 67.0 mt -87.55 125.67 64.53 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.616 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.0 Cg_endo -73.75 136.43 23.18 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.874 1.716 . . . . 0.0 110.716 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.514 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.8 mp -134.25 131.71 38.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.971 0.415 . . . . 0.0 110.496 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 5.1 m -111.4 117.32 32.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.631 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' A' ' 54' ' ' ILE . 25.6 mt -107.24 123.74 62.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 71.0 m-85 -107.48 138.4 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.913 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.5 t -84.01 130.79 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.018 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.607 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.434 -1.492 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.002 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -59.2 131.19 39.78 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.505 2.137 . . . . 0.0 111.595 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 m -116.88 136.84 52.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.923 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -115.49 145.14 42.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.822 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.96 123.89 29.82 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.8 158.45 43.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.93 128.21 49.1 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -121.06 141.34 50.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.677 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 30.2 m80 -71.49 131.32 43.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.52 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.58 111.55 3.99 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.024 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.63 0.87 52.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.723 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -95.09 150.71 19.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.17 0.509 . . . . 0.0 111.204 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -95.03 135.3 36.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.604 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.55 152.89 47.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.48 0.657 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.7 m80 -95.98 117.88 31.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.839 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD21 HD11 ' B' ' 12' ' ' LEU . 7.7 tp -108.78 121.36 44.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.159 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mt -129.57 126.49 63.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.076 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.5 p -117.92 135.05 59.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 7.1 p-10 -147.54 170.88 16.5 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.32 136.24 54.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.309 0.576 . . . . 0.0 111.88 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 9.2 t70 -81.25 165.64 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.005 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.1 m -54.88 -31.16 59.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.409 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 71.4 mt -73.11 -17.57 61.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.421 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.88 2.9 39.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.546 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 2.7 p-10 -85.99 142.23 36.17 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' CG ' HG21 ' A' ' 56' ' ' VAL . 44.2 Cg_endo -85.25 153.02 10.79 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.565 2.176 . . . . 0.0 112.434 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -126.24 149.9 48.77 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 54' ' ' ILE . 11.3 tp -128.67 123.86 34.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.703 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.5 m -122.0 119.47 31.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.999 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.8 t -124.17 122.42 64.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.072 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.76 131.34 24.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.783 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.34 136.36 50.76 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 122.331 2.02 . . . . 0.0 111.68 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.4 m -70.68 -25.18 62.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.078 0.466 . . . . 0.0 110.362 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -132.82 102.92 13.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.65 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.67 -21.31 39.25 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.797 2.331 . . . . 0.0 112.253 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -74.89 -32.71 61.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -73.65 -21.34 60.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.245 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 19.0 mm-40 -69.27 -35.19 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.923 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.88 -43.26 36.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.046 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 67.46 4.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 p -78.39 81.34 4.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.466 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.78 -7.85 59.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 p -102.44 137.66 19.46 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.603 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.16 156.36 46.83 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.435 2.09 . . . . 0.0 111.281 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.4 mt -87.66 138.8 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HD12 ' A' ' 52' ' ' LEU . 87.0 mt -108.73 124.06 35.4 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 73.5 Cg_endo -77.58 136.57 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.294 1.996 . . . . 0.0 111.675 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 50' ' ' ILE . 4.9 mp -133.93 130.09 37.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 m -109.21 118.63 37.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.564 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' B' ' 54' ' ' ILE . 37.0 mt -107.5 126.38 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.107 0.48 . . . . 0.0 110.777 -176.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -109.57 138.71 45.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CG ' ' A' ' 30' ' ' PRO . 1.1 t -89.4 140.86 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.228 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.519 ' CA ' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.937 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.18 131.39 40.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 111.593 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.2 m -116.94 137.03 52.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.51 144.92 43.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.143 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.68 123.9 30.38 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.64 158.57 43.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.666 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.96 128.37 49.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 50.9 mt -121.14 141.47 50.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 -173.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 30.0 m80 -71.45 130.98 42.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.558 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.39 111.88 4.25 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.085 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 1.16 53.34 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.842 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -95.64 150.62 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.18 0.514 . . . . 0.0 111.129 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -94.88 135.36 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.445 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -128.62 153.12 47.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.351 0.596 . . . . 0.0 110.68 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.8 m80 -96.23 117.83 31.57 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.842 172.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 12' ' ' LEU . 7.6 tp -108.56 121.51 45.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.222 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.65 126.3 62.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.095 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.6 p -117.23 134.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 7.1 p-10 -147.44 170.97 16.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.12 136.83 53.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.225 0.536 . . . . 0.0 111.737 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ASP . . . . . 0.429 ' HB3' ' ND2' ' B' ' 29' ' ' ASN . 9.1 t70 -81.09 165.97 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.115 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -55.03 -30.93 60.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 71.9 mt -73.35 -17.94 61.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.828 0.347 . . . . 0.0 111.293 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.06 39.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' B' ' 25' ' ' ASP . 2.6 p-10 -85.96 142.61 36.56 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.403 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.566 ' CG ' HG21 ' B' ' 56' ' ' VAL . 44.2 Cg_endo -85.46 153.37 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.658 2.239 . . . . 0.0 112.377 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -126.51 150.12 48.95 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.502 HD21 HD12 ' B' ' 54' ' ' ILE . 11.3 tp -128.85 123.7 33.42 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.746 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -121.96 119.24 30.92 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.144 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.0 t -123.99 122.67 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 110.081 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.91 131.47 24.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.859 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.62 136.21 48.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.293 1.995 . . . . 0.0 111.708 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 52.0 m -70.43 -25.34 63.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -132.87 102.91 13.26 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.725 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.01 -21.04 37.54 Favored 'Trans proline' 0 CA--C 1.526 0.116 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -74.99 -32.72 61.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.593 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -73.71 -21.53 60.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.25 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 20.0 mm-40 -68.82 -35.68 77.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.868 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.57 -43.36 39.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.036 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.9 mt -92.75 67.42 4.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -78.32 81.17 4.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.482 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -80.83 -7.08 59.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.958 0.885 . . . . 0.0 108.712 167.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 5.0 p -103.11 137.72 19.34 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.437 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.24 156.1 46.53 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.454 2.103 . . . . 0.0 111.58 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 48.9 mt -87.79 138.55 31.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.0 110.708 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 52' ' ' LEU . 85.3 mt -108.53 123.82 36.22 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 167.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.519 ' HG2' ' CA ' ' A' ' 57' ' ' GLY . 74.0 Cg_endo -77.37 136.55 15.94 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.065 . . . . 0.0 111.475 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.9 mp -133.89 130.11 37.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 m -108.83 118.72 37.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.733 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 54' ' ' ILE . 37.0 mt -107.57 126.49 63.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.115 0.483 . . . . 0.0 110.793 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -109.66 138.61 45.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.512 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' B' ' 30' ' ' PRO . 1.1 t -89.45 140.72 15.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.155 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.544 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.66 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PHE . 86.4 Cg_exo -51.85 139.25 50.35 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.502 2.801 . . . . 0.0 112.096 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.2 132.28 56.68 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.597 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -122.01 140.94 51.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.703 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 124.32 41.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.261 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.51 HD22 HG21 ' A' ' 34' ' ' VAL . 1.5 pp -141.42 157.9 44.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.249 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -119.27 127.42 53.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.368 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD11 HD21 ' B' ' 20' ' ' LEU . 65.6 mt -119.49 141.99 48.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.189 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -70.56 127.16 31.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.99 104.34 0.79 Allowed Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.144 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.29 11.86 26.58 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.623 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.435 ' OE1' ' HG2' ' A' ' 41' ' ' GLN . 25.4 mm-40 -109.57 154.83 22.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 111.599 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -96.66 137.16 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.654 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 34' ' ' VAL . 74.4 m-85 -129.61 154.89 46.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.852 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.691 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.6 m170 -95.03 117.62 30.47 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.321 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' LEU . 11.9 tp -110.64 123.15 49.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.51 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 13.8 mt -131.25 126.53 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.56 127.9 74.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.54 151.09 47.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.181 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -108.09 135.53 49.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -174.87 5.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -64.05 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.727 0.298 . . . . 0.0 111.563 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.413 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 42.2 mt -80.39 -24.48 39.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.59 17.96 9.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.436 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 27' ' ' LEU . 16.4 m120 -92.88 135.53 25.93 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' CG ' HG21 ' A' ' 56' ' ' VAL . 71.4 Cg_endo -75.07 144.08 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.522 2.148 . . . . 0.0 111.85 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.2 t -127.48 140.24 52.28 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 54' ' ' ILE . 12.6 tp -120.05 129.19 54.11 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.744 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 36.1 m -126.13 119.98 28.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.995 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 74.1 t -123.41 121.77 63.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.5 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.12 129.66 24.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.445 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.46 137.04 75.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.545 2.163 . . . . 0.0 112.16 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.0 t -68.94 -21.05 64.22 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.431 0.634 . . . . 0.0 109.998 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -140.29 103.24 6.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -11.71 33.0 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.541 2.161 . . . . 0.0 112.728 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -86.95 -27.67 23.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.033 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HG2' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mp0 -69.41 -23.78 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.85 -33.26 75.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.442 0.639 . . . . 0.0 109.672 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -85.21 -42.23 14.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.668 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.16 55.27 2.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.9 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -78.88 94.84 5.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.402 0.62 . . . . 0.0 112.075 -174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.13 -10.99 51.37 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 p -101.94 132.55 21.48 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.229 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.86 160.07 48.83 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.1 mt -92.91 120.15 32.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.111 0.481 . . . . 0.0 111.082 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 52' ' ' LEU . 80.8 mt -91.13 127.94 49.46 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.001 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.28 134.86 19.71 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.109 1.873 . . . . 0.0 111.739 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -136.02 135.18 39.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.371 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.4 m -115.38 120.95 41.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.849 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' B' ' 54' ' ' ILE . 31.8 mt -108.56 129.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 85.6 m-85 -111.56 138.75 47.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 30' ' ' PRO . 42.4 t -95.27 118.45 41.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.68 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.569 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.606 169.485 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 80.6 mtp . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' B' ' 55' ' ' PHE . 88.9 Cg_exo -51.86 139.15 50.66 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 C-N-CA 123.439 2.76 . . . . 0.0 112.248 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.36 132.18 56.64 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.709 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.9 140.8 51.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.631 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.57 123.98 41.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.294 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.531 HD22 HG21 ' B' ' 34' ' ' VAL . 1.6 pp -141.12 158.09 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.18 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -119.91 127.09 52.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.134 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 20' ' ' LEU . 65.8 mt -119.43 141.74 48.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.189 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -70.31 127.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.62 104.13 0.73 Allowed Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.159 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 11.74 26.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.676 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.42 ' OE1' ' HG2' ' B' ' 41' ' ' GLN . 26.3 mm-40 -109.53 155.14 21.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -97.18 137.07 36.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' B' ' 34' ' ' VAL . 73.3 m-85 -129.61 154.85 46.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.789 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.688 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 5.6 m170 -95.19 117.56 30.44 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.256 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.503 HD11 HD11 ' B' ' 32' ' ' LEU . 11.7 tp -110.35 123.11 49.25 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.489 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 13.6 mt -131.26 126.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.47 127.84 73.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -138.81 151.24 46.87 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -108.1 136.07 48.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.968 0.413 . . . . 0.0 111.041 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -175.03 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.48 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.2 m -63.79 -30.57 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.714 0.292 . . . . 0.0 111.52 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 41.7 mt -80.63 -24.3 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.265 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.19 18.22 9.42 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.474 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' B' ' 27' ' ' LEU . 16.1 m120 -92.76 135.43 26.23 Favored Pre-proline 0 CA--C 1.511 -0.548 0 CA-C-O 121.028 0.442 . . . . 0.0 109.841 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.438 ' CG ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -75.04 143.98 29.58 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.499 2.132 . . . . 0.0 111.858 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -127.61 140.28 52.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.591 HD21 HD12 ' B' ' 54' ' ' ILE . 12.6 tp -119.62 129.75 54.76 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.768 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 38.6 m -126.47 120.04 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.751 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 74.9 t -123.71 121.48 62.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 0.0 110.419 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.89 129.75 24.47 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 136.62 71.99 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.196 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 16.4 t -68.25 -21.68 64.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.155 0.503 . . . . 0.0 109.789 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -139.81 103.46 6.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.938 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.6 -12.22 34.94 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.694 2.262 . . . . 0.0 112.601 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -86.43 -27.7 23.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.103 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.42 ' HG2' ' OE1' ' B' ' 16' ' ' GLN . 1.2 mp0 -69.38 -24.0 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 175.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.62 -33.51 75.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.773 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -85.03 -42.06 15.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.787 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.31 55.37 2.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.037 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p -78.92 95.02 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.126 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.89 -10.08 51.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.0 p -102.22 132.46 21.46 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.157 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.85 160.07 48.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.841 2.361 . . . . 0.0 111.802 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.53 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 47.4 mt -93.17 120.06 33.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.933 0.397 . . . . 0.0 111.202 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.503 ' O ' HD12 ' B' ' 52' ' ' LEU . 81.3 mt -91.08 128.02 49.25 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.25 134.98 19.93 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.125 1.883 . . . . 0.0 111.784 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.503 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -136.19 134.77 38.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.518 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -115.01 120.97 41.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' A' ' 54' ' ' ILE . 30.4 mt -108.56 129.44 63.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.812 0.339 . . . . 0.0 110.769 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.8 m-85 -111.27 138.52 47.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.779 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' B' ' 30' ' ' PRO . 41.7 t -95.26 118.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.474 0 C-N-CA 119.119 -1.515 . . . . 0.0 113.583 169.834 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 18.8 ptp . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.335 0.588 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' A' ' 56' ' ' VAL . 2.8 Cg_exo -68.88 135.52 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.917 2.411 . . . . 0.0 111.569 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 m -113.85 148.73 36.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.158 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -123.47 140.09 53.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.878 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -127.12 123.78 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 52' ' ' LEU . 2.1 pp -140.62 158.62 43.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.85 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.23 128.46 51.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.686 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.449 HD11 HD21 ' B' ' 20' ' ' LEU . 50.0 mt -123.01 140.5 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 98.2 m-70 -72.05 132.11 43.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.99 108.03 1.57 Allowed Glycine 0 CA--C 1.516 0.142 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.792 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.84 -8.32 42.71 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.595 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -84.16 147.03 27.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.825 0.345 . . . . 0.0 110.255 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 4.4 m -96.22 136.3 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.1 m-85 -129.7 153.09 48.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.313 0.578 . . . . 0.0 111.158 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.4 m80 -95.82 117.64 30.94 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.736 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 32' ' ' LEU . 9.7 tp -107.98 123.32 48.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.508 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.65 126.43 54.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.327 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.64 133.69 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -147.17 159.82 43.17 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -116.13 140.69 49.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.87 0.366 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 23.3 p30 -81.3 -174.98 5.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.98 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -62.15 -28.89 69.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 0.0 111.401 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 44.9 mt -82.82 -23.67 33.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 110.64 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.53 19.71 10.21 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.916 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.447 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 18.9 m120 -87.57 131.0 45.12 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' HG11 ' A' ' 56' ' ' VAL . 58.0 Cg_endo -74.42 144.25 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.277 1.985 . . . . 0.0 112.093 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.6 t -130.06 140.18 50.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 20' ' ' LEU . 13.0 tp -122.97 130.09 52.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.905 0.383 . . . . 0.0 110.734 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -127.29 120.69 29.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.977 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.8 t -123.67 121.77 63.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.087 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.87 132.3 24.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.97 133.57 42.06 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.127 1.885 . . . . 0.0 111.713 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 50.5 m -73.41 -27.8 61.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.458 . . . . 0.0 110.248 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -121.32 103.57 41.62 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.35 -25.49 42.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.728 2.286 . . . . 0.0 112.86 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -81.75 -16.13 52.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.268 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -73.21 -26.15 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.031 0.443 . . . . 0.0 110.318 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -86.36 -43.21 13.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.435 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.42 58.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.926 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -83.89 91.1 7.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -85.64 -7.41 58.84 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.42 131.91 22.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.843 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.01 155.26 71.62 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.977 2.451 . . . . 0.0 112.173 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 28.9 mt -91.04 120.05 31.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.09 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 70.6 mt -91.5 129.25 43.57 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 44.0 Cg_endo -86.99 136.92 4.34 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.393 2.062 . . . . 0.0 110.953 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.8 128.72 41.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.769 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -106.22 115.87 30.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.586 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' B' ' 54' ' ' ILE . 27.9 mt -108.38 126.05 65.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -110.27 139.7 45.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.243 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' A' ' 6' ' ' PRO . 12.2 p -87.37 142.78 12.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.197 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.569 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.301 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 19.0 ptp . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' B' ' 56' ' ' VAL . 2.8 Cg_exo -69.43 135.44 31.26 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.744 2.296 . . . . 0.0 111.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 m -113.86 148.51 36.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.253 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -123.26 140.3 53.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.893 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.31 123.62 36.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' B' ' 52' ' ' LEU . 2.0 pp -140.56 158.78 43.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.57 128.53 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.801 0.334 . . . . 0.0 110.591 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 20' ' ' LEU . 49.9 mt -123.1 140.54 52.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 98.2 m-70 -71.99 131.97 43.65 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.71 107.71 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.883 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.89 -8.22 42.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.714 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -84.05 147.23 27.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 4.1 m -96.4 136.22 37.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' B' ' 34' ' ' VAL . 92.6 m-85 -129.69 153.21 48.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.113 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.4 m80 -95.78 117.74 31.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.659 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 32' ' ' LEU . 9.7 tp -108.11 123.27 48.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.431 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.57 126.51 55.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.172 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 133.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.54 160.96 41.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 140.21 49.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.917 0.389 . . . . 0.0 110.482 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' B' ' 29' ' ' ASN . 21.1 p30 -81.2 -175.41 5.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.832 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 22.2 t -61.24 -29.59 69.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.775 0.321 . . . . 0.0 111.505 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 45.5 mt -82.63 -23.9 34.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 0.0 110.463 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.0 10.49 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.048 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.46 ' HB2' ' OD2' ' B' ' 25' ' ' ASP . 18.7 m120 -86.95 130.92 46.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 56' ' ' VAL . 57.9 Cg_endo -74.09 144.36 33.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.313 2.009 . . . . 0.0 112.174 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 41.6 t -130.3 140.02 50.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 20' ' ' LEU . 13.0 tp -122.77 130.33 52.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.907 0.384 . . . . 0.0 110.543 -174.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m -127.58 120.73 28.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.056 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.6 t -123.78 121.52 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.331 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.73 132.38 24.28 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.07 133.45 41.17 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.082 1.855 . . . . 0.0 111.688 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 50.5 m -73.35 -27.9 61.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.157 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -121.29 103.65 41.6 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.56 -25.3 41.06 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.803 2.336 . . . . 0.0 112.879 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -81.78 -16.03 52.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.331 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -73.2 -26.04 61.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.077 0.465 . . . . 0.0 110.517 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -70.12 -27.68 64.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -86.33 -43.25 13.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.319 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -99.48 58.33 1.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.919 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' SER . . . . . 0.404 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 15.2 m -84.07 91.78 7.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.287 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.4 -7.24 58.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.672 0.749 . . . . 0.0 109.035 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.36 132.3 22.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.775 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.15 155.4 70.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.818 2.345 . . . . 0.0 112.124 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 29.7 mt -90.96 119.98 31.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 71.6 mt -91.51 129.21 43.7 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.4 Cg_endo -87.25 136.96 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.373 2.049 . . . . 0.0 110.912 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.2 mp -130.52 128.81 41.91 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.74 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.5 m -106.29 115.97 31.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' A' ' 54' ' ' ILE . 27.5 mt -108.5 126.4 65.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -110.57 139.62 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.116 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' B' ' 6' ' ' PRO . 11.8 p -87.35 142.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.132 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.559 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.66 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.288 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 18.3 ptp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 30.6 Cg_exo -42.75 130.98 5.55 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.786 2.99 . . . . 0.0 113.414 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -118.07 132.45 56.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.246 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.87 140.07 53.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.421 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -124.82 123.77 40.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.08 157.92 44.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.748 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -120.37 128.35 53.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 0.0 110.095 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' B' ' 20' ' ' LEU . 60.0 mt -117.2 141.21 48.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.53 ' CE1' ' HB3' ' A' ' 45' ' ' SER . 97.2 m-70 -70.7 127.58 33.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.7 7.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.533 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -0.74 65.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.631 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -85.73 151.62 23.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 110.608 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 3.0 m -102.03 135.65 43.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.579 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 34' ' ' VAL . 77.9 m-85 -128.59 154.04 46.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.266 0.555 . . . . 0.0 111.03 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.6 m170 -95.42 116.98 29.54 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 32' ' ' LEU . 15.7 tp -106.36 122.48 46.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.378 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.58 126.36 54.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.315 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.58 139.82 38.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.48 171.21 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -123.02 135.2 54.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.048 0.451 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -178.24 4.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.401 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 m -60.46 -31.09 70.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.8 0.333 . . . . 0.0 111.621 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.2 mt -81.81 -23.94 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 111.292 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.84 13.12 12.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.384 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -91.63 141.9 26.23 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.576 ' CB ' HG21 ' A' ' 56' ' ' VAL . 74.2 Cg_endo -72.06 147.25 48.39 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.803 2.335 . . . . 0.0 112.329 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.2 t -128.23 141.17 51.54 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 54' ' ' ILE . 15.5 tp -120.73 129.98 53.86 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.619 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -126.17 125.94 43.28 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 55.4 t -127.24 121.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.824 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.54 129.2 24.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.463 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.4 Cg_endo -60.91 133.74 49.33 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.442 2.095 . . . . 0.0 111.951 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 42.1 m -75.81 -22.35 56.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.2 0.524 . . . . 0.0 109.713 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -130.09 102.47 17.4 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.451 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.49 -13.93 30.47 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.801 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -76.88 -31.85 57.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.597 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.92 -19.74 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.949 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 74.9 mm-40 -69.61 -34.59 74.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.044 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.575 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 11.8 pt20 -87.02 -42.21 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 174.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 19.4 mt -97.13 60.87 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 5.1 m -83.42 85.88 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.143 -172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.93 -3.59 58.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.732 0.777 . . . . 0.0 108.992 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.9 128.74 28.94 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.69 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.56 157.19 62.86 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.84 2.36 . . . . 0.0 112.67 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 62.1 mt -98.85 126.07 44.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.432 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.7 mt -99.87 127.75 32.91 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.42 136.43 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.857 1.705 . . . . 0.0 111.754 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.4 mp -131.13 133.39 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.967 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -110.0 118.49 36.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.697 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' B' ' 54' ' ' ILE . 28.4 mt -106.91 125.79 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.918 0.39 . . . . 0.0 110.729 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 86.7 m-85 -111.17 134.97 52.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.083 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 30' ' ' PRO . 1.5 t -84.54 131.69 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.637 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.906 -178.705 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 18.5 ptp . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.562 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 33.6 Cg_exo -43.12 130.75 6.15 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.645 2.897 . . . . 0.0 113.513 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -117.73 132.52 56.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 112.239 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.93 140.41 53.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.382 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -125.36 123.6 39.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.16 158.14 44.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -120.78 128.31 52.77 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 20' ' ' LEU . 61.3 mt -117.3 141.31 48.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.502 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' B' ' 45' ' ' SER . 97.2 m-70 -70.58 127.63 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 115.47 7.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.432 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.99 -0.72 64.57 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.759 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -85.84 151.88 23.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.0 110.639 178.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 3.0 m -102.14 135.55 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.629 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' TYR . . . . . 0.508 ' HB3' HG13 ' B' ' 34' ' ' VAL . 78.2 m-85 -128.65 154.05 46.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.7 m170 -95.38 116.79 29.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 15.9 tp -106.24 122.47 46.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.342 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mt -132.56 126.13 54.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.438 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.4 140.06 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -149.38 171.57 16.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 3.5 p -124.03 134.33 53.46 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.43 -177.76 4.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.472 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 m -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.765 0.316 . . . . 0.0 111.554 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 mt -81.68 -24.29 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.275 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.15 13.06 12.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.54 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -91.41 141.92 26.5 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.577 ' CB ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -72.0 147.2 48.66 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.642 2.228 . . . . 0.0 112.321 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -127.95 141.18 51.61 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 15.4 tp -120.91 129.37 53.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.033 0.444 . . . . 0.0 110.819 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -125.91 125.64 43.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.508 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 54.6 t -127.22 121.23 57.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.859 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -124.61 129.22 24.71 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.477 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.2 Cg_endo -60.82 134.08 51.61 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.447 2.098 . . . . 0.0 111.821 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.484 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 37.2 m -75.93 -22.5 55.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.379 0.609 . . . . 0.0 109.689 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.98 102.45 17.58 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.577 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.6 -13.9 30.16 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.727 2.284 . . . . 0.0 112.672 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -76.8 -32.12 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.521 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -73.55 -19.98 60.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.953 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 76.2 mm-40 -69.58 -34.32 73.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.967 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.584 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 11.8 pt20 -87.29 -41.9 13.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.575 174.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 19.7 mt -97.42 60.36 1.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.788 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 5.2 m -83.04 85.85 7.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.281 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.56 -3.86 58.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.904 0.859 . . . . 0.0 108.919 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.72 128.6 29.52 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.711 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.75 157.37 62.14 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.873 2.382 . . . . 0.0 112.551 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.9 mt -99.43 125.18 45.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.514 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.462 ' O ' HD12 ' B' ' 52' ' ' LEU . 79.0 mt -99.13 127.42 34.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.12 136.45 18.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.782 1.655 . . . . 0.0 111.702 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.462 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.4 mp -131.15 133.36 45.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.131 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -109.87 118.44 36.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' A' ' 54' ' ' ILE . 28.3 mt -106.93 125.95 62.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.083 0.468 . . . . 0.0 110.696 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.6 m-85 -111.29 134.89 52.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.072 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' VAL . . . . . 0.577 HG21 ' CB ' ' B' ' 30' ' ' PRO . 1.5 t -84.59 131.47 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.815 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.927 -178.626 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.59 18.48 3.1 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.666 -0.314 . . . . 0.0 111.713 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.444 ' HG3' ' HG3' ' A' ' 4' ' ' GLU . 26.3 ptm -131.94 -31.67 1.49 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.15 0.5 . . . . 0.0 110.861 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HG3' ' HG3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -96.49 12.2 32.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.505 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.415 ' H ' ' HG2' ' A' ' 5' ' ' MET . 12.2 ptm -66.92 126.96 93.27 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.425 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.954 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 16.7 Cg_endo -56.94 132.35 51.12 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.546 2.831 . . . . 0.0 112.616 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m -116.11 137.33 52.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.588 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.56 145.97 46.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -129.15 124.05 33.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.125 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.92 158.52 43.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.689 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 128.1 48.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -122.0 140.98 51.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.616 -173.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.73 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 35.5 m80 -71.7 129.23 38.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.48 115.14 7.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.006 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.58 10.74 56.49 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.976 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 11.0 mm-40 -109.4 150.94 27.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 110.732 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 m -91.56 137.86 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.104 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.34 153.0 48.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.573 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.1 m170 -96.27 117.55 31.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.265 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD11 HD11 ' A' ' 32' ' ' LEU . 8.3 tp -109.08 119.63 40.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.103 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 mt -128.07 125.85 65.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.833 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.0 p -112.27 134.89 53.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -146.85 170.71 16.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 p -117.03 142.29 47.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.462 0.648 . . . . 0.0 112.164 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.12 164.68 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.461 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -56.49 -30.68 63.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.398 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.04 -18.01 62.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.48 1.75 53.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.956 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 78.5 m-20 -84.79 132.19 47.02 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.246 0.546 . . . . 0.0 110.082 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 56' ' ' VAL . 11.8 Cg_exo -66.39 150.02 84.58 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 122.983 2.455 . . . . 0.0 112.482 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -132.74 139.87 47.8 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.95 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 54' ' ' ILE . 13.8 tp -124.63 134.66 52.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.935 0.397 . . . . 0.0 111.162 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.8 m -134.89 123.29 23.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.392 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 68.8 t -125.98 122.4 61.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.94 131.04 24.59 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.872 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.76 42.12 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.417 2.078 . . . . 0.0 112.099 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.8 m -67.83 -23.67 65.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.241 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' OE1' ' A' ' 41' ' ' GLN . 77.1 m-20 -131.68 103.15 14.77 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.502 172.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.77 -23.8 22.15 Favored 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.096 2.53 . . . . 0.0 113.232 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -80.07 -22.71 41.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.692 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.615 ' OE1' ' HB3' ' A' ' 38' ' ' ASN . 12.1 mp0 -73.48 -20.93 60.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.254 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.73 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 46.6 mm-40 -67.38 -32.23 73.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.641 172.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -83.5 -43.15 16.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.89 77.58 3.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.742 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -91.3 78.69 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.335 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.01 -5.92 58.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 p -101.82 135.89 19.64 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.851 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.43 149.56 50.54 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.341 2.028 . . . . 0.0 111.853 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.62 123.73 35.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.3 mt -96.72 124.91 48.74 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 59' ' ' ASN . 77.2 Cg_endo -78.5 136.48 13.95 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.126 1.884 . . . . 0.0 111.135 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.23 133.17 46.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -110.14 115.95 30.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' B' ' 54' ' ' ILE . 31.3 mt -106.38 121.0 58.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.0 110.509 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -106.37 137.23 44.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.622 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.954 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -85.45 135.3 25.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.185 0.517 . . . . 0.0 110.799 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.61 156.86 18.29 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.03 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.81 115.96 26.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' B' ' 51' ' ' PRO . 17.0 t-20 -84.15 66.82 9.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.701 0.763 . . . . 0.0 109.013 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.6 m -75.97 -34.3 59.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.295 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.53 155.83 19.07 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.56 179.555 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.66 19.0 3.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.737 0.303 . . . . 0.0 111.595 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' MET . . . . . 0.456 ' HG3' ' HG3' ' B' ' 4' ' ' GLU . 26.3 ptm -132.42 -31.31 1.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.97 0.414 . . . . 0.0 110.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.456 ' HG3' ' HG3' ' B' ' 3' ' ' MET . 0.0 OUTLIER -96.96 12.56 31.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.459 0.647 . . . . 0.0 110.562 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.1 ptm -67.24 126.75 92.99 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.302 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.949 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 16.5 Cg_endo -56.9 132.34 51.05 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.59 2.86 . . . . 0.0 112.635 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -116.07 137.43 52.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.538 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -120.77 145.81 47.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.486 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -128.84 123.9 33.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.18 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.65 158.53 43.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.95 128.02 48.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.916 0.389 . . . . 0.0 110.02 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 22' ' ' VAL . 52.9 mt -121.89 140.9 51.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.741 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 35.6 m80 -71.67 129.51 38.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 115.52 8.02 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.018 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 10.57 56.7 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.963 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' B' ' 16' ' ' GLN . 11.0 mm-40 -109.36 150.99 27.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 8.4 m -91.83 137.75 32.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.027 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.405 ' HB3' HG13 ' B' ' 34' ' ' VAL . 86.7 m-85 -129.36 152.95 48.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.577 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.1 m170 -96.25 117.41 30.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.374 173.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 8.3 tp -108.89 119.27 39.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.53 125.85 66.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.014 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.2 p -112.07 134.67 53.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -146.67 170.75 16.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -116.83 142.61 46.7 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.475 0.655 . . . . 0.0 112.238 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.34 164.27 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.491 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -56.11 -30.95 62.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.53 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.87 -17.97 62.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.09 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.56 1.37 53.16 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.008 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 30' ' ' PRO . 79.4 m-20 -84.53 132.06 48.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.519 . . . . 0.0 109.913 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.708 ' HG2' HG11 ' B' ' 56' ' ' VAL . 11.7 Cg_exo -66.24 149.91 85.07 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.202 2.601 . . . . 0.0 112.402 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -132.54 139.93 48.08 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.787 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.518 HD21 HD12 ' B' ' 54' ' ' ILE . 13.8 tp -124.75 134.77 52.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.106 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -135.01 123.57 23.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.4 t -126.17 122.49 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.006 0.432 . . . . 0.0 110.517 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.02 130.97 24.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.862 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.439 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.32 40.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.433 2.089 . . . . 0.0 112.194 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 69.9 m -67.31 -23.87 65.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.126 0.489 . . . . 0.0 110.209 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASN . . . . . 0.635 ' HB3' ' OE1' ' B' ' 41' ' ' GLN . 77.8 m-20 -131.67 103.27 14.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.418 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.05 -23.83 21.19 Favored 'Trans proline' 0 CA--C 1.526 0.078 0 C-N-CA 123.115 2.544 . . . . 0.0 113.171 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.8 -22.88 42.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.856 0.36 . . . . 0.0 110.706 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.635 ' OE1' ' HB3' ' B' ' 38' ' ' ASN . 12.5 mp0 -73.48 -20.8 60.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.741 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 49.1 mm-40 -67.55 -32.12 72.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.678 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -83.57 -43.21 15.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.855 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.96 77.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 11.3 p -91.35 78.63 5.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.245 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.97 -5.56 58.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 166.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.1 p -102.32 135.8 19.53 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.9 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.45 149.55 50.4 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.246 1.964 . . . . 0.0 111.913 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.49 123.54 34.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.45 ' O ' HD12 ' B' ' 52' ' ' LEU . 64.8 mt -96.6 124.86 49.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 59' ' ' ASN . 76.4 Cg_endo -78.36 136.27 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.117 1.878 . . . . 0.0 111.129 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.3 mp -129.95 133.16 46.63 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.055 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -109.78 116.03 30.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.341 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' A' ' 54' ' ' ILE . 30.8 mt -106.52 120.86 58.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.226 0.536 . . . . 0.0 110.508 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -106.25 137.13 44.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.598 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.949 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -85.53 135.17 25.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 0.0 110.607 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.41 157.39 18.3 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.034 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.04 116.22 27.16 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 17.3 t-20 -84.86 66.94 9.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -76.19 -34.58 59.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.23 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.75 156.35 18.73 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.598 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.712 179.253 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.74 86.57 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 111.732 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ttt 65.45 41.69 4.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.077 169.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER -101.61 20.28 16.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.033 0.92 . . . . 0.0 109.642 172.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.1 ptp -98.13 141.34 22.8 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.006 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 86.1 Cg_exo -49.16 131.36 26.22 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 123.593 2.862 . . . . 0.0 113.14 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -117.74 138.38 52.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.69 142.34 51.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.647 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.13 125.02 40.47 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.162 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.94 158.07 44.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.02 127.59 51.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.897 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB2' HG11 ' B' ' 22' ' ' VAL . 57.7 mt -122.61 140.73 52.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.299 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.41 126.93 30.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.32 99.65 0.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.453 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -0.58 17.93 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.817 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -96.5 155.53 16.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.769 0.318 . . . . 0.0 110.645 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.599 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 6.9 m -98.19 136.9 37.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.389 0.614 . . . . 0.0 110.565 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 34' ' ' VAL . 96.5 m-85 -129.3 153.22 48.04 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.411 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m80 -95.29 117.16 29.79 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.605 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.01 119.53 39.62 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.463 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.62 125.72 64.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.91 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' B' ' 12' ' ' LEU . 14.8 p -112.19 132.52 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 24.2 t0 -135.91 169.87 16.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.74 0.305 . . . . 0.0 110.831 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -179.46 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -58.48 -30.87 67.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 59.3 mt -82.23 -22.23 35.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.413 . . . . 0.0 111.204 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 19.22 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.282 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.605 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 29.5 m-80 -88.33 136.99 31.06 Favored Pre-proline 0 CA--C 1.511 -0.53 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HG3' HG11 ' A' ' 56' ' ' VAL . 1.1 Cg_endo -80.47 144.27 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.858 2.372 . . . . 0.0 111.681 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.7 t -127.88 140.18 52.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.574 HD21 HD12 ' A' ' 54' ' ' ILE . 14.4 tp -115.77 132.14 56.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.43 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -130.6 120.4 23.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.133 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.4 t -127.0 122.2 59.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.96 131.04 23.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.89 139.76 69.75 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.347 2.031 . . . . 0.0 111.811 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 12.7 p -67.38 -29.86 69.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.345 0.593 . . . . 0.0 110.5 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.08 102.72 4.81 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.457 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.41 -15.03 44.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.162 2.575 . . . . 0.0 112.707 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -66.19 -35.65 81.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.112 0.482 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -74.83 -22.2 58.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.043 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -70.13 -43.71 70.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.673 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.566 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 12.9 pt20 -78.38 -33.89 48.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.746 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 22.7 mt -102.11 56.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 p -74.79 96.76 3.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.157 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.84 -18.49 40.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.07 137.89 19.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.532 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.33 157.68 52.96 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.972 2.448 . . . . 0.0 112.843 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.8 mt -85.26 124.46 31.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.693 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 52' ' ' LEU . 70.6 mt -96.21 126.88 42.48 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.58 135.54 18.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.146 1.898 . . . . 0.0 111.599 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.9 mp -134.87 131.1 36.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.379 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 m -110.9 119.05 37.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' B' ' 54' ' ' ILE . 30.0 mt -107.04 125.73 63.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.939 0.4 . . . . 0.0 110.711 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -108.56 137.47 46.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.234 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 5' ' ' MET . 40.3 t -93.58 119.44 41.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.629 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.52 170.67 15.88 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 118.853 -1.641 . . . . 0.0 114.275 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 60' ' ' THR . 33.0 mt-10 -70.18 -39.72 75.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.302 -169.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 71.13 -26.53 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 58' ' ' GLU . 21.0 m 83.87 -16.9 0.51 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.925 0.89 . . . . 0.0 111.065 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.36 64.51 4.25 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.557 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.704 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.1 86.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.546 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ttt 65.43 41.39 4.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.233 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' B' ' 4' ' ' GLU . 0.8 OUTLIER -101.37 19.76 17.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.995 0.902 . . . . 0.0 109.647 172.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.572 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 13.5 ptp -97.78 141.74 23.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.984 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.4 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 90.1 Cg_exo -49.39 131.13 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -117.72 138.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.284 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.38 142.32 51.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.684 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.26 125.22 40.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.912 0.387 . . . . 0.0 110.143 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.88 158.08 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.12 127.65 51.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 22' ' ' VAL . 57.5 mt -122.75 140.72 52.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.451 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.45 126.9 30.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.36 99.54 0.29 Allowed Glycine 0 C--O 1.228 -0.237 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.502 -176.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.19 0.58 18.99 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.797 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -97.2 155.66 16.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.34 . . . . 0.0 110.585 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.588 ' HB ' ' OG ' ' B' ' 37' ' ' SER . 7.1 m -98.21 136.76 37.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.461 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' B' ' 34' ' ' VAL . 96.4 m-85 -129.33 153.33 47.95 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.3 m80 -95.26 117.65 30.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.312 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.43 119.76 40.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.292 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.77 125.64 63.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.945 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 12' ' ' LEU . 14.8 p -112.22 132.32 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 23.4 t0 -135.87 170.23 16.32 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.87 133.51 45.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.93 -179.73 7.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.254 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -58.33 -31.02 67.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.609 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 58.2 mt -81.92 -22.5 36.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.94 0.4 . . . . 0.0 111.116 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.22 18.89 9.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.263 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 29.0 m-80 -87.8 137.29 31.85 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.53 ' HG3' HG11 ' B' ' 56' ' ' VAL . 1.1 Cg_endo -80.48 144.66 16.13 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.757 2.304 . . . . 0.0 111.614 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -128.41 140.27 51.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 54' ' ' ILE . 14.6 tp -116.28 131.42 56.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 110.438 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 21.3 m -130.15 120.21 24.21 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.944 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.8 t -126.64 122.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.518 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 131.03 23.66 Favored Pre-proline 0 C--O 1.223 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.79 139.46 68.82 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.376 2.051 . . . . 0.0 111.769 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' B' ' 17' ' ' THR . 12.4 p -67.15 -30.08 69.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.472 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -143.87 103.05 4.87 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.84 -15.09 43.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.109 2.539 . . . . 0.0 112.632 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -66.15 -35.47 80.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.177 0.513 . . . . 0.0 109.76 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.65 -22.44 58.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.198 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -69.85 -44.05 70.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.573 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 13.0 pt20 -78.14 -33.59 50.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.573 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 23.3 mt -102.37 56.22 0.79 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.319 0.58 . . . . 0.0 109.582 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -74.69 96.21 2.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.392 -173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.13 -18.47 42.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.23 138.14 19.64 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.457 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.47 157.65 52.56 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.914 2.409 . . . . 0.0 112.963 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.04 124.56 31.87 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.742 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.475 ' O ' HD12 ' B' ' 52' ' ' LEU . 70.9 mt -96.27 127.0 41.92 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.49 135.62 18.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.06 1.84 . . . . 0.0 111.559 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 50' ' ' ILE . 4.9 mp -134.85 131.19 37.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -111.2 118.9 37.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.659 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' A' ' 54' ' ' ILE . 29.7 mt -106.93 125.73 62.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.962 0.411 . . . . 0.0 110.696 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -108.72 137.27 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.297 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' B' ' 5' ' ' MET . 39.5 t -93.35 119.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.401 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.3 171.11 16.1 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 118.77 -1.681 . . . . 0.0 114.37 169.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' B' ' 60' ' ' THR . 33.7 mt-10 -70.63 -40.01 73.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.719 -0.741 . . . . 0.0 112.184 -169.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.38 -26.6 0.17 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' THR . . . . . 0.454 ' H ' ' C ' ' B' ' 58' ' ' GLU . 23.7 m 83.65 -16.61 0.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.972 0.909 . . . . 0.0 111.13 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 64.51 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.347 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.462 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.72 -89.95 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.055 0.542 . . . . 0.0 111.676 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -96.88 -25.59 15.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.111 0.482 . . . . 0.0 110.397 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.12 103.18 12.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.408 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 17.2 ptp -120.53 133.29 24.02 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.167 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.84 131.66 43.27 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.977 2.451 . . . . 0.0 111.639 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -112.13 136.82 51.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -115.1 139.81 49.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.11 123.37 36.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.98 158.63 43.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 129.38 50.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.816 0.341 . . . . 0.0 110.494 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD11 HD21 ' B' ' 20' ' ' LEU . 57.7 mt -119.98 146.29 45.98 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.32 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.562 ' HE1' ' HB3' ' A' ' 45' ' ' SER . 20.0 m-70 -70.77 127.35 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.001 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.55 112.03 3.97 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.171 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.24 3.98 56.5 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.422 -0.418 . . . . 0.0 113.125 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.4 156.66 17.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.965 0.412 . . . . 0.0 110.948 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -96.39 138.53 33.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.086 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.31 154.46 46.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.716 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.5 m80 -95.84 117.67 31.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.639 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 HD11 ' B' ' 12' ' ' LEU . 8.4 tp -108.85 120.83 43.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.37 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 10.5 mt -129.22 126.52 64.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.914 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.29 133.76 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.28 169.77 16.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 132.79 55.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 112.369 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.5 160.08 32.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.7 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.0 t -61.03 -24.56 66.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.96 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.425 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 54.1 mt -83.53 -12.38 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.441 . . . . 0.0 110.41 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.29 13.63 26.18 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.861 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 27' ' ' LEU . 27.2 m120 -85.65 129.34 55.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.56 148.74 42.82 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.962 . . . . 0.0 111.896 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -130.4 143.25 50.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.18 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.578 HD21 HD12 ' A' ' 54' ' ' ILE . 17.9 tp -124.29 133.33 53.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.635 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 15.7 m -131.96 120.82 23.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.5 t -127.77 122.11 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.268 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -121.78 133.15 24.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.62 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.82 137.14 66.16 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.307 2.005 . . . . 0.0 111.702 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.7 t -65.9 -23.65 66.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.51 . . . . 0.0 109.87 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -143.38 107.14 5.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.346 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.64 -18.59 64.89 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.073 2.515 . . . . 0.0 113.166 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.55 -22.72 43.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.632 0.253 . . . . 0.0 110.77 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -68.37 -25.08 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.136 0.493 . . . . 0.0 110.124 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.57 -32.98 72.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.345 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -79.57 -43.02 23.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.01 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -92.64 63.87 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.562 ' HB3' ' HE1' ' A' ' 13' ' ' HIS . 5.4 p -82.77 73.02 9.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.38 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.82 2.32 53.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.15 131.0 23.12 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.042 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.23 144.61 69.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.31 2.006 . . . . 0.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -87.25 129.79 34.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 52' ' ' LEU . 68.5 mt -104.91 122.25 43.9 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 168.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HG3' ' H ' ' B' ' 59' ' ' ASN . 73.0 Cg_endo -77.24 137.34 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.397 2.065 . . . . 0.0 111.557 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -129.21 136.6 50.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.082 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 m -111.29 116.82 31.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.844 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' B' ' 54' ' ' ILE . 38.6 mt -107.66 127.07 63.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.949 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 66.2 m-85 -112.35 141.41 46.11 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.738 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.0 141.41 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.935 0.398 . . . . 0.0 110.021 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.92 159.54 13.68 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.033 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.63 54.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 109.979 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.6 ' H ' ' HG3' ' B' ' 51' ' ' PRO . 23.8 t-20 60.74 81.72 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.96 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.8 p -115.14 6.28 15.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.7 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.68 -32.65 57.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.767 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.981 177.08 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.1 -90.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.698 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -96.79 -24.97 15.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 110.494 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -107.7 102.96 12.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.576 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 17.4 ptp -120.56 133.02 23.98 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.61 132.21 46.88 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.844 2.363 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -112.86 136.85 52.03 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.991 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.21 140.09 49.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.54 122.87 34.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.59 158.46 43.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.538 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.0 129.19 50.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.956 0.408 . . . . 0.0 110.585 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 20' ' ' LEU . 57.6 mt -119.85 146.25 45.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.465 -173.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.56 ' HE1' ' HB3' ' B' ' 45' ' ' SER . 19.7 m-70 -70.92 127.54 32.93 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.89 112.11 4.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.032 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 4.32 56.46 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.01 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.75 156.35 17.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.949 0.404 . . . . 0.0 110.849 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 15.3 m -95.97 138.65 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.128 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -129.43 154.19 47.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.737 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.5 m80 -95.59 117.73 30.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 12' ' ' LEU . 8.2 tp -108.99 120.86 43.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.344 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 10.4 mt -129.23 126.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.986 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.23 133.59 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.51 169.5 17.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.6 55.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.76 0.791 . . . . 0.0 112.526 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.97 160.23 32.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.751 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 t -61.44 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.082 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.444 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 52.1 mt -84.04 -12.43 55.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.33 13.75 25.8 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.985 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' B' ' 27' ' ' LEU . 26.5 m120 -85.95 129.37 54.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 110.334 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.59 148.72 42.66 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.253 1.969 . . . . 0.0 111.917 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -130.59 142.96 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.244 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 18.0 tp -123.96 133.56 53.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.901 0.381 . . . . 0.0 110.497 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.5 m -132.26 120.5 22.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.942 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.9 t -127.32 122.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.63 133.21 24.18 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.766 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.11 137.6 67.57 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.149 1.9 . . . . 0.0 111.667 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -66.16 -23.46 66.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.232 0.539 . . . . 0.0 109.876 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' B' ' 39' ' ' PRO . 27.8 t-20 -143.62 106.88 5.06 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.404 174.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' B' ' 38' ' ' ASN . 28.8 Cg_endo -63.63 -18.64 65.15 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.174 2.583 . . . . 0.0 113.087 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.48 -22.6 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.704 0.287 . . . . 0.0 110.852 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.39 -25.44 65.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.23 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.45 -32.71 71.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.398 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -79.69 -43.11 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 110.042 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.8 mt -92.38 63.62 4.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.063 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' SER . . . . . 0.56 ' HB3' ' HE1' ' B' ' 13' ' ' HIS . 4.9 p -82.69 72.54 9.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.28 2.11 53.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.95 131.73 22.41 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.992 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.48 144.41 67.04 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.478 2.119 . . . . 0.0 112.142 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -87.41 129.79 34.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.425 ' O ' HD12 ' B' ' 52' ' ' LEU . 68.9 mt -104.89 122.3 43.76 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.6 ' HG3' ' H ' ' A' ' 59' ' ' ASN . 72.4 Cg_endo -77.11 137.32 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.461 2.107 . . . . 0.0 111.599 175.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.425 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -129.4 136.32 49.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -110.94 116.64 31.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.834 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' A' ' 54' ' ' ILE . 39.5 mt -107.53 127.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.209 0.528 . . . . 0.0 111.096 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.404 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 65.0 m-85 -112.35 141.34 46.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.699 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.07 141.74 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.845 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.404 ' C ' ' HG2' ' A' ' 51' ' ' PRO . . . -114.93 159.19 13.87 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.03 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.68 55.32 0.82 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.412 0.625 . . . . 0.0 110.001 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.613 ' H ' ' HG3' ' A' ' 51' ' ' PRO . 23.7 t-20 60.02 81.54 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.057 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 17.3 p -115.17 6.5 15.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.25 -32.89 55.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.718 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.218 177.082 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.95 64.03 1.55 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -66.9 0.87 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.98 -172.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.23 58.2 1.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.604 . . . . 0.0 110.277 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.466 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 16.0 ptm -88.97 114.63 60.88 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.372 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.838 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 20.1 Cg_endo -59.9 140.4 92.82 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 112.353 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 m -115.75 136.46 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.168 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.69 147.0 45.09 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.97 124.03 30.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.97 158.1 44.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.16 129.01 51.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.932 0.396 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 HD21 ' B' ' 20' ' ' LEU . 60.7 mt -118.36 141.44 48.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.585 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.539 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 29.1 m80 -71.17 127.64 33.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.196 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.63 110.43 2.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.699 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.44 -1.12 46.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.787 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -87.88 152.27 22.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.025 0.44 . . . . 0.0 110.846 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.7 m -100.25 133.08 45.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.413 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.482 ' HB3' HG13 ' A' ' 34' ' ' VAL . 88.0 m-85 -124.19 152.88 42.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m170 -95.51 117.21 29.98 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 12' ' ' LEU . 11.8 tp -108.02 121.08 44.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.395 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -131.34 126.2 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.345 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.94 132.41 61.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.79 152.34 39.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.984 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 p -107.17 141.68 38.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -79.49 -175.04 4.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.3 p -55.38 -31.65 61.98 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.54 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.3 mt -87.06 -20.71 26.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.981 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 16.87 14.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.289 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 42.0 m-80 -82.33 128.82 65.84 Favored Pre-proline 0 CA--C 1.511 -0.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' CG ' HG21 ' A' ' 56' ' ' VAL . 56.6 Cg_endo -73.02 143.13 35.74 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.44 2.093 . . . . 0.0 112.182 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -127.72 147.39 50.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 54' ' ' ILE . 14.5 tp -119.35 129.82 55.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.899 0.381 . . . . 0.0 110.844 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -127.06 119.59 26.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.755 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.0 t -125.62 122.47 62.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.057 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.18 131.19 24.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 148.51 81.01 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.78 2.32 . . . . 0.0 112.205 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 p -68.88 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.353 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 50.2 t-20 -132.99 104.41 12.7 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.526 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 24.2 Cg_endo -62.95 -25.08 74.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.842 2.361 . . . . 0.0 112.238 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -82.6 -24.46 33.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -72.34 -24.72 61.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.118 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 49.3 mm-40 -65.76 -31.73 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.129 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.97 -43.1 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.4 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 58.94 5.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.81 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -77.48 76.43 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.395 0.617 . . . . 0.0 112.02 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.11 -15.58 61.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.079 0.942 . . . . 0.0 108.498 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -101.89 145.12 29.92 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.951 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.52 159.73 32.13 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 111.765 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 60.4 mt -94.55 131.59 40.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.137 0.494 . . . . 0.0 111.013 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 52' ' ' LEU . 69.8 mt -99.54 124.05 45.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 57.8 Cg_endo -74.7 137.47 22.5 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.194 1.929 . . . . 0.0 111.391 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -133.48 131.9 40.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 m -109.64 117.5 34.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.493 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' B' ' 54' ' ' ILE . 24.5 mt -107.03 123.33 62.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.341 0.591 . . . . 0.0 110.686 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.67 137.88 43.87 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.663 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.838 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.7 t -83.66 133.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.452 . . . . 0.0 109.881 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -81.31 122.47 5.71 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.644 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.06 95.62 3.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.061 0.934 . . . . 0.0 110.413 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -54.49 110.0 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.948 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 t -137.74 165.89 25.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.71 77.44 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.284 -178.68 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.31 63.9 1.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.6 mmm -97.09 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.02 -172.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.9 57.69 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.303 0.573 . . . . 0.0 110.12 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.463 ' HA ' ' HD2' ' B' ' 6' ' ' PRO . 15.7 ptm -88.39 114.44 59.63 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.442 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.863 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 19.9 Cg_endo -59.72 140.67 94.57 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.378 2.719 . . . . 0.0 112.247 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.08 136.03 53.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.234 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.32 147.13 44.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.06 124.09 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.78 158.27 44.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.555 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.41 128.82 51.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 20' ' ' LEU . 60.8 mt -118.43 141.46 48.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.674 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 29.4 m80 -71.07 127.39 32.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.78 110.94 3.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.544 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.96 -2.59 44.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.715 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -86.96 152.37 22.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.93 0.395 . . . . 0.0 110.925 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -100.59 132.98 45.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.463 175.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.503 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.5 m-85 -123.84 152.85 41.84 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.152 0.501 . . . . 0.0 110.644 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.4 m170 -95.66 117.12 29.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 12' ' ' LEU . 11.6 tp -108.13 121.1 44.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.14 126.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.316 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 p -112.62 132.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.51 152.27 39.49 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -107.18 141.85 37.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -79.57 -175.21 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.34 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 48.4 p -55.31 -31.74 61.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.542 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 54.8 mt -86.71 -21.27 26.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 16.8 14.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.273 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.542 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.6 m-80 -82.41 128.98 65.01 Favored Pre-proline 0 CA--C 1.51 -0.569 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' B' ' 56' ' ' VAL . 56.9 Cg_endo -73.21 143.37 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.292 1.995 . . . . 0.0 112.221 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -127.69 147.29 50.38 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.43 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.571 HD21 HD12 ' B' ' 54' ' ' ILE . 14.4 tp -119.2 130.03 55.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.855 0.36 . . . . 0.0 110.753 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -127.37 119.63 26.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.843 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.1 t -125.78 122.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.034 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.26 131.01 24.34 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.682 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.15 148.76 81.48 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.76 2.307 . . . . 0.0 112.335 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.5 p -69.4 -27.16 65.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.321 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -133.64 104.32 12.03 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.491 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.57 74.13 Favored 'Trans proline' 0 C--N 1.34 0.101 0 C-N-CA 122.748 2.299 . . . . 0.0 112.122 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.92 -24.61 35.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -72.08 -24.72 61.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.146 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.523 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 50.0 mm-40 -65.85 -32.06 73.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.903 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.44 -43.06 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.538 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.8 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.3 p -77.56 76.32 4.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.326 0.584 . . . . 0.0 111.989 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.78 -15.92 61.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -101.62 145.06 29.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.855 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.42 159.66 32.52 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.611 2.207 . . . . 0.0 111.653 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.3 mt -94.15 131.53 39.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.004 0.43 . . . . 0.0 111.134 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.434 ' O ' HD12 ' B' ' 52' ' ' LEU . 69.2 mt -99.49 124.11 45.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 168.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 57.4 Cg_endo -74.79 137.46 22.25 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.237 1.958 . . . . 0.0 111.406 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.4 mp -133.38 132.22 40.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.907 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -109.91 117.42 33.76 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 54' ' ' ILE . 24.3 mt -106.9 123.37 61.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.18 0.514 . . . . 0.0 110.702 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -106.69 137.95 43.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.553 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.863 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.7 t -83.55 133.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -81.41 121.98 5.57 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.606 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -74.71 94.94 2.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -54.09 109.92 0.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.841 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -137.51 166.28 24.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.52 77.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.274 -177.801 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 111.846 -0.501 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.59 48.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.017 0.437 . . . . 0.0 111.114 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.7 -58.97 2.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.479 . . . . 0.0 109.722 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.87 82.02 2.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 16.9 ptm -78.39 128.51 77.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.27 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.731 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 32.7 Cg_endo -64.69 134.76 42.17 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.356 2.704 . . . . 0.0 112.251 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m -116.63 134.72 54.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.232 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -115.3 140.42 49.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.905 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -125.61 123.71 39.61 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 1.7 pp -141.11 158.15 44.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.688 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -121.74 128.6 51.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 110.44 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' B' ' 20' ' ' LEU . 58.0 mt -120.62 141.23 50.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.536 -174.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 36.5 m80 -70.91 132.96 46.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.378 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.71 110.93 3.31 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.737 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.9 58.24 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.552 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -89.56 144.17 26.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 37' ' ' SER . 12.2 m -93.74 137.32 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.017 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.468 ' HB3' HG13 ' A' ' 34' ' ' VAL . 85.9 m-85 -129.75 154.64 46.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 0.0 110.802 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 3.1 m170 -95.26 117.41 30.23 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.071 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 32' ' ' LEU . 11.8 tp -108.74 121.4 44.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.173 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 11.2 mt -131.3 126.59 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -116.07 133.56 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -142.99 170.02 16.48 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -124.18 141.53 51.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.7 0.286 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -176.13 6.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.721 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -65.88 -30.43 71.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.057 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.28 -23.97 54.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 0.0 111.305 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.41 20.42 9.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.436 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -94.73 135.95 23.43 Favored Pre-proline 0 CA--C 1.509 -0.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' CB ' HG21 ' A' ' 56' ' ' VAL . 72.2 Cg_endo -76.27 147.67 29.63 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.542 2.161 . . . . 0.0 112.09 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -126.52 140.04 52.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' ILE . 10.9 tp -122.44 122.32 38.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.037 0.446 . . . . 0.0 110.507 -175.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 16.7 m -116.86 119.18 34.59 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.913 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 77.8 t -123.86 122.17 63.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.9 131.27 23.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.1 Cg_endo -61.22 133.51 47.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.168 1.912 . . . . 0.0 111.922 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 8.7 t -70.62 -37.07 73.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -107.81 101.18 39.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.65 -29.4 29.82 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.522 2.148 . . . . 0.0 111.926 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.6 -23.42 56.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.781 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.27 -28.63 66.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 15.2 mm-40 -69.67 -21.75 63.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -87.55 -42.25 12.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.987 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.0 43.49 1.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.697 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -74.4 87.42 2.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.37 0.605 . . . . 0.0 112.16 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -92.61 -1.62 56.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.81 142.39 24.5 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.48 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.12 152.3 50.67 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.464 2.109 . . . . 0.0 112.158 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 29.9 mt -92.49 120.63 33.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.713 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.2 mt -93.06 123.62 60.52 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.01 136.37 16.38 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.269 1.979 . . . . 0.0 111.521 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.3 mp -129.32 133.55 47.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.989 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -109.42 115.67 30.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.74 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' B' ' 54' ' ' ILE . 28.5 mt -107.6 125.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.187 0.518 . . . . 0.0 110.715 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -108.64 132.84 53.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.731 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -84.85 136.91 21.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.071 0.462 . . . . 0.0 110.661 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.61 15.65 Favored Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.889 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -137.05 41.0 2.49 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.06 0.933 . . . . 0.0 109.032 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -127.64 123.15 34.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.468 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -147.55 84.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.365 0.602 . . . . 0.0 109.575 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.47 -55.26 0.51 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.77 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.595 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.179 -0.368 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.35 48.57 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.093 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.0 mtp -87.12 -59.93 2.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.09 82.46 2.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 17.0 ptm -78.98 128.34 76.75 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.235 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 34.4 Cg_endo -64.54 134.43 41.25 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.241 2.628 . . . . 0.0 112.256 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.44 134.92 54.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -115.39 140.56 49.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.926 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.98 123.68 39.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.511 HD22 HG21 ' B' ' 34' ' ' VAL . 1.7 pp -141.21 158.35 44.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.729 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.1 128.33 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.861 0.362 . . . . 0.0 110.534 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 20' ' ' LEU . 58.1 mt -120.38 141.22 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.585 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 36.4 m80 -70.68 132.64 45.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.422 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.16 110.71 3.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.686 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.07 -0.43 58.89 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.522 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -89.68 144.22 26.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 37' ' ' SER . 14.3 m -93.8 137.12 33.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.996 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.459 ' HB3' HG13 ' B' ' 34' ' ' VAL . 85.5 m-85 -129.67 154.46 47.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.235 0.541 . . . . 0.0 110.572 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.67 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 3.1 m170 -95.09 117.27 29.91 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.118 172.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.532 HD11 HD11 ' B' ' 32' ' ' LEU . 11.6 tp -108.54 121.36 44.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.251 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 11.3 mt -131.39 126.29 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.86 133.56 61.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -143.0 170.19 16.16 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.855 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.6 p -124.16 141.63 51.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.661 0.267 . . . . 0.0 110.948 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -175.57 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t -66.54 -30.56 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.943 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -76.11 -23.66 54.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.607 0.242 . . . . 0.0 111.162 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 20.27 9.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.278 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -94.68 135.75 23.65 Favored Pre-proline 0 CA--C 1.511 -0.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.521 ' CB ' HG21 ' B' ' 56' ' ' VAL . 71.7 Cg_endo -75.98 147.87 30.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.472 2.114 . . . . 0.0 112.178 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -126.81 139.91 52.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' B' ' 54' ' ' ILE . 11.1 tp -122.44 122.12 38.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.208 0.527 . . . . 0.0 110.609 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.9 m -116.42 119.26 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.904 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 78.1 t -124.14 121.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 110.234 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.83 131.1 23.74 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.377 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.4 Cg_endo -61.38 133.27 45.22 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.229 1.953 . . . . 0.0 112.007 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.473 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 8.7 t -70.13 -37.01 75.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -107.98 101.34 40.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.84 -29.1 29.08 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.447 2.098 . . . . 0.0 112.121 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.73 -23.43 56.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.841 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.398 0.618 . . . . 0.0 110.182 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.495 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 15.9 mm-40 -69.76 -21.71 63.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.148 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -87.63 -42.41 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.003 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 16.1 mt -87.56 43.1 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.823 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -74.13 87.84 1.92 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.461 0.648 . . . . 0.0 112.072 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.26 -1.46 56.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.74 142.36 24.44 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.663 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 152.24 51.11 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.509 2.139 . . . . 0.0 112.135 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 30.7 mt -92.47 120.82 33.33 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.761 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' B' ' 52' ' ' LEU . 78.0 mt -93.15 123.86 59.66 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.21 136.13 15.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.289 1.993 . . . . 0.0 111.651 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.3 mp -129.14 133.28 47.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.959 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -109.25 115.76 30.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.678 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' A' ' 54' ' ' ILE . 27.4 mt -107.74 125.05 64.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.767 -176.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -108.45 132.8 53.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.848 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.729 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -84.82 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.52 168.86 15.67 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.927 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.48 41.45 2.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.919 0.866 . . . . 0.0 109.046 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -127.69 123.55 35.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.37 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -147.98 83.64 1.51 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.556 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.92 -54.21 0.55 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.678 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.744 -179.619 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.64 69.4 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptp -168.96 155.59 6.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.94 97.17 7.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.255 0.55 . . . . 0.0 109.947 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.547 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 21.3 ptp -74.23 142.68 79.02 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.761 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 21.7 Cg_endo -60.27 132.01 41.71 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.052 2.501 . . . . 0.0 111.809 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -114.24 141.28 47.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.673 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -121.69 148.81 44.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.697 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.43 125.03 26.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.4 pp -141.17 158.07 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.166 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.29 127.36 53.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.02 140.14 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.567 -175.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 16' ' ' GLN . 34.7 m80 -71.71 133.06 45.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.302 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.74 110.93 3.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.848 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.83 47.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.931 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HG3' ' HB2' ' A' ' 13' ' ' HIS . 16.4 mm100 -95.46 143.4 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.911 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -87.97 136.25 33.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.07 153.91 47.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.9 m80 -95.74 117.64 30.9 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.602 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 32' ' ' LEU . 9.1 tp -108.39 120.84 43.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.317 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.13 125.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.79 133.65 63.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.08 170.1 16.37 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p -123.56 136.63 54.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.37 168.7 19.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.765 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 p -54.77 -30.65 57.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.3 mt -73.89 -13.6 60.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.233 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.6 1.07 62.25 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.577 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -75.78 133.58 73.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HG3' HG21 ' A' ' 56' ' ' VAL . 91.7 Cg_endo -80.15 152.77 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 112.322 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -133.97 140.2 46.58 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.528 HD21 HD12 ' A' ' 54' ' ' ILE . 13.4 tp -124.78 125.84 44.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.13 120.62 32.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.03 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.9 t -125.49 122.51 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.17 129.07 24.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.68 136.27 57.19 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.539 2.159 . . . . 0.0 112.332 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 73.1 m -70.48 -25.56 63.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -134.69 103.6 11.05 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.72 -21.16 29.41 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -75.93 -35.73 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.469 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 110.331 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' CD ' ' HD1' ' A' ' 13' ' ' HIS . 27.3 mm-40 -69.97 -41.55 74.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.57 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -73.55 -42.94 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.272 0.558 . . . . 0.0 109.943 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 mt -99.9 71.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' NE2' ' A' ' 13' ' ' HIS . 1.1 m -67.94 -66.24 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.222 -167.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 44.72 25.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.783 0.801 . . . . 0.0 111.729 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -136.73 138.48 26.41 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.909 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.64 143.6 62.88 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.181 1.92 . . . . 0.0 111.822 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.11 119.46 30.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.071 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.1 mt -87.28 125.71 64.93 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 43.5 Cg_endo -73.84 136.68 23.37 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.826 1.684 . . . . 0.0 110.558 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.8 mp -134.39 131.78 38.63 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -111.32 117.65 33.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' B' ' 54' ' ' ILE . 24.9 mt -107.24 123.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.185 0.517 . . . . 0.0 110.764 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.547 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 70.4 m-85 -107.68 138.42 43.94 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.015 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.696 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.6 t -84.09 130.42 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.167 0.508 . . . . 0.0 109.951 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -71.37 122.82 9.84 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.806 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.84 -41.6 87.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 110.958 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -170.41 117.97 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 49.3 m -149.65 81.66 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.62 138.51 18.34 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.464 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.99 179.335 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.49 70.28 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.717 0.294 . . . . 0.0 111.742 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptp -169.74 154.94 5.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.166 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.67 97.84 8.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.093 0.473 . . . . 0.0 109.929 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 21.2 ptp -74.81 142.57 76.98 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.833 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.714 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 22.3 Cg_endo -60.01 131.93 41.97 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.414 . . . . 0.0 111.761 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -114.36 141.88 47.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.555 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.98 148.9 44.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.74 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.48 125.07 26.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.11 158.06 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.22 127.4 53.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.0 140.14 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.436 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.497 ' HB2' ' HG3' ' B' ' 16' ' ' GLN . 34.5 m80 -71.79 133.07 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.297 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.49 110.88 3.41 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.858 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.58 -0.49 49.43 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.329 -0.463 . . . . 0.0 113.077 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' B' ' 13' ' ' HIS . 16.6 mm100 -95.58 143.42 26.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 111.006 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 4.1 m -87.82 136.33 33.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.516 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.402 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.1 m-85 -128.92 153.93 47.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.672 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.9 m80 -95.76 117.78 31.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.47 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.456 HD11 HD11 ' B' ' 32' ' ' LEU . 9.0 tp -108.5 120.8 43.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.417 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.09 125.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.18 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.75 133.67 63.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -140.96 169.91 16.74 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 50' ' ' ILE . 1.3 p -122.93 137.03 55.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.21 0.528 . . . . 0.0 111.46 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.67 168.85 18.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.804 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -54.81 -30.89 58.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -73.51 -14.3 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.113 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.88 1.32 61.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.547 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -76.15 133.15 72.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.442 ' HG3' HG21 ' B' ' 56' ' ' VAL . 93.0 Cg_endo -79.91 152.79 22.16 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.793 2.329 . . . . 0.0 112.284 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -134.06 140.32 46.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.537 HD21 HD12 ' B' ' 54' ' ' ILE . 13.5 tp -125.09 125.89 44.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 -173.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -124.17 120.46 32.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.3 t -125.38 122.36 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.08 128.69 24.1 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.404 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.69 135.67 53.81 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.55 2.166 . . . . 0.0 112.398 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 72.5 m -70.31 -25.23 63.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -134.78 103.72 10.94 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.09 -20.62 28.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.726 2.284 . . . . 0.0 112.843 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -76.25 -35.88 58.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.4 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.42 -23.01 60.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.094 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.418 ' CD ' ' HD1' ' B' ' 13' ' ' HIS . 27.6 mm-40 -70.05 -41.16 74.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.607 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -74.06 -42.88 59.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.142 0.496 . . . . 0.0 109.967 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.77 70.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' B' ' 13' ' ' HIS . 1.1 m -67.71 -66.49 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.155 -167.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.97 25.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.824 0.821 . . . . 0.0 111.48 -171.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -136.71 138.51 26.52 Favored Pre-proline 0 N--CA 1.442 -0.855 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.97 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.77 143.66 62.35 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 23.0 mt -89.95 119.79 30.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.971 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.483 ' O ' HD12 ' B' ' 52' ' ' LEU . 67.0 mt -87.55 125.67 64.53 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.616 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.0 Cg_endo -73.75 136.43 23.18 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.874 1.716 . . . . 0.0 110.716 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.514 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.8 mp -134.25 131.71 38.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.971 0.415 . . . . 0.0 110.496 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 5.1 m -111.4 117.32 32.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.631 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' A' ' 54' ' ' ILE . 25.6 mt -107.24 123.74 62.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 71.0 m-85 -107.48 138.4 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.913 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.5 t -84.01 130.79 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.018 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.607 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -71.4 122.69 9.72 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.002 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.62 -41.78 87.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.443 -0.378 . . . . 0.0 110.994 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -170.29 116.91 0.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.497 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 53.8 m -148.71 81.99 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.52 138.92 19.03 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.155 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.078 178.732 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 127.72 37.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 110.734 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.84 -18.1 17.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 110.061 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -119.29 106.19 12.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -118.6 153.27 52.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.031 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -59.2 131.19 39.78 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.505 2.137 . . . . 0.0 111.595 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 m -116.88 136.84 52.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.923 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -115.49 145.14 42.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.822 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.96 123.89 29.82 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.8 158.45 43.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.93 128.21 49.1 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -121.06 141.34 50.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.677 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 30.2 m80 -71.49 131.32 43.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.52 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.58 111.55 3.99 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.024 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.63 0.87 52.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.723 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -95.09 150.71 19.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.17 0.509 . . . . 0.0 111.204 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -95.03 135.3 36.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.604 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.55 152.89 47.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.48 0.657 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.7 m80 -95.98 117.88 31.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.839 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD21 HD11 ' B' ' 12' ' ' LEU . 7.7 tp -108.78 121.36 44.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.159 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mt -129.57 126.49 63.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.076 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.5 p -117.92 135.05 59.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 7.1 p-10 -147.54 170.88 16.5 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.32 136.24 54.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.309 0.576 . . . . 0.0 111.88 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 9.2 t70 -81.25 165.64 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.005 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.1 m -54.88 -31.16 59.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.409 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 71.4 mt -73.11 -17.57 61.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.421 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.88 2.9 39.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.546 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 2.7 p-10 -85.99 142.23 36.17 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' CG ' HG21 ' A' ' 56' ' ' VAL . 44.2 Cg_endo -85.25 153.02 10.79 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.565 2.176 . . . . 0.0 112.434 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -126.24 149.9 48.77 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 54' ' ' ILE . 11.3 tp -128.67 123.86 34.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.703 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.5 m -122.0 119.47 31.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.999 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.8 t -124.17 122.42 64.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.072 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.76 131.34 24.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.783 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.34 136.36 50.76 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 122.331 2.02 . . . . 0.0 111.68 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.4 m -70.68 -25.18 62.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.078 0.466 . . . . 0.0 110.362 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -132.82 102.92 13.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.65 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.67 -21.31 39.25 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.797 2.331 . . . . 0.0 112.253 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -74.89 -32.71 61.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -73.65 -21.34 60.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.245 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 19.0 mm-40 -69.27 -35.19 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.923 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.88 -43.26 36.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.046 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 67.46 4.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 p -78.39 81.34 4.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.466 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.78 -7.85 59.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 p -102.44 137.66 19.46 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.603 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.16 156.36 46.83 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.435 2.09 . . . . 0.0 111.281 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.4 mt -87.66 138.8 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HD12 ' A' ' 52' ' ' LEU . 87.0 mt -108.73 124.06 35.4 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 73.5 Cg_endo -77.58 136.57 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.294 1.996 . . . . 0.0 111.675 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 50' ' ' ILE . 4.9 mp -133.93 130.09 37.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 m -109.21 118.63 37.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.564 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' B' ' 54' ' ' ILE . 37.0 mt -107.5 126.38 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.107 0.48 . . . . 0.0 110.777 -176.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -109.57 138.71 45.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CG ' ' A' ' 30' ' ' PRO . 1.1 t -89.4 140.86 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.228 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' CA ' ' HG2' ' B' ' 51' ' ' PRO . . . -110.71 -171.18 19.6 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.937 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -112.39 101.19 9.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.923 0.361 . . . . 0.0 111.504 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.0 -52.58 0.7 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.735 0.814 . . . . 0.0 113.196 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -144.57 162.88 35.51 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.994 -0.441 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.76 35.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.93 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.447 178.76 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.71 128.04 37.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.772 0.32 . . . . 0.0 110.725 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 73.2 mtm -100.17 -19.09 16.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -118.49 106.46 12.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.17 153.47 53.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.865 -174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.18 131.39 40.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 111.593 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.2 m -116.94 137.03 52.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.51 144.92 43.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.143 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.68 123.9 30.38 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.64 158.57 43.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.666 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.96 128.37 49.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 50.9 mt -121.14 141.47 50.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 -173.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 30.0 m80 -71.45 130.98 42.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.558 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.39 111.88 4.25 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.085 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 1.16 53.34 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.842 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -95.64 150.62 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.18 0.514 . . . . 0.0 111.129 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -94.88 135.36 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.445 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -128.62 153.12 47.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.351 0.596 . . . . 0.0 110.68 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.8 m80 -96.23 117.83 31.57 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.842 172.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 12' ' ' LEU . 7.6 tp -108.56 121.51 45.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.222 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.65 126.3 62.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.095 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.6 p -117.23 134.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 7.1 p-10 -147.44 170.97 16.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.12 136.83 53.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.225 0.536 . . . . 0.0 111.737 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ASP . . . . . 0.429 ' HB3' ' ND2' ' B' ' 29' ' ' ASN . 9.1 t70 -81.09 165.97 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.115 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -55.03 -30.93 60.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.408 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 71.9 mt -73.35 -17.94 61.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.828 0.347 . . . . 0.0 111.293 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.06 39.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' B' ' 25' ' ' ASP . 2.6 p-10 -85.96 142.61 36.56 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.403 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.566 ' CG ' HG21 ' B' ' 56' ' ' VAL . 44.2 Cg_endo -85.46 153.37 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.658 2.239 . . . . 0.0 112.377 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -126.51 150.12 48.95 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.502 HD21 HD12 ' B' ' 54' ' ' ILE . 11.3 tp -128.85 123.7 33.42 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.746 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -121.96 119.24 30.92 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.144 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.0 t -123.99 122.67 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 110.081 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.91 131.47 24.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.859 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.62 136.21 48.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.293 1.995 . . . . 0.0 111.708 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 52.0 m -70.43 -25.34 63.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -132.87 102.91 13.26 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.725 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.01 -21.04 37.54 Favored 'Trans proline' 0 CA--C 1.526 0.116 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -74.99 -32.72 61.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.593 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -73.71 -21.53 60.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.25 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 20.0 mm-40 -68.82 -35.68 77.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.868 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.57 -43.36 39.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.036 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.9 mt -92.75 67.42 4.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -78.32 81.17 4.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.482 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -80.83 -7.08 59.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.958 0.885 . . . . 0.0 108.712 167.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 5.0 p -103.11 137.72 19.34 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.437 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.24 156.1 46.53 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.454 2.103 . . . . 0.0 111.58 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 48.9 mt -87.79 138.55 31.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.0 110.708 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 52' ' ' LEU . 85.3 mt -108.53 123.82 36.22 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 167.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.519 ' HG2' ' CA ' ' A' ' 57' ' ' GLY . 74.0 Cg_endo -77.37 136.55 15.94 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.065 . . . . 0.0 111.475 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.9 mp -133.89 130.11 37.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 m -108.83 118.72 37.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.733 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 54' ' ' ILE . 37.0 mt -107.57 126.49 63.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.115 0.483 . . . . 0.0 110.793 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -109.66 138.61 45.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.512 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' B' ' 30' ' ' PRO . 1.1 t -89.45 140.72 15.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.155 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.544 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -110.6 -171.5 19.74 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.136 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -112.17 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.614 -0.345 . . . . 0.0 111.642 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 65.8 t30 72.11 -52.41 0.7 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 170.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -144.92 163.02 35.41 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.81 35.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.991 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.243 0.758 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.368 179.185 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.12 54.79 3.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.501 . . . . 0.0 110.371 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.1 ttp -160.32 110.15 1.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.52 144.19 28.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.919 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp -108.78 113.47 59.61 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 110.618 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PHE . 86.4 Cg_exo -51.85 139.25 50.35 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.502 2.801 . . . . 0.0 112.096 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.2 132.28 56.68 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.597 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -122.01 140.94 51.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.703 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 124.32 41.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.261 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.51 HD22 HG21 ' A' ' 34' ' ' VAL . 1.5 pp -141.42 157.9 44.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.249 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -119.27 127.42 53.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.368 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD11 HD21 ' B' ' 20' ' ' LEU . 65.6 mt -119.49 141.99 48.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.189 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -70.56 127.16 31.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.99 104.34 0.79 Allowed Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.144 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.29 11.86 26.58 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.623 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.435 ' OE1' ' HG2' ' A' ' 41' ' ' GLN . 25.4 mm-40 -109.57 154.83 22.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 111.599 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -96.66 137.16 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.654 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 34' ' ' VAL . 74.4 m-85 -129.61 154.89 46.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.852 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.691 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.6 m170 -95.03 117.62 30.47 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.321 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' LEU . 11.9 tp -110.64 123.15 49.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.51 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 13.8 mt -131.25 126.53 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.56 127.9 74.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.54 151.09 47.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.181 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -108.09 135.53 49.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -174.87 5.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -64.05 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.727 0.298 . . . . 0.0 111.563 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.413 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 42.2 mt -80.39 -24.48 39.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.59 17.96 9.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.436 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 27' ' ' LEU . 16.4 m120 -92.88 135.53 25.93 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' CG ' HG21 ' A' ' 56' ' ' VAL . 71.4 Cg_endo -75.07 144.08 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.522 2.148 . . . . 0.0 111.85 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.2 t -127.48 140.24 52.28 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 54' ' ' ILE . 12.6 tp -120.05 129.19 54.11 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.744 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 36.1 m -126.13 119.98 28.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.995 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 74.1 t -123.41 121.77 63.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.5 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.12 129.66 24.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.445 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.46 137.04 75.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.545 2.163 . . . . 0.0 112.16 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.0 t -68.94 -21.05 64.22 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.431 0.634 . . . . 0.0 109.998 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -140.29 103.24 6.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -11.71 33.0 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.541 2.161 . . . . 0.0 112.728 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -86.95 -27.67 23.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.033 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HG2' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mp0 -69.41 -23.78 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.85 -33.26 75.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.442 0.639 . . . . 0.0 109.672 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -85.21 -42.23 14.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.668 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.16 55.27 2.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.9 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -78.88 94.84 5.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.402 0.62 . . . . 0.0 112.075 -174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.13 -10.99 51.37 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 p -101.94 132.55 21.48 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.229 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.86 160.07 48.83 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.1 mt -92.91 120.15 32.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.111 0.481 . . . . 0.0 111.082 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 52' ' ' LEU . 80.8 mt -91.13 127.94 49.46 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.001 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.28 134.86 19.71 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.109 1.873 . . . . 0.0 111.739 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -136.02 135.18 39.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.371 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.4 m -115.38 120.95 41.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.849 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' B' ' 54' ' ' ILE . 31.8 mt -108.56 129.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 85.6 m-85 -111.56 138.75 47.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 30' ' ' PRO . 42.4 t -95.27 118.45 41.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.68 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.97 175.07 17.81 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.606 169.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HA ' ' OH ' ' B' ' 9' ' ' TYR . 42.1 mt-10 -88.41 105.08 17.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.859 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -91.52 -8.3 47.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.7 p -67.56 -57.25 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.041 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 65.21 2.68 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.635 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.835 -178.187 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.41 55.06 3.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.179 0.514 . . . . 0.0 110.323 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 53.5 ttp -160.5 109.66 1.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.124 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.15 144.08 29.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.075 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 80.6 mtp -108.56 113.22 60.22 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.564 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' B' ' 55' ' ' PHE . 88.9 Cg_exo -51.86 139.15 50.66 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 C-N-CA 123.439 2.76 . . . . 0.0 112.248 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.36 132.18 56.64 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.709 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.9 140.8 51.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.631 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.402 ' OH ' ' HA ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -124.57 123.98 41.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.294 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.531 HD22 HG21 ' B' ' 34' ' ' VAL . 1.6 pp -141.12 158.09 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.18 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -119.91 127.09 52.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.134 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 20' ' ' LEU . 65.8 mt -119.43 141.74 48.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.189 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -70.31 127.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.62 104.13 0.73 Allowed Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.159 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 11.74 26.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.676 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.42 ' OE1' ' HG2' ' B' ' 41' ' ' GLN . 26.3 mm-40 -109.53 155.14 21.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -97.18 137.07 36.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' B' ' 34' ' ' VAL . 73.3 m-85 -129.61 154.85 46.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.789 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.688 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 5.6 m170 -95.19 117.56 30.44 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.256 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.503 HD11 HD11 ' B' ' 32' ' ' LEU . 11.7 tp -110.35 123.11 49.25 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.489 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 13.6 mt -131.26 126.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.47 127.84 73.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -138.81 151.24 46.87 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -108.1 136.07 48.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.968 0.413 . . . . 0.0 111.041 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -175.03 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.48 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.2 m -63.79 -30.57 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.714 0.292 . . . . 0.0 111.52 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 41.7 mt -80.63 -24.3 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.265 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.19 18.22 9.42 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.474 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' B' ' 27' ' ' LEU . 16.1 m120 -92.76 135.43 26.23 Favored Pre-proline 0 CA--C 1.511 -0.548 0 CA-C-O 121.028 0.442 . . . . 0.0 109.841 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.438 ' CG ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -75.04 143.98 29.58 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.499 2.132 . . . . 0.0 111.858 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -127.61 140.28 52.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.591 HD21 HD12 ' B' ' 54' ' ' ILE . 12.6 tp -119.62 129.75 54.76 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.768 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 38.6 m -126.47 120.04 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.751 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 74.9 t -123.71 121.48 62.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 0.0 110.419 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.89 129.75 24.47 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 136.62 71.99 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.196 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 16.4 t -68.25 -21.68 64.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.155 0.503 . . . . 0.0 109.789 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -139.81 103.46 6.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.938 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.6 -12.22 34.94 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.694 2.262 . . . . 0.0 112.601 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -86.43 -27.7 23.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.103 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.42 ' HG2' ' OE1' ' B' ' 16' ' ' GLN . 1.2 mp0 -69.38 -24.0 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 175.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.62 -33.51 75.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.773 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -85.03 -42.06 15.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.787 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.31 55.37 2.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.037 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p -78.92 95.02 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.126 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.89 -10.08 51.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.0 p -102.22 132.46 21.46 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.157 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.85 160.07 48.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.841 2.361 . . . . 0.0 111.802 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.53 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 47.4 mt -93.17 120.06 33.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.933 0.397 . . . . 0.0 111.202 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.503 ' O ' HD12 ' B' ' 52' ' ' LEU . 81.3 mt -91.08 128.02 49.25 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.25 134.98 19.93 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.125 1.883 . . . . 0.0 111.784 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.503 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -136.19 134.77 38.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.518 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -115.01 120.97 41.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' A' ' 54' ' ' ILE . 30.4 mt -108.56 129.44 63.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.812 0.339 . . . . 0.0 110.769 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.8 m-85 -111.27 138.52 47.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.779 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' B' ' 30' ' ' PRO . 41.7 t -95.26 118.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 175.35 18.02 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.119 -1.515 . . . . 0.0 113.583 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -89.04 104.89 17.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -91.22 -7.93 49.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -67.8 -57.03 6.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.07 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.29 2.34 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.582 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.008 -177.875 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.14 -57.43 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.871 0.367 . . . . 0.0 110.701 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp -133.01 150.62 52.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.09 137.84 41.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.435 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 18.8 ptp -125.69 141.42 39.12 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.335 0.588 . . . . 0.0 111.066 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' A' ' 56' ' ' VAL . 2.8 Cg_exo -68.88 135.52 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.917 2.411 . . . . 0.0 111.569 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 m -113.85 148.73 36.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.158 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -123.47 140.09 53.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.878 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -127.12 123.78 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 52' ' ' LEU . 2.1 pp -140.62 158.62 43.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.85 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.23 128.46 51.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.686 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.449 HD11 HD21 ' B' ' 20' ' ' LEU . 50.0 mt -123.01 140.5 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 98.2 m-70 -72.05 132.11 43.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.99 108.03 1.57 Allowed Glycine 0 CA--C 1.516 0.142 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.792 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.84 -8.32 42.71 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.595 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -84.16 147.03 27.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.825 0.345 . . . . 0.0 110.255 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 4.4 m -96.22 136.3 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.1 m-85 -129.7 153.09 48.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.313 0.578 . . . . 0.0 111.158 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.4 m80 -95.82 117.64 30.94 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.736 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 32' ' ' LEU . 9.7 tp -107.98 123.32 48.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.508 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.65 126.43 54.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.327 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.64 133.69 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -147.17 159.82 43.17 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -116.13 140.69 49.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.87 0.366 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 23.3 p30 -81.3 -174.98 5.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.98 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -62.15 -28.89 69.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 0.0 111.401 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 44.9 mt -82.82 -23.67 33.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 110.64 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.53 19.71 10.21 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.916 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.447 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 18.9 m120 -87.57 131.0 45.12 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' HG11 ' A' ' 56' ' ' VAL . 58.0 Cg_endo -74.42 144.25 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.277 1.985 . . . . 0.0 112.093 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.6 t -130.06 140.18 50.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 20' ' ' LEU . 13.0 tp -122.97 130.09 52.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.905 0.383 . . . . 0.0 110.734 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -127.29 120.69 29.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.977 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.8 t -123.67 121.77 63.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.087 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.87 132.3 24.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.97 133.57 42.06 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.127 1.885 . . . . 0.0 111.713 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 50.5 m -73.41 -27.8 61.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.458 . . . . 0.0 110.248 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -121.32 103.57 41.62 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.35 -25.49 42.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.728 2.286 . . . . 0.0 112.86 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -81.75 -16.13 52.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.268 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -73.21 -26.15 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.031 0.443 . . . . 0.0 110.318 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -86.36 -43.21 13.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.435 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.42 58.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.926 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -83.89 91.1 7.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -85.64 -7.41 58.84 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.42 131.91 22.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.843 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.01 155.26 71.62 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.977 2.451 . . . . 0.0 112.173 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 28.9 mt -91.04 120.05 31.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.09 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 70.6 mt -91.5 129.25 43.57 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 44.0 Cg_endo -86.99 136.92 4.34 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.393 2.062 . . . . 0.0 110.953 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.8 128.72 41.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.769 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -106.22 115.87 30.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.586 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' B' ' 54' ' ' ILE . 27.9 mt -108.38 126.05 65.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -110.27 139.7 45.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.243 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' A' ' 6' ' ' PRO . 12.2 p -87.37 142.78 12.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.197 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.569 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -102.53 -167.21 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.301 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' H ' ' A' ' 59' ' ' ASN . 1.2 pp20? -108.97 -160.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.795 0.331 . . . . 0.0 111.474 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.41 ' H ' ' HB2' ' A' ' 58' ' ' GLU . 25.4 t-20 -44.72 -43.21 8.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.175 -175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 p 43.26 52.49 5.65 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 112.172 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.27 109.19 3.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.621 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 119.215 -0.422 . . . . 0.0 109.904 176.466 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.48 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.08 -56.9 1.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.877 0.37 . . . . 0.0 110.755 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 84.4 mtp -133.35 150.73 51.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.277 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.31 137.36 41.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 19.0 ptp -125.23 141.77 39.6 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.409 0.623 . . . . 0.0 111.163 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' B' ' 56' ' ' VAL . 2.8 Cg_exo -69.43 135.44 31.26 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.744 2.296 . . . . 0.0 111.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 m -113.86 148.51 36.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.253 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -123.26 140.3 53.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.893 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.31 123.62 36.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' B' ' 52' ' ' LEU . 2.0 pp -140.56 158.78 43.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.57 128.53 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.801 0.334 . . . . 0.0 110.591 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 20' ' ' LEU . 49.9 mt -123.1 140.54 52.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 98.2 m-70 -71.99 131.97 43.65 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.71 107.71 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.883 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.89 -8.22 42.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.714 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -84.05 147.23 27.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 4.1 m -96.4 136.22 37.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' B' ' 34' ' ' VAL . 92.6 m-85 -129.69 153.21 48.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.113 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.4 m80 -95.78 117.74 31.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.659 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 32' ' ' LEU . 9.7 tp -108.11 123.27 48.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.431 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.57 126.51 55.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.172 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 133.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.54 160.96 41.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 140.21 49.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.917 0.389 . . . . 0.0 110.482 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' B' ' 29' ' ' ASN . 21.1 p30 -81.2 -175.41 5.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.832 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 22.2 t -61.24 -29.59 69.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.775 0.321 . . . . 0.0 111.505 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.422 ' HB2' ' OD1' ' B' ' 29' ' ' ASN . 45.5 mt -82.63 -23.9 34.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 0.0 110.463 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.0 10.49 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.048 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.46 ' HB2' ' OD2' ' B' ' 25' ' ' ASP . 18.7 m120 -86.95 130.92 46.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 56' ' ' VAL . 57.9 Cg_endo -74.09 144.36 33.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.313 2.009 . . . . 0.0 112.174 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 41.6 t -130.3 140.02 50.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 20' ' ' LEU . 13.0 tp -122.77 130.33 52.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.907 0.384 . . . . 0.0 110.543 -174.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m -127.58 120.73 28.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.056 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.6 t -123.78 121.52 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.331 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.73 132.38 24.28 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.07 133.45 41.17 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.082 1.855 . . . . 0.0 111.688 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 50.5 m -73.35 -27.9 61.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.157 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -121.29 103.65 41.6 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.56 -25.3 41.06 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.803 2.336 . . . . 0.0 112.879 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -81.78 -16.03 52.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.331 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -73.2 -26.04 61.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.077 0.465 . . . . 0.0 110.517 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -70.12 -27.68 64.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -86.33 -43.25 13.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.319 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -99.48 58.33 1.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.919 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' SER . . . . . 0.404 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 15.2 m -84.07 91.78 7.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.287 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.4 -7.24 58.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.672 0.749 . . . . 0.0 109.035 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.36 132.3 22.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.775 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.15 155.4 70.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.818 2.345 . . . . 0.0 112.124 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 29.7 mt -90.96 119.98 31.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 71.6 mt -91.51 129.21 43.7 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.4 Cg_endo -87.25 136.96 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.373 2.049 . . . . 0.0 110.912 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.2 mp -130.52 128.81 41.91 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.74 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.5 m -106.29 115.97 31.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' A' ' 54' ' ' ILE . 27.5 mt -108.5 126.4 65.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -110.57 139.62 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.116 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' B' ' 6' ' ' PRO . 11.8 p -87.35 142.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.132 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.559 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -102.83 -167.22 26.17 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.288 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' B' ' 59' ' ' ASN . 1.1 pp20? -108.83 -159.93 0.7 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.741 0.305 . . . . 0.0 111.505 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' B' ' 58' ' ' GLU . 25.6 t-20 -44.99 -42.92 8.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.226 -174.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 6.6 p 43.23 51.93 5.68 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.91 109.46 3.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.246 0.905 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.025 176.864 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.54 74.44 9.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.21 0.529 . . . . 0.0 110.995 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptm -140.25 147.95 40.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.019 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -96.9 146.36 25.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 18.3 ptp -115.66 141.11 26.92 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.782 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 30.6 Cg_exo -42.75 130.98 5.55 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.786 2.99 . . . . 0.0 113.414 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -118.07 132.45 56.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.246 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.87 140.07 53.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.421 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -124.82 123.77 40.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.08 157.92 44.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.748 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -120.37 128.35 53.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 0.0 110.095 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' B' ' 20' ' ' LEU . 60.0 mt -117.2 141.21 48.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.53 ' CE1' ' HB3' ' A' ' 45' ' ' SER . 97.2 m-70 -70.7 127.58 33.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.7 7.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.533 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -0.74 65.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.631 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -85.73 151.62 23.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 110.608 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 3.0 m -102.03 135.65 43.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.579 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 34' ' ' VAL . 77.9 m-85 -128.59 154.04 46.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.266 0.555 . . . . 0.0 111.03 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.6 m170 -95.42 116.98 29.54 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 32' ' ' LEU . 15.7 tp -106.36 122.48 46.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.378 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.58 126.36 54.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.315 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.58 139.82 38.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.48 171.21 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -123.02 135.2 54.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.048 0.451 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -178.24 4.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.401 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 m -60.46 -31.09 70.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.8 0.333 . . . . 0.0 111.621 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.2 mt -81.81 -23.94 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 111.292 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.84 13.12 12.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.384 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -91.63 141.9 26.23 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.576 ' CB ' HG21 ' A' ' 56' ' ' VAL . 74.2 Cg_endo -72.06 147.25 48.39 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.803 2.335 . . . . 0.0 112.329 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.2 t -128.23 141.17 51.54 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 54' ' ' ILE . 15.5 tp -120.73 129.98 53.86 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.619 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -126.17 125.94 43.28 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 55.4 t -127.24 121.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.824 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.54 129.2 24.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.463 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.4 Cg_endo -60.91 133.74 49.33 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.442 2.095 . . . . 0.0 111.951 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 42.1 m -75.81 -22.35 56.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.2 0.524 . . . . 0.0 109.713 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -130.09 102.47 17.4 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.451 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.49 -13.93 30.47 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.801 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -76.88 -31.85 57.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.597 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.92 -19.74 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.949 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 74.9 mm-40 -69.61 -34.59 74.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.044 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.575 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 11.8 pt20 -87.02 -42.21 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 174.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 19.4 mt -97.13 60.87 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 5.1 m -83.42 85.88 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.143 -172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.93 -3.59 58.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.732 0.777 . . . . 0.0 108.992 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.9 128.74 28.94 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.69 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.56 157.19 62.86 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.84 2.36 . . . . 0.0 112.67 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 62.1 mt -98.85 126.07 44.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.432 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.7 mt -99.87 127.75 32.91 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' B' ' 59' ' ' ASN . 70.6 Cg_endo -76.42 136.43 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.857 1.705 . . . . 0.0 111.754 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.4 mp -131.13 133.39 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.967 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -110.0 118.49 36.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.697 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' B' ' 54' ' ' ILE . 28.4 mt -106.91 125.79 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.918 0.39 . . . . 0.0 110.729 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 86.7 m-85 -111.17 134.97 52.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.083 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 30' ' ' PRO . 1.5 t -84.54 131.69 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.04 150.5 25.03 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.906 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -91.34 11.26 24.27 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.207 1.003 . . . . 0.0 108.889 175.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.648 ' HB3' ' HG3' ' B' ' 51' ' ' PRO . 61.3 t30 -80.81 73.32 7.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.041 -172.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 p -91.79 2.99 56.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.787 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.81 132.12 3.27 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.525 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.438 -0.792 . . . . 0.0 109.974 -179.594 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.03 74.23 9.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.017 0.437 . . . . 0.0 111.063 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptm -140.14 147.62 40.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.015 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.4 146.94 24.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.367 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 18.5 ptp -115.84 141.29 27.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.901 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.562 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 33.6 Cg_exo -43.12 130.75 6.15 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.645 2.897 . . . . 0.0 113.513 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -117.73 132.52 56.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 112.239 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.93 140.41 53.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.382 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -125.36 123.6 39.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.16 158.14 44.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -120.78 128.31 52.77 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 20' ' ' LEU . 61.3 mt -117.3 141.31 48.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.502 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' B' ' 45' ' ' SER . 97.2 m-70 -70.58 127.63 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 115.47 7.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.432 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.99 -0.72 64.57 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.759 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -85.84 151.88 23.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.0 110.639 178.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 3.0 m -102.14 135.55 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.629 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' TYR . . . . . 0.508 ' HB3' HG13 ' B' ' 34' ' ' VAL . 78.2 m-85 -128.65 154.05 46.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.7 m170 -95.38 116.79 29.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 15.9 tp -106.24 122.47 46.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.342 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mt -132.56 126.13 54.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.438 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.4 140.06 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -149.38 171.57 16.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 3.5 p -124.03 134.33 53.46 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.43 -177.76 4.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.472 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 m -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.765 0.316 . . . . 0.0 111.554 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 mt -81.68 -24.29 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.275 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.15 13.06 12.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.54 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -91.41 141.92 26.5 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.577 ' CB ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -72.0 147.2 48.66 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.642 2.228 . . . . 0.0 112.321 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -127.95 141.18 51.61 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 15.4 tp -120.91 129.37 53.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.033 0.444 . . . . 0.0 110.819 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -125.91 125.64 43.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.508 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 54.6 t -127.22 121.23 57.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.859 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -124.61 129.22 24.71 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.477 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.2 Cg_endo -60.82 134.08 51.61 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.447 2.098 . . . . 0.0 111.821 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.484 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 37.2 m -75.93 -22.5 55.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.379 0.609 . . . . 0.0 109.689 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.98 102.45 17.58 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.577 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.6 -13.9 30.16 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.727 2.284 . . . . 0.0 112.672 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -76.8 -32.12 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.521 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -73.55 -19.98 60.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.953 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 76.2 mm-40 -69.58 -34.32 73.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.967 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.584 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 11.8 pt20 -87.29 -41.9 13.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.575 174.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 19.7 mt -97.42 60.36 1.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.788 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 5.2 m -83.04 85.85 7.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.281 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.56 -3.86 58.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.904 0.859 . . . . 0.0 108.919 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.72 128.6 29.52 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.711 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.75 157.37 62.14 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.873 2.382 . . . . 0.0 112.551 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.9 mt -99.43 125.18 45.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.514 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.462 ' O ' HD12 ' B' ' 52' ' ' LEU . 79.0 mt -99.13 127.42 34.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.648 ' HG3' ' HB3' ' A' ' 59' ' ' ASN . 67.9 Cg_endo -76.12 136.45 18.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.782 1.655 . . . . 0.0 111.702 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.462 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.4 mp -131.15 133.36 45.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.131 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -109.87 118.44 36.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' A' ' 54' ' ' ILE . 28.3 mt -106.93 125.95 62.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.083 0.468 . . . . 0.0 110.696 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.6 m-85 -111.29 134.89 52.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.072 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.577 HG21 ' CB ' ' B' ' 30' ' ' PRO . 1.5 t -84.59 131.47 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.66 150.24 25.27 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.927 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -91.2 11.48 23.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.069 0.938 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.663 ' HB3' ' HG3' ' A' ' 51' ' ' PRO . 61.1 t30 -80.96 73.8 7.98 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.084 -172.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 7.9 p -92.16 3.27 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.727 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.0 131.72 3.12 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.487 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.754 -179.407 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.2 ptm . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 121.106 0.479 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.954 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 16.7 Cg_endo -56.94 132.35 51.12 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.546 2.831 . . . . 0.0 112.616 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m -116.11 137.33 52.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.588 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.56 145.97 46.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -129.15 124.05 33.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.125 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.92 158.52 43.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.689 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 128.1 48.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -122.0 140.98 51.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.616 -173.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.73 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 35.5 m80 -71.7 129.23 38.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.48 115.14 7.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.006 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.58 10.74 56.49 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.976 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.991 ' HA ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -109.4 150.94 27.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 110.732 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 m -91.56 137.86 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.104 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.34 153.0 48.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.573 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.1 m170 -96.27 117.55 31.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.265 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD11 HD11 ' A' ' 32' ' ' LEU . 8.3 tp -109.08 119.63 40.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.103 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 mt -128.07 125.85 65.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.833 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.0 p -112.27 134.89 53.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -146.85 170.71 16.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 p -117.03 142.29 47.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.462 0.648 . . . . 0.0 112.164 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.12 164.68 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.461 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -56.49 -30.68 63.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.398 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.04 -18.01 62.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.48 1.75 53.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.956 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 78.5 m-20 -84.79 132.19 47.02 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.246 0.546 . . . . 0.0 110.082 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 56' ' ' VAL . 11.8 Cg_exo -66.39 150.02 84.58 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 122.983 2.455 . . . . 0.0 112.482 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -132.74 139.87 47.8 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.95 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 54' ' ' ILE . 13.8 tp -124.63 134.66 52.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.935 0.397 . . . . 0.0 111.162 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.8 m -134.89 123.29 23.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.392 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 68.8 t -125.98 122.4 61.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.94 131.04 24.59 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.872 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.76 42.12 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.417 2.078 . . . . 0.0 112.099 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.8 m -67.83 -23.67 65.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.241 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' OE1' ' A' ' 41' ' ' GLN . 77.1 m-20 -131.68 103.15 14.77 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.502 172.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.77 -23.8 22.15 Favored 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.096 2.53 . . . . 0.0 113.232 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -80.07 -22.71 41.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.692 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.615 ' OE1' ' HB3' ' A' ' 38' ' ' ASN . 12.1 mp0 -73.48 -20.93 60.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.254 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.73 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 46.6 mm-40 -67.38 -32.23 73.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.641 172.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.5 -43.15 16.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.89 77.58 3.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.742 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -91.3 78.69 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.335 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.01 -5.92 58.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 p -101.82 135.89 19.64 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.851 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.43 149.56 50.54 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.341 2.028 . . . . 0.0 111.853 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.62 123.73 35.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.3 mt -96.72 124.91 48.74 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.5 136.48 13.95 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.126 1.884 . . . . 0.0 111.135 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.23 133.17 46.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -110.14 115.95 30.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' B' ' 54' ' ' ILE . 31.3 mt -106.38 121.0 58.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.0 110.509 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -106.37 137.23 44.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.622 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.954 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -85.45 135.3 25.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.185 0.517 . . . . 0.0 110.799 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.03 178.284 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.094 0.473 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.949 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 16.5 Cg_endo -56.9 132.34 51.05 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.59 2.86 . . . . 0.0 112.635 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -116.07 137.43 52.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.538 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -120.77 145.81 47.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.486 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -128.84 123.9 33.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.18 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.65 158.53 43.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.95 128.02 48.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.916 0.389 . . . . 0.0 110.02 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 22' ' ' VAL . 52.9 mt -121.89 140.9 51.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.741 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 35.6 m80 -71.67 129.51 38.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 115.52 8.02 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.018 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 10.57 56.7 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.963 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.947 HE21 ' HA ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -109.36 150.99 27.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 8.4 m -91.83 137.75 32.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.027 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.405 ' HB3' HG13 ' B' ' 34' ' ' VAL . 86.7 m-85 -129.36 152.95 48.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.577 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.1 m170 -96.25 117.41 30.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.374 173.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 8.3 tp -108.89 119.27 39.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.53 125.85 66.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.014 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.2 p -112.07 134.67 53.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -146.67 170.75 16.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -116.83 142.61 46.7 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.475 0.655 . . . . 0.0 112.238 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.34 164.27 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.491 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -56.11 -30.95 62.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.53 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.87 -17.97 62.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.09 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.56 1.37 53.16 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.008 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 30' ' ' PRO . 79.4 m-20 -84.53 132.06 48.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.519 . . . . 0.0 109.913 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.708 ' HG2' HG11 ' B' ' 56' ' ' VAL . 11.7 Cg_exo -66.24 149.91 85.07 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.202 2.601 . . . . 0.0 112.402 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -132.54 139.93 48.08 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.787 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.518 HD21 HD12 ' B' ' 54' ' ' ILE . 13.8 tp -124.75 134.77 52.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.106 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -135.01 123.57 23.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.4 t -126.17 122.49 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.006 0.432 . . . . 0.0 110.517 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.02 130.97 24.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.862 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.439 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.32 40.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.433 2.089 . . . . 0.0 112.194 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 69.9 m -67.31 -23.87 65.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.126 0.489 . . . . 0.0 110.209 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . 0.635 ' HB3' ' OE1' ' B' ' 41' ' ' GLN . 77.8 m-20 -131.67 103.27 14.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.418 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.05 -23.83 21.19 Favored 'Trans proline' 0 CA--C 1.526 0.078 0 C-N-CA 123.115 2.544 . . . . 0.0 113.171 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.8 -22.88 42.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.856 0.36 . . . . 0.0 110.706 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.635 ' OE1' ' HB3' ' B' ' 38' ' ' ASN . 12.5 mp0 -73.48 -20.8 60.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.741 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 49.1 mm-40 -67.55 -32.12 72.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.678 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.57 -43.21 15.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.855 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.96 77.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 11.3 p -91.35 78.63 5.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.245 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.97 -5.56 58.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 166.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.1 p -102.32 135.8 19.53 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.9 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.45 149.55 50.4 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.246 1.964 . . . . 0.0 111.913 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.49 123.54 34.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.45 ' O ' HD12 ' B' ' 52' ' ' LEU . 64.8 mt -96.6 124.86 49.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.36 136.27 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.117 1.878 . . . . 0.0 111.129 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.3 mp -129.95 133.16 46.63 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.055 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -109.78 116.03 30.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.341 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' A' ' 54' ' ' ILE . 30.8 mt -106.52 120.86 58.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.226 0.536 . . . . 0.0 110.508 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -106.25 137.13 44.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.598 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.949 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -85.53 135.17 25.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 0.0 110.607 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.757 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.034 178.152 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.1 ptp . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 86.1 Cg_exo -49.16 131.36 26.22 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 123.593 2.862 . . . . 0.0 113.14 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -117.74 138.38 52.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.69 142.34 51.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.647 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.13 125.02 40.47 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.162 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.94 158.07 44.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.02 127.59 51.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.897 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB2' HG11 ' B' ' 22' ' ' VAL . 57.7 mt -122.61 140.73 52.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.299 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.41 126.93 30.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.32 99.65 0.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.453 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -0.58 17.93 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.817 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -96.5 155.53 16.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.769 0.318 . . . . 0.0 110.645 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.599 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 6.9 m -98.19 136.9 37.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.389 0.614 . . . . 0.0 110.565 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 34' ' ' VAL . 96.5 m-85 -129.3 153.22 48.04 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.411 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m80 -95.29 117.16 29.79 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.605 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.01 119.53 39.62 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.463 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.62 125.72 64.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.91 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' B' ' 12' ' ' LEU . 14.8 p -112.19 132.52 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 24.2 t0 -135.91 169.87 16.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.74 0.305 . . . . 0.0 110.831 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -179.46 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -58.48 -30.87 67.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 59.3 mt -82.23 -22.23 35.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.413 . . . . 0.0 111.204 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 19.22 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.282 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.605 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 29.5 m-80 -88.33 136.99 31.06 Favored Pre-proline 0 CA--C 1.511 -0.53 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HG3' HG11 ' A' ' 56' ' ' VAL . 1.1 Cg_endo -80.47 144.27 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.858 2.372 . . . . 0.0 111.681 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.7 t -127.88 140.18 52.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.574 HD21 HD12 ' A' ' 54' ' ' ILE . 14.4 tp -115.77 132.14 56.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.43 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -130.6 120.4 23.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.133 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.4 t -127.0 122.2 59.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.96 131.04 23.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.89 139.76 69.75 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.347 2.031 . . . . 0.0 111.811 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 12.7 p -67.38 -29.86 69.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.345 0.593 . . . . 0.0 110.5 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.08 102.72 4.81 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.457 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.41 -15.03 44.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.162 2.575 . . . . 0.0 112.707 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -66.19 -35.65 81.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.112 0.482 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -74.83 -22.2 58.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.043 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -70.13 -43.71 70.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.673 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.566 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.8 pt20 -78.38 -33.89 48.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.746 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 22.7 mt -102.11 56.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 p -74.79 96.76 3.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.157 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.84 -18.49 40.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.07 137.89 19.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.532 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.33 157.68 52.96 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.972 2.448 . . . . 0.0 112.843 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.8 mt -85.26 124.46 31.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.693 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 52' ' ' LEU . 70.6 mt -96.21 126.88 42.48 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.58 135.54 18.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.146 1.898 . . . . 0.0 111.599 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.9 mp -134.87 131.1 36.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.379 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 m -110.9 119.05 37.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' B' ' 54' ' ' ILE . 30.0 mt -107.04 125.73 63.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.939 0.4 . . . . 0.0 110.711 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -108.56 137.47 46.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.234 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 5' ' ' MET . 40.3 t -93.58 119.44 41.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.629 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.56 0 C-N-CA 118.853 -1.641 . . . . 0.0 114.275 169.79 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.572 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 13.5 ptp . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.4 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 90.1 Cg_exo -49.39 131.13 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -117.72 138.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.284 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.38 142.32 51.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.684 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.26 125.22 40.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.912 0.387 . . . . 0.0 110.143 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.88 158.08 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.12 127.65 51.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 22' ' ' VAL . 57.5 mt -122.75 140.72 52.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.451 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.45 126.9 30.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.36 99.54 0.29 Allowed Glycine 0 C--O 1.228 -0.237 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.502 -176.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.19 0.58 18.99 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.797 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -97.2 155.66 16.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.34 . . . . 0.0 110.585 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.588 ' HB ' ' OG ' ' B' ' 37' ' ' SER . 7.1 m -98.21 136.76 37.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.461 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' B' ' 34' ' ' VAL . 96.4 m-85 -129.33 153.33 47.95 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.3 m80 -95.26 117.65 30.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.312 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.43 119.76 40.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.292 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.77 125.64 63.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.945 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 12' ' ' LEU . 14.8 p -112.22 132.32 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 23.4 t0 -135.87 170.23 16.32 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.87 133.51 45.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.93 -179.73 7.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.254 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -58.33 -31.02 67.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.609 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 58.2 mt -81.92 -22.5 36.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.94 0.4 . . . . 0.0 111.116 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.22 18.89 9.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.263 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 29.0 m-80 -87.8 137.29 31.85 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.53 ' HG3' HG11 ' B' ' 56' ' ' VAL . 1.1 Cg_endo -80.48 144.66 16.13 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.757 2.304 . . . . 0.0 111.614 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -128.41 140.27 51.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 54' ' ' ILE . 14.6 tp -116.28 131.42 56.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 110.438 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 21.3 m -130.15 120.21 24.21 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.944 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.8 t -126.64 122.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.518 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 131.03 23.66 Favored Pre-proline 0 C--O 1.223 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.79 139.46 68.82 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.376 2.051 . . . . 0.0 111.769 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' B' ' 17' ' ' THR . 12.4 p -67.15 -30.08 69.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.472 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -143.87 103.05 4.87 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.84 -15.09 43.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.109 2.539 . . . . 0.0 112.632 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -66.15 -35.47 80.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.177 0.513 . . . . 0.0 109.76 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.65 -22.44 58.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.198 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -69.85 -44.05 70.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.573 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.8 pt20 -78.14 -33.59 50.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.573 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 23.3 mt -102.37 56.22 0.79 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.319 0.58 . . . . 0.0 109.582 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -74.69 96.21 2.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.392 -173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.13 -18.47 42.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.23 138.14 19.64 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.457 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.47 157.65 52.56 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.914 2.409 . . . . 0.0 112.963 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.04 124.56 31.87 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.742 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.475 ' O ' HD12 ' B' ' 52' ' ' LEU . 70.9 mt -96.27 127.0 41.92 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.49 135.62 18.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.06 1.84 . . . . 0.0 111.559 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 50' ' ' ILE . 4.9 mp -134.85 131.19 37.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -111.2 118.9 37.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.659 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' A' ' 54' ' ' ILE . 29.7 mt -106.93 125.73 62.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.962 0.411 . . . . 0.0 110.696 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -108.72 137.27 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.297 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' B' ' 5' ' ' MET . 39.5 t -93.35 119.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.401 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.619 0 C-N-CA 118.77 -1.681 . . . . 0.0 114.37 169.56 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.408 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 17.2 ptp . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.034 0.445 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.84 131.66 43.27 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.977 2.451 . . . . 0.0 111.639 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -112.13 136.82 51.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -115.1 139.81 49.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.11 123.37 36.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.98 158.63 43.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 129.38 50.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.816 0.341 . . . . 0.0 110.494 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.44 HD11 HD21 ' B' ' 20' ' ' LEU . 57.7 mt -119.98 146.29 45.98 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.32 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.562 ' HE1' ' HB3' ' A' ' 45' ' ' SER . 20.0 m-70 -70.77 127.35 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.001 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.55 112.03 3.97 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.171 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.24 3.98 56.5 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.422 -0.418 . . . . 0.0 113.125 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.4 156.66 17.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.965 0.412 . . . . 0.0 110.948 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -96.39 138.53 33.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.086 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.31 154.46 46.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.716 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.5 m80 -95.84 117.67 31.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.639 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 HD11 ' B' ' 12' ' ' LEU . 8.4 tp -108.85 120.83 43.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.37 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 10.5 mt -129.22 126.52 64.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.914 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.29 133.76 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.28 169.77 16.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 132.79 55.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 112.369 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.5 160.08 32.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.7 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.0 t -61.03 -24.56 66.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.96 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.1 mt -83.53 -12.38 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.441 . . . . 0.0 110.41 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.29 13.63 26.18 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.861 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.575 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 55.7 m-80 -85.65 129.34 55.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.56 148.74 42.82 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.962 . . . . 0.0 111.896 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -130.4 143.25 50.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.18 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.578 HD21 HD12 ' A' ' 54' ' ' ILE . 17.9 tp -124.29 133.33 53.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.635 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 15.7 m -131.96 120.82 23.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.5 t -127.77 122.11 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.268 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -121.78 133.15 24.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.62 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.82 137.14 66.16 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.307 2.005 . . . . 0.0 111.702 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.7 t -65.9 -23.65 66.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.51 . . . . 0.0 109.87 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -143.38 107.14 5.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.346 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.64 -18.59 64.89 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.073 2.515 . . . . 0.0 113.166 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.55 -22.72 43.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.632 0.253 . . . . 0.0 110.77 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -68.37 -25.08 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.136 0.493 . . . . 0.0 110.124 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.57 -32.98 72.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.345 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -79.57 -43.02 23.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.01 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -92.64 63.87 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.562 ' HB3' ' HE1' ' A' ' 13' ' ' HIS . 5.4 p -82.77 73.02 9.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.38 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.82 2.32 53.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.15 131.0 23.12 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.042 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.23 144.61 69.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.31 2.006 . . . . 0.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -87.25 129.79 34.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 52' ' ' LEU . 68.5 mt -104.91 122.25 43.9 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 168.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HG2' ' C ' ' B' ' 57' ' ' GLY . 73.0 Cg_endo -77.24 137.34 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.397 2.065 . . . . 0.0 111.557 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -129.21 136.6 50.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.082 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 m -111.29 116.82 31.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.844 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' B' ' 54' ' ' ILE . 38.6 mt -107.66 127.07 63.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.949 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 66.2 m-85 -112.35 141.41 46.11 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.738 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.0 141.41 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.935 0.398 . . . . 0.0 110.021 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.012 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.033 177.864 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 17.4 ptp . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.978 0.418 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.61 132.21 46.88 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.844 2.363 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -112.86 136.85 52.03 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.991 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.21 140.09 49.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.54 122.87 34.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.59 158.46 43.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.538 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.0 129.19 50.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.956 0.408 . . . . 0.0 110.585 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 20' ' ' LEU . 57.6 mt -119.85 146.25 45.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.465 -173.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.56 ' HE1' ' HB3' ' B' ' 45' ' ' SER . 19.7 m-70 -70.92 127.54 32.93 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.89 112.11 4.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.032 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 4.32 56.46 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.01 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.75 156.35 17.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.949 0.404 . . . . 0.0 110.849 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 15.3 m -95.97 138.65 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.128 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -129.43 154.19 47.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.737 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.5 m80 -95.59 117.73 30.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 12' ' ' LEU . 8.2 tp -108.99 120.86 43.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.344 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 10.4 mt -129.23 126.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.986 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.23 133.59 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.51 169.5 17.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.6 55.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.76 0.791 . . . . 0.0 112.526 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.97 160.23 32.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.751 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 t -61.44 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.082 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.594 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 52.1 mt -84.04 -12.43 55.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.33 13.75 25.8 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.985 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 52.9 m-80 -85.95 129.37 54.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 110.334 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.59 148.72 42.66 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.253 1.969 . . . . 0.0 111.917 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -130.59 142.96 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.244 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 18.0 tp -123.96 133.56 53.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.901 0.381 . . . . 0.0 110.497 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.5 m -132.26 120.5 22.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.942 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.9 t -127.32 122.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.63 133.21 24.18 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.766 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.11 137.6 67.57 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.149 1.9 . . . . 0.0 111.667 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -66.16 -23.46 66.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.232 0.539 . . . . 0.0 109.876 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' B' ' 39' ' ' PRO . 27.8 t-20 -143.62 106.88 5.06 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.404 174.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' B' ' 38' ' ' ASN . 28.8 Cg_endo -63.63 -18.64 65.15 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.174 2.583 . . . . 0.0 113.087 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.48 -22.6 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.704 0.287 . . . . 0.0 110.852 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.39 -25.44 65.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.23 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.45 -32.71 71.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.398 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -79.69 -43.11 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 110.042 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.8 mt -92.38 63.62 4.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.063 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . 0.56 ' HB3' ' HE1' ' B' ' 13' ' ' HIS . 4.9 p -82.69 72.54 9.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.28 2.11 53.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.95 131.73 22.41 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.992 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.48 144.41 67.04 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.478 2.119 . . . . 0.0 112.142 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -87.41 129.79 34.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.425 ' O ' HD12 ' B' ' 52' ' ' LEU . 68.9 mt -104.89 122.3 43.76 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 137.32 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.461 2.107 . . . . 0.0 111.599 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.425 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -129.4 136.32 49.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -110.94 116.64 31.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.834 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' A' ' 54' ' ' ILE . 39.5 mt -107.53 127.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.209 0.528 . . . . 0.0 111.096 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.404 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 65.0 m-85 -112.35 141.34 46.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.699 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.07 141.74 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.845 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.404 ' C ' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.44 -1.061 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.03 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.466 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 16.0 ptm . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.439 0.637 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.838 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 20.1 Cg_endo -59.9 140.4 92.82 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 112.353 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 m -115.75 136.46 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.168 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.69 147.0 45.09 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.97 124.03 30.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.97 158.1 44.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.16 129.01 51.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.932 0.396 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 HD21 ' B' ' 20' ' ' LEU . 60.7 mt -118.36 141.44 48.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.585 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.539 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 29.1 m80 -71.17 127.64 33.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.196 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.63 110.43 2.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.699 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.44 -1.12 46.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.787 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -87.88 152.27 22.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.025 0.44 . . . . 0.0 110.846 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.7 m -100.25 133.08 45.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.413 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.482 ' HB3' HG13 ' A' ' 34' ' ' VAL . 88.0 m-85 -124.19 152.88 42.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m170 -95.51 117.21 29.98 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 12' ' ' LEU . 11.8 tp -108.02 121.08 44.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.395 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -131.34 126.2 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.345 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.94 132.41 61.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.79 152.34 39.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.984 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 p -107.17 141.68 38.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -79.49 -175.04 4.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.3 p -55.38 -31.65 61.98 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.54 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.3 mt -87.06 -20.71 26.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.981 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 16.87 14.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.289 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 42.0 m-80 -82.33 128.82 65.84 Favored Pre-proline 0 CA--C 1.511 -0.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' CG ' HG21 ' A' ' 56' ' ' VAL . 56.6 Cg_endo -73.02 143.13 35.74 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.44 2.093 . . . . 0.0 112.182 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -127.72 147.39 50.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 54' ' ' ILE . 14.5 tp -119.35 129.82 55.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.899 0.381 . . . . 0.0 110.844 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -127.06 119.59 26.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.755 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.0 t -125.62 122.47 62.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.057 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.18 131.19 24.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 148.51 81.01 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.78 2.32 . . . . 0.0 112.205 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 p -68.88 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.353 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 50.2 t-20 -132.99 104.41 12.7 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.526 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 24.2 Cg_endo -62.95 -25.08 74.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.842 2.361 . . . . 0.0 112.238 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -82.6 -24.46 33.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.765 ' HA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.34 -24.72 61.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.118 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 49.3 mm-40 -65.76 -31.73 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.129 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.97 -43.1 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.4 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 58.94 5.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.81 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -77.48 76.43 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.395 0.617 . . . . 0.0 112.02 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.11 -15.58 61.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.079 0.942 . . . . 0.0 108.498 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -101.89 145.12 29.92 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.951 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.52 159.73 32.13 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 111.765 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 60.4 mt -94.55 131.59 40.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.137 0.494 . . . . 0.0 111.013 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 52' ' ' LEU . 69.8 mt -99.54 124.05 45.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 57.8 Cg_endo -74.7 137.47 22.5 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.194 1.929 . . . . 0.0 111.391 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -133.48 131.9 40.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 m -109.64 117.5 34.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.493 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' B' ' 54' ' ' ILE . 24.5 mt -107.03 123.33 62.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.341 0.591 . . . . 0.0 110.686 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.67 137.88 43.87 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.663 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.838 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.7 t -83.66 133.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.452 . . . . 0.0 109.881 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.901 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.644 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.463 ' HA ' ' HD2' ' B' ' 6' ' ' PRO . 15.7 ptm . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.177 0.513 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.863 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 19.9 Cg_endo -59.72 140.67 94.57 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.378 2.719 . . . . 0.0 112.247 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.08 136.03 53.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.234 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.32 147.13 44.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.06 124.09 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.78 158.27 44.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.555 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.41 128.82 51.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 20' ' ' LEU . 60.8 mt -118.43 141.46 48.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.674 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 29.4 m80 -71.07 127.39 32.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.78 110.94 3.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.544 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.96 -2.59 44.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.715 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -86.96 152.37 22.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.93 0.395 . . . . 0.0 110.925 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -100.59 132.98 45.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.463 175.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.503 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.5 m-85 -123.84 152.85 41.84 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.152 0.501 . . . . 0.0 110.644 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.4 m170 -95.66 117.12 29.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 12' ' ' LEU . 11.6 tp -108.13 121.1 44.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.14 126.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.316 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 p -112.62 132.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.51 152.27 39.49 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -107.18 141.85 37.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -79.57 -175.21 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.34 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 48.4 p -55.31 -31.74 61.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.542 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 54.8 mt -86.71 -21.27 26.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 16.8 14.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.273 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.542 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.6 m-80 -82.41 128.98 65.01 Favored Pre-proline 0 CA--C 1.51 -0.569 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' B' ' 56' ' ' VAL . 56.9 Cg_endo -73.21 143.37 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.292 1.995 . . . . 0.0 112.221 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -127.69 147.29 50.38 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.43 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.571 HD21 HD12 ' B' ' 54' ' ' ILE . 14.4 tp -119.2 130.03 55.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.855 0.36 . . . . 0.0 110.753 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -127.37 119.63 26.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.843 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.1 t -125.78 122.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.034 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.26 131.01 24.34 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.682 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.15 148.76 81.48 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.76 2.307 . . . . 0.0 112.335 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.5 p -69.4 -27.16 65.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.321 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -133.64 104.32 12.03 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.491 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.57 74.13 Favored 'Trans proline' 0 C--N 1.34 0.101 0 C-N-CA 122.748 2.299 . . . . 0.0 112.122 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.92 -24.61 35.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.757 ' HA ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -72.08 -24.72 61.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.146 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.523 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 50.0 mm-40 -65.85 -32.06 73.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.903 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.44 -43.06 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.538 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.8 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.3 p -77.56 76.32 4.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.326 0.584 . . . . 0.0 111.989 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.78 -15.92 61.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -101.62 145.06 29.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.855 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.42 159.66 32.52 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.611 2.207 . . . . 0.0 111.653 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.3 mt -94.15 131.53 39.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.004 0.43 . . . . 0.0 111.134 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.434 ' O ' HD12 ' B' ' 52' ' ' LEU . 69.2 mt -99.49 124.11 45.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 168.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 57.4 Cg_endo -74.79 137.46 22.25 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.237 1.958 . . . . 0.0 111.406 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.4 mp -133.38 132.22 40.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.907 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -109.91 117.42 33.76 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 54' ' ' ILE . 24.3 mt -106.9 123.37 61.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.18 0.514 . . . . 0.0 110.702 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -106.69 137.95 43.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.553 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.863 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.7 t -83.55 133.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.427 -1.93 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.606 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.296 0.569 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.731 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 32.7 Cg_endo -64.69 134.76 42.17 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.356 2.704 . . . . 0.0 112.251 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m -116.63 134.72 54.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.232 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -115.3 140.42 49.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.905 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -125.61 123.71 39.61 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 1.7 pp -141.11 158.15 44.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.688 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -121.74 128.6 51.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 110.44 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' B' ' 20' ' ' LEU . 58.0 mt -120.62 141.23 50.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.536 -174.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 36.5 m80 -70.91 132.96 46.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.378 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.71 110.93 3.31 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.737 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.9 58.24 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.552 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -89.56 144.17 26.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 37' ' ' SER . 12.2 m -93.74 137.32 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.017 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.468 ' HB3' HG13 ' A' ' 34' ' ' VAL . 85.9 m-85 -129.75 154.64 46.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 0.0 110.802 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 3.1 m170 -95.26 117.41 30.23 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.071 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 32' ' ' LEU . 11.8 tp -108.74 121.4 44.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.173 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 11.2 mt -131.3 126.59 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -116.07 133.56 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -142.99 170.02 16.48 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -124.18 141.53 51.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.7 0.286 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -176.13 6.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.721 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -65.88 -30.43 71.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.057 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 61.1 mt -76.28 -23.97 54.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 0.0 111.305 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.41 20.42 9.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.436 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 40.2 m-80 -94.73 135.95 23.43 Favored Pre-proline 0 CA--C 1.509 -0.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' CB ' HG21 ' A' ' 56' ' ' VAL . 72.2 Cg_endo -76.27 147.67 29.63 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.542 2.161 . . . . 0.0 112.09 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -126.52 140.04 52.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' ILE . 10.9 tp -122.44 122.32 38.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.037 0.446 . . . . 0.0 110.507 -175.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 16.7 m -116.86 119.18 34.59 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.913 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 77.8 t -123.86 122.17 63.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.9 131.27 23.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.1 Cg_endo -61.22 133.51 47.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.168 1.912 . . . . 0.0 111.922 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 8.7 t -70.62 -37.07 73.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -107.81 101.18 39.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.65 -29.4 29.82 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.522 2.148 . . . . 0.0 111.926 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.6 -23.42 56.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.781 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.27 -28.63 66.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 15.2 mm-40 -69.67 -21.75 63.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -87.55 -42.25 12.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.987 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.0 43.49 1.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.697 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -74.4 87.42 2.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.37 0.605 . . . . 0.0 112.16 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -92.61 -1.62 56.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.81 142.39 24.5 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.48 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.12 152.3 50.67 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.464 2.109 . . . . 0.0 112.158 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 29.9 mt -92.49 120.63 33.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.713 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.2 mt -93.06 123.62 60.52 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.01 136.37 16.38 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.269 1.979 . . . . 0.0 111.521 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.3 mp -129.32 133.55 47.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.989 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -109.42 115.67 30.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.74 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' B' ' 54' ' ' ILE . 28.5 mt -107.6 125.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.187 0.518 . . . . 0.0 110.715 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -108.64 132.84 53.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.731 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -84.85 136.91 21.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.071 0.462 . . . . 0.0 110.661 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.81 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.889 176.761 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 34.4 Cg_endo -64.54 134.43 41.25 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.241 2.628 . . . . 0.0 112.256 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.44 134.92 54.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -115.39 140.56 49.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.926 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.98 123.68 39.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.511 HD22 HG21 ' B' ' 34' ' ' VAL . 1.7 pp -141.21 158.35 44.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.729 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.1 128.33 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.861 0.362 . . . . 0.0 110.534 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 20' ' ' LEU . 58.1 mt -120.38 141.22 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.585 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 36.4 m80 -70.68 132.64 45.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.422 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.16 110.71 3.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.686 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.07 -0.43 58.89 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.522 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -89.68 144.22 26.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 37' ' ' SER . 14.3 m -93.8 137.12 33.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.996 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.459 ' HB3' HG13 ' B' ' 34' ' ' VAL . 85.5 m-85 -129.67 154.46 47.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.235 0.541 . . . . 0.0 110.572 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.67 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 3.1 m170 -95.09 117.27 29.91 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.118 172.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.532 HD11 HD11 ' B' ' 32' ' ' LEU . 11.6 tp -108.54 121.36 44.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.251 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 11.3 mt -131.39 126.29 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.86 133.56 61.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -143.0 170.19 16.16 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.855 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.6 p -124.16 141.63 51.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.661 0.267 . . . . 0.0 110.948 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -175.57 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t -66.54 -30.56 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.943 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.472 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 64.6 mt -76.11 -23.66 54.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.607 0.242 . . . . 0.0 111.162 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 20.27 9.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.278 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.2 m-80 -94.68 135.75 23.65 Favored Pre-proline 0 CA--C 1.511 -0.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.521 ' CB ' HG21 ' B' ' 56' ' ' VAL . 71.7 Cg_endo -75.98 147.87 30.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.472 2.114 . . . . 0.0 112.178 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -126.81 139.91 52.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' B' ' 54' ' ' ILE . 11.1 tp -122.44 122.12 38.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.208 0.527 . . . . 0.0 110.609 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.9 m -116.42 119.26 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.904 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 78.1 t -124.14 121.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 110.234 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.83 131.1 23.74 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.377 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.4 Cg_endo -61.38 133.27 45.22 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.229 1.953 . . . . 0.0 112.007 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.473 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 8.7 t -70.13 -37.01 75.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -107.98 101.34 40.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.84 -29.1 29.08 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.447 2.098 . . . . 0.0 112.121 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.73 -23.43 56.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.841 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.398 0.618 . . . . 0.0 110.182 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.495 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 15.9 mm-40 -69.76 -21.71 63.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.148 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -87.63 -42.41 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.003 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 16.1 mt -87.56 43.1 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.823 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -74.13 87.84 1.92 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.461 0.648 . . . . 0.0 112.072 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.26 -1.46 56.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.74 142.36 24.44 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.663 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 152.24 51.11 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.509 2.139 . . . . 0.0 112.135 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 30.7 mt -92.47 120.82 33.33 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.761 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' B' ' 52' ' ' LEU . 78.0 mt -93.15 123.86 59.66 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.21 136.13 15.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.289 1.993 . . . . 0.0 111.651 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.3 mp -129.14 133.28 47.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.959 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -109.25 115.76 30.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.678 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' A' ' 54' ' ' ILE . 27.4 mt -107.74 125.05 64.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.767 -176.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -108.45 132.8 53.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.848 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.729 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -84.82 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.846 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.927 176.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.547 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 21.3 ptp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 21.7 Cg_endo -60.27 132.01 41.71 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.052 2.501 . . . . 0.0 111.809 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -114.24 141.28 47.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.673 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -121.69 148.81 44.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.697 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.43 125.03 26.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.4 pp -141.17 158.07 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.166 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.29 127.36 53.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.02 140.14 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.567 -175.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 16' ' ' GLN . 34.7 m80 -71.71 133.06 45.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.302 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.74 110.93 3.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.848 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.83 47.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.931 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HG3' ' HB2' ' A' ' 13' ' ' HIS . 16.4 mm100 -95.46 143.4 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.911 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -87.97 136.25 33.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.07 153.91 47.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.9 m80 -95.74 117.64 30.9 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.602 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 32' ' ' LEU . 9.1 tp -108.39 120.84 43.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.317 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.13 125.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.79 133.65 63.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.08 170.1 16.37 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p -123.56 136.63 54.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.37 168.7 19.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.765 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 p -54.77 -30.65 57.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.3 mt -73.89 -13.6 60.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.233 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.6 1.07 62.25 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.577 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -75.78 133.58 73.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HG3' HG21 ' A' ' 56' ' ' VAL . 91.7 Cg_endo -80.15 152.77 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 112.322 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -133.97 140.2 46.58 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.528 HD21 HD12 ' A' ' 54' ' ' ILE . 13.4 tp -124.78 125.84 44.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.13 120.62 32.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.03 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.9 t -125.49 122.51 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.17 129.07 24.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.68 136.27 57.19 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.539 2.159 . . . . 0.0 112.332 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 73.1 m -70.48 -25.56 63.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -134.69 103.6 11.05 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.72 -21.16 29.41 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -75.93 -35.73 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.469 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 110.331 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' CD ' ' HD1' ' A' ' 13' ' ' HIS . 27.3 mm-40 -69.97 -41.55 74.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.57 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -73.55 -42.94 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.272 0.558 . . . . 0.0 109.943 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 mt -99.9 71.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' NE2' ' A' ' 13' ' ' HIS . 1.1 m -67.94 -66.24 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.222 -167.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 44.72 25.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.783 0.801 . . . . 0.0 111.729 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -136.73 138.48 26.41 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.909 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.64 143.6 62.88 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.181 1.92 . . . . 0.0 111.822 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.11 119.46 30.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.071 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.1 mt -87.28 125.71 64.93 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 43.5 Cg_endo -73.84 136.68 23.37 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.826 1.684 . . . . 0.0 110.558 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.8 mp -134.39 131.78 38.63 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -111.32 117.65 33.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' B' ' 54' ' ' ILE . 24.9 mt -107.24 123.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.185 0.517 . . . . 0.0 110.764 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.547 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 70.4 m-85 -107.68 138.42 43.94 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.015 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.696 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.6 t -84.09 130.42 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.167 0.508 . . . . 0.0 109.951 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.433 -1.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.806 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 21.2 ptp . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.714 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 22.3 Cg_endo -60.01 131.93 41.97 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.414 . . . . 0.0 111.761 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -114.36 141.88 47.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.555 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.98 148.9 44.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.74 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.48 125.07 26.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.11 158.06 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.22 127.4 53.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.0 140.14 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.436 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.497 ' HB2' ' HG3' ' B' ' 16' ' ' GLN . 34.5 m80 -71.79 133.07 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.297 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.49 110.88 3.41 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.858 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.58 -0.49 49.43 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.329 -0.463 . . . . 0.0 113.077 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' B' ' 13' ' ' HIS . 16.6 mm100 -95.58 143.42 26.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 111.006 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 4.1 m -87.82 136.33 33.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.516 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.402 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.1 m-85 -128.92 153.93 47.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.672 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.9 m80 -95.76 117.78 31.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.47 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.456 HD11 HD11 ' B' ' 32' ' ' LEU . 9.0 tp -108.5 120.8 43.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.417 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.09 125.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.18 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.75 133.67 63.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -140.96 169.91 16.74 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 50' ' ' ILE . 1.3 p -122.93 137.03 55.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.21 0.528 . . . . 0.0 111.46 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.67 168.85 18.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.804 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -54.81 -30.89 58.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -73.51 -14.3 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.113 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.88 1.32 61.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.547 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.415 ' N ' HD22 ' B' ' 29' ' ' ASN . 0.9 OUTLIER -76.15 133.15 72.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.442 ' HG3' HG21 ' B' ' 56' ' ' VAL . 93.0 Cg_endo -79.91 152.79 22.16 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.793 2.329 . . . . 0.0 112.284 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -134.06 140.32 46.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.537 HD21 HD12 ' B' ' 54' ' ' ILE . 13.5 tp -125.09 125.89 44.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 -173.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -124.17 120.46 32.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.3 t -125.38 122.36 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.08 128.69 24.1 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.404 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.69 135.67 53.81 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.55 2.166 . . . . 0.0 112.398 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 72.5 m -70.31 -25.23 63.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -134.78 103.72 10.94 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.09 -20.62 28.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.726 2.284 . . . . 0.0 112.843 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -76.25 -35.88 58.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.4 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.42 -23.01 60.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.094 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.418 ' CD ' ' HD1' ' B' ' 13' ' ' HIS . 27.6 mm-40 -70.05 -41.16 74.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.607 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.06 -42.88 59.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.142 0.496 . . . . 0.0 109.967 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.77 70.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' B' ' 13' ' ' HIS . 1.1 m -67.71 -66.49 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.155 -167.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.97 25.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.824 0.821 . . . . 0.0 111.48 -171.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -136.71 138.51 26.52 Favored Pre-proline 0 N--CA 1.442 -0.855 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.97 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.77 143.66 62.35 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 23.0 mt -89.95 119.79 30.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.971 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.483 ' O ' HD12 ' B' ' 52' ' ' LEU . 67.0 mt -87.55 125.67 64.53 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.616 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.0 Cg_endo -73.75 136.43 23.18 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.874 1.716 . . . . 0.0 110.716 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.514 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.8 mp -134.25 131.71 38.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.971 0.415 . . . . 0.0 110.496 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 5.1 m -111.4 117.32 32.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.631 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' A' ' 54' ' ' ILE . 25.6 mt -107.24 123.74 62.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 71.0 m-85 -107.48 138.4 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.913 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.5 t -84.01 130.79 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.018 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.607 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.434 -1.492 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.002 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -59.2 131.19 39.78 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.505 2.137 . . . . 0.0 111.595 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 m -116.88 136.84 52.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.923 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -115.49 145.14 42.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.822 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.96 123.89 29.82 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.8 158.45 43.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.93 128.21 49.1 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -121.06 141.34 50.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.677 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 30.2 m80 -71.49 131.32 43.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.52 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.58 111.55 3.99 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.024 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.63 0.87 52.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.723 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -95.09 150.71 19.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.17 0.509 . . . . 0.0 111.204 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -95.03 135.3 36.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.604 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.55 152.89 47.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.48 0.657 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.7 m80 -95.98 117.88 31.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.839 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD21 HD11 ' B' ' 12' ' ' LEU . 7.7 tp -108.78 121.36 44.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.159 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mt -129.57 126.49 63.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.076 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.5 p -117.92 135.05 59.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 7.1 p-10 -147.54 170.88 16.5 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.32 136.24 54.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.309 0.576 . . . . 0.0 111.88 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.25 165.64 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.005 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.1 m -54.88 -31.16 59.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.548 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 71.4 mt -73.11 -17.57 61.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.421 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.88 2.9 39.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.546 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.548 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 7.7 p30 -85.99 142.23 36.17 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.572 ' CG ' HG21 ' A' ' 56' ' ' VAL . 44.2 Cg_endo -85.25 153.02 10.79 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.565 2.176 . . . . 0.0 112.434 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -126.24 149.9 48.77 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 54' ' ' ILE . 11.3 tp -128.67 123.86 34.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.703 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.5 m -122.0 119.47 31.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.999 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.8 t -124.17 122.42 64.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.072 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.76 131.34 24.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.783 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.34 136.36 50.76 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 122.331 2.02 . . . . 0.0 111.68 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.4 m -70.68 -25.18 62.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.078 0.466 . . . . 0.0 110.362 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -132.82 102.92 13.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.65 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.67 -21.31 39.25 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.797 2.331 . . . . 0.0 112.253 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -74.89 -32.71 61.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -73.65 -21.34 60.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.245 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 19.0 mm-40 -69.27 -35.19 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.923 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.88 -43.26 36.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.046 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 67.46 4.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 p -78.39 81.34 4.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.466 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.78 -7.85 59.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 p -102.44 137.66 19.46 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.603 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.16 156.36 46.83 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.435 2.09 . . . . 0.0 111.281 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.4 mt -87.66 138.8 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HD12 ' A' ' 52' ' ' LEU . 87.0 mt -108.73 124.06 35.4 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 73.5 Cg_endo -77.58 136.57 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.294 1.996 . . . . 0.0 111.675 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 50' ' ' ILE . 4.9 mp -133.93 130.09 37.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 m -109.21 118.63 37.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.564 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' B' ' 54' ' ' ILE . 37.0 mt -107.5 126.38 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.107 0.48 . . . . 0.0 110.777 -176.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -109.57 138.71 45.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CG ' ' A' ' 30' ' ' PRO . 1.1 t -89.4 140.86 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.228 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.519 ' CA ' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.937 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.18 131.39 40.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 111.593 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.2 m -116.94 137.03 52.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.51 144.92 43.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.143 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.68 123.9 30.38 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.64 158.57 43.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.666 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.96 128.37 49.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 50.9 mt -121.14 141.47 50.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 -173.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 30.0 m80 -71.45 130.98 42.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.558 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.39 111.88 4.25 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.085 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 1.16 53.34 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.842 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -95.64 150.62 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.18 0.514 . . . . 0.0 111.129 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -94.88 135.36 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.445 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -128.62 153.12 47.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.351 0.596 . . . . 0.0 110.68 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.8 m80 -96.23 117.83 31.57 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.842 172.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 12' ' ' LEU . 7.6 tp -108.56 121.51 45.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.222 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.65 126.3 62.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.095 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.6 p -117.23 134.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 7.1 p-10 -147.44 170.97 16.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.12 136.83 53.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.225 0.536 . . . . 0.0 111.737 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.09 165.97 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.115 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -55.03 -30.93 60.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.558 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 71.9 mt -73.35 -17.94 61.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.828 0.347 . . . . 0.0 111.293 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.06 39.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.558 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 7.7 p30 -85.96 142.61 36.56 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.403 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.566 ' CG ' HG21 ' B' ' 56' ' ' VAL . 44.2 Cg_endo -85.46 153.37 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.658 2.239 . . . . 0.0 112.377 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -126.51 150.12 48.95 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.502 HD21 HD12 ' B' ' 54' ' ' ILE . 11.3 tp -128.85 123.7 33.42 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.746 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -121.96 119.24 30.92 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.144 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.0 t -123.99 122.67 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 110.081 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.91 131.47 24.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.859 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.62 136.21 48.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.293 1.995 . . . . 0.0 111.708 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 52.0 m -70.43 -25.34 63.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -132.87 102.91 13.26 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.725 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.01 -21.04 37.54 Favored 'Trans proline' 0 CA--C 1.526 0.116 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -74.99 -32.72 61.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.593 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -73.71 -21.53 60.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.25 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 20.0 mm-40 -68.82 -35.68 77.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.868 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.57 -43.36 39.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.036 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.9 mt -92.75 67.42 4.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -78.32 81.17 4.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.482 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -80.83 -7.08 59.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.958 0.885 . . . . 0.0 108.712 167.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 5.0 p -103.11 137.72 19.34 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.437 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.24 156.1 46.53 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.454 2.103 . . . . 0.0 111.58 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 48.9 mt -87.79 138.55 31.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.0 110.708 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 52' ' ' LEU . 85.3 mt -108.53 123.82 36.22 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 167.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.519 ' HG2' ' CA ' ' A' ' 57' ' ' GLY . 74.0 Cg_endo -77.37 136.55 15.94 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.065 . . . . 0.0 111.475 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.9 mp -133.89 130.11 37.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 m -108.83 118.72 37.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.733 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 54' ' ' ILE . 37.0 mt -107.57 126.49 63.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.115 0.483 . . . . 0.0 110.793 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -109.66 138.61 45.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.512 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' B' ' 30' ' ' PRO . 1.1 t -89.45 140.72 15.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.155 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.544 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.66 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.136 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PHE . 86.4 Cg_exo -51.85 139.25 50.35 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.502 2.801 . . . . 0.0 112.096 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.2 132.28 56.68 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.597 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -122.01 140.94 51.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.703 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 124.32 41.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.261 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.51 HD22 HG21 ' A' ' 34' ' ' VAL . 1.5 pp -141.42 157.9 44.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.249 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -119.27 127.42 53.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.368 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD11 HD21 ' B' ' 20' ' ' LEU . 65.6 mt -119.49 141.99 48.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.189 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -70.56 127.16 31.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.99 104.34 0.79 Allowed Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.144 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.29 11.86 26.58 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.623 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.435 ' OE1' ' HG2' ' A' ' 41' ' ' GLN . 25.4 mm-40 -109.57 154.83 22.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 111.599 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -96.66 137.16 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.654 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 34' ' ' VAL . 74.4 m-85 -129.61 154.89 46.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.852 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.691 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.6 m170 -95.03 117.62 30.47 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.321 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' LEU . 11.9 tp -110.64 123.15 49.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.51 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 13.8 mt -131.25 126.53 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.56 127.9 74.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.54 151.09 47.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.181 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -108.09 135.53 49.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -174.87 5.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -64.05 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.727 0.298 . . . . 0.0 111.563 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -80.39 -24.48 39.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.59 17.96 9.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.436 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 31.1 m-80 -92.88 135.53 25.93 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' CG ' HG21 ' A' ' 56' ' ' VAL . 71.4 Cg_endo -75.07 144.08 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.522 2.148 . . . . 0.0 111.85 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.2 t -127.48 140.24 52.28 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 54' ' ' ILE . 12.6 tp -120.05 129.19 54.11 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.744 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 36.1 m -126.13 119.98 28.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.995 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 74.1 t -123.41 121.77 63.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.5 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.12 129.66 24.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.445 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.46 137.04 75.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.545 2.163 . . . . 0.0 112.16 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.0 t -68.94 -21.05 64.22 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.431 0.634 . . . . 0.0 109.998 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -140.29 103.24 6.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -11.71 33.0 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.541 2.161 . . . . 0.0 112.728 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -86.95 -27.67 23.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.033 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HG2' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mp0 -69.41 -23.78 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.85 -33.26 75.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.442 0.639 . . . . 0.0 109.672 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -85.21 -42.23 14.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.668 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.16 55.27 2.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.9 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -78.88 94.84 5.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.402 0.62 . . . . 0.0 112.075 -174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.13 -10.99 51.37 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 p -101.94 132.55 21.48 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.229 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.86 160.07 48.83 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.1 mt -92.91 120.15 32.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.111 0.481 . . . . 0.0 111.082 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 52' ' ' LEU . 80.8 mt -91.13 127.94 49.46 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.001 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.28 134.86 19.71 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.109 1.873 . . . . 0.0 111.739 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -136.02 135.18 39.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.371 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.4 m -115.38 120.95 41.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.849 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' B' ' 54' ' ' ILE . 31.8 mt -108.56 129.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 85.6 m-85 -111.56 138.75 47.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 30' ' ' PRO . 42.4 t -95.27 118.45 41.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.68 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.569 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.606 169.485 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 80.6 mtp . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.823 0.344 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' B' ' 55' ' ' PHE . 88.9 Cg_exo -51.86 139.15 50.66 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 C-N-CA 123.439 2.76 . . . . 0.0 112.248 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.36 132.18 56.64 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.709 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.9 140.8 51.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.631 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.57 123.98 41.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.294 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.531 HD22 HG21 ' B' ' 34' ' ' VAL . 1.6 pp -141.12 158.09 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.18 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -119.91 127.09 52.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.134 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 20' ' ' LEU . 65.8 mt -119.43 141.74 48.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.189 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -70.31 127.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.62 104.13 0.73 Allowed Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.159 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 11.74 26.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.676 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.42 ' OE1' ' HG2' ' B' ' 41' ' ' GLN . 26.3 mm-40 -109.53 155.14 21.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -97.18 137.07 36.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' B' ' 34' ' ' VAL . 73.3 m-85 -129.61 154.85 46.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.789 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.688 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 5.6 m170 -95.19 117.56 30.44 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.256 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.503 HD11 HD11 ' B' ' 32' ' ' LEU . 11.7 tp -110.35 123.11 49.25 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.489 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 13.6 mt -131.26 126.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.47 127.84 73.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -138.81 151.24 46.87 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -108.1 136.07 48.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.968 0.413 . . . . 0.0 111.041 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -175.03 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.48 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.2 m -63.79 -30.57 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.714 0.292 . . . . 0.0 111.52 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.55 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 41.7 mt -80.63 -24.3 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.265 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.19 18.22 9.42 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.474 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.55 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 30.0 m-80 -92.76 135.43 26.23 Favored Pre-proline 0 CA--C 1.511 -0.548 0 CA-C-O 121.028 0.442 . . . . 0.0 109.841 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.438 ' CG ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -75.04 143.98 29.58 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.499 2.132 . . . . 0.0 111.858 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -127.61 140.28 52.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.591 HD21 HD12 ' B' ' 54' ' ' ILE . 12.6 tp -119.62 129.75 54.76 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.768 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 38.6 m -126.47 120.04 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.751 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 74.9 t -123.71 121.48 62.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 0.0 110.419 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.89 129.75 24.47 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 136.62 71.99 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.196 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 16.4 t -68.25 -21.68 64.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.155 0.503 . . . . 0.0 109.789 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -139.81 103.46 6.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.938 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.6 -12.22 34.94 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.694 2.262 . . . . 0.0 112.601 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -86.43 -27.7 23.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.103 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.42 ' HG2' ' OE1' ' B' ' 16' ' ' GLN . 1.2 mp0 -69.38 -24.0 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 175.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.62 -33.51 75.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.773 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -85.03 -42.06 15.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.787 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.31 55.37 2.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.037 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p -78.92 95.02 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.126 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.89 -10.08 51.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.0 p -102.22 132.46 21.46 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.157 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.85 160.07 48.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.841 2.361 . . . . 0.0 111.802 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.53 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 47.4 mt -93.17 120.06 33.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.933 0.397 . . . . 0.0 111.202 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.503 ' O ' HD12 ' B' ' 52' ' ' LEU . 81.3 mt -91.08 128.02 49.25 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.25 134.98 19.93 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.125 1.883 . . . . 0.0 111.784 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.503 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -136.19 134.77 38.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.518 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -115.01 120.97 41.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' A' ' 54' ' ' ILE . 30.4 mt -108.56 129.44 63.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.812 0.339 . . . . 0.0 110.769 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.8 m-85 -111.27 138.52 47.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.779 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' B' ' 30' ' ' PRO . 41.7 t -95.26 118.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.474 0 C-N-CA 119.119 -1.515 . . . . 0.0 113.583 169.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 18.8 ptp . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.335 0.588 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' A' ' 56' ' ' VAL . 2.8 Cg_exo -68.88 135.52 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.917 2.411 . . . . 0.0 111.569 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 m -113.85 148.73 36.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.158 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -123.47 140.09 53.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.878 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -127.12 123.78 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 52' ' ' LEU . 2.1 pp -140.62 158.62 43.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.85 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.23 128.46 51.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.686 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.449 HD11 HD21 ' B' ' 20' ' ' LEU . 50.0 mt -123.01 140.5 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 98.2 m-70 -72.05 132.11 43.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.99 108.03 1.57 Allowed Glycine 0 CA--C 1.516 0.142 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.792 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.84 -8.32 42.71 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.595 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -84.16 147.03 27.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.825 0.345 . . . . 0.0 110.255 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 4.4 m -96.22 136.3 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.1 m-85 -129.7 153.09 48.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.313 0.578 . . . . 0.0 111.158 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.4 m80 -95.82 117.64 30.94 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.736 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 32' ' ' LEU . 9.7 tp -107.98 123.32 48.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.508 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.65 126.43 54.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.327 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.64 133.69 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -147.17 159.82 43.17 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -116.13 140.69 49.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.87 0.366 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 23.3 p30 -81.3 -174.98 5.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.98 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -62.15 -28.89 69.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 0.0 111.401 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.574 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 44.9 mt -82.82 -23.67 33.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 110.64 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.53 19.71 10.21 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.916 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.574 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 34.4 m-80 -87.57 131.0 45.12 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' HG11 ' A' ' 56' ' ' VAL . 58.0 Cg_endo -74.42 144.25 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.277 1.985 . . . . 0.0 112.093 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.6 t -130.06 140.18 50.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 20' ' ' LEU . 13.0 tp -122.97 130.09 52.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.905 0.383 . . . . 0.0 110.734 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -127.29 120.69 29.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.977 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.8 t -123.67 121.77 63.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.087 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.87 132.3 24.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.97 133.57 42.06 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.127 1.885 . . . . 0.0 111.713 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 50.5 m -73.41 -27.8 61.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.458 . . . . 0.0 110.248 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -121.32 103.57 41.62 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.35 -25.49 42.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.728 2.286 . . . . 0.0 112.86 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -81.75 -16.13 52.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.268 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -73.21 -26.15 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.031 0.443 . . . . 0.0 110.318 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.36 -43.21 13.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.435 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.42 58.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.926 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -83.89 91.1 7.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -85.64 -7.41 58.84 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.42 131.91 22.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.843 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.01 155.26 71.62 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.977 2.451 . . . . 0.0 112.173 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 28.9 mt -91.04 120.05 31.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.09 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 70.6 mt -91.5 129.25 43.57 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 44.0 Cg_endo -86.99 136.92 4.34 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.393 2.062 . . . . 0.0 110.953 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.8 128.72 41.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.769 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -106.22 115.87 30.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.586 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' B' ' 54' ' ' ILE . 27.9 mt -108.38 126.05 65.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -110.27 139.7 45.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.243 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' A' ' 6' ' ' PRO . 12.2 p -87.37 142.78 12.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.197 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.569 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.771 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.301 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 19.0 ptp . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' B' ' 56' ' ' VAL . 2.8 Cg_exo -69.43 135.44 31.26 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.744 2.296 . . . . 0.0 111.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 m -113.86 148.51 36.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.253 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -123.26 140.3 53.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.893 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.31 123.62 36.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' B' ' 52' ' ' LEU . 2.0 pp -140.56 158.78 43.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.57 128.53 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.801 0.334 . . . . 0.0 110.591 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 20' ' ' LEU . 49.9 mt -123.1 140.54 52.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 98.2 m-70 -71.99 131.97 43.65 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.71 107.71 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.883 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.89 -8.22 42.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.714 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -84.05 147.23 27.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 4.1 m -96.4 136.22 37.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' B' ' 34' ' ' VAL . 92.6 m-85 -129.69 153.21 48.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.113 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.4 m80 -95.78 117.74 31.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.659 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 32' ' ' LEU . 9.7 tp -108.11 123.27 48.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.431 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.57 126.51 55.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.172 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 133.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.54 160.96 41.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 140.21 49.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.917 0.389 . . . . 0.0 110.482 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' B' ' 29' ' ' ASN . 21.1 p30 -81.2 -175.41 5.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.832 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 22.2 t -61.24 -29.59 69.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.775 0.321 . . . . 0.0 111.505 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.573 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 45.5 mt -82.63 -23.9 34.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 0.0 110.463 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.0 10.49 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.048 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 34.2 m-80 -86.95 130.92 46.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 56' ' ' VAL . 57.9 Cg_endo -74.09 144.36 33.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.313 2.009 . . . . 0.0 112.174 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 41.6 t -130.3 140.02 50.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 20' ' ' LEU . 13.0 tp -122.77 130.33 52.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.907 0.384 . . . . 0.0 110.543 -174.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m -127.58 120.73 28.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.056 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.6 t -123.78 121.52 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.331 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.73 132.38 24.28 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.07 133.45 41.17 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.082 1.855 . . . . 0.0 111.688 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 50.5 m -73.35 -27.9 61.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.157 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -121.29 103.65 41.6 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.56 -25.3 41.06 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.803 2.336 . . . . 0.0 112.879 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -81.78 -16.03 52.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.331 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -73.2 -26.04 61.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.077 0.465 . . . . 0.0 110.517 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -70.12 -27.68 64.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.33 -43.25 13.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.319 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -99.48 58.33 1.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.919 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . 0.404 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 15.2 m -84.07 91.78 7.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.287 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.4 -7.24 58.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.672 0.749 . . . . 0.0 109.035 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.36 132.3 22.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.775 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.15 155.4 70.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.818 2.345 . . . . 0.0 112.124 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 29.7 mt -90.96 119.98 31.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 71.6 mt -91.51 129.21 43.7 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.4 Cg_endo -87.25 136.96 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.373 2.049 . . . . 0.0 110.912 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.2 mp -130.52 128.81 41.91 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.74 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.5 m -106.29 115.97 31.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' A' ' 54' ' ' ILE . 27.5 mt -108.5 126.4 65.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -110.57 139.62 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.116 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' B' ' 6' ' ' PRO . 11.8 p -87.35 142.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.132 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.559 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.66 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.288 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 18.3 ptp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 30.6 Cg_exo -42.75 130.98 5.55 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.786 2.99 . . . . 0.0 113.414 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -118.07 132.45 56.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.246 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.87 140.07 53.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.421 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -124.82 123.77 40.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.08 157.92 44.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.748 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -120.37 128.35 53.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 0.0 110.095 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' B' ' 20' ' ' LEU . 60.0 mt -117.2 141.21 48.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.53 ' CE1' ' HB3' ' A' ' 45' ' ' SER . 97.2 m-70 -70.7 127.58 33.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.7 7.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.533 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -0.74 65.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.631 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -85.73 151.62 23.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 110.608 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 3.0 m -102.03 135.65 43.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.579 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 34' ' ' VAL . 77.9 m-85 -128.59 154.04 46.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.266 0.555 . . . . 0.0 111.03 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.6 m170 -95.42 116.98 29.54 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 32' ' ' LEU . 15.7 tp -106.36 122.48 46.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.378 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.58 126.36 54.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.315 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.58 139.82 38.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.48 171.21 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -123.02 135.2 54.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.048 0.451 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -178.24 4.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.401 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 m -60.46 -31.09 70.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.8 0.333 . . . . 0.0 111.621 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -81.81 -23.94 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 111.292 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.84 13.12 12.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.384 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 36.0 m-80 -91.63 141.9 26.23 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.576 ' CB ' HG21 ' A' ' 56' ' ' VAL . 74.2 Cg_endo -72.06 147.25 48.39 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.803 2.335 . . . . 0.0 112.329 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.2 t -128.23 141.17 51.54 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 54' ' ' ILE . 15.5 tp -120.73 129.98 53.86 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.619 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -126.17 125.94 43.28 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 55.4 t -127.24 121.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.824 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.54 129.2 24.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.463 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.4 Cg_endo -60.91 133.74 49.33 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.442 2.095 . . . . 0.0 111.951 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 42.1 m -75.81 -22.35 56.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.2 0.524 . . . . 0.0 109.713 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -130.09 102.47 17.4 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.451 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.49 -13.93 30.47 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.801 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -76.88 -31.85 57.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.597 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.92 -19.74 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.949 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 74.9 mm-40 -69.61 -34.59 74.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.044 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.575 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.9 pt20 -87.02 -42.21 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 174.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 19.4 mt -97.13 60.87 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 5.1 m -83.42 85.88 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.143 -172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.93 -3.59 58.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.732 0.777 . . . . 0.0 108.992 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.9 128.74 28.94 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.69 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.56 157.19 62.86 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.84 2.36 . . . . 0.0 112.67 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 62.1 mt -98.85 126.07 44.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.432 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.7 mt -99.87 127.75 32.91 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.42 136.43 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.857 1.705 . . . . 0.0 111.754 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.4 mp -131.13 133.39 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.967 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -110.0 118.49 36.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.697 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' B' ' 54' ' ' ILE . 28.4 mt -106.91 125.79 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.918 0.39 . . . . 0.0 110.729 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 86.7 m-85 -111.17 134.97 52.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.083 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 30' ' ' PRO . 1.5 t -84.54 131.69 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.637 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.906 -178.705 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 18.5 ptp . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.562 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 33.6 Cg_exo -43.12 130.75 6.15 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.645 2.897 . . . . 0.0 113.513 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -117.73 132.52 56.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 112.239 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.93 140.41 53.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.382 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -125.36 123.6 39.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.16 158.14 44.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -120.78 128.31 52.77 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 20' ' ' LEU . 61.3 mt -117.3 141.31 48.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.502 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' B' ' 45' ' ' SER . 97.2 m-70 -70.58 127.63 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 115.47 7.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.432 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.99 -0.72 64.57 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.759 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -85.84 151.88 23.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.0 110.639 178.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 3.0 m -102.14 135.55 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.629 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' TYR . . . . . 0.508 ' HB3' HG13 ' B' ' 34' ' ' VAL . 78.2 m-85 -128.65 154.05 46.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.7 m170 -95.38 116.79 29.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 15.9 tp -106.24 122.47 46.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.342 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mt -132.56 126.13 54.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.438 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.4 140.06 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -149.38 171.57 16.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 3.5 p -124.03 134.33 53.46 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.43 -177.76 4.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.472 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 m -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.765 0.316 . . . . 0.0 111.554 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.474 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 43.0 mt -81.68 -24.29 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.275 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.15 13.06 12.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.54 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 36.3 m-80 -91.41 141.92 26.5 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.577 ' CB ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -72.0 147.2 48.66 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.642 2.228 . . . . 0.0 112.321 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -127.95 141.18 51.61 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 15.4 tp -120.91 129.37 53.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.033 0.444 . . . . 0.0 110.819 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -125.91 125.64 43.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.508 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 54.6 t -127.22 121.23 57.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.859 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -124.61 129.22 24.71 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.477 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.2 Cg_endo -60.82 134.08 51.61 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.447 2.098 . . . . 0.0 111.821 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.484 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 37.2 m -75.93 -22.5 55.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.379 0.609 . . . . 0.0 109.689 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.98 102.45 17.58 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.577 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.6 -13.9 30.16 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.727 2.284 . . . . 0.0 112.672 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -76.8 -32.12 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.521 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -73.55 -19.98 60.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.953 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 76.2 mm-40 -69.58 -34.32 73.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.967 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.584 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.9 pt20 -87.29 -41.9 13.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.575 174.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 19.7 mt -97.42 60.36 1.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.788 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 5.2 m -83.04 85.85 7.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.281 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.56 -3.86 58.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.904 0.859 . . . . 0.0 108.919 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.72 128.6 29.52 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.711 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.75 157.37 62.14 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.873 2.382 . . . . 0.0 112.551 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.9 mt -99.43 125.18 45.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.514 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.462 ' O ' HD12 ' B' ' 52' ' ' LEU . 79.0 mt -99.13 127.42 34.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.12 136.45 18.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.782 1.655 . . . . 0.0 111.702 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.462 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.4 mp -131.15 133.36 45.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.131 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -109.87 118.44 36.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' A' ' 54' ' ' ILE . 28.3 mt -106.93 125.95 62.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.083 0.468 . . . . 0.0 110.696 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.6 m-85 -111.29 134.89 52.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.072 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' VAL . . . . . 0.577 HG21 ' CB ' ' B' ' 30' ' ' PRO . 1.5 t -84.59 131.47 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.815 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.927 -178.626 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.59 18.48 3.1 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.666 -0.314 . . . . 0.0 111.713 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.444 ' HG3' ' HG3' ' A' ' 4' ' ' GLU . 26.3 ptm -131.94 -31.67 1.49 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.15 0.5 . . . . 0.0 110.861 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HG3' ' HG3' ' A' ' 3' ' ' MET . 0.0 OUTLIER -96.49 12.2 32.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.505 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.415 ' H ' ' HG2' ' A' ' 5' ' ' MET . 12.2 ptm -66.92 126.96 93.27 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.425 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.954 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 16.7 Cg_endo -56.94 132.35 51.12 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.546 2.831 . . . . 0.0 112.616 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 m -116.11 137.33 52.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.588 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.56 145.97 46.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -129.15 124.05 33.69 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.125 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.92 158.52 43.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.689 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 128.1 48.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -122.0 140.98 51.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.616 -173.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.73 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 35.5 m80 -71.7 129.23 38.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.48 115.14 7.49 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.006 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.58 10.74 56.49 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.976 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.991 ' HA ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -109.4 150.94 27.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.898 0.38 . . . . 0.0 110.732 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 m -91.56 137.86 32.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.104 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -129.34 153.0 48.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.573 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.1 m170 -96.27 117.55 31.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.265 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD11 HD11 ' A' ' 32' ' ' LEU . 8.3 tp -109.08 119.63 40.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.103 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.6 mt -128.07 125.85 65.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.833 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.0 p -112.27 134.89 53.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -146.85 170.71 16.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 p -117.03 142.29 47.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.462 0.648 . . . . 0.0 112.164 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.12 164.68 25.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.461 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.9 m -56.49 -30.68 63.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.398 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.04 -18.01 62.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.48 1.75 53.45 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.956 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 78.5 m-20 -84.79 132.19 47.02 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.246 0.546 . . . . 0.0 110.082 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.69 ' HG2' HG11 ' A' ' 56' ' ' VAL . 11.8 Cg_exo -66.39 150.02 84.58 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 122.983 2.455 . . . . 0.0 112.482 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -132.74 139.87 47.8 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 113.485 -1.689 . . . . 0.0 108.95 -172.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 54' ' ' ILE . 13.8 tp -124.63 134.66 52.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.935 0.397 . . . . 0.0 111.162 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.8 m -134.89 123.29 23.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.392 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 68.8 t -125.98 122.4 61.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -120.94 131.04 24.59 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.872 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.76 42.12 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.417 2.078 . . . . 0.0 112.099 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.8 m -67.83 -23.67 65.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 110.241 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.615 ' HB3' ' OE1' ' A' ' 41' ' ' GLN . 77.1 m-20 -131.68 103.15 14.77 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.502 172.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.77 -23.8 22.15 Favored 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.096 2.53 . . . . 0.0 113.232 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -80.07 -22.71 41.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.692 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.615 ' OE1' ' HB3' ' A' ' 38' ' ' ASN . 12.1 mp0 -73.48 -20.93 60.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.254 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.73 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 46.6 mm-40 -67.38 -32.23 73.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.641 172.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -83.5 -43.15 16.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.0 mt -94.89 77.58 3.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.742 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -91.3 78.69 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.335 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.01 -5.92 58.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.2 p -101.82 135.89 19.64 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.851 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.43 149.56 50.54 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.341 2.028 . . . . 0.0 111.853 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 mt -91.62 123.73 35.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 52' ' ' LEU . 65.3 mt -96.72 124.91 48.74 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 59' ' ' ASN . 77.2 Cg_endo -78.5 136.48 13.95 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.126 1.884 . . . . 0.0 111.135 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.23 133.17 46.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -110.14 115.95 30.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' B' ' 54' ' ' ILE . 31.3 mt -106.38 121.0 58.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.29 0.567 . . . . 0.0 110.509 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -106.37 137.23 44.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.622 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.954 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -85.45 135.3 25.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.185 0.517 . . . . 0.0 110.799 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.61 156.86 18.29 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.03 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.81 115.96 26.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' B' ' 51' ' ' PRO . 17.0 t-20 -84.15 66.82 9.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.701 0.763 . . . . 0.0 109.013 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.6 m -75.97 -34.3 59.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.295 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -125.53 155.83 19.07 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.56 179.555 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.66 19.0 3.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.737 0.303 . . . . 0.0 111.595 -176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . 0.456 ' HG3' ' HG3' ' B' ' 4' ' ' GLU . 26.3 ptm -132.42 -31.31 1.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.97 0.414 . . . . 0.0 110.934 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.456 ' HG3' ' HG3' ' B' ' 3' ' ' MET . 0.0 OUTLIER -96.96 12.56 31.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.459 0.647 . . . . 0.0 110.562 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 12.1 ptm -67.24 126.75 92.99 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.302 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.949 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 16.5 Cg_endo -56.9 132.34 51.05 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.59 2.86 . . . . 0.0 112.635 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -116.07 137.43 52.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.538 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -120.77 145.81 47.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.486 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -128.84 123.9 33.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.18 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.65 158.53 43.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.828 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.95 128.02 48.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.916 0.389 . . . . 0.0 110.02 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 22' ' ' VAL . 52.9 mt -121.89 140.9 51.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.741 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 35.6 m80 -71.67 129.51 38.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 115.52 8.02 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.018 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 10.57 56.7 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.963 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.947 HE21 ' HA ' ' B' ' 16' ' ' GLN . 0.0 OUTLIER -109.36 150.99 27.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.995 0.426 . . . . 0.0 110.891 -179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 8.4 m -91.83 137.75 32.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.027 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.405 ' HB3' HG13 ' B' ' 34' ' ' VAL . 86.7 m-85 -129.36 152.95 48.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.577 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.1 m170 -96.25 117.41 30.74 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.374 173.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 8.3 tp -108.89 119.27 39.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.082 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.4 mt -127.53 125.85 66.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.014 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.2 p -112.07 134.67 53.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -146.67 170.75 16.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.9 p -116.83 142.61 46.7 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.475 0.655 . . . . 0.0 112.238 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.34 164.27 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.491 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 18.7 m -56.11 -30.95 62.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.884 0.373 . . . . 0.0 111.53 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.87 -17.97 62.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.09 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.56 1.37 53.16 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.008 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' B' ' 30' ' ' PRO . 79.4 m-20 -84.53 132.06 48.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.189 0.519 . . . . 0.0 109.913 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.708 ' HG2' HG11 ' B' ' 56' ' ' VAL . 11.7 Cg_exo -66.24 149.91 85.07 Favored 'Trans proline' 0 CA--C 1.506 -0.907 0 C-N-CA 123.202 2.601 . . . . 0.0 112.402 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -132.54 139.93 48.08 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.787 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.518 HD21 HD12 ' B' ' 54' ' ' ILE . 13.8 tp -124.75 134.77 52.69 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.106 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -135.01 123.57 23.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.392 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.4 t -126.17 122.49 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.006 0.432 . . . . 0.0 110.517 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.02 130.97 24.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.862 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.439 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 35.6 Cg_endo -65.99 135.32 40.42 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.433 2.089 . . . . 0.0 112.194 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 69.9 m -67.31 -23.87 65.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.126 0.489 . . . . 0.0 110.209 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . 0.635 ' HB3' ' OE1' ' B' ' 41' ' ' GLN . 77.8 m-20 -131.67 103.27 14.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.418 172.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.05 -23.83 21.19 Favored 'Trans proline' 0 CA--C 1.526 0.078 0 C-N-CA 123.115 2.544 . . . . 0.0 113.171 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.8 -22.88 42.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.856 0.36 . . . . 0.0 110.706 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.635 ' OE1' ' HB3' ' B' ' 38' ' ' ASN . 12.5 mp0 -73.48 -20.8 60.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.741 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 49.1 mm-40 -67.55 -32.12 72.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.678 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.57 -43.21 15.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.855 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -94.96 77.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 11.3 p -91.35 78.63 5.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.245 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.97 -5.56 58.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 166.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.1 p -102.32 135.8 19.53 Favored Pre-proline 0 N--CA 1.445 -0.695 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.9 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.45 149.55 50.4 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.246 1.964 . . . . 0.0 111.913 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 36.3 mt -91.49 123.54 34.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.45 ' O ' HD12 ' B' ' 52' ' ' LEU . 64.8 mt -96.6 124.86 49.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 59' ' ' ASN . 76.4 Cg_endo -78.36 136.27 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.117 1.878 . . . . 0.0 111.129 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.3 mp -129.95 133.16 46.63 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.055 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -109.78 116.03 30.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.341 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.664 HG12 HG12 ' A' ' 54' ' ' ILE . 30.8 mt -106.52 120.86 58.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.226 0.536 . . . . 0.0 110.508 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -106.25 137.13 44.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.598 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.949 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -85.53 135.17 25.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 0.0 110.607 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.41 157.39 18.3 Favored Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.034 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.04 116.22 27.16 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 17.3 t-20 -84.86 66.94 9.95 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 2.8 m -76.19 -34.58 59.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.23 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.75 156.35 18.73 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.598 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.551 -0.738 . . . . 0.0 110.712 179.253 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.74 86.57 0.65 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.839 0.352 . . . . 0.0 111.732 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ttt 65.45 41.69 4.11 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.077 169.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER -101.61 20.28 16.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.033 0.92 . . . . 0.0 109.642 172.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 13.1 ptp -98.13 141.34 22.8 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.006 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 86.1 Cg_exo -49.16 131.36 26.22 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 123.593 2.862 . . . . 0.0 113.14 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -117.74 138.38 52.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -124.69 142.34 51.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.647 175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.13 125.02 40.47 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.162 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.94 158.07 44.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.02 127.59 51.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.897 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB2' HG11 ' B' ' 22' ' ' VAL . 57.7 mt -122.61 140.73 52.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.299 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.41 126.93 30.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.32 99.65 0.3 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.453 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -0.58 17.93 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.817 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -96.5 155.53 16.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.769 0.318 . . . . 0.0 110.645 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.599 ' HB ' ' OG ' ' A' ' 37' ' ' SER . 6.9 m -98.19 136.9 37.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.389 0.614 . . . . 0.0 110.565 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 34' ' ' VAL . 96.5 m-85 -129.3 153.22 48.04 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.411 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.683 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m80 -95.29 117.16 29.79 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.605 172.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.01 119.53 39.62 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.463 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.62 125.72 64.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.91 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' B' ' 12' ' ' LEU . 14.8 p -112.19 132.52 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 24.2 t0 -135.91 169.87 16.9 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.59 133.48 46.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.74 0.305 . . . . 0.0 110.831 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -179.46 7.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -58.48 -30.87 67.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 59.3 mt -82.23 -22.23 35.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.413 . . . . 0.0 111.204 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.0 19.22 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.282 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.605 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 29.5 m-80 -88.33 136.99 31.06 Favored Pre-proline 0 CA--C 1.511 -0.53 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.525 ' HG3' HG11 ' A' ' 56' ' ' VAL . 1.1 Cg_endo -80.47 144.27 15.88 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.858 2.372 . . . . 0.0 111.681 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.7 t -127.88 140.18 52.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.574 HD21 HD12 ' A' ' 54' ' ' ILE . 14.4 tp -115.77 132.14 56.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.43 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -130.6 120.4 23.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.133 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.4 t -127.0 122.2 59.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.96 131.04 23.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.89 139.76 69.75 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.347 2.031 . . . . 0.0 111.811 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 17' ' ' THR . 12.7 p -67.38 -29.86 69.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.345 0.593 . . . . 0.0 110.5 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.08 102.72 4.81 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.457 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.41 -15.03 44.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.162 2.575 . . . . 0.0 112.707 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -66.19 -35.65 81.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.112 0.482 . . . . 0.0 109.709 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -74.83 -22.2 58.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.043 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -70.13 -43.71 70.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.673 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.566 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.8 pt20 -78.38 -33.89 48.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.746 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 22.7 mt -102.11 56.3 0.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 p -74.79 96.76 3.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.157 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -82.84 -18.49 40.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.07 137.89 19.61 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.532 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.33 157.68 52.96 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.972 2.448 . . . . 0.0 112.843 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.8 mt -85.26 124.46 31.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.693 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.473 ' O ' HD12 ' A' ' 52' ' ' LEU . 70.6 mt -96.21 126.88 42.48 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -75.58 135.54 18.16 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.146 1.898 . . . . 0.0 111.599 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.9 mp -134.87 131.1 36.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.379 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 m -110.9 119.05 37.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' B' ' 54' ' ' ILE . 30.0 mt -107.04 125.73 63.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.939 0.4 . . . . 0.0 110.711 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -108.56 137.47 46.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.234 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 5' ' ' MET . 40.3 t -93.58 119.44 41.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.629 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.52 170.67 15.88 Favored Glycine 0 N--CA 1.433 -1.56 0 C-N-CA 118.853 -1.641 . . . . 0.0 114.275 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 60' ' ' THR . 33.0 mt-10 -70.18 -39.72 75.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.302 -169.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 71.13 -26.53 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 58' ' ' GLU . 21.0 m 83.87 -16.9 0.51 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.925 0.89 . . . . 0.0 111.065 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.36 64.51 4.25 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.557 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.704 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.1 86.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.546 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 25.7 ttt 65.43 41.39 4.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.233 169.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' B' ' 4' ' ' GLU . 0.8 OUTLIER -101.37 19.76 17.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.995 0.902 . . . . 0.0 109.647 172.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.572 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 13.5 ptp -97.78 141.74 23.47 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.984 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.4 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 90.1 Cg_exo -49.39 131.13 26.83 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -117.72 138.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.284 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.38 142.32 51.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.684 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -127.26 125.22 40.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.912 0.387 . . . . 0.0 110.143 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.88 158.08 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.818 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.12 127.65 51.8 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 22' ' ' VAL . 57.5 mt -122.75 140.72 52.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.451 -174.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -71.45 126.9 30.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.36 99.54 0.29 Allowed Glycine 0 C--O 1.228 -0.237 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.502 -176.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.19 0.58 18.99 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.797 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -97.2 155.66 16.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.34 . . . . 0.0 110.585 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.588 ' HB ' ' OG ' ' B' ' 37' ' ' SER . 7.1 m -98.21 136.76 37.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.461 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' B' ' 34' ' ' VAL . 96.4 m-85 -129.33 153.33 47.95 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.319 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.68 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.3 m80 -95.26 117.65 30.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.312 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -107.43 119.76 40.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.292 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 7.6 mt -128.77 125.64 63.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.945 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 12' ' ' LEU . 14.8 p -112.22 132.32 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 23.4 t0 -135.87 170.23 16.32 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.87 133.51 45.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.93 -179.73 7.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.254 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.9 m -58.33 -31.02 67.17 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.609 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 58.2 mt -81.92 -22.5 36.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.94 0.4 . . . . 0.0 111.116 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.22 18.89 9.89 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.263 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 29.0 m-80 -87.8 137.29 31.85 Favored Pre-proline 0 CA--C 1.513 -0.475 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.53 ' HG3' HG11 ' B' ' 56' ' ' VAL . 1.1 Cg_endo -80.48 144.66 16.13 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.757 2.304 . . . . 0.0 111.614 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.1 t -128.41 140.27 51.93 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.565 HD21 HD12 ' B' ' 54' ' ' ILE . 14.6 tp -116.28 131.42 56.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.907 0.384 . . . . 0.0 110.438 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 21.3 m -130.15 120.21 24.21 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.944 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.8 t -126.64 122.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.518 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 131.03 23.66 Favored Pre-proline 0 C--O 1.223 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.708 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.79 139.46 68.82 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.376 2.051 . . . . 0.0 111.769 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' B' ' 17' ' ' THR . 12.4 p -67.15 -30.08 69.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.472 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -143.87 103.05 4.87 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.84 -15.09 43.31 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.109 2.539 . . . . 0.0 112.632 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -66.15 -35.47 80.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.177 0.513 . . . . 0.0 109.76 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -74.65 -22.44 58.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.198 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -69.85 -44.05 70.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.573 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.8 pt20 -78.14 -33.59 50.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.573 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 23.3 mt -102.37 56.22 0.79 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.319 0.58 . . . . 0.0 109.582 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -74.69 96.21 2.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.392 -173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.13 -18.47 42.77 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.23 138.14 19.64 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.457 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.47 157.65 52.56 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.914 2.409 . . . . 0.0 112.963 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 33.3 mt -85.04 124.56 31.87 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.742 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.475 ' O ' HD12 ' B' ' 52' ' ' LEU . 70.9 mt -96.27 127.0 41.92 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -75.49 135.62 18.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.06 1.84 . . . . 0.0 111.559 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 50' ' ' ILE . 4.9 mp -134.85 131.19 37.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 m -111.2 118.9 37.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.659 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.791 HG12 HG12 ' A' ' 54' ' ' ILE . 29.7 mt -106.93 125.73 62.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 120.962 0.411 . . . . 0.0 110.696 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -108.72 137.27 46.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.297 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' B' ' 5' ' ' MET . 39.5 t -93.35 119.64 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.401 175.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.3 171.11 16.1 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 118.77 -1.681 . . . . 0.0 114.37 169.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' B' ' 60' ' ' THR . 33.7 mt-10 -70.63 -40.01 73.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.719 -0.741 . . . . 0.0 112.184 -169.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 71.38 -26.6 0.17 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . 0.454 ' H ' ' C ' ' B' ' 58' ' ' GLU . 23.7 m 83.65 -16.61 0.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.972 0.909 . . . . 0.0 111.13 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 64.51 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.347 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.462 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.72 -89.95 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.055 0.542 . . . . 0.0 111.676 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -96.88 -25.59 15.38 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.111 0.482 . . . . 0.0 110.397 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -107.12 103.18 12.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.447 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.408 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 17.2 ptp -120.53 133.29 24.02 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.167 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.84 131.66 43.27 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.977 2.451 . . . . 0.0 111.639 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 m -112.13 136.82 51.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -115.1 139.81 49.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.11 123.37 36.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.98 158.63 43.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.525 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.12 129.38 50.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.816 0.341 . . . . 0.0 110.494 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD11 HD21 ' B' ' 20' ' ' LEU . 57.7 mt -119.98 146.29 45.98 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.32 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.562 ' HE1' ' HB3' ' A' ' 45' ' ' SER . 20.0 m-70 -70.77 127.35 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.001 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.55 112.03 3.97 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.171 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.24 3.98 56.5 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.422 -0.418 . . . . 0.0 113.125 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.4 156.66 17.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.965 0.412 . . . . 0.0 110.948 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -96.39 138.53 33.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.086 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -129.31 154.46 46.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.716 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.5 m80 -95.84 117.67 31.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.639 173.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 HD11 ' B' ' 12' ' ' LEU . 8.4 tp -108.85 120.83 43.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.37 -176.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 10.5 mt -129.22 126.52 64.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.914 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.29 133.76 60.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -142.28 169.77 16.97 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 132.79 55.77 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 112.369 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.5 160.08 32.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.7 173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.0 t -61.03 -24.56 66.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.96 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.1 mt -83.53 -12.38 56.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.441 . . . . 0.0 110.41 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.29 13.63 26.18 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.861 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.575 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 55.7 m-80 -85.65 129.34 55.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.56 148.74 42.82 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.962 . . . . 0.0 111.896 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -130.4 143.25 50.65 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.18 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.578 HD21 HD12 ' A' ' 54' ' ' ILE . 17.9 tp -124.29 133.33 53.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.635 -176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 15.7 m -131.96 120.82 23.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.5 t -127.77 122.11 58.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.953 0.406 . . . . 0.0 110.268 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -121.78 133.15 24.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.62 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.82 137.14 66.16 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.307 2.005 . . . . 0.0 111.702 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.7 t -65.9 -23.65 66.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.51 . . . . 0.0 109.87 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -143.38 107.14 5.17 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.346 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.64 -18.59 64.89 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.073 2.515 . . . . 0.0 113.166 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.55 -22.72 43.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.632 0.253 . . . . 0.0 110.77 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -68.37 -25.08 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.136 0.493 . . . . 0.0 110.124 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.57 -32.98 72.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.345 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -79.57 -43.02 23.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.01 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -92.64 63.87 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.562 ' HB3' ' HE1' ' A' ' 13' ' ' HIS . 5.4 p -82.77 73.02 9.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.38 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.82 2.32 53.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 168.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.15 131.0 23.12 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.042 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.23 144.61 69.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.31 2.006 . . . . 0.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 mt -87.25 129.79 34.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.081 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 52' ' ' LEU . 68.5 mt -104.91 122.25 43.9 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 168.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HG3' ' H ' ' B' ' 59' ' ' ASN . 73.0 Cg_endo -77.24 137.34 16.88 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.397 2.065 . . . . 0.0 111.557 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -129.21 136.6 50.34 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.082 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 m -111.29 116.82 31.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.844 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' B' ' 54' ' ' ILE . 38.6 mt -107.66 127.07 63.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.21 0.528 . . . . 0.0 110.949 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 66.2 m-85 -112.35 141.41 46.11 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.738 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.0 141.41 14.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.935 0.398 . . . . 0.0 110.021 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.92 159.54 13.68 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.033 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.63 54.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 109.979 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.6 ' H ' ' HG3' ' B' ' 51' ' ' PRO . 9.0 t30 60.74 81.72 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.96 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.8 p -115.14 6.28 15.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.7 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.68 -32.65 57.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.767 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.504 HG23 HD21 ' A' ' 59' ' ' ASN . 8.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.981 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.178 -0.369 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.1 -90.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.698 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -96.79 -24.97 15.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.033 0.444 . . . . 0.0 110.494 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -107.7 102.96 12.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.576 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 17.4 ptp -120.56 133.02 23.98 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.61 132.21 46.88 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.844 2.363 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -112.86 136.85 52.03 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.991 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -115.21 140.09 49.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -127.54 122.87 34.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.59 158.46 43.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.538 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.0 129.19 50.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.956 0.408 . . . . 0.0 110.585 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 20' ' ' LEU . 57.6 mt -119.85 146.25 45.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.465 -173.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.56 ' HE1' ' HB3' ' B' ' 45' ' ' SER . 19.7 m-70 -70.92 127.54 32.93 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.89 112.11 4.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.032 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.2 4.32 56.46 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.01 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.75 156.35 17.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.949 0.404 . . . . 0.0 110.849 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 15.3 m -95.97 138.65 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.128 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -129.43 154.19 47.19 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.737 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.623 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.5 m80 -95.59 117.73 30.99 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 12' ' ' LEU . 8.2 tp -108.99 120.86 43.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.344 -176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 10.4 mt -129.23 126.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.986 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.23 133.59 61.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.51 169.5 17.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.44 132.6 55.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.76 0.791 . . . . 0.0 112.526 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.97 160.23 32.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.751 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 t -61.44 -23.83 66.11 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.082 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.594 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 52.1 mt -84.04 -12.43 55.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.411 . . . . 0.0 110.541 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.33 13.75 25.8 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.985 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 52.9 m-80 -85.95 129.37 54.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 110.334 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.59 148.72 42.66 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.253 1.969 . . . . 0.0 111.917 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 7.8 t -130.59 142.96 50.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.244 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 18.0 tp -123.96 133.56 53.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.901 0.381 . . . . 0.0 110.497 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.5 m -132.26 120.5 22.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.942 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.9 t -127.32 122.37 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.978 0.418 . . . . 0.0 110.244 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.63 133.21 24.18 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.766 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.11 137.6 67.57 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.149 1.9 . . . . 0.0 111.667 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -66.16 -23.46 66.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.232 0.539 . . . . 0.0 109.876 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' B' ' 39' ' ' PRO . 27.8 t-20 -143.62 106.88 5.06 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.404 174.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' B' ' 38' ' ' ASN . 28.8 Cg_endo -63.63 -18.64 65.15 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.174 2.583 . . . . 0.0 113.087 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.48 -22.6 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.704 0.287 . . . . 0.0 110.852 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -68.39 -25.44 65.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.23 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.45 -32.71 71.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.398 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -79.69 -43.11 23.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.272 0.558 . . . . 0.0 110.042 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 45.8 mt -92.38 63.62 4.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.063 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . 0.56 ' HB3' ' HE1' ' B' ' 13' ' ' HIS . 4.9 p -82.69 72.54 9.77 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.28 2.11 53.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.95 131.73 22.41 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.992 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.48 144.41 67.04 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.478 2.119 . . . . 0.0 112.142 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 43.0 mt -87.41 129.79 34.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.425 ' O ' HD12 ' B' ' 52' ' ' LEU . 68.9 mt -104.89 122.3 43.76 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 168.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.6 ' HG3' ' H ' ' A' ' 59' ' ' ASN . 72.4 Cg_endo -77.11 137.32 17.11 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.461 2.107 . . . . 0.0 111.599 175.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.425 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -129.4 136.32 49.81 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.814 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.8 m -110.94 116.64 31.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.834 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.774 HG12 HG12 ' A' ' 54' ' ' ILE . 39.5 mt -107.53 127.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.209 0.528 . . . . 0.0 111.096 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.404 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 65.0 m-85 -112.35 141.34 46.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.699 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.07 141.74 14.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.587 -0.445 . . . . 0.0 109.845 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.404 ' C ' ' HG2' ' A' ' 51' ' ' PRO . . . -114.93 159.19 13.87 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.03 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -116.68 55.32 0.82 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.412 0.625 . . . . 0.0 110.001 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.613 ' H ' ' HG3' ' A' ' 51' ' ' PRO . 8.8 t30 60.02 81.54 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.057 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 17.3 p -115.17 6.5 15.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.25 -32.89 55.06 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.718 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.499 HG23 HD21 ' B' ' 59' ' ' ASN . 6.9 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.218 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.95 64.03 1.55 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -66.9 0.87 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.98 -172.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.23 58.2 1.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.604 . . . . 0.0 110.277 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.466 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 16.0 ptm -88.97 114.63 60.88 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.372 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.838 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 20.1 Cg_endo -59.9 140.4 92.82 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 112.353 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 m -115.75 136.46 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.168 -175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.69 147.0 45.09 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.97 124.03 30.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.5 pp -140.97 158.1 44.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.582 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.16 129.01 51.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.932 0.396 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.462 HD11 HD21 ' B' ' 20' ' ' LEU . 60.7 mt -118.36 141.44 48.53 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.585 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.539 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 29.1 m80 -71.17 127.64 33.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.196 175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.63 110.43 2.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.699 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.44 -1.12 46.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.787 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -87.88 152.27 22.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.025 0.44 . . . . 0.0 110.846 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.7 m -100.25 133.08 45.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.413 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.482 ' HB3' HG13 ' A' ' 34' ' ' VAL . 88.0 m-85 -124.19 152.88 42.36 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.1 0.476 . . . . 0.0 110.664 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.4 m170 -95.51 117.21 29.98 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 12' ' ' LEU . 11.8 tp -108.02 121.08 44.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.395 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -131.34 126.2 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.345 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.94 132.41 61.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.79 152.34 39.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.984 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 p -107.17 141.68 38.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.847 0.356 . . . . 0.0 111.23 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -79.49 -175.04 4.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.3 p -55.38 -31.65 61.98 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.54 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 54.3 mt -87.06 -20.71 26.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.981 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 16.87 14.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.289 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 42.0 m-80 -82.33 128.82 65.84 Favored Pre-proline 0 CA--C 1.511 -0.525 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' CG ' HG21 ' A' ' 56' ' ' VAL . 56.6 Cg_endo -73.02 143.13 35.74 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.44 2.093 . . . . 0.0 112.182 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.2 t -127.72 147.39 50.39 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 54' ' ' ILE . 14.5 tp -119.35 129.82 55.03 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.899 0.381 . . . . 0.0 110.844 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -127.06 119.59 26.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.755 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 75.0 t -125.62 122.47 62.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.057 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.18 131.19 24.34 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.618 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 148.51 81.01 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.78 2.32 . . . . 0.0 112.205 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 p -68.88 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.353 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 50.2 t-20 -132.99 104.41 12.7 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.526 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 24.2 Cg_endo -62.95 -25.08 74.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.842 2.361 . . . . 0.0 112.238 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -82.6 -24.46 33.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.145 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.765 ' HA ' HE21 ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.34 -24.72 61.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.118 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 49.3 mm-40 -65.76 -31.73 72.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.129 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.97 -43.1 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.4 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.06 58.94 5.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.81 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -77.48 76.43 4.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.395 0.617 . . . . 0.0 112.02 -174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.11 -15.58 61.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.079 0.942 . . . . 0.0 108.498 168.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -101.89 145.12 29.92 Favored Pre-proline 0 N--CA 1.445 -0.7 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.951 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.52 159.73 32.13 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 111.765 175.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 60.4 mt -94.55 131.59 40.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.137 0.494 . . . . 0.0 111.013 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 52' ' ' LEU . 69.8 mt -99.54 124.05 45.86 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 168.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 57.8 Cg_endo -74.7 137.47 22.5 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.194 1.929 . . . . 0.0 111.391 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -133.48 131.9 40.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 m -109.64 117.5 34.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.493 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' B' ' 54' ' ' ILE . 24.5 mt -107.03 123.33 62.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.341 0.591 . . . . 0.0 110.686 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -106.67 137.88 43.87 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.663 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.838 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.7 t -83.66 133.11 29.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.452 . . . . 0.0 109.881 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -81.31 122.47 5.71 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.644 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.06 95.62 3.08 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.061 0.934 . . . . 0.0 110.413 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -54.49 110.0 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.948 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 t -137.74 165.89 25.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.71 77.44 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.333 -0.842 . . . . 0.0 110.284 -178.68 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.31 63.9 1.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.6 mmm -97.09 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.02 -172.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.9 57.69 1.77 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.303 0.573 . . . . 0.0 110.12 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.463 ' HA ' ' HD2' ' B' ' 6' ' ' PRO . 15.7 ptm -88.39 114.44 59.63 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.442 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.863 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 19.9 Cg_endo -59.72 140.67 94.57 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.378 2.719 . . . . 0.0 112.247 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.08 136.03 53.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.234 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.32 147.13 44.65 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -131.06 124.09 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.5 pp -140.78 158.27 44.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.555 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.41 128.82 51.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 20' ' ' LEU . 60.8 mt -118.43 141.46 48.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.674 -173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 29.4 m80 -71.07 127.39 32.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.309 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.78 110.94 3.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.544 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.96 -2.59 44.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.715 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -86.96 152.37 22.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.93 0.395 . . . . 0.0 110.925 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -100.59 132.98 45.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.463 175.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.503 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.5 m-85 -123.84 152.85 41.84 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.152 0.501 . . . . 0.0 110.644 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.628 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.4 m170 -95.66 117.12 29.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 12' ' ' LEU . 11.6 tp -108.13 121.1 44.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.438 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.14 126.05 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.316 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 p -112.62 132.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.51 152.27 39.49 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -107.18 141.85 37.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -79.57 -175.21 4.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.34 178.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 48.4 p -55.31 -31.74 61.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.542 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 54.8 mt -86.71 -21.27 26.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 16.8 14.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.273 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.542 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.6 m-80 -82.41 128.98 65.01 Favored Pre-proline 0 CA--C 1.51 -0.569 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' B' ' 56' ' ' VAL . 56.9 Cg_endo -73.21 143.37 35.45 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.292 1.995 . . . . 0.0 112.221 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 32.8 t -127.69 147.29 50.38 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.43 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.571 HD21 HD12 ' B' ' 54' ' ' ILE . 14.4 tp -119.2 130.03 55.27 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.855 0.36 . . . . 0.0 110.753 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -127.37 119.63 26.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.843 176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.1 t -125.78 122.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.034 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -123.26 131.01 24.34 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.682 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.15 148.76 81.48 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.76 2.307 . . . . 0.0 112.335 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.5 p -69.4 -27.16 65.04 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.321 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -133.64 104.32 12.03 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.491 177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.95 -25.57 74.13 Favored 'Trans proline' 0 C--N 1.34 0.101 0 C-N-CA 122.748 2.299 . . . . 0.0 112.122 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.92 -24.61 35.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.757 ' HA ' HE21 ' B' ' 41' ' ' GLN . 0.0 OUTLIER -72.08 -24.72 61.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.146 -179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.523 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 50.0 mm-40 -65.85 -32.06 73.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.903 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -81.44 -43.06 19.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.538 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.8 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.3 p -77.56 76.32 4.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.326 0.584 . . . . 0.0 111.989 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.78 -15.92 61.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -101.62 145.06 29.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.855 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.42 159.66 32.52 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.611 2.207 . . . . 0.0 111.653 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.474 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.3 mt -94.15 131.53 39.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.004 0.43 . . . . 0.0 111.134 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.434 ' O ' HD12 ' B' ' 52' ' ' LEU . 69.2 mt -99.49 124.11 45.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 168.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.565 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 57.4 Cg_endo -74.79 137.46 22.25 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.237 1.958 . . . . 0.0 111.406 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.4 mp -133.38 132.22 40.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.907 177.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -109.91 117.42 33.76 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 54' ' ' ILE . 24.3 mt -106.9 123.37 61.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.18 0.514 . . . . 0.0 110.702 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -106.69 137.95 43.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.553 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.863 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.7 t -83.55 133.34 29.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.912 0.387 . . . . 0.0 109.992 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -81.41 121.98 5.57 Favored Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.606 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -74.71 94.94 2.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.875 0.845 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -54.09 109.92 0.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.841 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -137.51 166.28 24.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.439 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 143.52 77.97 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.274 -177.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 111.846 -0.501 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.59 48.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.017 0.437 . . . . 0.0 111.114 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.0 mtp -87.7 -58.97 2.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.479 . . . . 0.0 109.722 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.87 82.02 2.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 16.9 ptm -78.39 128.51 77.65 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.27 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.731 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 32.7 Cg_endo -64.69 134.76 42.17 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.356 2.704 . . . . 0.0 112.251 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 m -116.63 134.72 54.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.232 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -115.3 140.42 49.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.905 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -125.61 123.71 39.61 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 1.7 pp -141.11 158.15 44.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.688 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -121.74 128.6 51.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 110.44 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' B' ' 20' ' ' LEU . 58.0 mt -120.62 141.23 50.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.536 -174.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 36.5 m80 -70.91 132.96 46.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.378 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.71 110.93 3.31 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.737 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.9 58.24 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.552 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -89.56 144.17 26.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 37' ' ' SER . 12.2 m -93.74 137.32 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.017 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.468 ' HB3' HG13 ' A' ' 34' ' ' VAL . 85.9 m-85 -129.75 154.64 46.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.375 0.607 . . . . 0.0 110.802 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.678 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 3.1 m170 -95.26 117.41 30.23 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.071 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 32' ' ' LEU . 11.8 tp -108.74 121.4 44.97 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.173 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 11.2 mt -131.3 126.59 58.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -116.07 133.56 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -142.99 170.02 16.48 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -124.18 141.53 51.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.7 0.286 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.26 -176.13 6.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.721 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -65.88 -30.43 71.03 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.057 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 61.1 mt -76.28 -23.97 54.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 0.0 111.305 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.41 20.42 9.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.436 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 40.2 m-80 -94.73 135.95 23.43 Favored Pre-proline 0 CA--C 1.509 -0.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' CB ' HG21 ' A' ' 56' ' ' VAL . 72.2 Cg_endo -76.27 147.67 29.63 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.542 2.161 . . . . 0.0 112.09 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -126.52 140.04 52.76 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 54' ' ' ILE . 10.9 tp -122.44 122.32 38.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.037 0.446 . . . . 0.0 110.507 -175.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 16.7 m -116.86 119.18 34.59 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.913 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 77.8 t -123.86 122.17 63.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.996 0.427 . . . . 0.0 110.174 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.9 131.27 23.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.1 Cg_endo -61.22 133.51 47.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.168 1.912 . . . . 0.0 111.922 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 17' ' ' THR . 8.7 t -70.62 -37.07 73.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -107.81 101.18 39.26 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.65 -29.4 29.82 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.522 2.148 . . . . 0.0 111.926 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.6 -23.42 56.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.781 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.27 -28.63 66.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 15.2 mm-40 -69.67 -21.75 63.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.156 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -87.55 -42.25 12.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.987 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 mt -88.0 43.49 1.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.697 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 m -74.4 87.42 2.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.37 0.605 . . . . 0.0 112.16 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -92.61 -1.62 56.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.81 142.39 24.5 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.48 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.12 152.3 50.67 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.464 2.109 . . . . 0.0 112.158 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 29.9 mt -92.49 120.63 33.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.713 176.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.2 mt -93.06 123.62 60.52 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 172.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.01 136.37 16.38 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.269 1.979 . . . . 0.0 111.521 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.3 mp -129.32 133.55 47.49 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.989 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.6 m -109.42 115.67 30.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.74 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' B' ' 54' ' ' ILE . 28.5 mt -107.6 125.21 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.187 0.518 . . . . 0.0 110.715 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -108.64 132.84 53.5 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.731 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 2.2 t -84.85 136.91 21.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.071 0.462 . . . . 0.0 110.661 175.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.48 168.61 15.65 Favored Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.889 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -137.05 41.0 2.49 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.06 0.933 . . . . 0.0 109.032 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -127.64 123.15 34.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.468 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.7 m -147.55 84.07 1.55 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.365 0.602 . . . . 0.0 109.575 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.47 -55.26 0.51 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.77 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.595 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.179 -0.368 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.35 48.57 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.093 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.0 mtp -87.12 -59.93 2.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.09 82.46 2.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 17.0 ptm -78.98 128.34 76.75 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.235 -174.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.729 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 34.4 Cg_endo -64.54 134.43 41.25 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.241 2.628 . . . . 0.0 112.256 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 m -116.44 134.92 54.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -115.39 140.56 49.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.926 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -125.98 123.68 39.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.511 HD22 HG21 ' B' ' 34' ' ' VAL . 1.7 pp -141.21 158.35 44.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.729 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.1 128.33 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.861 0.362 . . . . 0.0 110.534 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 20' ' ' LEU . 58.1 mt -120.38 141.22 50.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.585 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 36.4 m80 -70.68 132.64 45.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.422 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.16 110.71 3.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.686 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.07 -0.43 58.89 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.522 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -89.68 144.22 26.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 37' ' ' SER . 14.3 m -93.8 137.12 33.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.996 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.459 ' HB3' HG13 ' B' ' 34' ' ' VAL . 85.5 m-85 -129.67 154.46 47.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.235 0.541 . . . . 0.0 110.572 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.67 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 3.1 m170 -95.09 117.27 29.91 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.118 172.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.532 HD11 HD11 ' B' ' 32' ' ' LEU . 11.6 tp -108.54 121.36 44.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.251 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 11.3 mt -131.39 126.29 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.86 133.56 61.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -143.0 170.19 16.16 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.855 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.6 p -124.16 141.63 51.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.661 0.267 . . . . 0.0 110.948 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -175.57 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t -66.54 -30.56 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.943 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.472 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 64.6 mt -76.11 -23.66 54.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.607 0.242 . . . . 0.0 111.162 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 20.27 9.2 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.278 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 41.2 m-80 -94.68 135.75 23.65 Favored Pre-proline 0 CA--C 1.511 -0.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.521 ' CB ' HG21 ' B' ' 56' ' ' VAL . 71.7 Cg_endo -75.98 147.87 30.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.472 2.114 . . . . 0.0 112.178 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.7 t -126.81 139.91 52.76 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.569 HD21 HD12 ' B' ' 54' ' ' ILE . 11.1 tp -122.44 122.12 38.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.208 0.527 . . . . 0.0 110.609 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 15.9 m -116.42 119.26 35.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.904 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 78.1 t -124.14 121.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 110.234 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.83 131.1 23.74 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.377 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.495 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.4 Cg_endo -61.38 133.27 45.22 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.229 1.953 . . . . 0.0 112.007 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.473 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 8.7 t -70.13 -37.01 75.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -107.98 101.34 40.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.84 -29.1 29.08 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.447 2.098 . . . . 0.0 112.121 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -75.73 -23.43 56.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.841 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -69.46 -28.38 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.398 0.618 . . . . 0.0 110.182 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.495 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 15.9 mm-40 -69.76 -21.71 63.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.148 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -87.63 -42.41 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.262 0.553 . . . . 0.0 110.003 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 16.1 mt -87.56 43.1 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.823 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -74.13 87.84 1.92 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.461 0.648 . . . . 0.0 112.072 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.26 -1.46 56.09 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.3 p -101.74 142.36 24.44 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.663 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.02 152.24 51.11 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.509 2.139 . . . . 0.0 112.135 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 30.7 mt -92.47 120.82 33.33 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.761 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.454 ' O ' HD12 ' B' ' 52' ' ' LEU . 78.0 mt -93.15 123.86 59.66 Favored Pre-proline 0 C--N 1.314 -0.949 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.21 136.13 15.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.289 1.993 . . . . 0.0 111.651 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.3 mp -129.14 133.28 47.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.959 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.8 m -109.25 115.76 30.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.678 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.641 HG12 HG12 ' A' ' 54' ' ' ILE . 27.4 mt -107.74 125.05 64.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.12 0.486 . . . . 0.0 110.767 -176.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -108.45 132.8 53.42 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.848 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.729 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 2.2 t -84.82 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 0.0 110.594 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.52 168.86 15.67 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.927 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.48 41.45 2.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.919 0.866 . . . . 0.0 109.046 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -127.69 123.55 35.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.37 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 27.1 m -147.98 83.64 1.51 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.556 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.92 -54.21 0.55 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.678 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.744 -179.619 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.64 69.4 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptp -168.96 155.59 6.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.273 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.94 97.17 7.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.255 0.55 . . . . 0.0 109.947 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.547 ' SD ' ' HB3' ' A' ' 55' ' ' PHE . 21.3 ptp -74.23 142.68 79.02 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.761 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 21.7 Cg_endo -60.27 132.01 41.71 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.052 2.501 . . . . 0.0 111.809 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -114.24 141.28 47.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.673 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -121.69 148.81 44.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.697 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.43 125.03 26.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.4 pp -141.17 158.07 44.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.166 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.29 127.36 53.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.295 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.02 140.14 53.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.567 -175.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 16' ' ' GLN . 34.7 m80 -71.71 133.06 45.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.302 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.74 110.93 3.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.848 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.99 -0.83 47.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.931 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HG3' ' HB2' ' A' ' 13' ' ' HIS . 16.4 mm100 -95.46 143.4 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.978 0.418 . . . . 0.0 110.911 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -87.97 136.25 33.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -129.07 153.91 47.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.684 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 1.9 m80 -95.74 117.64 30.9 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.602 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 32' ' ' LEU . 9.1 tp -108.39 120.84 43.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.317 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.13 125.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.79 133.65 63.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -141.08 170.1 16.37 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p -123.56 136.63 54.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.101 0.477 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.37 168.7 19.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.765 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 p -54.77 -30.65 57.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.3 mt -73.89 -13.6 60.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.233 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.6 1.07 62.25 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.577 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER -75.78 133.58 73.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HG3' HG21 ' A' ' 56' ' ' VAL . 91.7 Cg_endo -80.15 152.77 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.822 2.348 . . . . 0.0 112.322 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -133.97 140.2 46.58 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.528 HD21 HD12 ' A' ' 54' ' ' ILE . 13.4 tp -124.78 125.84 44.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.7 m -124.13 120.62 32.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.03 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.9 t -125.49 122.51 62.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.81 0.338 . . . . 0.0 110.708 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.17 129.07 24.01 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.155 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.68 136.27 57.19 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.539 2.159 . . . . 0.0 112.332 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 73.1 m -70.48 -25.56 63.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.191 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -134.69 103.6 11.05 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.72 -21.16 29.41 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -75.93 -35.73 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.469 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -73.39 -23.14 60.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 110.331 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' CD ' ' HD1' ' A' ' 13' ' ' HIS . 27.3 mm-40 -69.97 -41.55 74.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.57 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -73.55 -42.94 61.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.272 0.558 . . . . 0.0 109.943 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 mt -99.9 71.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' NE2' ' A' ' 13' ' ' HIS . 1.1 m -67.94 -66.24 0.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.222 -167.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 44.72 25.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.783 0.801 . . . . 0.0 111.729 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -136.73 138.48 26.41 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.909 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.64 143.6 62.88 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.181 1.92 . . . . 0.0 111.822 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.8 mt -90.11 119.46 30.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.071 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.1 mt -87.28 125.71 64.93 Favored Pre-proline 0 C--N 1.311 -1.072 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 43.5 Cg_endo -73.84 136.68 23.37 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.826 1.684 . . . . 0.0 110.558 172.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 10' ' ' LEU . 4.8 mp -134.39 131.78 38.63 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 110.384 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.3 m -111.32 117.65 33.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.626 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' B' ' 54' ' ' ILE . 24.9 mt -107.24 123.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.185 0.517 . . . . 0.0 110.764 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.547 ' HB3' ' SD ' ' A' ' 5' ' ' MET . 70.4 m-85 -107.68 138.42 43.94 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.015 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.696 ' HB ' ' HG2' ' A' ' 6' ' ' PRO . 1.6 t -84.09 130.42 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.167 0.508 . . . . 0.0 109.951 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -71.37 122.82 9.84 Favored Glycine 0 N--CA 1.433 -1.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.806 -174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.84 -41.6 87.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.161 0.505 . . . . 0.0 110.958 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -170.41 117.97 0.54 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 49.3 m -149.65 81.66 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.62 138.51 18.34 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.464 -176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.99 179.335 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.49 70.28 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.717 0.294 . . . . 0.0 111.742 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 22.1 ptp -169.74 154.94 5.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.166 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.67 97.84 8.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.093 0.473 . . . . 0.0 109.929 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' B' ' 55' ' ' PHE . 21.2 ptp -74.81 142.57 76.98 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.833 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.714 ' HG2' ' HB ' ' B' ' 56' ' ' VAL . 22.3 Cg_endo -60.01 131.93 41.97 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.922 2.414 . . . . 0.0 111.761 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 m -114.36 141.88 47.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.555 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.98 148.9 44.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.74 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -134.48 125.07 26.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.11 158.06 44.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.22 127.4 53.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.554 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -123.0 140.14 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.436 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.497 ' HB2' ' HG3' ' B' ' 16' ' ' GLN . 34.5 m80 -71.79 133.07 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.297 176.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.49 110.88 3.41 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.858 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.58 -0.49 49.43 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.329 -0.463 . . . . 0.0 113.077 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.497 ' HG3' ' HB2' ' B' ' 13' ' ' HIS . 16.6 mm100 -95.58 143.42 26.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 111.006 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 4.1 m -87.82 136.33 33.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.516 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.402 ' HB3' HG13 ' B' ' 34' ' ' VAL . 88.1 m-85 -128.92 153.93 47.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.672 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 1.9 m80 -95.76 117.78 31.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.47 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.456 HD11 HD11 ' B' ' 32' ' ' LEU . 9.0 tp -108.5 120.8 43.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.417 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.09 125.91 60.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.18 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.75 133.67 63.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -140.96 169.91 16.74 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 50' ' ' ILE . 1.3 p -122.93 137.03 55.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.21 0.528 . . . . 0.0 111.46 -178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.67 168.85 18.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.804 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -54.81 -30.89 58.3 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -73.51 -14.3 61.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.005 0.431 . . . . 0.0 111.113 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.88 1.32 61.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.547 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.415 ' N ' HD22 ' B' ' 29' ' ' ASN . 0.9 OUTLIER -76.15 133.15 72.37 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.442 ' HG3' HG21 ' B' ' 56' ' ' VAL . 93.0 Cg_endo -79.91 152.79 22.16 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.793 2.329 . . . . 0.0 112.284 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 27.7 t -134.06 140.32 46.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.537 HD21 HD12 ' B' ' 54' ' ' ILE . 13.5 tp -125.09 125.89 44.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 -173.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 16.5 m -124.17 120.46 32.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.207 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 72.3 t -125.38 122.36 62.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 0.0 110.646 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.08 128.69 24.1 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.404 -176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.69 135.67 53.81 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.55 2.166 . . . . 0.0 112.398 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 72.5 m -70.31 -25.23 63.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.141 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -134.78 103.72 10.94 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.09 -20.62 28.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.726 2.284 . . . . 0.0 112.843 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -76.25 -35.88 58.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.4 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.42 -23.01 60.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.094 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.418 ' CD ' ' HD1' ' B' ' 13' ' ' HIS . 27.6 mm-40 -70.05 -41.16 74.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.607 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.06 -42.88 59.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.142 0.496 . . . . 0.0 109.967 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.77 70.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' B' ' 13' ' ' HIS . 1.1 m -67.71 -66.49 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.155 -167.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.97 25.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.824 0.821 . . . . 0.0 111.48 -171.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -136.71 138.51 26.52 Favored Pre-proline 0 N--CA 1.442 -0.855 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.97 178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.77 143.66 62.35 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 23.0 mt -89.95 119.79 30.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.971 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.483 ' O ' HD12 ' B' ' 52' ' ' LEU . 67.0 mt -87.55 125.67 64.53 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.616 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.0 Cg_endo -73.75 136.43 23.18 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.874 1.716 . . . . 0.0 110.716 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.514 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.8 mp -134.25 131.71 38.8 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.971 0.415 . . . . 0.0 110.496 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 5.1 m -111.4 117.32 32.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.631 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.785 HG12 HG12 ' A' ' 54' ' ' ILE . 25.6 mt -107.24 123.74 62.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 -177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' B' ' 5' ' ' MET . 71.0 m-85 -107.48 138.4 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.913 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.714 ' HB ' ' HG2' ' B' ' 6' ' ' PRO . 1.5 t -84.01 130.79 35.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.018 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.607 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -71.4 122.69 9.72 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.002 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.62 -41.78 87.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.443 -0.378 . . . . 0.0 110.994 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -170.29 116.91 0.52 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.497 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 53.8 m -148.71 81.99 1.45 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.52 138.92 19.03 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.155 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.078 178.732 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 127.72 37.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 110.734 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.9 mtm -99.84 -18.1 17.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 110.061 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -119.29 106.19 12.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -118.6 153.27 52.07 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.031 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HG2' ' HB ' ' A' ' 56' ' ' VAL . 23.1 Cg_endo -59.2 131.19 39.78 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.505 2.137 . . . . 0.0 111.595 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 m -116.88 136.84 52.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.923 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -115.49 145.14 42.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.822 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.96 123.89 29.82 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' A' ' 52' ' ' LEU . 1.6 pp -140.8 158.45 43.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.93 128.21 49.1 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HB2' HG11 ' B' ' 22' ' ' VAL . 51.8 mt -121.06 141.34 50.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.677 -173.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 42' ' ' GLU . 30.2 m80 -71.49 131.32 43.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.52 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.58 111.55 3.99 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.024 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.63 0.87 52.9 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.483 -0.389 . . . . 0.0 112.723 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -95.09 150.71 19.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.17 0.509 . . . . 0.0 111.204 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.7 m -95.03 135.3 36.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.604 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -128.55 152.89 47.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.48 0.657 . . . . 0.0 110.635 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.666 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.7 m80 -95.98 117.88 31.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.839 172.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD21 HD11 ' B' ' 12' ' ' LEU . 7.7 tp -108.78 121.36 44.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.159 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.1 mt -129.57 126.49 63.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.076 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' B' ' 12' ' ' LEU . 13.5 p -117.92 135.05 59.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 7.1 p-10 -147.54 170.88 16.5 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.32 136.24 54.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.309 0.576 . . . . 0.0 111.88 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.25 165.64 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.005 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.1 m -54.88 -31.16 59.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.548 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 71.4 mt -73.11 -17.57 61.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.706 0.289 . . . . 0.0 111.421 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.88 2.9 39.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.546 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.548 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 7.7 p30 -85.99 142.23 36.17 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.961 0.41 . . . . 0.0 110.522 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' CG ' HG21 ' A' ' 56' ' ' VAL . 44.2 Cg_endo -85.25 153.02 10.79 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.565 2.176 . . . . 0.0 112.434 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -126.24 149.9 48.77 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 54' ' ' ILE . 11.3 tp -128.67 123.86 34.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.703 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.5 m -122.0 119.47 31.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.999 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 71.8 t -124.17 122.42 64.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.072 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.76 131.34 24.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.783 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.34 136.36 50.76 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 122.331 2.02 . . . . 0.0 111.68 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.4 m -70.68 -25.18 62.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.078 0.466 . . . . 0.0 110.362 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -132.82 102.92 13.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.65 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.67 -21.31 39.25 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.797 2.331 . . . . 0.0 112.253 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -74.89 -32.71 61.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -73.65 -21.34 60.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.245 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HA ' ' CE1' ' A' ' 13' ' ' HIS . 19.0 mm-40 -69.27 -35.19 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.923 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -76.88 -43.26 36.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.046 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 mt -92.84 67.46 4.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.604 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 p -78.39 81.34 4.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.466 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -80.78 -7.85 59.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 p -102.44 137.66 19.46 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.603 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.16 156.36 46.83 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.435 2.09 . . . . 0.0 111.281 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.4 mt -87.66 138.8 31.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HD12 ' A' ' 52' ' ' LEU . 87.0 mt -108.73 124.06 35.4 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 73.5 Cg_endo -77.58 136.57 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.294 1.996 . . . . 0.0 111.675 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 50' ' ' ILE . 4.9 mp -133.93 130.09 37.24 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.344 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 m -109.21 118.63 37.23 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.564 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' B' ' 54' ' ' ILE . 37.0 mt -107.5 126.38 63.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.107 0.48 . . . . 0.0 110.777 -176.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -109.57 138.71 45.53 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.271 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' CG ' ' A' ' 30' ' ' PRO . 1.1 t -89.4 140.86 15.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.228 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' CA ' ' HG2' ' B' ' 51' ' ' PRO . . . -110.71 -171.18 19.6 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.937 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -112.39 101.19 9.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.923 0.361 . . . . 0.0 111.504 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 72.0 -52.58 0.7 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.735 0.814 . . . . 0.0 113.196 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -144.57 162.88 35.51 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 121.994 -0.441 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.76 35.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.93 -177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.447 178.76 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.71 128.04 37.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.772 0.32 . . . . 0.0 110.725 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 73.2 mtm -100.17 -19.09 16.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.982 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -118.49 106.46 12.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -119.17 153.47 53.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.865 -174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.18 131.39 40.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.631 2.22 . . . . 0.0 111.593 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 14.2 m -116.94 137.03 52.49 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -115.51 144.92 43.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.143 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.68 123.9 30.38 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.6 pp -140.64 158.57 43.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.666 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.96 128.37 49.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 50.9 mt -121.14 141.47 50.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.473 -173.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' B' ' 42' ' ' GLU . 30.0 m80 -71.45 130.98 42.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.558 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.39 111.88 4.25 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.085 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.5 1.16 53.34 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.842 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -95.64 150.62 20.16 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.18 0.514 . . . . 0.0 111.129 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -94.88 135.36 36.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.445 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -128.62 153.12 47.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.351 0.596 . . . . 0.0 110.68 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.644 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.8 m80 -96.23 117.83 31.57 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.842 172.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 12' ' ' LEU . 7.6 tp -108.56 121.51 45.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.222 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.65 126.3 62.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.095 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 12' ' ' LEU . 13.6 p -117.23 134.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' B' ' 30' ' ' PRO . 7.1 p-10 -147.44 170.97 16.26 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.12 136.83 53.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.225 0.536 . . . . 0.0 111.737 -177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.09 165.97 21.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.115 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -55.03 -30.93 60.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.558 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 71.9 mt -73.35 -17.94 61.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.828 0.347 . . . . 0.0 111.293 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 3.06 39.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.558 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 7.7 p30 -85.96 142.61 36.56 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.403 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.566 ' CG ' HG21 ' B' ' 56' ' ' VAL . 44.2 Cg_endo -85.46 153.37 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.658 2.239 . . . . 0.0 112.377 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -126.51 150.12 48.95 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.502 HD21 HD12 ' B' ' 54' ' ' ILE . 11.3 tp -128.85 123.7 33.42 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.746 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -121.96 119.24 30.92 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.144 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 69.0 t -123.99 122.67 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.903 0.382 . . . . 0.0 110.081 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.91 131.47 24.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.859 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.62 136.21 48.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.293 1.995 . . . . 0.0 111.708 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 52.0 m -70.43 -25.34 63.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.242 0.544 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -132.87 102.91 13.26 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.725 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.01 -21.04 37.54 Favored 'Trans proline' 0 CA--C 1.526 0.116 0 C-N-CA 122.583 2.189 . . . . 0.0 112.385 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -74.99 -32.72 61.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.593 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -73.71 -21.53 60.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.25 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.46 ' HA ' ' CE1' ' B' ' 13' ' ' HIS . 20.0 mm-40 -68.82 -35.68 77.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.868 173.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.57 -43.36 39.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.036 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 53.9 mt -92.75 67.42 4.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.642 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -78.32 81.17 4.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.482 -173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -80.83 -7.08 59.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.958 0.885 . . . . 0.0 108.712 167.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 5.0 p -103.11 137.72 19.34 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.437 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.24 156.1 46.53 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.454 2.103 . . . . 0.0 111.58 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 48.9 mt -87.79 138.55 31.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.94 0.4 . . . . 0.0 110.708 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.443 ' O ' HD12 ' B' ' 52' ' ' LEU . 85.3 mt -108.53 123.82 36.22 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 167.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.519 ' HG2' ' CA ' ' A' ' 57' ' ' GLY . 74.0 Cg_endo -77.37 136.55 15.94 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.065 . . . . 0.0 111.475 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.451 ' HB2' HD12 ' B' ' 10' ' ' LEU . 4.9 mp -133.89 130.11 37.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 m -108.83 118.72 37.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.733 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 54' ' ' ILE . 37.0 mt -107.57 126.49 63.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.115 0.483 . . . . 0.0 110.793 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -109.66 138.61 45.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.512 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.566 HG21 ' CG ' ' B' ' 30' ' ' PRO . 1.1 t -89.45 140.72 15.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.155 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.544 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -110.6 -171.5 19.74 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.136 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -112.17 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.614 -0.345 . . . . 0.0 111.642 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.11 -52.41 0.7 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 170.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -144.92 163.02 35.41 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.81 35.22 0.37 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.991 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.243 0.758 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.368 179.185 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.12 54.79 3.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.501 . . . . 0.0 110.371 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.1 ttp -160.32 110.15 1.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.119 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.52 144.19 28.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.919 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp -108.78 113.47 59.61 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.781 0.324 . . . . 0.0 110.618 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' PHE . 86.4 Cg_exo -51.85 139.25 50.35 Favored 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.502 2.801 . . . . 0.0 112.096 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.2 132.28 56.68 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.597 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -122.01 140.94 51.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.703 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 124.32 41.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.261 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.51 HD22 HG21 ' A' ' 34' ' ' VAL . 1.5 pp -141.42 157.9 44.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.249 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -119.27 127.42 53.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.368 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD11 HD21 ' B' ' 20' ' ' LEU . 65.6 mt -119.49 141.99 48.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.189 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -70.56 127.16 31.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.99 104.34 0.79 Allowed Glycine 0 N--CA 1.453 -0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.144 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.29 11.86 26.58 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.623 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.435 ' OE1' ' HG2' ' A' ' 41' ' ' GLN . 25.4 mm-40 -109.57 154.83 22.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 111.599 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 m -96.66 137.16 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.654 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 34' ' ' VAL . 74.4 m-85 -129.61 154.89 46.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.852 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.691 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.6 m170 -95.03 117.62 30.47 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.321 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' LEU . 11.9 tp -110.64 123.15 49.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.51 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 13.8 mt -131.25 126.53 59.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.339 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 p -116.56 127.9 74.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -138.54 151.09 47.01 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.181 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.0 p -108.09 135.53 49.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.762 0.315 . . . . 0.0 111.121 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -174.87 5.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -64.05 -30.78 71.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.727 0.298 . . . . 0.0 111.563 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -80.39 -24.48 39.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.59 17.96 9.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.436 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 31.1 m-80 -92.88 135.53 25.93 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' CG ' HG21 ' A' ' 56' ' ' VAL . 71.4 Cg_endo -75.07 144.08 29.6 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.522 2.148 . . . . 0.0 111.85 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.2 t -127.48 140.24 52.28 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 54' ' ' ILE . 12.6 tp -120.05 129.19 54.11 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.744 -174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 36.1 m -126.13 119.98 28.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.995 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 74.1 t -123.41 121.77 63.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.5 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.12 129.66 24.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.445 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.46 137.04 75.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.545 2.163 . . . . 0.0 112.16 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.0 t -68.94 -21.05 64.22 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.431 0.634 . . . . 0.0 109.998 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -140.29 103.24 6.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -11.71 33.0 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 122.541 2.161 . . . . 0.0 112.728 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -86.95 -27.67 23.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.033 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HG2' ' OE1' ' A' ' 16' ' ' GLN . 1.2 mp0 -69.41 -23.78 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.283 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.85 -33.26 75.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.442 0.639 . . . . 0.0 109.672 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -85.21 -42.23 14.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.668 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.16 55.27 2.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.9 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 p -78.88 94.84 5.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.402 0.62 . . . . 0.0 112.075 -174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.13 -10.99 51.37 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.6 p -101.94 132.55 21.48 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.229 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.86 160.07 48.83 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 48.1 mt -92.91 120.15 32.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.111 0.481 . . . . 0.0 111.082 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 52' ' ' LEU . 80.8 mt -91.13 127.94 49.46 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.001 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.28 134.86 19.71 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.109 1.873 . . . . 0.0 111.739 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.0 mp -136.02 135.18 39.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.371 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.4 m -115.38 120.95 41.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.849 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' B' ' 54' ' ' ILE . 31.8 mt -108.56 129.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.43 . . . . 0.0 110.876 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 85.6 m-85 -111.56 138.75 47.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.493 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 30' ' ' PRO . 42.4 t -95.27 118.45 41.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.68 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.97 175.07 17.81 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.081 -1.533 . . . . 0.0 113.606 169.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' HA ' ' OH ' ' B' ' 9' ' ' TYR . 42.1 mt-10 -88.41 105.08 17.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.017 0.437 . . . . 0.0 110.859 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.52 -8.3 47.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.7 p -67.56 -57.25 6.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.041 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 65.21 2.68 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.635 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.835 -178.187 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.41 55.06 3.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.179 0.514 . . . . 0.0 110.323 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 53.5 ttp -160.5 109.66 1.7 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.124 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -84.15 144.08 29.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.075 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . . . . . . . . . 80.6 mtp -108.56 113.22 60.22 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.564 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' B' ' 55' ' ' PHE . 88.9 Cg_exo -51.86 139.15 50.66 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 C-N-CA 123.439 2.76 . . . . 0.0 112.248 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -117.36 132.18 56.64 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.709 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.9 140.8 51.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.631 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.402 ' OH ' ' HA ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -124.57 123.98 41.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.294 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.531 HD22 HG21 ' B' ' 34' ' ' VAL . 1.6 pp -141.12 158.09 44.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.18 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -119.91 127.09 52.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.134 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 20' ' ' LEU . 65.8 mt -119.43 141.74 48.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.189 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -70.31 127.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.62 104.13 0.73 Allowed Glycine 0 N--CA 1.453 -0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.159 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 11.74 26.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.676 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.42 ' OE1' ' HG2' ' B' ' 41' ' ' GLN . 26.3 mm-40 -109.53 155.14 21.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -97.18 137.07 36.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' B' ' 34' ' ' VAL . 73.3 m-85 -129.61 154.85 46.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.789 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.688 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 5.6 m170 -95.19 117.56 30.44 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.256 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.503 HD11 HD11 ' B' ' 32' ' ' LEU . 11.7 tp -110.35 123.11 49.25 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.489 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' B' ' 33' ' ' SER . 13.6 mt -131.26 126.46 58.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.47 127.84 73.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -138.81 151.24 46.87 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.4 p -108.1 136.07 48.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.968 0.413 . . . . 0.0 111.041 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.31 -175.03 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.48 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 12.2 m -63.79 -30.57 71.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.714 0.292 . . . . 0.0 111.52 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.55 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 41.7 mt -80.63 -24.3 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 111.265 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.19 18.22 9.42 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.474 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.55 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 30.0 m-80 -92.76 135.43 26.23 Favored Pre-proline 0 CA--C 1.511 -0.548 0 CA-C-O 121.028 0.442 . . . . 0.0 109.841 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.438 ' CG ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -75.04 143.98 29.58 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.499 2.132 . . . . 0.0 111.858 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -127.61 140.28 52.2 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.591 HD21 HD12 ' B' ' 54' ' ' ILE . 12.6 tp -119.62 129.75 54.76 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.768 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' B' ' 21' ' ' ILE . 38.6 m -126.47 120.04 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.751 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 74.9 t -123.71 121.48 62.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 0.0 110.419 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.89 129.75 24.47 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 -176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 136.62 71.99 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 0.0 112.196 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 16.4 t -68.25 -21.68 64.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.155 0.503 . . . . 0.0 109.789 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -139.81 103.46 6.93 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.938 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.6 -12.22 34.94 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.694 2.262 . . . . 0.0 112.601 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -86.43 -27.7 23.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.103 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.42 ' HG2' ' OE1' ' B' ' 16' ' ' GLN . 1.2 mp0 -69.38 -24.0 63.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 175.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -63.62 -33.51 75.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.773 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -85.03 -42.06 15.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.787 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.3 mt -92.31 55.37 2.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.037 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p -78.92 95.02 5.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.126 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.89 -10.08 51.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 3.0 p -102.22 132.46 21.46 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.157 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.85 160.07 48.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.841 2.361 . . . . 0.0 111.802 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.53 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 47.4 mt -93.17 120.06 33.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.933 0.397 . . . . 0.0 111.202 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.503 ' O ' HD12 ' B' ' 52' ' ' LEU . 81.3 mt -91.08 128.02 49.25 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.25 134.98 19.93 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.125 1.883 . . . . 0.0 111.784 175.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.503 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.0 mp -136.19 134.77 38.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.518 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.3 m -115.01 120.97 41.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.011 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.807 HG12 HG12 ' A' ' 54' ' ' ILE . 30.4 mt -108.56 129.44 63.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.812 0.339 . . . . 0.0 110.769 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.8 m-85 -111.27 138.52 47.63 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.779 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' B' ' 30' ' ' PRO . 41.7 t -95.26 118.44 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.819 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 175.35 18.02 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 119.119 -1.515 . . . . 0.0 113.583 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -89.04 104.89 17.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -91.22 -7.93 49.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 8.1 p -67.8 -57.03 6.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.07 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.29 2.34 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.582 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.008 -177.875 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.14 -57.43 1.09 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.871 0.367 . . . . 0.0 110.701 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp -133.01 150.62 52.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.09 137.84 41.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.435 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 18.8 ptp -125.69 141.42 39.12 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.335 0.588 . . . . 0.0 111.066 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' A' ' 56' ' ' VAL . 2.8 Cg_exo -68.88 135.52 32.83 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.917 2.411 . . . . 0.0 111.569 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 m -113.85 148.73 36.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.158 -172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -123.47 140.09 53.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.878 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -127.12 123.78 37.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 52' ' ' LEU . 2.1 pp -140.62 158.62 43.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.85 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -122.23 128.46 51.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.686 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.449 HD11 HD21 ' B' ' 20' ' ' LEU . 50.0 mt -123.01 140.5 52.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.235 -175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . 98.2 m-70 -72.05 132.11 43.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.99 108.03 1.57 Allowed Glycine 0 CA--C 1.516 0.142 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.792 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.84 -8.32 42.71 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.595 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -84.16 147.03 27.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.825 0.345 . . . . 0.0 110.255 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 4.4 m -96.22 136.3 36.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.309 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.1 m-85 -129.7 153.09 48.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.313 0.578 . . . . 0.0 111.158 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.4 m80 -95.82 117.64 30.94 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.736 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 32' ' ' LEU . 9.7 tp -107.98 123.32 48.47 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.508 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.65 126.43 54.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.327 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.64 133.69 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -147.17 159.82 43.17 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -116.13 140.69 49.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.87 0.366 . . . . 0.0 110.765 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 29' ' ' ASN . 23.3 p30 -81.3 -174.98 5.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.98 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -62.15 -28.89 69.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.74 0.305 . . . . 0.0 111.401 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.574 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 44.9 mt -82.82 -23.67 33.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 110.64 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.53 19.71 10.21 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.916 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.574 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 34.4 m-80 -87.57 131.0 45.12 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG3' HG11 ' A' ' 56' ' ' VAL . 58.0 Cg_endo -74.42 144.25 32.25 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.277 1.985 . . . . 0.0 112.093 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.6 t -130.06 140.18 50.87 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 20' ' ' LEU . 13.0 tp -122.97 130.09 52.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.905 0.383 . . . . 0.0 110.734 -174.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m -127.29 120.69 29.21 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.977 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 72.8 t -123.67 121.77 63.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.087 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.87 132.3 24.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.97 133.57 42.06 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.127 1.885 . . . . 0.0 111.713 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 50.5 m -73.41 -27.8 61.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.458 . . . . 0.0 110.248 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -121.32 103.57 41.62 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.35 -25.49 42.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.728 2.286 . . . . 0.0 112.86 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -81.75 -16.13 52.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.268 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -73.21 -26.15 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.031 0.443 . . . . 0.0 110.318 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.36 -43.21 13.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.435 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.42 58.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.926 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -83.89 91.1 7.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -85.64 -7.41 58.84 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.42 131.91 22.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.843 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.01 155.26 71.62 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.977 2.451 . . . . 0.0 112.173 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 28.9 mt -91.04 120.05 31.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.09 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 70.6 mt -91.5 129.25 43.57 Favored Pre-proline 0 C--N 1.316 -0.889 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HG2' ' HA3' ' B' ' 57' ' ' GLY . 44.0 Cg_endo -86.99 136.92 4.34 Favored 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 122.393 2.062 . . . . 0.0 110.953 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 10' ' ' LEU . 5.2 mp -130.8 128.72 41.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.769 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -106.22 115.87 30.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.586 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' B' ' 54' ' ' ILE . 27.9 mt -108.38 126.05 65.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.146 0.498 . . . . 0.0 110.862 -176.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -110.27 139.7 45.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.243 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' A' ' 6' ' ' PRO . 12.2 p -87.37 142.78 12.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.197 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.569 ' HA3' ' HG2' ' B' ' 51' ' ' PRO . . . -102.53 -167.21 26.48 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.301 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' H ' ' A' ' 59' ' ' ASN . 1.2 pp20? -108.97 -160.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.795 0.331 . . . . 0.0 111.474 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.41 ' H ' ' HB2' ' A' ' 58' ' ' GLU . 25.4 t-20 -44.72 -43.21 8.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.175 -175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 p 43.26 52.49 5.65 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.118 0.485 . . . . 0.0 112.172 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.27 109.19 3.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.621 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 119.215 -0.422 . . . . 0.0 109.904 176.466 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.48 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.08 -56.9 1.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.877 0.37 . . . . 0.0 110.755 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 84.4 mtp -133.35 150.73 51.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.277 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.31 137.36 41.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.485 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 19.0 ptp -125.23 141.77 39.6 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.409 0.623 . . . . 0.0 111.163 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.59 ' HD2' ' CG1' ' B' ' 56' ' ' VAL . 2.8 Cg_exo -69.43 135.44 31.26 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.744 2.296 . . . . 0.0 111.707 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 m -113.86 148.51 36.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.253 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -123.26 140.3 53.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.893 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -127.31 123.62 36.78 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' B' ' 52' ' ' LEU . 2.0 pp -140.56 158.78 43.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -122.57 128.53 50.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.801 0.334 . . . . 0.0 110.591 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' A' ' 20' ' ' LEU . 49.9 mt -123.1 140.54 52.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.283 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.55 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . 98.2 m-70 -71.99 131.97 43.65 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.71 107.71 1.4 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.883 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.89 -8.22 42.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.714 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -84.05 147.23 27.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.539 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 4.1 m -96.4 136.22 37.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.283 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' B' ' 34' ' ' VAL . 92.6 m-85 -129.69 153.21 48.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.113 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.663 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.4 m80 -95.78 117.74 31.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.659 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 32' ' ' LEU . 9.7 tp -108.11 123.27 48.45 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.431 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 mt -132.57 126.51 55.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.172 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 133.34 66.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.54 160.96 41.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 140.21 49.8 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.917 0.389 . . . . 0.0 110.482 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' B' ' 29' ' ' ASN . 21.1 p30 -81.2 -175.41 5.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.832 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 22.2 t -61.24 -29.59 69.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.775 0.321 . . . . 0.0 111.505 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.573 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 45.5 mt -82.63 -23.9 34.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.179 0.514 . . . . 0.0 110.463 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.0 10.49 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.048 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 34.2 m-80 -86.95 130.92 46.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.494 ' HG3' HG11 ' B' ' 56' ' ' VAL . 57.9 Cg_endo -74.09 144.36 33.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.313 2.009 . . . . 0.0 112.174 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 41.6 t -130.3 140.02 50.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.533 HD11 HD11 ' B' ' 20' ' ' LEU . 13.0 tp -122.77 130.33 52.78 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.907 0.384 . . . . 0.0 110.543 -174.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m -127.58 120.73 28.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.056 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 75.6 t -123.78 121.52 62.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.331 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mt -122.73 132.38 24.28 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.744 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -63.07 133.45 41.17 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.082 1.855 . . . . 0.0 111.688 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 50.5 m -73.35 -27.9 61.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.157 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -121.29 103.65 41.6 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.56 -25.3 41.06 Favored 'Trans proline' 0 N--CA 1.466 -0.117 0 C-N-CA 122.803 2.336 . . . . 0.0 112.879 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -81.78 -16.03 52.31 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.331 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -73.2 -26.04 61.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.077 0.465 . . . . 0.0 110.517 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -70.12 -27.68 64.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.33 -43.25 13.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.319 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -99.48 58.33 1.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.919 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . 0.404 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 15.2 m -84.07 91.78 7.73 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.287 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.4 -7.24 58.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.672 0.749 . . . . 0.0 109.035 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -101.36 132.3 22.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.775 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.15 155.4 70.85 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.818 2.345 . . . . 0.0 112.124 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 29.7 mt -90.96 119.98 31.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.296 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 71.6 mt -91.51 129.21 43.7 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 43.4 Cg_endo -87.25 136.96 4.19 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.373 2.049 . . . . 0.0 110.912 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.482 ' HB2' HD12 ' B' ' 10' ' ' LEU . 5.2 mp -130.52 128.81 41.91 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.74 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.5 m -106.29 115.97 31.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.649 HG12 HG12 ' A' ' 54' ' ' ILE . 27.5 mt -108.5 126.4 65.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -110.57 139.62 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.116 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.59 ' CG1' ' HD2' ' B' ' 6' ' ' PRO . 11.8 p -87.35 142.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.132 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.559 ' HA3' ' HG2' ' A' ' 51' ' ' PRO . . . -102.83 -167.22 26.17 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.288 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' B' ' 59' ' ' ASN . 1.1 pp20? -108.83 -159.93 0.7 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.741 0.305 . . . . 0.0 111.505 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' B' ' 58' ' ' GLU . 25.6 t-20 -44.99 -42.92 8.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.226 -174.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 6.6 p 43.23 51.93 5.68 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.91 109.46 3.63 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.685 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.246 0.905 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.025 176.864 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.54 74.44 9.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.21 0.529 . . . . 0.0 110.995 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptm -140.25 147.95 40.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.019 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -96.9 146.36 25.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.373 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 18.3 ptp -115.66 141.11 26.92 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.782 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 56' ' ' VAL . 30.6 Cg_exo -42.75 130.98 5.55 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.786 2.99 . . . . 0.0 113.414 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -118.07 132.45 56.36 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.246 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.87 140.07 53.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.421 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -124.82 123.77 40.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.08 157.92 44.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.748 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 49' ' ' LEU . . . -120.37 128.35 53.15 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.001 0.429 . . . . 0.0 110.095 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.453 HD11 HD21 ' B' ' 20' ' ' LEU . 60.0 mt -117.2 141.21 48.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.626 -174.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.53 ' CE1' ' HB3' ' A' ' 45' ' ' SER . 97.2 m-70 -70.7 127.58 33.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.43 115.7 7.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.533 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.78 -0.74 65.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.631 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -85.73 151.62 23.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.946 0.403 . . . . 0.0 110.608 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 37' ' ' SER . 3.0 m -102.03 135.65 43.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.579 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 34' ' ' VAL . 77.9 m-85 -128.59 154.04 46.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.266 0.555 . . . . 0.0 111.03 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.6 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 2.6 m170 -95.42 116.98 29.54 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 173.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD11 HD11 ' A' ' 32' ' ' LEU . 15.7 tp -106.36 122.48 46.33 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.378 -176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.58 126.36 54.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.315 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.58 139.82 38.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.48 171.21 16.96 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -123.02 135.2 54.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.048 0.451 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -178.24 4.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.401 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 m -60.46 -31.09 70.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.8 0.333 . . . . 0.0 111.621 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 42.2 mt -81.81 -23.94 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.682 0.277 . . . . 0.0 111.292 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.84 13.12 12.98 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.384 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 27' ' ' LEU . 36.0 m-80 -91.63 141.9 26.23 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.576 ' CB ' HG21 ' A' ' 56' ' ' VAL . 74.2 Cg_endo -72.06 147.25 48.39 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.803 2.335 . . . . 0.0 112.329 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.2 t -128.23 141.17 51.54 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 54' ' ' ILE . 15.5 tp -120.73 129.98 53.86 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.619 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -126.17 125.94 43.28 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 55.4 t -127.24 121.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.824 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mt -124.54 129.2 24.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.463 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 20.4 Cg_endo -60.91 133.74 49.33 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.442 2.095 . . . . 0.0 111.951 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 42.1 m -75.81 -22.35 56.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.2 0.524 . . . . 0.0 109.713 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -130.09 102.47 17.4 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.451 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.49 -13.93 30.47 Favored 'Trans proline' 0 CA--C 1.527 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.801 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -76.88 -31.85 57.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.597 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.92 -19.74 60.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.949 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 36' ' ' PRO . 74.9 mm-40 -69.61 -34.59 74.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.044 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.575 ' HG3' ' HG ' ' A' ' 44' ' ' LEU . 3.9 pt20 -87.02 -42.21 13.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 174.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' A' ' 43' ' ' GLN . 19.4 mt -97.13 60.87 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB3' ' CE1' ' A' ' 13' ' ' HIS . 5.1 m -83.42 85.88 7.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.143 -172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.93 -3.59 58.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.732 0.777 . . . . 0.0 108.992 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.9 128.74 28.94 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.69 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.56 157.19 62.86 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.84 2.36 . . . . 0.0 112.67 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 62.1 mt -98.85 126.07 44.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.432 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.453 ' O ' HD12 ' A' ' 52' ' ' LEU . 78.7 mt -99.87 127.75 32.91 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 169.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' B' ' 59' ' ' ASN . 70.6 Cg_endo -76.42 136.43 17.6 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.857 1.705 . . . . 0.0 111.754 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 50' ' ' ILE . 5.4 mp -131.13 133.39 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.967 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -110.0 118.49 36.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.697 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' B' ' 54' ' ' ILE . 28.4 mt -106.91 125.79 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.918 0.39 . . . . 0.0 110.729 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 86.7 m-85 -111.17 134.97 52.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.083 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG21 ' CB ' ' A' ' 30' ' ' PRO . 1.5 t -84.54 131.69 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.04 150.5 25.03 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.906 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -91.34 11.26 24.27 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.207 1.003 . . . . 0.0 108.889 175.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.648 ' HB3' ' HG3' ' B' ' 51' ' ' PRO . 61.3 t30 -80.81 73.32 7.81 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.041 -172.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 p -91.79 2.99 56.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.787 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.81 132.12 3.27 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.525 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.438 -0.792 . . . . 0.0 109.974 -179.594 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.03 74.23 9.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.017 0.437 . . . . 0.0 111.063 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptm -140.14 147.62 40.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.015 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -96.4 146.94 24.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.367 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' B' ' 56' ' ' VAL . 18.5 ptp -115.84 141.29 27.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.901 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.562 ' HB2' ' HB ' ' B' ' 56' ' ' VAL . 33.6 Cg_exo -43.12 130.75 6.15 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.645 2.897 . . . . 0.0 113.513 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -117.73 132.52 56.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 112.239 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.93 140.41 53.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.382 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -125.36 123.6 39.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' B' ' 52' ' ' LEU . 1.4 pp -141.16 158.14 44.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 49' ' ' LEU . . . -120.78 128.31 52.77 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 20' ' ' LEU . 61.3 mt -117.3 141.31 48.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.502 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' B' ' 45' ' ' SER . 97.2 m-70 -70.58 127.63 33.35 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 115.47 7.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.432 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.99 -0.72 64.57 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.759 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' B' ' 13' ' ' HIS . 0.0 OUTLIER -85.84 151.88 23.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.057 0.456 . . . . 0.0 110.639 178.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' B' ' 37' ' ' SER . 3.0 m -102.14 135.55 43.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.629 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' TYR . . . . . 0.508 ' HB3' HG13 ' B' ' 34' ' ' VAL . 78.2 m-85 -128.65 154.05 46.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.351 0.596 . . . . 0.0 110.96 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' B' ' 34' ' ' VAL . 2.7 m170 -95.38 116.79 29.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.463 HD11 HD11 ' B' ' 32' ' ' LEU . 15.9 tp -106.24 122.47 46.29 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.342 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 13.8 mt -132.56 126.13 54.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.438 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.4 140.06 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -149.38 171.57 16.33 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 3.5 p -124.03 134.33 53.46 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.43 -177.76 4.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.472 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 10.7 m -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.765 0.316 . . . . 0.0 111.554 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.474 ' HB2' ' ND2' ' B' ' 29' ' ' ASN . 43.0 mt -81.68 -24.29 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.275 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.15 13.06 12.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.54 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' B' ' 27' ' ' LEU . 36.3 m-80 -91.41 141.92 26.5 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.577 ' CB ' HG21 ' B' ' 56' ' ' VAL . 72.6 Cg_endo -72.0 147.2 48.66 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.642 2.228 . . . . 0.0 112.321 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -127.95 141.18 51.61 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.575 HD21 HD12 ' B' ' 54' ' ' ILE . 15.4 tp -120.91 129.37 53.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.033 0.444 . . . . 0.0 110.819 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -125.91 125.64 43.11 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.508 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' B' ' 19' ' ' HIS . 54.6 t -127.22 121.23 57.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.859 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mt -124.61 129.22 24.71 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.477 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.469 ' HG3' ' HG3' ' B' ' 42' ' ' GLU . 20.2 Cg_endo -60.82 134.08 51.61 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.447 2.098 . . . . 0.0 111.821 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.484 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 37.2 m -75.93 -22.5 55.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.379 0.609 . . . . 0.0 109.689 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.98 102.45 17.58 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.577 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.6 -13.9 30.16 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.727 2.284 . . . . 0.0 112.672 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -76.8 -32.12 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.521 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -73.55 -19.98 60.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.953 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' B' ' 36' ' ' PRO . 76.2 mm-40 -69.58 -34.32 73.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.967 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.584 ' HG3' ' HG ' ' B' ' 44' ' ' LEU . 3.9 pt20 -87.29 -41.9 13.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.575 174.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HG ' ' HG3' ' B' ' 43' ' ' GLN . 19.7 mt -97.42 60.36 1.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.788 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' B' ' 13' ' ' HIS . 5.2 m -83.04 85.85 7.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.281 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.56 -3.86 58.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.904 0.859 . . . . 0.0 108.919 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -100.72 128.6 29.52 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.711 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.75 157.37 62.14 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.873 2.382 . . . . 0.0 112.551 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB3' ' HB1' ' B' ' 11' ' ' ALA . 61.9 mt -99.43 125.18 45.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.514 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.462 ' O ' HD12 ' B' ' 52' ' ' LEU . 79.0 mt -99.13 127.42 34.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.648 ' HG3' ' HB3' ' A' ' 59' ' ' ASN . 67.9 Cg_endo -76.12 136.45 18.21 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.782 1.655 . . . . 0.0 111.702 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.462 HD12 ' O ' ' B' ' 50' ' ' ILE . 5.4 mp -131.15 133.36 45.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.131 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -109.87 118.44 36.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.672 HG12 HG12 ' A' ' 54' ' ' ILE . 28.3 mt -106.93 125.95 62.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.083 0.468 . . . . 0.0 110.696 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' B' ' 6' ' ' PRO . 86.6 m-85 -111.29 134.89 52.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.072 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.577 HG21 ' CB ' ' B' ' 30' ' ' PRO . 1.5 t -84.59 131.47 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.66 150.24 25.27 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.021 -1.085 . . . . 0.0 112.927 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -91.2 11.48 23.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 122.069 0.938 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.663 ' HB3' ' HG3' ' A' ' 51' ' ' PRO . 61.1 t30 -80.96 73.8 7.98 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.084 -172.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 7.9 p -92.16 3.27 55.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.727 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.0 131.72 3.12 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.487 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.153 -0.927 . . . . 0.0 109.754 -179.407 . . . . . . . . 0 0 . 1 stop_ save_